pyrimethamine has been researched along with fanasil, pyrimethamine drug combination in 1505 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 192 (12.76) | 18.7374 |
| 1990's | 119 (7.91) | 18.2507 |
| 2000's | 584 (38.80) | 29.6817 |
| 2010's | 503 (33.42) | 24.3611 |
| 2020's | 107 (7.11) | 2.80 |
| Authors | Studies |
|---|---|
| Garber, G; Thind, J | 1 |
| Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
| Bunnag, D; Chindanond, D; Chittamas, S; Fernex, M; Harinasuta, T; Kristiansen, S; Malikul, S; Mittelholzer, ML; Sturchler, D | 1 |
| Adio, RA; Dickschat, U; Mittelholzer, ML; Reber-Liske, R; Salako, LA; Sowunmi, A; Stürchler, D; Walker, O | 1 |
| Gottschalk, J; Grünewald, T; Jautzke, G; Köppen, S; Pohle, HD; Ruf, B | 1 |
| Choisy, H; Dorangeon, PH; Fay, R; Leroux, B; Marx-Chemla, C; Pinon, JM; Quereux, C; Wahl, P | 1 |
| Nzala, S; Puta, C; Sijumbila, G | 1 |
| Ameh, JO; Daniel, HI; Gadzama, NM; Molta, NB; Oguche, SO; Otu, TI; Watila, IM | 1 |
| Marsh, K; Mberu, E; Mwangi, IN; Nevill, C; Newton, CR; Warn, PA; Warrell, DA; Waruiru, CM; Watkins, WM; Winstanley, PA | 1 |
| Salako, LA; Sowunmi, A | 1 |
| Hardy, WD | 2 |
| Bateman, NT; O'Doherty, MJ | 1 |
| Shanks, GD; Watt, G | 1 |
| Hioki, A; Ohtomo, H | 1 |
| Irare, SG; Lemnge, MM; Mhina, JI | 1 |
| Carme, B | 1 |
| Baird, JK; Bangs, MJ; Basri, H; Jones, TR; Ritonga, A | 1 |
| Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
| Nevill, CG; Watkins, WM | 1 |
| Gozal, D; Hengy, C | 1 |
| Holdener, F; Nurminen, L; Steffen, R; Wyss, R | 1 |
| Baird, JK; Jones, TR; Leksana, B; Masbar, S; Ratiwayanto, S | 1 |
| Gardner, A; Nevill, CG | 1 |
| Domínguez-Corrales, MV; Regordan, C; Sánchez-Porto, A | 1 |
| Phillips-Howard, PA; West, LJ | 1 |
| Krzeminska, EC; Tanner, NS; Ward, DJ | 1 |
| Pleyer, U; Richter, U; Steuhl, KP; Thiel, HJ; Zierhut, M | 1 |
| Hall, AP; Malin, AS | 1 |
| Eberlé, F; Gazin, P; Gelas, H; Hengy, C; Jambou, R; Kouka-Bemba, D | 1 |
| Bjorkman, AB; Phillips-Howard, PA | 1 |
| Meier, P; Schmid, M; Stäubli, M | 1 |
| Fasunon, OD; Uwaifo, AO | 1 |
| Behrens, RH; Dunlop, J; Phillips-Howard, PA | 1 |
| Doi, H; Ishii, A; Kaneko, A; Panjaitan, W | 1 |
| Hansford, CF | 1 |
| Comte, P; Le Bras, M; Verin, P | 1 |
| Berg, PA; Daniel, PT; Holzschuh, J | 1 |
| Ndumbe, PM | 1 |
| Davis, R; Ellis-Pegler, RB; Ingram, RJ | 1 |
| Newbold, CI; Pasvol, G; Peto, TE | 1 |
| Arnold, K | 1 |
| Bunnag, D; Harinasuta, T; Lasserre, R; Leimer, R; Vinijanont, S | 1 |
| Lobel, HO; Miller, KD; Navin, TR; Satriale, RF | 1 |
| Gottlieb, MS; Young, LS | 1 |
| Hall, AP; Tjokrosonto, S; Warhurst, DC | 1 |
| Campbell, JR; Dimpudus, AJ; Harun, S; Heizmann, P; Hoffman, SL; Marwoto, HA; Oetomo, HS; Punjabi, NH; Rustama, D; Sukri, N | 1 |
| Campbell, CC; Lobel, HO; Miller, KD; Papaioanou, M; Rombo, L; Stenbeck, J | 1 |
| Somaini, B; Steffen, R | 1 |
| Lindberg, J; Malmvall, BE; Norkrans, G; Wejstal, R | 1 |
| Keschamrus, N; Kölle, EU; Leimer, R; Noeypatimanond, S; Sarikabhuti, B; Weidekamm, E; Wernsdorfer, W | 1 |
| Hönigsmann, H; Ortel, B; Sivayathorn, A | 1 |
| Barrington, P; Harper, JI; Langtry, JA; Staughton, RC | 1 |
| Heusser, R; Steffen, R | 1 |
| Campbell, CC; Kuritsky, JN; Lobel, HO; Miller, KD; Satriale, RF; Stern, R | 1 |
| Kollisch, DO | 1 |
| Alexander, J; Howrie, DL; Kuritsky, JN; Miller, KD; Perez, TH; Taylor, S; Van Thiel, DH; Zitelli, BJ | 1 |
| Fernandez, E; Lyn, PC | 1 |
| Elsås, T; Hallan, H | 1 |
| Berg, B; Carlson, J; Hellgren, U; Rombo, L; Wiholm, BE | 1 |
| Raeber, PA; Ruedi, B | 1 |
| Druilhe, P; Gentilini, M; Stahel, E | 1 |
| Birk, O; Golinski, M; Sack, J | 1 |
| Fernex, M | 2 |
| Dastych, P; Giboda, M; Vanista, J | 1 |
| Beltzner, B; Kupferschmidt, HG; Schröder, K | 1 |
| Beeching, NJ; Eales, M; Ellis-Pegler, RB; Fraser, AG; Wells, AU | 1 |
| Buranasin, P; Harinasuta, T; Viravan, C | 1 |
| Cai, XZ; Fu, SG; Huang, JK; Huang, QL; Huang, XF; Pan, XJ; Quyang, WC; Wu, Z; Zhang, KY; Zhou, JX | 1 |
| Rolfe, M | 1 |
| Jeffrey, RF | 1 |
| Bröker, HJ; Gersch, K; Mörl, H; Waldherr, R | 1 |
| Ladusans, EJ; Selby, CD; Smith, PG | 1 |
| Danner, SA; Eeftinck Schattenkerk, JK; Frissen, PH; Stronkhorst, A | 1 |
| Dinan, WA; Pablos-Mendez, A; Palagiano, A; Raviglione, MC; Sabatini, MT | 1 |
| Burchard, GD; Winkler, E | 1 |
| Beltzner, BE; Kupferschmidt, HG; Schröder, K | 1 |
| Petersen, E | 1 |
| Campbell, J; Dimpudus, AJ; Hoffman, SL; Marwoto, H; Rusch, J; Rustama, D; Surumpaet, B | 1 |
| Biddulph, J | 2 |
| Rieckmann, K; Rooney, W; Suebsaeng, L | 1 |
| Ekue, JM; Mukunyandela, M; Phiri, DE; Sheth, UK | 1 |
| Assefa, T | 1 |
| Chiodini, PL | 1 |
| Laughlin, LW; Padre, LP; Tuazon, LR; Watt, G | 1 |
| Charmot, G; Le Bras, J; Simon, F | 1 |
| Brandicourt, O; Brasseur, P; Brucker, G; Danis, M; Datry, A; Druilhe, P; Duflo, B; Gentilini, M; Rosenheim, M | 1 |
| Buregea, H; Cibanguka, J; Delacollette, C; Nkera, J | 1 |
| Dixon, PA; Makanjuola, RO; Oforah, E | 1 |
| Dickinson, GM; Fischl, MA | 1 |
| Dubach, VC; Forgo, I; Ranalder, VB; Schwartz, DE; Weber, B; Weidekamm, E | 1 |
| Bath, PM; Lillicrap, DA; Winter, M | 1 |
| Fox, E; Hassan, H; Khaliq, AA; Pervez, M; Sarwar, M; Strickland, GT | 1 |
| Bentzon, MW; Bygbjerg, IC; Flachs, H; Jepsen, S; Schapira, A | 1 |
| Fox, E; Khaliq, AA; Macdonald, M; Sarwar, M; Strickland, GT | 1 |
| Afshar, A; Edrissian, GH; Emadi, AM; Ghorbani, M; Hajseyed-Javadi, J; Khaleghian, B; Pishva, E; Saghari, H; Shahabi, S | 1 |
| Mravak, S; Trautmann, M; Weinke, T | 1 |
| Cook, GC | 1 |
| Churchill, FC; Lobel, HO; Miller, KD; Pappaioanou, M; Patchen, LC | 1 |
| Dallas, AB; Mutambu, SL; Okwanga, PN; Pfumojena, JW | 1 |
| Bhattacharya, DN; Hall, AP | 1 |
| Ebisawa, I; Ohara, H | 1 |
| Björkman, A; Willcox, M | 1 |
| Hewlett, EL; Pearson, RD | 1 |
| Lobel, HO; Roberts, JM; Somaini, B; Steffen, R | 1 |
| McMeeking, AA | 1 |
| Edstein, MD | 1 |
| Dubach, UC; Schwartz, DE; Weber, B; Weidekamm, E | 1 |
| Groth, H; Rhyner, K; Vetter, W | 1 |
| McCormack, D; Morgan, WK | 1 |
| Bamber, MG; Elder, AT; Gray, JA; Minns, RA | 1 |
| Bergqvist, Y; Lindberg, A; Rombo, L | 1 |
| Lenox-Smith, I | 1 |
| Brossier, N; Garin, JP; Moyne, T; Tran Manh Sung, R | 1 |
| Glasner, H; Landscheidt, H; Niklewski, G | 1 |
| Arias, AE; Cortes, GT; Espinal, CA; Guerra, P | 1 |
| Ainsworth, B; Breman, JG; Patchen, LC; Teklehaimanot, A; Wolfe, MS | 1 |
| Attanath, P; Chongsuphajaisiddhi, T; Doberstyn, EB; Kanjanapipatkul, K; Sabchareon, A; Suebsaeng, L | 1 |
| de Oliveira, RM; de Souza, JM; de Souza, SD; Roulet, H; Sheth, UK | 1 |
| Cavalcante, EQ; de Oliveira, RM; de Souza, JM; Gomes, AT; Sheth, UK | 1 |
| Beale, GH; Thaithong, S | 1 |
| Giboda, M | 1 |
| Kissane, D | 1 |
| Kilimali, VA; Mkufya, AR | 1 |
| Botero, D; Montoya, A; Restrepo, M | 1 |
| Ahlqvist, J | 1 |
| Danis, M; Gentilini, M | 1 |
| Bradley, DJ; Hall, AP; Peters, W; Warhurst, D | 1 |
| Murphy, RL; Phair, JP | 1 |
| Olsen, VV | 1 |
| Adams, SJ; Broadbent, J; Clayden, LM; Ridley, CM | 1 |
| Lazar, HP; Murphy, RL; Phair, JP | 1 |
| Bernard, KW; Fishbein, DB; Johnson, BK; Miller, KD; Oster, CN; Parker, RA; Reid, FL; Rollins, AJ; Sumner, JW; Waterman, S | 1 |
| Hemmer, R | 1 |
| Buser, P; Räber, J | 1 |
| Claréus, BW; Hammar, H | 1 |
| Granz, W; Kupferschmidt, HG; Schubert, S | 1 |
| Wolfensberger, HR | 1 |
| Aalpers, M; Darlow, B; Heywood, P; Stace, J; Vrbova, H | 1 |
| Nurse, GT | 1 |
| Campbell, CC; Hurwitz, ES; Johnson, D | 1 |
| Brandling-Bennett, AD; Campbell, CC; Doberstyn, EB; Freeman, J; Reacher, M | 1 |
| Lelijveld, J | 1 |
| Degrémont, A; Lagler, U; Stahel, E | 1 |
| Hess, U; Jones, ME; Timmermanns, PM | 1 |
| Christensen, KD; Loft, S; Olsen, VV | 1 |
| Eichenlaub, D; Hoffmann, HG; Rogler, G; Weise, HJ | 2 |
| Hodel, C; Koch-Weser, J; Leimer, R; Styk, S | 1 |
| Boriga, DA; Kariuki, DM; Kipingor, T; Koech, DK; Sixsmith, DG; Spencer, HC; Watkins, WM | 1 |
| Gottlieb, MS; Knight, S; Mitsuyasu, R; Roth, M; Weisman, J; Young, LS | 1 |
| Aubert, B; Jaatinen, M; Kihamia, CH; Kumano, M; Magnuson, LW; McLarty, DG; Murru, M; Webber, RH | 1 |
| Arnold, K; Fu, LC; Guo, XB; Jian, HX; Li, GQ | 1 |
| Leimer, R; Stemberger, H; Wiedermann, G | 2 |
| Faber, C; Garin, JP; Maisonneuve, H; Piens, MA | 1 |
| Diesfeld, HJ; Kroeger, A | 1 |
| Hess, U; Jones, M; Timmermans, PM | 1 |
| Eastham, GM; Rieckmann, KH | 1 |
| Vestergaard Olsen, V | 1 |
| Rieckmann, KH | 1 |
| Jozefzoon, LM; Oostburg, BF | 1 |
| Ferraroni, JJ | 1 |
| Overbosch, D; Stuiver, PC; van den Wall Bake, AW; van der Kaay, HJ | 1 |
| Spracklen, FH | 1 |
| Midskov, C | 1 |
| Juma, FD | 1 |
| Ferraroni, JJ; Genaro, O | 1 |
| Turner, GD | 1 |
| Tan, HS; Tan, PE | 1 |
| Ittiravivongs, A; Kongrod, S; Vasuvat, C | 1 |
| Ellis, CJ; Herzog, C; Kibbler, CC; Mtawali, CV | 1 |
| Jaatinen, M; Kihamia, CM; McLarty, DG | 1 |
| Eyre, SJ | 1 |
| Gustafsson, L; Rombo, L; Svanbom, M | 1 |
| Kofoed, PE | 1 |
| Lorentzon, B | 1 |
| Djajadiningrat, AP; Ligthelm, RJ; Stuiver, PC; van Zwienen, J | 1 |
| Høiby, N; Kharazmi, A; Valerius, NH | 1 |
| Ferraroni, JJ; Speer, CA | 2 |
| Johnson, DE; Roendej, P; Williams, RG | 1 |
| Brockelman, CR; Tan-Ariya, P | 1 |
| Dixon, KE; Phintuyothin, P; Pitaktong, U; Pongsupat, T; Williams, RG | 1 |
| De Geus, A; Meuwissen, JH; van Rijn, A | 1 |
| Meuwissen, JH; Vleugels, MP; Wetsteyn, JC | 1 |
| Alencar, FH; Ferraroni, JJ; Shrimpton, R | 1 |
| LaBraico, JM | 1 |
| Ojewole, JA; Thompson, EB | 1 |
| Ranalder, UB; Schwartz, DE | 1 |
| Timm, U; Weidekamm, E | 1 |
| Smith, RP; Wolff, JA | 1 |
| Cooke, R; Lamont, G; Rubis, C; Wilson, M | 1 |
| Black, F; Bygbjerg, I; Effersøe, P; Gomme, G; Jensen, GA; Jepsen, S | 1 |
| Olatunde, A; Salako, LA; Walker, O | 1 |
| Davis, S; Sharp, P; Sinclair, N | 1 |
| Markwalder, KA; Meyer, HE | 1 |
| Ponnampalam, JT | 1 |
| Campbell, CC; Schwartz, IK | 1 |
| Lang, W | 1 |
| Hornstein, OP; Ruprecht, KW | 1 |
| Hölzer, E; Padelt, H | 1 |
| Khoo, KK | 1 |
| Brown, N | 1 |
| Hansen, MB; Puta, C | 1 |
| Bekobita, D; Munafu, CG; Nevill, CG; Ochen, K; Sezi, CL | 1 |
| Adagu, SI; Faji, JT; Lege-Oguntoye, L; Ogala, WN; Ogunrinde, GO; Okoyeh, JN; Sani, AH | 1 |
| Reeve, PA | 1 |
| Deacon, HE; Freese, JA; Sharp, BL | 1 |
| Kabalimu, TK; Killewo, JZ; Mnyika, KS | 1 |
| Cimino, D; Gereige, RS | 1 |
| Dua, VK; Sarin, R; Sharma, VP | 1 |
| Barreto, J; Dgedge, M; Fleck, SL; Hetzel, C; Hogh, B; Jones, I; Kruse, NA; Sinden, RE; Thompson, R | 1 |
| Al-Yaman, F; Alpers, MP; Genton, B; Mokela, D | 1 |
| Burnham, G; Kamugisha, J; Kipp, W | 1 |
| Mharakurwa, S; Mugochi, T | 2 |
| Mberu, E; Murphy, SA | 1 |
| Chatnugrob, P; Eamsila, C; Lasserre, R; Mittelholzer, ML; Nopavong Na Ayuthya, A; Singharaj, P; Stürchler, D; Webster, HK; Yooyen, P | 1 |
| Yang, H; Yang, P; Yang, Y | 1 |
| Chitsulo, L; Kazembe, P; Macheso, A; Schultz, LJ; Steketee, RW; Wirima, JJ | 1 |
| Derouin, F; Devergie, A; Foot, AB; Garin, YJ; Gluckman, E; Ribaud, P | 1 |
| Ajuyah, CO; Obasohan, AO; Ukoh, V | 1 |
| Angel, VH; Friman, G; Hellgren, U; Mittelholzer, ML; Rombo, L; Stürchler, D | 1 |
| Bálint, GS | 1 |
| Alvar, J; Amela, C; Ayecaba, S; Benito, A; Molina, R; Roche, J | 1 |
| Bergmann, F; Gottschalk, HJ; Grünewald, T; Pohle, HD; Ruf, B; Schüler-Maué, W; Schürmann, D; Witt, H | 1 |
| Kerr, L; Mittelholzer, ML; Stürchler, D | 1 |
| Mharakurwa, S | 1 |
| Bienzle, U; Graninger, W; Kremsner, PG; Metzger, W; Mordmüller, B | 1 |
| Chitsulo, L; Kazembe, P; Kumwenda, N; Nwanyanwu, OC; Redd, SC; Wirima, JJ; Ziba, C | 1 |
| Drakeley, C; Greenwood, B; Jaffar, S; Joof, D; Müller, O; Okorie, C; Pinder, M; van Hensbroek, MB | 1 |
| Anabwani, GM; Esamai, FO; Menya, DA | 1 |
| Havlíková, M; Michalová, K; Ríhová, E | 1 |
| Corrah, PT; de Veer, GE; Giadom, B; Greenwood, BM; Jaffar, S; van Hensbroek, MB | 1 |
| Bakker, DA; Docters van Leeuwen, B; Eggelte, TA; Henry, MC; Kluin, J; Watson, P | 1 |
| Diop, S; Djimde, A; Doumbo, OK; Kouriba, B; Plowe, CV; Wellems, TE | 1 |
| Alene, GD; Bennett, S | 1 |
| Kagawa, T; Matsuzaki, S; Nakano, A; Nishizaki, Y; Okazaki, Y; Uchiyama, J; Watanabe, N | 1 |
| Hyde, JE; Read, M; Sims, PF; Wang, P | 1 |
| Oduola, AM; Sowunmi, A | 2 |
| Gunasekera, DP; Perera, DP | 1 |
| Mboera, LE; Ndawi, BT; Wakibara, JV | 1 |
| Magnussen, P; Ndyomugyenyi, R | 2 |
| Garg, MR; Gogtay, NJ; Kshirsagar, NA | 1 |
| Hyde, JE; Sims, PF; Wang, P | 1 |
| Burger, M; Edoh, D; Jenkins, J; Mshinda, H | 1 |
| Ansaloni, L; Falaschi, F | 1 |
| Bayoumi, R; Dao, LD; Djimde, A; Doumbo, O; Hyde, JE; Lee, CS; Mshinda, H; Sims, PF; Swedberg, G; Tanner, M; Wang, P; Watkins, WM | 1 |
| Falade, CO; Fehintola, FA; Kyle, DE; Makler, MT; Milhous, WK; Oduola, AM; Ogundahunsi, OA; Omitowoju, GO; Piper, RC; Schuster, BG; Sowunmi, A | 1 |
| Czarnecka-Rudnik, D; Stanek-Bazylko, F | 1 |
| Durrani, N; Hewitt, S; Rowland, M; Sondorp, E | 1 |
| Bygbjerg, IC; Curtis, J; Duraisingh, MT; Jelinek, T; Lemnge, MM; Mhina, J; Rønn, AM; Warhurst, DC | 1 |
| Avila, JC; Carter, D; Cespedes, JL; Cortese, JF; Djimde, A; Doumbo, OK; Estrada-Franco, JG; Mollinedo, RE; Nwanyanwu, OC; Plowe, CV; Watkins, WM; Winstanley, PA | 1 |
| Manyando, C; Puta, C | 1 |
| Uche-Nwachi, EO | 1 |
| White, NJ | 1 |
| Anumudu, CA; Gordon, DM; Lyon, JA; Nwagwu, M; Obi, TU; Ologunde, CA; Sodeinde, O; Wirtz, RA | 1 |
| Caxton-Martins, AE; Uche-Nwachi, EO | 1 |
| Basco, LK; Ringwald, P; Tahar, R | 1 |
| Grünewald, T; Pohle, HD; Reichart, PA; Schmidt-Westhausen, A | 1 |
| Bakkus, MH; Balduck, N; De Raeve, H; Demanet, C; Desprechins, B; Otten, J; Thielemans, K; van der Werff ten Bosch, JE | 1 |
| Barat, LM; Bloland, PB; Ettling, M; Himonga, B; Kapelwa, W; Nkunika, S; Ruebush, TK | 1 |
| Barat, LM; Bloland, PB; Himonga, B; Kazembe, PN; Oloo, AJ; Ruebush, TK | 1 |
| Edwards, R; Fuchs, E; Kerr, L; Phillips-Howard, PA; Schildknecht, J; Steffen, R; Vanhauwere, B | 1 |
| Aubert, D; Bonhomme, A; Chemla, C; Dupouy, D; Guenounou, M; Leroux, B; Pinon, JM; Pluot, M; Quereux, C; Schmit, G; Talmud, M; Trenque, T; Villena, I | 1 |
| Ayisi, JG; Misore, A; Muga, R; Nahlen, BL; Oloo, AJ; Parise, ME; Roberts, JM; Schultz, LJ; Steketee, RW | 1 |
| Bourgeade, A; Delmont, J | 1 |
| Brabin, BJ; Broadhead, RL; Chimsuku, L; Hart, CA; Kazembe, P; Verhoeff, FH | 1 |
| Mberu, EK; Plowe, CV; Watkins, WM; Winstanley, PA | 1 |
| Hyde, JE; Sims, P; Wang, P | 1 |
| Bangs, MJ; Fryauff, DJ; Ingkokusumo, G; Kadir, A; Richie, TL; Sumawinata, I; Tjitra, E | 1 |
| Brobey, RK; Horii, T; Hyde, JE; Sims, PF; Wang, P | 1 |
| Barat, L; Chipipa, J; Kolczak, M; Sukwa, T | 1 |
| Caraballo, A; Rodriguez-Acosta, A | 1 |
| Giraldo, LE; Osorio, LE; Rallón, NI | 1 |
| Jelinek, T; Kabagambe, G; Kilian, AH; Löscher, T; Nothdurft, HD; Pröll, S; von Sonnenburg, F; Westermeier, A | 1 |
| Fukutomi, Y; Goto, H; Hara, T; Moriwaki, H; Murakami, N; Tajika, M; Tsurumi, H; Yoshimura, K | 1 |
| Goldman, I; Lal, AA; Plowe, C; Urdaneta, L | 1 |
| Jelinek, T; Kabagambe, G; Kilian, AH; von Sonnenburg, F | 1 |
| Makwaya, C; Minjas, JN; Premji, Z | 1 |
| Hightower, A; Kachur, SP; Mphande, PC; Nalwamba, NC; Simoonga, C; Williams, HA | 1 |
| Alpers, M; Klabunde, J; Kremsner, PG; Kun, JF; Lell, B; Luckner, D; May, J; Meyer, C | 1 |
| Basco, LK; Ringwald, P | 2 |
| Briceño, J; De la Mata, M; Miño, G; Pera, C; Pozo, JC; Sánchez-Guijo, P; Serrano, P; Solórzano, G; Torre-Cisneros, J | 1 |
| Alloueche, A; Anyalebechi, C; Bojang, K; Coleman, R; Doherty, T; Duraisingh, M; Gosling, R; Greenwood, B; McAdam, K; Milligan, P; Olliaro, P; Pinder, M; Sadiq, A; Targett, G; Ude, JI; von Seidlein, L; Walraven, G; Warhurst, D | 1 |
| Andrade, AL; Arriaga, AL; Barat, LM; Giraldo, LE; Grajales, LF; Osorio, LE; Ruebush, TK | 1 |
| Bussaratid, V; Krudsood, S; Looareesuwan, S; Phumratanaprapin, W; Silachamroon, U; Singhasivanon, P; Srivilirit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
| Hombhanje, FW | 1 |
| Abdel-Muhsin, AA; Babiker, HA; Hamad, A; Hill, WG; Mackinnon, MJ; Walliker, D | 1 |
| Choi, YK; Kim, MH; Nam, HW; Park, YK | 1 |
| Makonnen, E; Mengesha, T | 1 |
| Addiss, DG; Boyd, HA; Cetron, MS; Cookson, ST; Gonzaga, PS; Gushulak, BD; Miller, JM; Nguyen-Dinh, P; Ostrowski, SR; Parise, ME; Wahlquist, SP; Wainwright, RB; Weld, LH; Wilson, M | 1 |
| Algarin, E; Banguero, M; Barker, RH; Carrasquilla, G; Carvajal, F; Gervais, GW; Sanchez, P; Serrano, AE | 1 |
| Awono-Ambene, HP; Le Hesran, JY; Robert, V; Trape, JF | 1 |
| Dalvi, SS; Gogtay, NJ; Kshirsagar, NA; Rajgor, D; Wakde, M | 1 |
| Challand, S | 1 |
| Faiz, MA; Hassan, MR; Jalil, MA; Paul, B; Rahman, MR; Samad, R | 1 |
| Basco, LK; Keundjian, A; Ringwald, P; Tahar, R | 1 |
| Bijl, HM; Kager, J; Koetsier, DW; van der Werf, TS | 1 |
| Björkman, A; Ekvall, H; Premji, Z | 1 |
| Basco, LK; Keundjian, A; Ringwald, P; Same Ekobo, A | 1 |
| Baume, C; Helitzer, D; Kachur, SP | 1 |
| Saul, A | 1 |
| Hampers, LC; MacAlister, J; Moody, L | 1 |
| Vogel, G | 3 |
| Albrecht, H; Behnsch, M; Bergmann, F; Grobusch, M; Grünewald, T; Padberg, J; Ruf, B; Schürmann, D; Suttorp, N; Vallée, M; Wünsche, T | 1 |
| Coleman, R; Doherty, T; Jawara, M; Targett, G; von Seidlein, L; Walraven, G | 1 |
| Blair, S; Fonseca, JC; Lacharme, LL; Tobón, A | 1 |
| Nahlen, B; Newman, RD; Parise, M | 1 |
| Alonso, P; Aponte, J; Kahigwa, E; Menendez, C; Mshinda, H; Schellenberg, D; Tanner, M; Vidal, J | 1 |
| Kamya, MR; Kigonya, CN; McFarland, W | 1 |
| Hattori, Y; Kawauchi, S; Kohno, M; Nakamura, Y; Oga, A; Sadamitu, D; Sasaki, K | 1 |
| Campos, P; Canfield, CJ; Clendenes, M; Hutchinson, DB; Llanos-Cuentas, A | 1 |
| Athan, E; Barnes, K; Dürrheim, DN; Govere, J; Mabuza, A; Mngomezulu, NM | 1 |
| D'Alessandro, U | 1 |
| Hills, E; Mberu, E; Mutabingwa, T; Nduati, E; Nzila, A; Watkins, W; Winstanley, P | 1 |
| Aida, AO; Christophel, EM; Eberl, KJ; el Valy, AO; Heuschkel, C; Jelinek, T; Peyerl-Hoffmann, G | 1 |
| McIntosh, HM | 1 |
| Anstey, NM; Currie, BJ; Morris, PS; Saunders, JR; Suprianto, S; Tjitra, E | 1 |
| Nwaiwu, O; Okafor, HU | 1 |
| Buttiëns, H; D'Alessandro, U | 1 |
| Bygbjerg, IC; Minjas, JN; Tarimo, DS | 2 |
| Coleman, PG; Goodman, CA; Mills, AJ | 1 |
| Cowman, AF; Hyde, JE; Kublin, JG; Mberu, EK; Nzila, AM; Plowe, CV; Sibley, CH; Sims, PF; Watkins, WM; Winstanley, PA | 1 |
| Ali, D; Barat, LM; Green, MD; Kazembe, PN; Kolczak, MS; MacArthur, J; Macheso, A; Ruebush, TK; Stennies, GM | 1 |
| Basco, LK; Blackett, KN; Keundjian, A; Ngouesse, B; Ringwald, P | 1 |
| Chimpeni, P; Cortese, JF; Dzinjalamala, FK; Kamwendo, DD; Kublin, JG; Lescano, AG; Malkin, EM; Martino, LM; Molyneux, ME; Mukadam, RA; Plowe, CV; Rogerson, SJ; Taylor, TE; Winstanley, PA | 1 |
| Barnes, KI; Bredenkamp, BL; Durrheim, DN; Mthembu, SD; Sharp, BL | 1 |
| Barnes, K; Bredenkamp, B; Durrheim, D; Govere, J; Mabuza, A; Mngomezulu, N; Sharp, B | 1 |
| Aubert, D; Chemla, C; Dupouy, D; Leroux, B; Pinon, JM; Villena, I | 1 |
| Wendo, C | 1 |
| Arola, M; Azzi, N; Beyaert, R; Boehler, T; Demanet, C; Ferster, A; Laurey, G; Otten, J; Schotte, P; Thielemans, K; van der Werff Ten Bosch, J | 1 |
| Adjetey, TA; Barro-Kiki, PC; Konan, YJ; Koné, M; Menan, EI; Nebavi, NG; Nigué, L; Yavo, W | 1 |
| Bonsu, G; Driessen, GJ; Schouwenberg, BJ; van Kerkhoven, S; Verhave, JP | 1 |
| Bustos, DG; Diquet, B; Gay, F; Laracas, CJ; Lazaro, JE; Pottier, A; Traore, B | 1 |
| Hayton, K; Ranford-Cartwright, LC; Walliker, D | 1 |
| Diallo, D; Dicko, A; Dolo, G; Doumbo, O; Guindo, A; Kaslow, DC; Klion, AD; Miller, LH; Niambélé, MB; Sagara, I; Sangaré, D; Sissoko, M; Sogoba, M; Touré, Y; Yalcoué, D | 1 |
| Arévalo-Herrera, M; Carrasquilla, G; Cortese, JF; Jurado, D; Méndez, F; Muñoz, A; Plowe, CV | 1 |
| Basco, LK; Metoh, T; Ndounga, M; Ngane, VF; Ringwald, P; Same-Ekobo, A; Soula, G | 1 |
| Ebrahim, GJ | 1 |
| Hashimoto, H; Iida, N; Maeda, M; Mori, K; Nawata, M; Sekigawa, I; Seta, N; Shimizu, T; Wada, R | 1 |
| Broder, JS; Colletti, JE; Geroff, AJ; Grundmann, KA; Hanna, JR; Jerrard, DA; Mattu, A | 1 |
| Aché, A; Díaz, O; Escorihuela, M; Izarra, E; Matos, A; Miranda, L; Páez, E; Pérez, W; Vivas, E | 1 |
| de Vogel, S; Kok, FJ; Kuijsten, A; Nzyuko, SM; van der Valk, R; Veenemans, J; Verhoef, H; Wanga, MA; West, CE | 1 |
| Bedos, JP; Bruneel, F; Danis, M; Gachot, B; Regnier, B; Vachon, F; Wolff, M | 1 |
| Alonso, PL; Aponte, JJ; Drakeley, C; Kahigwa, E; Malende, A; Menendez, C; Mshinda, H; Msokame, C; Schellenberg, D; Tanner, M; Wigayi, J | 1 |
| Hyde, JE; Nirmalan, N; Sims, PF; Wang, P | 1 |
| Abdillahi, A; Duale, ON; Hassan, AM; Ismail, AN; Mohamed, A; Warsame, A; Warsame, M | 1 |
| Cheng, Q; Rieckmann, K | 1 |
| Chimpeni, P; Hatcher, J; Kublin, JG; Marsh, K; Molyneux, ME; Plowe, CV; Sulo, J; Taylor, TE; Watkins, WM; Winstanley, PA | 1 |
| Coulibaly, SO; D'Alessandro, U; Guiguemde, TR; Ouedraogo, JB; Tinto, H; Traoré, M; Van Marck, E; Zoungrana, EB | 1 |
| Anstey, NM; Baker, J; Cheng, Q; Suprianto, S; Tjitra, E | 1 |
| Aidoo, MA; Kager, PA; Kolczak, MS; Kuile, FO; Lal, AA; Nahlen, BL; Oloo, AJ; Terlouw, DJ; Udhayakumar, V | 1 |
| Faizal, HM; Fernando, WP; Galappaththy, G; Weerasinghe, KL; Wickremasinghe, AR; Wickremasinghe, DR | 1 |
| Dosekun, E; Ladhani, S; Patel, V; Shingadia, D | 1 |
| Ariey, F; Jaureguiberry, S; Raharimalala, AL; Rakotomalala, E; Ranarivelo, LA; Randriamanantena, A; Randrianarivelojosia, M; Rason, MA | 1 |
| Aida, AO; Christophel, EM; el Valy, AO; Heuschkel, C; Jelinek, T; Jordan, S; Mayor, A; Peyerl-Hoffmann, G; von Sonnenburg, F | 1 |
| Evers, S; Fischer, A; Freund, M; Grüneberg, U; Happe, S; Heese, Ch; Husstedt, IW; Kloska, S; Reichelt, D | 1 |
| Aubouy, A; Bakary, M; Cot, M; Deloron, P; Keundjian, A; Le Bras, J; Makita, JR; Mbomat, B; Migot-Nabias, F | 1 |
| Ramsay, S | 1 |
| Cissoko, Y; Coulibaly, D; Coulibaly, S; Diallo, DA; Dicko, A; Djimdé, A; Doumbo, OK; Guindo, AB; Koné, AK; Lyke, K; Plowe, CV; Thera, MA | 1 |
| Christophel, EM; Jelinek, T; Jordan, S; Phetsouvanh, R; Phompida, S; Schwöbel, B; Vanisaveth, V; von Sonnenburg, F | 1 |
| Baird, JK; Bangs, MJ; Barcus, MJ; Basuki, W; Edstein, MD; Lacy, MD; Laksana, B; Maguire, JD; Marwoto, H; Masbar, S; Sismadi, P; Susanti, I; Tjokrosonto, S; Wiady, I | 1 |
| Courval, JM; Kager, PA; Kolczak, MS; Lal, AA; Nahlen, BL; Oloo, AJ; Rosenberg, OS; ter Kuile, FO; Terlouw, DJ | 1 |
| Arróspide, N; Arrunátegui, M; Barat, LM; Cabezas, C; Carrillo, C; Chafloque, ML; Garavito, G; Gutierrez, S; MacArthur, JR; Marquiño, W; Oblitas, FE; Pardavé, B; Ruebush, TK | 1 |
| Castillo, CM; Ferro, BE; Osorio, L | 1 |
| Chen, YZ; Jin, T | 1 |
| Jelinek, T; Peyerl-Hoffmann, G; Restrepo, M; Schmider, N | 1 |
| Miyoshi, I; Saito, T; Taguchi, H; Takeuchi, S | 1 |
| Del Rosso, J; Marsh, D; Mukaka, M; Pasha, O | 1 |
| Desai, MR; Kager, PA; Kariuki, SK; Mei, JV; Nahlen, BL; Phillips-Howard, PA; ter Kuile, FO; Vulule, JM; Wannemuehler, KA | 1 |
| Dorsey, G; Gasasira, AF; Kamya, MR; Nassali, A; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Cattamanchi, A; Dorsey, G; Hubbard, A; Kyabayinze, D; Rosenthal, PJ | 1 |
| Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
| Andrianaivolambo, L; Andrianantenaina, HB; Ariey, F; Duchemin, JB; Léon, T; Leong Pock Tsi, JM; Rabarijaona, L; Raharimalala, LA; Rajaonarivelo, E; Rakotoniaina, JC; Randrianarivelojosia, M; Rason, MA; Razanavololo, F | 1 |
| Chandramohan, D; Drakeley, C; Mosha, F; Pearce, RJ; Roper, C | 1 |
| Bergqvist, Y; Björkman, A; Bwijo, B; Kaneko, A; Kobayakawa, T; Lum, JK; Mita, T; Moriyama, Y; Takahashi, N; Takechi, M; Tsukahara, T; Zungu, IL | 1 |
| Mishra, SS; Nagpal, AC; Singh, N; Subbarao, SK; Valecha, N; Varma, HS | 1 |
| Bredenkamp, B; Chandramohan, D; Drakeley, C; Gumede, J; Mosha, F; Pearce, R; Roper, C; Sharp, B | 1 |
| Giraldo, LE; González, IJ; Padilla, JO; Saravia, NG | 1 |
| Ericsson, O; Gustafsson, LL; Hipolite, D; Massele, AY; Minzi, OM; Moshi, MJ; Tomson, G | 1 |
| Nakajima, Y | 1 |
| Bereckzy, S; Bjorkman, A; Djadid, ND; Gil, JP; Zakeri, S | 1 |
| Pfeifer, C; Strauss, R | 1 |
| Tumwesigire, S; Watson, S | 1 |
| Nahlen, B; Newman, RD; Parise, ME; Slutsker, L; Steketee, RW | 1 |
| Cortese, JF; Djimdé, AA; Kazembe, PN; Kouriba, B; Kublin, JG; Mukadam, RA; Njunju, EM; Plowe, CV; Taylor, TE; Wirima, JJ | 1 |
| Sowunmi, A | 1 |
| Asmar, M; Durand, R; Jafari, S; Le Bras, J | 1 |
| Mussano, P; Olliaro, P | 1 |
| Makama, S; Shabahang, J; Tavrow, P | 1 |
| Verhoef, H; West, CE | 1 |
| D'Alessandro, U; Dujardin, JC; Karema, C; Mugisha, V; Niyitegeka, F; Rwagacondo, CE; Sarushi, J; van den Ende, J; Van Overmeir, C | 1 |
| Fateye, BA; Sowunmi, A | 3 |
| Schubert, C | 1 |
| Berens, N; Christophel, EM; Jelinek, T; Jordan, S; Phetsouvanh, R; Phompida, S; Schwoebel, B; Vanisaveth, V | 1 |
| D'Alessandro, U; Egwang, TG; Hastings, IM; Langi, P; Mutabingwa, TK; Speybroeck, N; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| Bille, J; Francioli, P; Hauser, PM; Meneau, I; Nahimana, A; Rabodonirina, M; Zanetti, G | 1 |
| Kabuya, W; Kazadi, WM; Kebela, BI; Makina, BN; Mantshumba, JC; Ngimbi, NP; Vong, S | 1 |
| Gonzaga, V; Levin, A; Marquiño, W; Neyra, D; Ruebush, TK | 1 |
| Brockman, A; Khanthavong, M; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Tiengkham, P; White, NJ | 1 |
| Dorsey, G; Kamya, MR; Rosenthal, PJ; Staedke, SG; Vlahos, J | 1 |
| Fischer, PR; Stauffer, W | 1 |
| Cox-Singh, J; Davis, TM; Doan, HN; Hewitt, S; Le, DC; Nguyen, MH; Nguyen, TH; Tran, BK; Tran, QT; Vo, NP | 1 |
| Zimmerman, PA | 1 |
| Alifrangis, M; Bygbjerg, IC; Khalil, IF; Lemnge, MM; Magesa, SM; Rønn, AM; Segeja, MD | 1 |
| Cattamanchi, A; Dorsey, G; Kamya, MR; Kyabayinze, D; Rosenthal, PJ | 1 |
| Bodaghi, B; Cassoux, N; Fardeau, C; Le Mer, Y; LeHoang, P; Lemaitre, C; Romand, S; Theaudin, M; Thulliez, P | 1 |
| Björkman, A; Hugosson, E; Montgomery, SM; Premji, Z; Tarimo, D; Troye-Blomberg, M | 1 |
| Anderson, TJ; Balkan, S; Jacobzone, C; Nair, S; Zavai, A | 1 |
| Clarke, S; Magnussen, P; Ndyomugyenyi, R | 2 |
| Balkan, S; Depoortere, E; Fermon, F; Guthmann, JP; Legros, D; Nkandu, E; Sipilanyambe, N | 1 |
| Chizani, N; Holtz, TH; Kachur, SP; Macheso, A; Marum, LH; Mkandala, C; Parise, ME; Roberts, JM | 1 |
| Alfrangis, M; Gjedde, SB; Kofoed, PE; Poulsen, A; Rodrigues, A; Rombo, L; Rønn, A | 1 |
| Attaran, A; Barnes, KI; Curtis, C; d'Alessandro, U; Fanello, CI; Galinski, MR; Kokwaro, G; Looareesuwan, S; Makanga, M; Mutabingwa, TK; Talisuna, A; Trape, JF; Watkins, WM | 1 |
| Alifrangis, M; Bygbjerg, IC; Enosse, S; Khalil, IF; Lemnge, MM; Rønn, AM; Tarimo, DS; Thompson, R | 1 |
| Barman, K; Dev, V; Phookan, S | 1 |
| Chimpeni, P; Dzinjalamala, FK; Kamwendo, DS; Kublin, JG; Molyneux, ME; Mukadam, RA; Plowe, CV; Taylor, TE | 1 |
| Desai, MR; Kager, PA; Kariuki, SK; Pfeiffer, CM; Shi, YP; Ter Kuile, FO; Terlouw, DJ; Wannemuehler, KA | 1 |
| Ebata-Mongo, S; Kiori, J; Le Bras, J; Louya, F; Malanda, M; Malonga, DA; Mouata, AM; Nsimba, B; Oko-Ossho, J; Yocka, D | 1 |
| Ayisi, JG; Kager, PA; Misore, AO; Nahlen, BL; Odondi, JO; Otieno, JA; Rosen, DH; Steketee, RW; ter Kuile, FO; van Eijk, AM | 1 |
| Bienzle, U; Ehrhardt, S; Jelinek, T; Mockenhaupt, FP; Muehlen, M; Otchwemah, R; Schreiber, J | 1 |
| Asha, AW; Ezard, N; Nellepalli, P | 1 |
| Hoshen, M | 1 |
| Greenwood, B | 1 |
| Abdel-Muhsin, AM; Ahmed, S; Ali, E; Babiker, HA; Mackinnon, MJ; Nassir, el-KA; Suleiman, S; Walliker, D | 1 |
| Abacassamo, F; Alonso, PL; Aponte, JJ; Barreto, A; Enosse, S; Gómez-Olivé, FX; Mabunda, S; Magnussen, P; Quintó, L; Rønn, AM; Thompson, R | 1 |
| Bakyaita, N; D'Alessandro, U; Egwang, TG; Langi, P; Mutabingwa, TK; Nalunkuma-Kazibwe, A; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| Guyatt, HL; Noor, AM; Ochola, SA; Snow, RW | 1 |
| Ardizzoni, E; Bakyaita, N; Balkan, S; Brockman, A; Checchi, F; Guthmann, JP; Klarkowski, D; Kosack, C; Kwezi, E; Piola, P; Priotto, G | 1 |
| Eriksen, J; Gustafsson, LL; Kitua, A; Mduma, S; Mwankusye, S; Swedberg, G; Tomson, G; Warsame, M | 1 |
| Desai, MR; Dhar, R; Kager, PA; Kariuki, SK; Rosen, DH; Shi, YP; Ter Kuile, FO | 1 |
| Adedeji, AA; Falade, CO; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Dorsey, G; Kamya, MR; Lamola, S; Rosenthal, PJ; Sendagire, H; Staedke, SG | 1 |
| Ayisi, JG; Kager, PA; Misore, AO; Nahlen, BL; Odondi, JO; Otieno, JA; Rosen, DH; Slutsker, L; Steketee, RW; ter Kuile, FO; van Eijk, AM | 1 |
| Cravo, P; do Rosario, VE; Ferreira, C; Ferreira, ID; Figueiredo, S; Gil, JP; Lopes, D; Nogueira, F | 1 |
| Kouyate, B; Müller, O; Traore, C | 1 |
| Bangali, M; Das, S; Rahman, M; Rahman, R; Ringwald, P; Talukder, MR | 1 |
| Barnes, KI; Folb, PI; Gomes, M; Little, F; McIlleron, H; Molyneux, ME; Mwenechanya, J; Ribeiro, I; Tembo, M | 1 |
| Chemla, C; Dupouy, D; Jaussaud, R; Leroux, B; Millart, H; Pinon, JM; Quereux, C; Rémy, G; Simon, N; Trenque, T; Urien, S; Villena, I | 1 |
| White, N | 1 |
| Ringwald, P | 1 |
| Bangs, MJ; Maguire, JD; Ruckert, P; Supriyanto, S; Sutanto, I | 1 |
| Imwong, M; Looareesuwan, S; Wilairatana, P | 1 |
| Alloueche, A; Bailey, W; Barton, S; Bwika, J; Chimpeni, P; Falade, CO; Fehintola, FA; Horton, J; Jaffar, S; Kanyok, T; Kremsner, PG; Kublin, JG; Lang, T; Missinou, MA; Mkandala, C; Oduola, AM; Premji, Z; Robertson, L; Sowunmi, A; Ward, SA; Winstanley, PA | 1 |
| Anderson, TC; Brockman, A; Chakma, S; Nair, S; Talukder, L; van den Broek, IV; van der Wardt, S | 1 |
| Akim, IN; Beier, JC; Bousema, JT; Drakeley, CJ; Githure, JI; Gouagna, LC; Meutstege, AM; Okech, BA; Sauerwein, RW | 1 |
| Alvarez, T; Arango, E; Blair, S; Carmona, J | 1 |
| Diakité, S; Djimdé, AA; Dolo, A; Doumbo, OK; Ouattara, A; Plowe, CV | 1 |
| John, CC; Koech, DK; Ouma, JH; Sumba, PO | 1 |
| Dorman, EK; Hviid, L; Kawuondo, K; Marsh, K; Shulman, CE; Staalsoe, T | 1 |
| Domarle, O; Ranarivelo, L; Randriamanantena, A; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A | 1 |
| Cassano, F; Cavailler, P; Guthmann, JP; Kariuki, D; Mwangi, J; Omar, SA; Piola, P; Stivanello, E | 1 |
| Garner, P; Omari, A | 1 |
| Basco, LK; Djaman, JA; Kauffy, PC; Kone, M; Yavo, W | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Happi, TC; Sowunmi, A | 1 |
| Bergström, S; Challis, K; Cotiro, M; Dgedge, M; Nordahl, G; Osman, NB | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Adedeji, AA; Babalola, CP; Fateye, BA; Sowunmi, A | 1 |
| Adam, I; Ahmed, GI; Elbashir, MI; Elghzali, G; Gustafssons, LL; Osman, ME | 1 |
| Drakeley, C; Marchant, T; Nganda, RY; Reyburn, H | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Cobelens, FG; Gikunda, S; Hoogstraatte, SR; Kager, PA; Scheper, FY; Smolders, M; Vreugdenhil, CJ | 1 |
| Coulibaly, D; Doumbo, O; Doumtabe, D; Kayentao, K; Keita, AS; Kodio, M; Maiga, B; Maiga, H; Mungai, M; Newman, RD; Ongoiba, A; Parise, ME | 1 |
| Abdulla, S; Beck, HP; Kataraihya, J; Lemnge, M; Malisa, A; Mshinda, H; Mugittu, K; Mwita, A; Ndejembi, M; Nkya, W; Premji, Z | 1 |
| Abdulla, SM; Bloland, PB; Fox, SS; Kachur, SP; Kaizer, E; Khatib, RA | 1 |
| Ariey, F; Domarle, O; Paul, RE; Robert, V; Sokhna, CS; Talman, AM; Trape, JF | 1 |
| Dokomajilar, C; Dorsey, G; Kamya, MR; Kiggundu, M; Rosenthal, PJ; Staedke, SG | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Sowunmi, A | 1 |
| Rakotondrajaona, N; Rakotoson, JD; Randriamanantena, A; Randriambelosoa, J; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Balkan, S; de Pécoulas, PE; Depoortere, E; Guthmann, JP; Legros, D; Nkandu, E; Pressé, J; Sipilanyambe, N | 1 |
| Baerwaldt, T; Checchi, F; Danks, A; Durand, R; Heinzelmann, A; Hora, B; Kamara, S; Lamotte, Nd; Morineau, G; Oloo, A; Pinoges, L; Ranford-Cartwright, L; Roddy, P; Smet, M; Williams, A; Wurie, AR | 1 |
| Abou-Eisha, A; Afifi, M | 1 |
| Meshnick, SR; Prajakwong, S; Shanks, GD; Thimasarn, K; Wongsrichanalai, C | 1 |
| Arroyave, M; Blair, S; Franco, L; González, L; Maestre, A; Ochoa, J; Restrepo, E | 1 |
| Browne, EN; Eggelte, TA; Evans, J; Flessner, C; Horstmann, RD; Marks, F; May, J; Meyer, CG; von Kalckreuth, V | 1 |
| Amankwa, J; Ansah, NA; Ansah, P; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Mumuni, G; Oduro, AR | 1 |
| Al-Faith, M; Alemu, E; Amsalu, R; Balasegaram, M; Checchi, F; Hepple, P; Hussein, el B; Montgomery, J; van den Broek, I | 1 |
| Alifrangis, M; Bygbjerg, IC; Drakeley, C; Enosse, S; Khalil, IF; Nkya, WM; Pearce, R; Roper, C; Rønn, AM; Theander, TG | 1 |
| Hastings, IM; Sibley, CH; Watkins, WM | 1 |
| Adam, I; Elbashir, MI; Himeidan, YE; Malik, EM; Mohammed, MM; Salah, MT | 1 |
| Gilbert, K; Marsh, K; Nduati, E; Nzila, A; Ochong, E; Ward, S; Winstanley, P | 1 |
| Kaniaru, S; Mens, PF; Mwangi, J; Omar, SA; Omer, GA; Schallig, HD; Schoone, GJ; Yusuf, A | 1 |
| Diallo, TO; Doui-Doumgba, K; Flori, P; Garraud, O; Gbagba, FE; Nambei, WS; Ndadjimbaye, V; Ndémanga, J; Perraut, R | 1 |
| Midia, B; Ochola, SA; Snow, RW; Zurovac, D | 1 |
| Baird, JK | 1 |
| Adak, T; Ansari, MA; Bannerjee, S; Bista, MB; Chand, PB; Jha, J; Pandey, S; Shahi, B; Valecha, N; Wijeyaratne, PM | 1 |
| Alexander, N; Coleman, R; Drakeley, CJ; Dunyo, S; Jawara, M; Ord, R; Pinder, M; Sutherland, CJ; Targett, GA; Walraven, G | 1 |
| Bhattacharyya, DR; Borgohain, BK; Gohain, AC; Goswami, BK; Mahanta, J; Mohapatra, PK; Namchoom, NS; Negmu, K; Prakash, A; Taison, K; Wange, D | 1 |
| Kokwaro, GO; Lowe, B; Marsh, K; Mithwani, S; Newton, CR; Nzila, AM; Ochong, E; Ogutu, BR; Olola, CH; Wamola, B | 1 |
| Göbels, K; Graupner, J; Grobusch, MP; Häussinger, D; Lund, A; Richter, J | 1 |
| Atkin, S; Checchi, F; Ford, N; Hamour, S; Hook, C; Keus, K; Melaku, Y; Montgomery, J; Wambugu, J | 1 |
| Ampuero, J; Balkan, S; D'Alessandro, U; Denoncin, A; Dujardin, JC; Dunand, J; Fortes, F; Franco, J; Gaboulaud, V; Gillet, P; Guthmann, JP; Legros, D; Saraiva, N; Tobback, S; van Herp, M; van Overmeir, C | 1 |
| Barnes, KI; White, NJ | 1 |
| Degefa, T | 1 |
| Arróspide, N; Cabezas, C; Falconí, E; Gutierrez, S; Hermenegildo, Y; Marquiño, W; Palacios, AM; Ruebush, TK; Ylquimiche, L | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, S; Reingold, A; Rosenthal, PJ; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M | 1 |
| Barnes, K; Kachur, SP; Malisa, A; Pearce, R; Roper, C; Sharp, B | 1 |
| Allen, E; Barnes, K; Durrheim, D; Govere, J; La Grange, K; Mabuza, A; Mbokazi, F; Mngomezulu, N; Zitha, A | 1 |
| Anemana, SD; Bienzle, U; Cramer, JP; Dzisi, SY; Eggelte, TA; Ehrhardt, S; Mockenhaupt, FP; Otchwemah, RN; Sauerwein, RW; Schreiber, J; Teun Bousema, J; Wassilew, N | 1 |
| Ahmad, F; Durrani, N; Graham, K; Leslie, T; Rahim, S; Rowland, M | 1 |
| Kironde, F; Kyabayinze, D; Sendagire, H; Swedberg, G | 1 |
| Chukwuka, JO; Ekejindu, IM; Ibeh, CC; Ibeh, NC; Shu, EN | 1 |
| Abdo-Rabbo, A; Atta, H; Bassili, A | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI; Idris, SM; Malik, EM | 1 |
| Benito, A; Berzosa, PJ; Puente, S | 1 |
| Aguttu, C; Kaddumukasa, M; Kironde, F; Nassejje, M; Ndagire, D; Pettersson, M; Sendagire, H; Swedberg, G | 1 |
| Akinboye, DO; Ebong, OO; Folarin, OA; Gbotosho, GO; Happi, CT; Kyle, DE; Milhous, W; Oduola, AM; Sowunmi, A; Wirth, DF; Yusuf, BO | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, SL; Reingold, A; Rosenthal, PJ; Slater, M; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Bloch, P; Ijumba, J; Kamugisha, M; Kitua, A; Mubyazi, G | 1 |
| De Koning, L; Gerrish, SJ | 1 |
| Smego, RA | 1 |
| Abuaku, B; Duah, N; Koram, KA; Quashie, N | 1 |
| Black, RE; Cusick, SE; Jape, JK; Ramsan, M; Sazawal, S; Stoltzfus, RJ; Tielsch, JM | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Adedeji, AA; Babalola, CP; Bamgboye, AE; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Sowunmi, A | 1 |
| Magnussen, P; Mbonye, AK; Neema, S | 1 |
| Bienzle, U; Eggelte, TA; Ehrhardt, S; Mockenhaupt, FP; Otchwemah, RN; Sauerwein, RW; Schreiber, J; Teun Bousema, J; Wassilew, N | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Abdelgadir, T; Adam, I; Ahmed, ES; Elamin, SB; Khamiss, AH; Malik, EM; Mohammed, MM | 1 |
| Demirev, PA; Feldman, AB; Kumar, N; Lin, JS; Nyunt, M; Pisciotta, J; Scholl, PF; Shi, L; Sullivan, DJ; Thuma, P | 1 |
| Bloland, P; Chizani, N; Hamel, MJ; Holtz, T; Kaimila, N; Kazembe, P; Kublin, J; Mkandala, C; Steketee, R | 1 |
| Alker, AP; Kazadi, W; Meshnick, SR; Wilson, PE | 1 |
| Durand, R; Jafari-Guemouri, S; Kiori, J; Le Bras, J; Louya, F; Malanda, M; Malonga, DA; Mouata, AM; Nsimba, B; Yocka, D | 1 |
| Eriksen, J; Gustafsson, LL; Minzi, OM; Nsimba, SE; Petzold, M; Sanga, AJ; Tomson, G; Warsame, MY | 1 |
| Amponsa-Achiano, K; Awine, T; Baiden, R; Binka, F; Carneiro, I; Chandramohan, D; Greenwood, B; Hodgson, A; Jaffar, S; Mensah, N; Owusu-Agyei, S | 1 |
| Hamer, DH; Ndhlovu, M; Rowe, AK; Snow, RW; Thea, DM; Zurovac, D | 1 |
| A/elbasit, IA; Adam, I; Elbashir, MI; Ibrahim, MH | 1 |
| Abdulla, KH; Abdulla, R; Ali, AS; Fakih, K; Juma, MS; Lemnge, MM; Malecela, EK; Njau, RJ; Sambu, E | 1 |
| Kremsner, PG; Krishna, S; Lell, B; Ramharter, M; Uhlemann, AC | 1 |
| Jones, KL; McIntosh, HM | 1 |
| Gonzalez-Block, MA; Mubyazi, GM | 1 |
| Abdel-Muhsin, AM; Ahmed, S; Ali, E; Babiker, HA; Mackinnon, MJ; Walliker, D | 1 |
| Argaw, D; Babaniyi, O; Jima, D; Kebede, A; Medhin, A; Tesfaye, G | 1 |
| Adazu, K; Ayisi, JG; Bles, HM; Blokland, IE; Lindblade, KA; Odhiambo, F; Rosen, DH; Slutsker, L; van Eijk, AM | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Breman, JG; O'Meara, WP | 1 |
| Adjei, O; Adjei, S; Horstmann, RD; Kobbe, R; Marks, F; May, J; Meyer, CG; von Kalckreuth, V | 1 |
| Alker, AP; Meshnick, SR | 1 |
| Dokomajilar, C; Dorsey, G; Lankoande, M; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Zongo, I | 1 |
| Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
| Abdulla, S; Beck, HP; Falk, N; Felger, I; Genton, B; Masanja, H; Mshinda, H; Mugittu, K | 1 |
| Bachy, C; D'Alessandro, U; Donam, I; Grandesso, F; Guthmann, JP; Habimana, J; Kerah, CH; Maikere, J; Ntambi, J; Vanlerberghe, V | 1 |
| Amin, AA; Kokwaro, GO; Snow, RW | 1 |
| Hebron, Y; Pournamdari, M; Tettey, JN; Watson, DG | 1 |
| Ali, MS; Kadaru, AG | 1 |
| Gebru-Woldearegai, T; Grobusch, MP; Hailu, A; Kun, JF | 1 |
| Chemla, C; Pinon, JM; Trenque, T; Villena, I | 1 |
| Nsimba, SE | 1 |
| Barugahare, B; Cao, H; Dorsey, G; Eggena, MP; Hopkins, H; Mugyenyi, P; Okello, M; Rosenthal, PJ; Ssali, F | 1 |
| Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
| Abdalla, MA; Adam, I; Ali, DM | 1 |
| Bukirwa, H; Critchley, J | 1 |
| Abeyewickreme, W; Abeysundara, S; Bandara, KB; Dayanath, MY; de Silva, NR; Hapuarachchi, HC; Hunt, SY; Sibley, CH | 1 |
| Djalle, D; Manirakiza, A; Menard, D; Talarmin, A; Yapou, F | 1 |
| Bousema, T; Gouagna, L; Omar, S; Sauerwein, R; Sawa, P; Schallig, H; Schneider, P | 1 |
| Alexander, N; Bâ, el H; Boulanger, D; Cissé, B; Gaye, O; Greenwood, B; Hallett, R; Lines, J; Milet, J; Richardson, K; Simondon, F; Simondon, K; Sokhna, C; Sutherland, C; Targett, G; Trape, JF | 1 |
| Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
| Eapen, A; Joshi, H; Kumar, A; Prajapati, SK; Ravinderan, J; Ringwald, P; Valecha, N | 1 |
| Dokomajilar, C; Dorsey, G; Francis, D; Kamya, MR; Machekano, R; Nsobya, SL; Rosenthal, PJ; Talisuna, A; Yeka, A | 1 |
| Auliff, AM; Baker, J; Burns, M; Cheng, Q; Edstein, MD; Gatton, ML | 1 |
| Hill, J; Kazembe, P | 1 |
| English, M; Midia, B; Ochola, SA; Snow, RW; Zurovac, D | 1 |
| Abdulla, S; Bloland, PB; Causer, LM; Elling, BF; Goodman, CA; Kassala, H; Khatib, RA; Mkikima, S; Patrick Kachur, S; Schulden, J | 1 |
| Abdulla, S; Bloland, P; Mandike, R; Mills, A; Mulligan, JA; Palmer, N; Williams, H | 1 |
| Benga-De, E; Doumbo, O; Faye, O; Gaye, O; Kayentao, K; Lo, Y; Moran, AC; Moreira, PM; Newman, RD; Parise, ME; Steketee, RW; Yameogo, M | 1 |
| Björkman, A; Hwaihwanje, I; Kaneko, A; Kobayakawa, T; Mita, T; Osawa, H; Takahashi, N; Tanabe, K; Tsukahara, T | 1 |
| Ayala, E; Cabrera, L; Calderón, M; Gilman, RH; Lescano, AG; Pinedo, VV; Terry, H; Vinetz, JM | 1 |
| Ericsson, O; Gustafsson, LL; Justin-Temu, M; Massele, A; Minzi, OM | 1 |
| Abdulmumini, U; Gebremeskel, T; Gebremichael, A; Ghebrat, Y; Gunawardena, D; Kosia, A; Mebrahtu, G; Mufunda, J; Nyarango, PM; Ogbamariam, A; Okbaldet, Y | 1 |
| Brabin, BJ; Hill, J; Kalanda, GC; Verhoeff, FH | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Rwagacondo, CE; van Doren, W | 1 |
| A-Elbasit, IE; Alifrangis, M; Elbashir, MI; Giha, HA; Khalil, IF | 1 |
| Cheng, Q; Gatton, ML | 1 |
| Chandramohan, D; Gosling, RD; Schellenberg, DM | 1 |
| Kokwaro, G; Marsh, K; Nzila, AM; Ward, SA; Winstanley, PA | 1 |
| Boctor, F | 1 |
| Campbell, CH; Chizani, N; Gimnig, JE; Kramer, MH; M'bang'ombe, M; MacArthur, JR; Mkandala, C; Newman, RD; Steketee, RW; Stern, RS | 1 |
| Dokomajilar, C; Dorsey, G; Hopkins, H; Kamya, MR; Leemann, E; Myrick, A; Rosenthal, PJ | 1 |
| Bienzle, U; Elbashir, MI; Giha, HA; Mockenhaupt, FP; Osman, ME | 1 |
| Collins, A; Kolaczinski, JH; Meek, S; Ojok, N; Opwonya, J | 1 |
| Balajo, B; Dunyo, S; Greenwood, B; Mbaye, A; Milligan, P; Richardson, K; Shulman, C; Walraven, G | 2 |
| Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P | 1 |
| de Radiguès, X; Diallo, KI; Diallo, M; Djimdé, A; Doumbo, O; Guthmann, JP; Maiga, H; Ngwakum, PA; Sacko, M | 1 |
| Boulanger, D; Capuano, F; Cisse, B; Dieme, JL; Dieng, Y; Greenwood, B; Ndiaye, T; Remoue, F; Simondon, F; Sokhna, C; Trape, JF | 1 |
| Bitarakwate, E; Dorsey, G; Hwang, J; Pai, M; Reingold, A; Rosenthal, PJ | 1 |
| Aldrovandi, G; Ghosh, M; Kankasa, C; Kasonde, P; Kuhn, L; Semrau, K; Shutes, E; Sinkala, M; Thea, DM; Vwalika, C | 1 |
| Coulibaly, SO; Koné, B; Magnussen, P; Nezien, D; Traoré, S | 1 |
| Barnwell, JW; Bloland, P; Escalante, AA; Hamel, M; Huber, C; McCollum, AM; Ouma, P; Poe, AC; Shi, YP; Slutsker, L; Udhayakumar, V; Vulule, J; Zhou, Z | 1 |
| Alano, A; Bienzle, U; Kumma, WP; Löscher, T; Miranda, IB; Mockenhaupt, FP; Osman, ME; Roewer, S; Schunk, M | 1 |
| Steketee, RW; ter Kuile, FO | 2 |
| Meshnick, SR; Mwapasa, V; Rogerson, SJ | 1 |
| Aide, P; Alonso, P; Aponte, JJ; DgeDge, M; Dobaño, C; Espasa, M; Mabunda, S; Macete, E; Mandomando, I; Menendez, C; Sanz, S; Sigauque, B | 1 |
| Filler, SJ; Hamel, M; Kazembe, P; Macheso, A; Newman, RD; Parise, ME; Steketee, RW; Thigpen, M | 1 |
| Bonnet, M; Cohuet, S; D'Alessandro, U; Guthmann, JP; Van Herp, M; Van Overmeir, C | 1 |
| Dokomajilar, C; Dorsey, G; Lankoande, ZM; Ouedraogo, JB; Rosenthal, PJ; Zongo, I | 1 |
| Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
| Aubouy, A; Deloron, P; Migot-Nabias, F | 1 |
| Asamoa, K; Bougouma, EC; Cotte, AH; Diarra, A; Konaté, A; Moran, AC; Newman, RD; Ouédraogo, A; Parise, ME; Sirima, SB | 1 |
| Anokbonggo, WW; Gustafsson, LL; Hellgren, U; Lundblad, MS; Mahindi, M; Ntale, M; Obua, C; Ogwal-Okeng, JW | 1 |
| Chalwe, V; Chilengi, R; D'Alessandro, U; Dujardin, JC; Moerman, F; Mulenga, M; Mwananyanda, L; Van Overmeir, C; VangGeertruyden, JP | 1 |
| Balkan, S; Checchi, F; Cousens, S; Guthmann, JP; Legros, D; Olliaro, P; Pinoges, L; van Herp, M | 1 |
| Chalwe, V; Chilengi, R; Colebunders, R; D'Alessandro, U; Dujardin, JC; Kasongo, W; Kestens, L; Moerman, F; Mulenga, M; Mwananyanda, L; Van Geertruyden, JP; Van Overmeir, C | 1 |
| Björkman, A; Hugosson, E; Montgomery, SM; Premji, Z; Troye-Blomberg, M | 1 |
| Dorsey, G; Downing, R; Hubbard, A; Hunt, BM; Kigozi, A; Lule, JR; Malamba, SS; Mermin, J; Ransom, R; Reingold, A; Rosenthal, PJ | 1 |
| Abodo, RT; Basco, LK; Ndounga, M; Ngane, VF; Same-Ekobo, A; Soula, G; Youmba, JC | 1 |
| Juma, EA; Lau, J; Obonyo, CO; Ogutu, BR; Vulule, JM | 1 |
| Ahmed, A; Das, MK; Dev, V; Lumb, V; Sharma, YD | 1 |
| D'Alessandro, U; Erhart, A; Guiguemdé, TR; Ouédraogo, JB; Sanou, B; Tinto, H | 1 |
| Bisser, S; Mazier, D; Mezui-Me-Ndong, J; Ollomo, B; Ouwe-Missi-Oukem-Boyer, O; Touré, FS | 1 |
| Kayembe, G; Montgomery, J; Pota, H; Roper, C; Swarthout, TD; van den Broek, IV | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Ngamije, D; van Doren, W; Van Overmeir, C | 1 |
| Anstey, NM; Brockman, A; Ebsworth, EP; Edstein, MD; Kenangalem, E; Laihad, F; Price, RN; Ratcliff, A; Siswantoro, H; Tjitra, E; Wuwung, M | 1 |
| Kim, M; Mutabingwa, TK; Whitty, CJ; Wiseman, V | 1 |
| Anh, le N; Auliff, A; Bell, D; Chen, N; Cheng, Q; Gao, Q; Maguire, J; O'Neil, MT; Russell, B; Wilson, DW | 1 |
| Méndez, F; Muñoz, A; Plowe, CV | 1 |
| Akther, S; Attlmayr, B; Fukuda, M; Haque, R; Miller, RS; Noedl, H; Salam, MA; Schaecher, K; Thriemer, K; Wagatsuma, Y | 1 |
| D'Alessandro, U; ter Kuile, FO | 1 |
| Browne, E; Bruce, J; Chandramohan, D; Greenwood, B; Randal, A; Tagbor, H | 1 |
| Alloueche, A; Bennett, S; Fielding, K; Greenwood, BM; Malunga, F; Mulenga, M; Shulman, C; Thuma, PE | 1 |
| Balthazary, ST; Malisa, AL; Mbugi, EV; Mshinda, H; Mutayoba, BM; Nyambo, TB | 1 |
| Bloland, PB; Hamel, MJ; Kain, KC; Obonyo, CO; Shah, SN; Slutsker, L; Smith, EE | 1 |
| Bedu-Addo, G; Bienzle, U; Eggelte, TA; Hommerich, L; Junge, C; Mockenhaupt, FP | 1 |
| Dzinjalamala, FK; Eddington, ND; Laufer, MK; Masonga, R; Plowe, CV; Takala, SL; Taylor, TE; Thesing, PC | 1 |
| Baird, JK; Bangs, MJ; Chand, K; Elyazar, I; Estiana, L; Lederman, ER; Maguire, JD; Sismadi, P; Sumawinata, IW | 1 |
| Goodman, C; Hetzel, MW; Kachur, SP; Lengeler, C; Makemba, A; Msechu, JJ; Mshinda, H; Nathan, R; Obrist, B; Schulze, A | 1 |
| Aguttu, C; Anokbonggo, WW; Chiria, J; Gustafsson, LL; Hellgren, U; Obua, C; Ogwal-Okeng, JW | 1 |
| Carnevale, EP; DaRe, JT; Kouri, D; McNamara, DT; Mueller, I; Zimmerman, PA | 1 |
| Nakazibwe, C | 1 |
| Issifou, S; Kremsner, PG; Matsiegui, PB; Missinou, MA; Necek, M | 1 |
| Dike, N; Ezumah, N; Ojukwu, J; Okonkwo, P; Onwujekwe, O; Shu, E; Uzochukwu, B | 1 |
| Barnes, KI; Evans, A; Little, F; Smith, PJ; Watkins, WM; White, NJ | 1 |
| Ermak, TN; Gruzdev, BM; Peregudova, AV | 1 |
| Barreto Miranda, I; Berens-Riha, N; Hoelscher, M; Kitua, A; Löscher, T; Maboko, L; Maduhu, I; Schönfeld, M; Schunk, M | 1 |
| Bjorkman, A; Farnert, A; Isabel Veiga, M; Martensson, A; Membi, C; Montgomery, SM; Ngasala, B; Premji, Z; Ursing, J; Wiklund, L | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Ibrahium, AM; Khalil, IF; Kheir, MM; Malik, EM; Osman, ME | 1 |
| Asamoa, K; Ba-Nguz, A; Crawley, J; Hill, J; Palmer, A; Robalo, M; Roman, E; Serufilira, A; Steketee, R; Yartey, J | 1 |
| Ayede, I; Dada-Adegbola, HO; Fadero, FF; Falade, AG; Falade, CO; Gbotosho, GO; Happi, CT; Oduola, AM; Salako, LA | 1 |
| Källander, K; Nsabagasani, X; Pariyo, G; Peterson, S; Tomson, G | 1 |
| Escalante, AA; McCollum, AM; Mueller, K; Udhayakumar, V; Villegas, L | 1 |
| Morrow, RH | 1 |
| Dokomajilar, C; Dorsey, G; Guiguemde, RT; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Tinto, H; Zongo, I | 1 |
| Adedeji, AA; Fateye, BA; Gbotosho, GO; Happi, TC; Sowunmi, A | 1 |
| Cousens, SN; Diallo, DA; Greenwood, BM; Ilboudo-Sanogo, E; Konaté, AT; Nebié, I; Ord, R; Pota, H; Roper, C; Sutherland, C | 1 |
| Adjuik, M; Beck, HP; Guthmann, JP; Kiguli, J; Mshinda, H; Mugittu, K; Olliaro, PL; Priotto, G; Snounou, G; Taylor, WR | 1 |
| Ayisi, JG; Kager, PA; Nahlen, BL; Otieno, JA; Rosen, DH; Shi, YP; Slutsker, L; Steketee, RW; Ter Kuile, FO; van Eijk, AM | 1 |
| Keola, S; Khanthavong, M; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Taylor, AM; White, NJ | 1 |
| Conteh, L; Stevens, W; Wiseman, V | 1 |
| Basco, L; Djaman, JA; Mazabraud, A | 1 |
| Barondi, F; Issifou, S; Kremsner, PG; Kun, JF; Lell, B; Missinou, MA; Oyakhirome, S; Pongratz, P; Ramharter, M | 1 |
| Gupta, A; Gustafsson, LL; Haule, AF; Kagashe, GA; Massele, AY; Minzi, OM | 1 |
| Alifrangis, M; Amerasinghe, PH; Bygbjerg, IC; Galappaththy, GN; Hapuarachchi, HC; Konradsen, F; Rajakaruna, RS; Salanti, A; Schousboe, ML | 1 |
| Singh, RK | 1 |
| Hawkins, VN; Joshi, H; Na-Bangchang, K; Rungsihirunrat, K; Sibley, CH | 1 |
| Cravo, P; do Rosário, VE; Fernandes, N; Figueiredo, P | 1 |
| Atemnkeng, MA; Chimanuka, B; Plaizier-Vercammen, J | 1 |
| D'Alessandro, U; Guiguemdé, TR; Ouédraogo, JB; Tinto, H; van Marck, E; van Overmeir, C; Zongo, I | 1 |
| Arrospide, N; Bacon, DJ; Cabezas, C; Cairo, J; Durand, S; Fiestas, V; Gutierrez, S; Lucas, C; Marquiño, W; Puray, M; Ruebush, TK; Salas, C; Utz, G | 1 |
| Bygbjerg, IB; Magnussen, P; Mbonye, AK | 1 |
| Amogne, W; Teshager, G; Zenebe, G | 1 |
| Abebe, W | 1 |
| Bonnet, M; Coulibaly, L; Félix, M; Guthmann, JP; Kankolongo, GM; Roper, C | 1 |
| Ayisi, J; Brouwer, KC; Kolczak, MS; Lal, AA; Lal, RB; Mirel, LB; Nahlen, BL; Otieno, JA; Shi, YP; Steketee, R; Van Eijk, AM; Yang, C | 1 |
| Andrianina, NN; Jahevitra, M; Ménard, D; Ramiandrasoa, Z; Randriamanantena, A; Rasoarilalao, N; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Hasan, MA; Klinkenberg, E; Leslie, T; Mayan, MI; Rowland, M; Safi, MH; Whitty, CJ | 1 |
| Clark, TD; Dokomajilar, C; Dorsey, G; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, S | 1 |
| Bjorkman, A; Ekvall, H; Kaneko, A; Obonyo, CO; Olliaro, P; Oloo, AJ; Taylor, W; Ter Kuile, F | 1 |
| Newman, RD; Parise, ME; Peters, PJ; Thigpen, MC | 1 |
| Coulibaly, D; Doumbo, OK; Kayentao, K; Keita, AS; Kodio, M; Maiga, B; Mungai, M; Parise, M; Traoré, B | 1 |
| Molyneux, M; Nkhoma, S; Ward, S | 1 |
| Chivenga, J; Gemperli, A; Kumar, N; Mbedzi, J; Mlambo, G; Mutambu, SL; Soko, W; Sullivan, D | 1 |
| Abruquah, HH; Adjei, O; Adjei, S; Amoah, K; Ayim, M; Busch, W; Kobbe, R; Kreuels, B; Kreuzberg, C; Langefeld, I; Marks, F; May, J; Meyer, CG; Opoku, E; Thompson, B; Thompson, PA | 1 |
| Madaki, JK; Sagay, AS; Thacher, TD; Tukur, IU | 1 |
| Ariey, F; Bedja, SA; Rabarijaona, LP; Randrianarivelojosia, M; Robert, V; Tall, A | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Filler, SJ; ter Kuile, FO; van Eijk, AM | 1 |
| Al Harthi, SA | 1 |
| Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
| Fadero, FF; Falade, CO; Hamer, DH; Mokuolu, OA; Salako, LA; Yusuf, BO | 1 |
| Anderson, TJ; Imwong, M; Mayxay, M; Nair, S; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Sudimack, D; Tanomsing, N; White, NJ | 1 |
| Babiker, A; El-Sayed, BB; El-Zaki, SE; Gadalla, NB; Mansour, FA; Mukhtar, EA; Mukhtar, I | 1 |
| Basco, LK; Tahar, R | 1 |
| Basco, LK; Casimiro, PN; Mallanda, G; Malonga, DA; Matondo Maya, DW; Mayengue, PI; Miakassissa-Mpassi, V; Ndounga, M; Nsonde-Ntandou, F; Ntoumi, F; Ringwald, P; Tahar, R | 1 |
| Honkasalo, ML; Launiala, A | 1 |
| Sharma, VP | 1 |
| A-Elbasit, IE; Alifrangis, M; Bygbjerg, IC; Elbashir, MI; Giha, HA; Khalil, IF; Masuadi, EM | 1 |
| Enevold, A | 1 |
| Ayisi, JG; Hamel, MJ; Kager, PA; Munguti, K; Odhiambo, F; Ouma, PO; Sikuku, E; Slutsker, L; Van Eijk, AM | 1 |
| Durrani, N; Kolaczinski, K; Rahim, S; Rowland, M | 1 |
| Basco, L; Djaman, J; Ferreira, C; Tahar, R | 1 |
| Bygbjerg, IC; Magnussen, P; Mbonye, AK | 2 |
| Bista, MB; Cox-Singh, J; Davis, TM; Davis, WA; Hollander, J; Linehan, M; Thakur, GD; Thapa, S | 1 |
| Gutiérrez, A; Herrera, S; Manzano, M; Méndez, F; Moreno, LA; Muñoz, A; Murrain, B; Plowe, CV | 1 |
| Amin, AA; Kokwaro, GO | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Kahigwa, E; Macete, E; Menendez, C; Mshinda, H; Sacarlal, J; Sanz, S; Schellenberg, D; Tanner, M | 1 |
| Malekela, DA; Tarimo, DS | 1 |
| Ayisi, JG; Green, MD; Kager, PA; Nahlen, BL; Nettey, H; Parise, ME; Steketee, R; van Eijk, AM; van Ter Kuile, FO | 1 |
| Alam, MT; Das, MK; Dash, AP; Dev, V; Sharma, YD; Singh, N; Upadhyay, M; Vinayak, S | 1 |
| Alifrangis, M; Bousema, T; Drakeley, C; Enevold, A; Gosling, R; Mosha, F; Ndaro, A; Sauerwein, R; Shekalaghe, S; van Meegeren, M | 1 |
| Nsungwa-Sabiiti, J; Ogwal-Okeng, J; Pariyo, G; Peterson, S; Petzold, MG; Tomson, G | 1 |
| Browne, E; Bruce, J; Chandramohan, D; Greenwood, B; Ord, R; Randall, A; Tagbor, H | 1 |
| Adjei, O; Adjei, S; Klinkert, MQ; Kobbe, R; May, J; Schreiber, N | 1 |
| Basco, LK; Casimiro, PN; Malonga, DA; Ndounga, M; Ntoumi, F; Tahar, R | 1 |
| Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Lammey, J; Law, I; Lin, E; Mueller, I; Page-Sharp, M; Siba, P | 1 |
| Gatarayiha, JP; Kabarisa, T; Ndayisaba, G; Rulisa, S | 1 |
| Beraho, L; Dzinjalamala, FK; Graham, SM; Hsi, T; Laufer, MK; Plowe, CV; Taylor, TE; Thesing, PC; van Oosterhout, JJ | 1 |
| Beck, HP; Genton, B; Goroti, M; Maku, P; Marfurt, J; Müeller, I; Reeder, JC; Sie, A | 1 |
| Dokomajilar, C; Dorsey, G; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, Y; Zongo, I | 1 |
| Acquah, PA; Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C | 1 |
| Afsharpad, M; Djadid, ND; Raeisi, A; Zakeri, S | 1 |
| Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM | 1 |
| Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mubikayi, L; Mukwamataba, D; Mulele, CK; Mulenga, M; Mwanakasale, V; Mwananyanda, L; Thea, DM | 1 |
| Adegnika, AA; Agnandji, ST; Altun, H; Borchert, L; Decker, M; Dornemann, J; Gabor, J; Glasenapp, Iv; Goesch, J; Grobusch, MP; Issifou, S; Kiessling, GC; Klein Klouwenberg, P; Klopfer, A; Kombila, DU; Koster, KB; Kremsner, PG; Langin, MU; Lell, B; Naumann, B; Necek, M; Oyakhirome, S; Pongratz, P; Potschke, M; Salazar, CL; Schwarz, NG; Supan, C | 1 |
| Alifrangis, M; Bygbjerg, IC; Enevold, A; Jensen, AT; Nkya, WM; Staalsoe, T; Theander, TG; Theisen, M; Vestergaard, LS | 1 |
| Arrospide, N; de Oliveira, AM; Escalante, AA; Griffing, SM; McCollum, AM; Quezada, WM; Udhayakumar, V; Zhou, Z | 1 |
| Brentlinger, PE; Correia, MA; Dgedge, M; Gimbel-Sherr, KH; Gloyd, S; Mercer, MA; Rojas, AJ; Saúte, F; Stubbs, BA | 1 |
| Briand, V; Cot, M; Cottrell, G; Massougbodji, A | 1 |
| Adjei, O; Adjei, S; Busch, W; Kobbe, R; Kreuels, B; Kreuzberg, C; Marks, F; May, J; Meyer, CG; Opoku, E; Schreiber, N; Thompson, B; Thompson, PA; Tosun, M | 1 |
| Ageep, T; Babiker, A; Babiker, H; Baraka, O; El-Sayed, B; El-Zaki, SE; Gadalla, N; Mansour, F; Milligan, P | 1 |
| Ayisi, JG; Hamel, MJ; Kager, PA; Otieno, K; Ouma, P; Parise, M; Slutsker, L; van Eijk, AM | 1 |
| Eriksen, J; Gustafsson, LL; Kitua, A; Mduma, S; Mwankusye, S; Petzold, MG; Swedberg, G; Tomson, G; Veiga, MI; Warsame, M | 1 |
| Tarimo, SD | 1 |
| Agbowai, C; Akogbeto, M; Coosemans, M; D'Alessandro, U; Erhart, A; Gazard, D; Massougbodji, A; Menten, J; Nahum, A; van Loen, H; Van Overmeir, C | 1 |
| Bissagnene, E; Die-Kakou, H; Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJ | 1 |
| Bâ, el H; Boulanger, D; Cissé, B; Gaye, O; Greenwood, B; Hallett, R; Lines, J; Milligan, P; Simondon, F; Simondon, K; Sokhna, C; Sutherland, C; Targett, G; Trape, JF | 1 |
| Dabo, CA; Diallo, M; Diarra, MA; Doumbo, O; Kayentao, K; Ongoiba, A; Sangho, H; Saye, R; Yattara, O | 1 |
| Ilombu, CA; Temiye, EO; Ugburo, AO | 1 |
| Bell, DJ; Molyneux, ME; Mukaka, M; Nyirongo, SK; Plowe, CV; Ward, SA; Winstanley, PA; Zijlstra, EE | 1 |
| Abiona, TC; Asa, OO; Fatusi, AO; Ijadunola, KT; Onayade, AA | 1 |
| Barnadas, C; Bouchier, C; Jahevitra, M; Ménard, D; Picot, S; Raherinjafy, R; Randrianasolo, L; Ratsimbasoa, A; Tichit, M | 1 |
| Ajanga, AA; Gikandi, PW; Gitonga, CW; Noor, AM; Snow, RW | 1 |
| Kiwuwa, MS; Mufubenga, P | 1 |
| Bloland, P; Escalante, A; Hamel, MJ; McCollum, A; Otieno, K; Ouma, P; Poe, A; Shi, YP; Slutsker, L; Udhayakumar, V; Vulule, J; Zhou, Z | 1 |
| Arens, T; Bousema, JT; Drakeley, CJ; Gouagna, LC; Houben, R; Mens, PF; Omar, SA; Sauerwein, RW; Schallig, H | 1 |
| Dama, S; Dembele, D; Dicko, A; Djimdé, AA; Doumbo, OK; Fofana, B; Ouologuem, D; Sagara, I; Sidibe, B; Toure, S | 1 |
| Bygbjerg, IC; Magnussen, P; Mbonye, AK; Schultz Hansen, K | 1 |
| Kolawole, SO; Ogungbamigbe, TO; Ogunro, PS; Ojurongbe, O; Okanlawon, BM | 1 |
| Chandramohan, D; Deen, JL; Ghani, AC; Gosling, RD; Greenwood, BM; von Seidlein, L | 1 |
| Aide, P; Alonso, P; Aponte, JJ; Benito, A; Berzosa, P; Dobaño, C; Macete, E; Mandomando, I; Mayor, A; Menéndez, C; Puyol, L; Sacarlal, J; Sanz, S; Serra-Casas, E | 1 |
| Beck, HP; Genton, B; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Ajonuma, LC; Ajuonuma, BC; Ajuonuma, FO; Ajuonuma, MK; Ajuonuma, MU; Chukwu, CL; Uzo-Ngerem, A | 1 |
| Kar, SK; Kerketta, AS; Mohapatra, SS | 1 |
| Balema, MB; Blanke, CH; Heide, L; Mbaruku, GM; Müller, MS; Naisabha, GB | 1 |
| Barnes, KI; Durrheim, D; Govere, J; Little, F; Mabuza, A; Mngomezulu, N; Roper, C; Watkins, B; White, NJ | 1 |
| Awine, T; Cairns, M; Carneiro, I; Chandramohan, D; Gosling, R; Greenwood, B; Milligan, P; Owusu-Agyei, S | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Chauhan, VS; Chitnis, CE; Dobaño, C; Macete, E; Mandomando, I; Mayor, A; Menéndez, C; Nhampossa, T; Puyol, L; Quelhas, D; Quintó, L; Sanz, S; Serra-Casas, E | 1 |
| Bygbjerg, IC; Hansen, KS; Magnussen, P; Mbonye, AK | 1 |
| Ahouidi, AD; Daily, JP; Ly, O; Mboup, S; Ndiaye, D; Ndir, O; Sarr, O; Wirth, DF | 1 |
| Diarra, M; Guissou, IP; Ouédraogo, LT; Somé, IT | 1 |
| Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM | 1 |
| Barbollat, L; Beck, HP; Brega, S; de Monbrison, F; Genton, B; Goroti, M; Marfurt, J; Müller, I; Picot, S; Reeder, JC; Sie, A | 1 |
| Abacassamo, F; Alifrangis, M; Enosse, S; Gómez-Olivé, X; Magnussen, P; Rønn, AM; Thompson, R | 1 |
| Andriantsoanirina, V; Barnadas, C; Bouchier, C; Hopkins Sibley, C; Jahevitra, M; Ménard, D; Tichit, M | 1 |
| Lalou, R; Le Hesran, JY; Sene, I; Souares, A; Sow, D | 2 |
| Bacon, DJ; Cabezas, C; Cairo, J; Durand, S; Lachira, A; Marquiño, W; Quintana, F; Ruebush, TK; Utz, G; Vegas, W | 1 |
| Abe, E; Feyi-Waboso, P; Okonofua, FE; Omo-Aghoja, LO | 1 |
| Diallo, AI; Dicko, A; Doumbo, OK; Guindo, O; Kone, M; Sacko, M; Sagara, I; Sissoko, MS; Toure, OB | 1 |
| Brooker, S; Clarke, SE; Crudder, C; Cundill, B; Estambale, BB; Jukes, MC; Khasakhala, L; Njagi, JK; Otido, J | 1 |
| Carneiro, I; Greenwood, B; Maire, N; Penny, M; Ross, A; Schellenberg, D; Smith, T; Studer, A; Tanner, M | 1 |
| Abdulla, S; Bloland, PB; Habbema, JD; Kabanywanyi, AM; Kachur, SP; Macarthur, JR; Mshinda, H; Stolk, WA | 1 |
| Cortés, LJ; Guerra, AP; Knudson, A; Nicholls, RS; Pérez, MA; Usta, C | 1 |
| Alonso, P; Aponte, J; Bardaji, A; Berenguera, A; David, C; Lahuerta, M; Mandomando, I; Menendez, C; Naniche, D; Ordi, J; Romagosa, C; Sanz, S; Sigauque, B | 1 |
| Afrane, Y; Cui, L; Githeko, A; Menge, DM; Yan, G; Zhong, D | 1 |
| Alonso, P; Hutton, G; Manzi, F; Mshinda, H; Schellenberg, D; Schellenberg, J; Tanner, M | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Arango, E; Blair, S; Carmona-Fonseca, J | 1 |
| Mathew, JL | 1 |
| Affipunguh, PK; Bruce, J; Chandramohan, D; Clerk, CA; Greenwood, B; Hodgson, A; Mensah, N | 1 |
| Briand, V; Buffet, PA; Danis, M; Mazier, D; Rénia, L; Thellier, M | 1 |
| Lepère, JF | 1 |
| Brabin, BJ; Coulibaly, SO; D'Alessandro, U; Gies, S; Ky, C; Ouattara, FT | 2 |
| Alonso, P; Manzi, F; Mbuya, C; Mponda, H; Mrisho, M; Mshinda, H; Mushi, AK; Pool, R; Schellenberg, D; Schellenberg, J; Tanner, M | 1 |
| Akhwale, W; Brooker, S; Clarke, SE; Estambale, BB; Jukes, MC; Mueller, DH; Njagi, JK; Temperley, M | 1 |
| Adjei, O; Adjei, S; Busch, W; Gabor, JJ; Grobusch, MP; Issifou, S; Kobbe, R; Kremsner, PG; Kreuels, B; Lell, B; May, J; Schwarz, NG | 1 |
| Ayisi, JG; Hamel, MJ; Kager, PA; Kariuki, S; Otieno, K; Ouma, PO; Parise, M; Slutsker, L; Ter Kuile, FO; van Eijk, AM; Williamson, J | 1 |
| Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C | 1 |
| Badiane, M; Brasseur, P; Cisse, M; Delenne, H; Olliaro, A; Olliaro, PL; Vaillant, M | 1 |
| Benchimol, C; Bernardino, L; do Rosário, VE; Figueiredo, P; Lopes, D; Nogueira, F; Varandas, L | 1 |
| Haule, AF; Minzi, OM | 1 |
| Atta, H; Elmi, HH; Hassan, AM; Hassan, HM; Jibril, AM; Klena, JD; Waqar, BA; Warsame, M | 1 |
| Alker, AP; Bloland, PB; Kazadi, WM; Kutelemeni, AK; Meshnick, SR; Tshefu, AK | 1 |
| Drakeley, CJ; Nosten, F; Price, RN; Stepniewska, K; Sutherland, CJ; von Seidlein, L; White, NJ | 1 |
| Biggs, BA; Caruana, SR; Cowman, AF; Phuc, BQ; Thanh, NV; Thuan, le K; Tien, NT | 1 |
| Dietmann, A; Helbok, R; Issifou, S; Kremsner, PG; Lackner, P; Lell, B; Reindl, M; Schmutzhard, E; Spora, K | 1 |
| Plowe, CV | 1 |
| Bruce, J; Hanson, K; Jones, C; Marchant, T; Mponda, H; Mshinda, H; Nathan, R; Schellenberg, J; Sedekia, Y | 1 |
| Adjuik, M; Binka, F; Chandramohan, D; Greenwood, B; Kweku, M; Liu, D; Seidu, M | 1 |
| Avellino, P; Bancone, G; d'Alessandro, U; Fanello, CI; Karema, C; Lee, SJ; Modiano, D; Uwimana, A | 1 |
| Billal, DS; Hotomi, M; Yamanaka, N | 1 |
| Djimde, A; Doumbo, OK; Guirou, EA; Hoppe, A; Kayentao, K; Kone, Y; Maiga, H; McMorrow, ML; Newman, RD; Saye, R; Traore, B; Traore, H; Yattara, O | 1 |
| Alonso, PL; Aponte, JJ; Bardají, A; Cisteró, P; Mandomando, I; Mayor, A; Menéndez, C; Puyol, L; Sanz, S; Serra-Casas, E; Sigauque, B | 1 |
| Coulibaly, SO; D'Alessandro, U; Gies, S; Ouattara, FT | 1 |
| Dankyau, M; Madaki, AJ; Ogunfowokan, O; Thacher, TD | 1 |
| Alifrangis, M; Bousema, T; Gouagna, LC; Howitt, C; Oesterholt, MJ; Omar, SA; Sauerwein, RW; Sawa, P; Sutherland, CJ | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Hubbard, A; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Slater, M; Staedke, SG | 1 |
| Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, PN; Msyamboza, KP; Savage, EJ | 1 |
| Björkman, A; Fidock, DA; Gil, JP; Mårtensson, A; Petersen, I; Premji, Z; Sisowath, C; Veiga, MI | 1 |
| Brabin, L; Dumbaya, I; Owens, S; Stokes, E | 1 |
| Ahmed, A; Das, MK; Dash, AP; Kaur, P; Kumar, M; Lumb, V; Mittra, P; Sharma, YD; Singh, SS | 1 |
| Bienzle, U; Danquah, I; Dietz, E; Mockenhaupt, FP; Reither, K; Zanger, P; Ziniel, P | 1 |
| Chandramohan, D; Gesase, S; Gosling, RD; Greenwood, B; Hashim, R; Joho, A; Lemnge, M; Madebe, R; Mandia, V; Mapunda, E; Mosha, FW; Mosha, JF; Mrema, H; Naidoo, I; Ord, R; Roper, C; Savael, Z | 1 |
| Beavogui, AH; Dama, S; Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Kone, A; Maiga, H; Ouologuem, D; Sagara, I; Tekete, M; Wele, M | 1 |
| Ahounou, D; Akogbeto, M; Bonou, D; Coosemans, M; D'Alessandro, U; Erhart, A; Massougbodji, A; Menten, J; Nahum, A; Van Overmeir, C | 1 |
| Adam, I; Ahmed, Ael A; Eldein, WN; Gasim, GI; Magzoub, M; Mahgoub, HM; Mohamed, AA | 1 |
| Abdelgadir, T; Adam, I; Ali, SH; Elhassan, AH; Elmardi, KA; Elsyed, AH; Malik, EM; Mudather, MA | 1 |
| Alonso, P; Hutton, G; Kahigwa, E; Macete, E; Mas, X; Menendez, C; Schellenberg, D; Sigauque, B; Tanner, M; Tediosi, F; Trapero, M; Trilla, A | 1 |
| Anvikar, A; Bhatt, RM; Dua, VK; Kar, PK | 1 |
| Briceño, M; Drakeley, C; Greenwood, BM; Mutabingwa, TK; Muze, K; Ord, R; Whitty, CJ | 1 |
| Björkman, A; Dahlström, S; Gil, JP; Mårtensson, A; Veiga, MI | 1 |
| Anderson, T | 1 |
| A-Elbasit, IE; Agboghoroma, CO; Bâ, el-H; Barnes, KI; Bonnet, M; Chanda, P; Chandramohan, D; Cissé, B; Clarke, S; Dejene, S; Diallo, DA; Dunyo, S; Elegba, OY; Evehe, MS; Getachew, A; Giha, HA; Grobusch, MP; Guthmann, JP; Hawela, M; Inojosa, W; Kachur, SP; Katokele, ST; Kweku, M; Lynch, C; Malisa, AL; Matondo, A; Mbacham, W; Mombo-Ngoma, G; Naidoo, I; Njie, F; Ord, R; Owusu-Agyei, S; Pearce, RJ; Pota, H; Roper, C; Rwakimari, JB; Sharp, B; Streat, E; Swarthout, TD; Uusiku, P; van den Broek, IV | 1 |
| Abdel-Muhsin, AM; Al-Ghazali, A; Al-Saai, S; Babiker, HA; Kheir, A; Nwakanma, D; Swedberg, G | 1 |
| Afrane, Y; Amenya, DA; Baliraine, FN; Bonizzoni, M; Githeko, AK; Yan, G | 1 |
| Assouline, C; Ayoubi, JM; Berrebi, A; Berry, A; Bessières, MH; Cambus, JP; Cassaing, S; Fillaux, J; Magnaval, JF | 1 |
| bin Reza, F; Chiodini, PL; Doherty, JF; Fifer, H; Gothard, P; Haustein, T; Nicholas, M; Njimgye-Tekumafor, NE; Pearce, RJ; Polley, SD; Sutherland, CJ | 1 |
| Abdirahman, A; Borrmann, S; Kiara, SM; Kokwaro, G; Mackinnon, M; Marsh, K; Mwai, L; Nzila, A; Ochong, E; Sasi, P; Ward, S | 1 |
| Bolla, MC; Duffy, PE; Fried, M; Harrington, WE; Muehlenbachs, A; Mutabingwa, TK; Sorensen, B | 1 |
| Adeothy, A; Amedome, H; Aubouy, A; Cot, M; Cottrell, G; Deloron, P; Doritchamou, J; Faucher, JF; Gourmel, B; Houzé, P; Kossou, H; Massougbodji, A | 1 |
| Agbenyega, T; Ehiri, JE; Ellis, WO; Funkhouser, E; Jolly, PE; Rayner, JC; Stiles, JK; Turpin, A; Williams, JH; Yatich, NJ; Yi, J | 1 |
| Barger, B; Dara, A; Djimde, AA; Doumbo, OK; Gantt, S; Maiga, H; Tekete, M; Tembine, I; Traore, OB; Traore, ZI | 1 |
| Barnadas, C; Bouchier, C; Briolant, S; Fusai, T; Legrand, E; Ménard, D; Musset, L; Picot, S; Rogier, C; Tichit, M | 1 |
| Allen, EN; Barnes, KI; Boulle, A; Camba, T; Cassam, Y; Little, F; Raman, J | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Daniel-Ribeiro, CT; de Oliveira, NK; de Souza, JM; Ferreira-da-Cruz, Mde F; Gama, BE; Santos, F; Zalis, MG | 1 |
| Baiwog, F; Davis, TM; Gomorrai, S; Ilett, KF; Karunajeewa, HA; Law, I; Mueller, I; Page-Sharp, M; Rogerson, S; Salman, S; Siba, P | 1 |
| Anyachebelu, EJ; Geddes, R; Knight, SE; Maharaj, R | 1 |
| Bley, D; Gausseres, M; Malvy, D; Millet, P; Sayang, C; Vernazza-Licht, N | 1 |
| Ayemonna, P; Bottero, J; Briand, V; Cordel, H; Cot, M; Fayomi, B; Fievet, N; Guerra, J; Kossou, H; Masse, V; Massougbodji, A; Noël, H | 1 |
| Ashley, E; Bonnet, M; Broek, Iv; Guthmann, JP; Kyomuhendo, J; Ndosimao, CN; Urrutia, PP; van Herp, M; van Overmeir, C | 1 |
| Geita, J; Hiawalyer, G; Hombhanje, FW; Jones, R; Kevau, I; Kuanch, C; Linge, D; Masta, A; Sapuri, M; Saweri, A; Toraso, S | 1 |
| Andrianaranjaka, V; Andriantsoanirina, V; Bouchier, C; Durand, R; Jahevitra, M; Ménard, D; Mercereau-Puijalon, O; Rabarijaona, LP; Rabearimanana, S; Radrianjafy, R; Randriantsoa, T; Rason, MA; Ratsimbasoa, A; Tichit, M | 1 |
| Bell, DJ; Chimpeni, P; Hughes, DA; Kayange, N; Lalloo, DG; Molyneux, ME; Montgomery, J; Mukaka, M; Ward, SA; Winstanley, PA; Wootton, D | 1 |
| Lalou, R; Le Hesran, JY; Senghor, P; Souares, A | 1 |
| Bishop, D; Cohen, JM; Goodman, C; Gordon, M; Ipuge, Y; Mwita, A; Odhiambo, M; Sabot, OJ; Ward, L | 1 |
| Boly, MD; Deloron, P; Faucher, JF; Houzé, S; Le Bras, J | 1 |
| Cairns, M; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Mosha, J | 1 |
| McGready, R | 1 |
| Carneiro, I; Chandramohan, D; Gesase, S; Gosling, RD; Greenwood, B; Hashim, R; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
| Adjei, S; Alonso, P; Anemana, S; Aponte, JJ; Breckenridge, A; Carneiro, I; Chandramohan, D; Critchley, J; Danquah, I; Dodoo, A; Egan, A; Greenwood, B; Grobusch, MP; Issifou, S; Kobbe, R; Kremsner, PG; Lell, B; Macete, E; May, J; Menendez, C; Mockenhaupt, F; Mshinda, H; Newman, RD; Owusu-Agyei, S; Premji, Z; Sanz, S; Schellenberg, D; Sevene, E; Slutsker, L; Soulaymani-Becheikh, R; Tanner, M; Winstanley, P | 1 |
| Adam, I; Barnes, KI; Cassam, Y; Doumbo, O; Guirou, E; Kayentao, K; Little, F; Mauff, K; Nyunt, MM; Smith, P; Sullivan, D; Thuma, P; Traore, B; van Dijk, J | 1 |
| Cairns, M; Cames, C; Cheng, Y; Cisse, B; Faye, B; Faye, E; Faye, O; Gaye, O; Greenwood, B; Lô, AC; Milligan, P; NDiaye, JL; NDiaye, M; NDiaye, O; Simondon, K; Trape, JF | 1 |
| Das, MK; Dev, V; Lumb, V; Sharma, YD; Singh, N | 1 |
| Asih, PB; Coutrier, FN; Dewi, RM; Kusumaningtyas, MA; Rahmat, A; Rogers, WO; Rozi, IE; Sauerwein, RW; Susanti, AI; Sutamihardja, A; Syafruddin, D; van der Ven, AJ | 1 |
| Abudey, S; Adjuik, M; Chandramohan, D; Greenwood, B; Kweku, M; Webster, J | 1 |
| Bougouma, EC; Diarra, A; Konaté, AT; Nébié, I; Ouedraogo, A; Sirima, SB; Tiono, AB | 1 |
| Aprioku, JS; Obianime, AW | 2 |
| Day, NP; Dondorp, A; Fanello, CI; Imwong, M; Karema, C; Nakeesathit, S; Stepniewska, K; Uwimana, A; White, NJ | 1 |
| Aponte, JJ; Borchert, LB; Doernemann, J; Gabor, JJ; Grobusch, MP; Issifou, S; Koester, KB; Kremsner, PG; Kurth, F; Lell, B; Poetschke, M; Pongratz, P; Profanter, K; Schuster, K; Schwarz, NG | 1 |
| Nakiboneka, D; Nakibuuka, V; Ndeezi, G; Ndugwa, CM; Tumwine, JK | 1 |
| Eastman, RT; Fidock, DA | 1 |
| Kaur, H; Kolaczinski, K; Leslie, T; Mohammed, N; Ord, RL; Rowland, M | 1 |
| Joloba, M; Kiggundu, M; Nawaz, F; Nsobya, SL; Rosenthal, PJ | 1 |
| Dembele, B; Friedman, A; Yakubu, AA | 1 |
| Achan, J; Arinaitwe, E; Clark, TD; Cohan, D; Dorsey, G; Havlir, D; Newman, PM; Rosenthal, PJ; Tumwine, G; Waldman, S; Wanzira, H | 1 |
| Gbotosho, GO; Happi, CT; Oduola, A; Sijuade, A; Sowunmi, A | 1 |
| Carlotti, MP; Lalou, R; Le Hesran, JY; Moulin, P; Sarrassat, S; Souares, A | 1 |
| Alonso, PL; Bardají, A; Chauhan, VS; Chitnis, CE; Dobaño, C; Jiménez, A; Mandomando, I; Mayor, A; Menéndez, C; Quintó, L; Serra-Casas, E; Sigauque, B | 1 |
| Giha, HA | 1 |
| Baisor, M; Beck, HP; Genton, B; Hastings, IM; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP; Tchantchou, Tde D | 1 |
| Barry, A; Coulibaly, OM; Dama, S; de Sousa, A; Diallo, AI; Dicko, A; Dicko, M; Djimdé, AA; Doumbo, OK; Rogier, C; Sagara, I; Touré, SO; Traore, M | 1 |
| Ba, EH; Cairns, M; Cames, C; Cisse, B; Gaye, O; Greenwood, BM; Milligan, PJ; Simondon, K; Sokhna, C; Trape, JF | 1 |
| Cames, C; Cournil, A; Fillol, F; Simondon, KB; Sokhna, C | 1 |
| Endo, H; Eto, H; Marma, AS; Mita, T; Sarker, S; Tsukahara, T | 1 |
| Ajua, A; Ateh, IA; Echouffo-Tcheugui, JB; Evehe, MS; Greenwood, B; Hallett, R; Irenee, D; Mbacham, WF; Mimche, PN; Netongo, PM; Nji, AM; Roper, C; Targett, G; Tawe, B | 1 |
| Parikh, S; Rosenthal, PJ | 1 |
| Chopra, M; de Sousa, A; Salama, P | 1 |
| Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Lekana-Douki, JB; Mounanga, M; Ngoungou, EB; Nzenze-Afene, S; Obono-Obiang, G; Owono-Medang, M | 1 |
| Basco, LK; Foumane, VN; Gwét, H; Soula, G; Tahar, R; Thalabard, JC; Whegang, SY | 1 |
| Barnes, KI; Distiller, GB; Little, F | 1 |
| Bousema, T; Daou, M; Drakeley, C; Kavishe, R; Koenderink, JB; Luty, AJ; Sauerwein, RW; Shekalaghe, SA; ter Braak, R; van den Bijllaardt, W; van den Bosch, S; Whitty, CJ | 1 |
| Alonso, PL; Aponte, JJ; Bardají, A; Mabunda, S; Menéndez, C; Sanz, S; Sigauque, B | 1 |
| Beshir, K; Dlamini, SV; Sutherland, CJ | 1 |
| Cairns, M; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Hashim, R; Kaur, H; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
| Ngure, RM; Omar, SA; Yusuf, RU | 1 |
| Afsharpad, M; Atta, H; Butt, W; Djadid, ND; Ghasemi, F; Raeisi, A; Safi, N; Zakeri, S | 1 |
| Katamanywa, J; Ndyomugyenyi, R | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Aitken, EH; Ashorn, P; Beeson, JG; Fowkes, FJ; Friso, MJ; Kulmala, T; Luntamo, M; Maleta, K; Mbewe, B; Rogerson, SJ | 1 |
| Hamel, MJ; Kariuki, S; Lindblade, K; Newman, RD; Odhiambo, FO; Otieno, P; Peterson, E; Slutsker, L; ter Kuile, FO; Vulule, J; Williamson, J | 1 |
| Bangs, MJ; Basri, H; Chand, K; Elyazar, I; Kinzer, MH; Lederman, ER; Maguire, JD; Rogers, WO; Susanti, AI; Taleo, G | 1 |
| Afsharpad, M; Djadid, ND; Farahani, MS; Raeisi, A; Salehi, M; Zakeri, S | 1 |
| Agomo, CO; Oyibo, WA | 1 |
| Barnes, KI; Cassam, Y; Kleinschmidt, I; Little, F; Maharaj, R; Raman, J; Roper, C | 1 |
| Cairns, ME; Chandramohan, D; Chico, RM; Gosling, RD | 1 |
| Beavogui, AH; Coulibaly, B; Dao, A; Djimde, AA; Doumbo, OK; Fofana, B; Gregson, A; Kone, A; Niare, O; Ouologuem, D; Picot, S; Plowe, CV; Sacko, A; Tekete, M; Toure, AM; Wele, M | 1 |
| Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C | 1 |
| Benavides, J; Corredor, V; Echeverry, DF; Guerra, AP; Murillo, C; Osorio, L; Pearce, RJ; Roper, C | 1 |
| Dara, A; Djimde, AA; Doumbo, OK; Kone, A; Luty, A; Niangaly, H; Sauerwein, R; Siebelink-Stoter, R; van de Vegte-Bolmer, M; van Gemert, GJ | 1 |
| Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, P; Msyamboza, K; Savage, E | 1 |
| Alonso, P; Aponte, JJ; Biao, P; Chandramohan, D; Conteh, L; Egan, A; Gosling, RD; Grobusch, MP; Hamel, M; Hutton, G; Kremsner, PG; Macete, E; Manzi, F; Masika, P; Matovu, F; Menéndez, C; Newman, RD; Obonyo, B; Odhiambo, FO; Otieno, P; Schellenberg, D; Sicuri, E; Slutsker, L; Tanner, M; Tediosi, F | 1 |
| Basco, LK; Gwét, H; Thalabard, JC; Whegang, SY | 1 |
| Abubakr, I; Bojang, KA; Conway, DJ; Greenwood, B; Jallow, M; Milligan, PJ; Njie, F; Nwakanma, DC; Sisay-Joof, F | 1 |
| Adjuik, M; Ansah, P; Anto, F; Anyorigiya, T; Atuguba, F; Fryauff, DJ; Hodgson, A; Koram, KA; Nkrumah, F; Oduro, AR; Rogers, WO | 1 |
| Abdulla, S; Bloland, P; Kachur, PS; Malisa, AL; Mshinda, H; Pearce, RJ; Roper, C | 1 |
| Assouline, C; Ayoubi, JM; Berrébi, A; Bessières, MH; Cassaing, S; Lathière, M; Minville, V | 1 |
| Dhanoa, J; Gera, C | 1 |
| Afsharpad, M; Atta, H; Djadid, ND; Ghasemi, F; Kakar, Q; Raeisi, A; Zakeri, S | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Fawole, AO; Onyeaso, NC | 1 |
| Diakhaté, L; Diéye, TN; Diop, S; Fall, AO; Guèye, YB; Sall, A; Seck, M; Soudré, F; Thiam, D | 1 |
| Chaluluka, E; Feng, G; Molyneux, ME; Rogerson, SJ; Simpson, JA | 1 |
| Coulibaly, SO; D'Alessandro, U; Gies, S; Grietens, KP; Ky, C; Muela Ribera, J; Somda, J; Toomer, E | 1 |
| Naidoo, I; Roper, C | 3 |
| Abruquah, HH; Buchholz, U; Danquah, I; Grobusch, MP; Kobbe, R; May, J; Mockenhaupt, FP; Reither, K; Zanger, P; Ziniel, P | 1 |
| Barnwell, JW; Herman, KM; McClintock, SK; Sridaran, S; Syphard, LM; Udhayakumar, V | 1 |
| Balu, L; Chevret, L; Habes, D; Orostegui, L; Pussard, E | 1 |
| Chandramohan, D; Conteh, L; Greenwood, B; Kweku, M; Legood, R; Patouillard, E | 1 |
| Cairns, M; Carneiro, I; Chandramohan, D; Ghani, AC; Gosling, RD; Greenwood, B; Griffin, JT; Grobusch, MP; Newman, RD; Roper, C; Schellenberg, D | 1 |
| Cravo, P; Henriques, G; Hunt, P; Martinelli, A | 1 |
| Gara, SN; Madaki, AJ; Thacher, TD | 1 |
| Ballif, M; Beck, HP; Crameri, A; Fafale, A; Felger, I; Genton, B; Hii, J; Marfurt, J | 1 |
| Akubuo, KK; Aziken, ME; Gharoro, EP | 1 |
| Diarra, A; Konaté, AT; Nébié, IO; Ouédraogo, A; Sirima, SB; Tiono, AB | 1 |
| Capan, M; Makristathis, A; Mombo-Ngoma, G; Ramharter, M | 1 |
| Bertin, G; Briand, V; Cot, M; Deloron, P; Massougbodji, A | 1 |
| Alonso, PL; Bardají, A; Cisteró, P; Dobaño, C; Mandomando, I; Mayor, A; Menéndez, C; Ordi, J; Quintó, L; Serra-Casas, E; Sigauque, B | 1 |
| Chandramohan, D; Färnert, A; Greenwood, B; Kweku, M; Liljander, A; Montgomery, SM; Olsson, D | 1 |
| Akala, HM; Bedno, SA; Coldren, RL; Eyase, FL; Moss, WJ; Prigge, ST; Spalding, MD; Waters, NC | 1 |
| Ahlum, J; Cui, L; Huang, Y; Miao, M; Yang, Z | 1 |
| Ashorn, P; Cheung, YB; Kulmala, T; Luntamo, M; Maleta, K; Mbewe, B | 1 |
| Brentlinger, PE; Kiwuwa, MS; Richardson, BA; Sangaré, LR; Staedke, SG; Stergachis, A; Weiss, NS | 1 |
| Alonso, PL; Bardají, A; Cisteró, P; Dobaño, C; Mandomando, I; Mayor, A; Menéndez, C; Nhabomba, A; Sanz, S; Scahill, MD; Serra-Casas, E; Sigauque, B | 1 |
| Boulanger, D; Cisse, B; Fillol, F; Greenwood, B; Remoué, F; Riveau, G; Sarr, JB; Schacht, AM; Simondon, F; Sokhna, C; Trape, JF | 1 |
| Arora, U; Dash, AP; Dhillon, GP; Meshnick, SR; Shah, NK; Valecha, N | 1 |
| Bell, DJ; Molyneux, ME; Mukaka, M; Nyirongo, SK; Ward, SA; Winstanley, PA | 1 |
| Alonso, PL; Aponte, JJ; Bardají, A; Mabunda, S; Maixenchs, M; Menéndez, C; Ordi, J; Sanz, S; Sigauque, B | 1 |
| Agbo, M; Bruce, J; Chandramohan, D; Greenwood, B; Tagbor, H | 1 |
| Annie, A; De Sousa, A; Faye, B; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, M; Sow, D; Tine, RC | 1 |
| Bojang, KA; Greenwood, BM; Milligan, P; Sesay, S; Sowe, M; Touray, E; Webb, EL | 1 |
| Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB | 1 |
| Abdulla, S; Bloland, PB; Goodman, C; Kachur, SP; Kahigwa, E; Mills, A; Mkikima, S; Munkondya, J; Njau, JD; Thwing, JI | 1 |
| Adjei, O; Adjei, S; Hogan, B; Klein, P; Kobbe, R; Kreuels, B; Loag, W; May, J | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Beeson, JG; Cisteró, P; Dobaño, C; Jiménez, A; Macete, E; Mandomando, I; Mayor, A; Menéndez, C; Nhampossa, T; Puyol, L; Quelhas, D; Quintó, L; Richards, JS; Sanz, S; Serra-Casas, E; Wilson, DW | 1 |
| Beg, MA; Ghanchi, NK; Jafri, S; Mårtensson, A; Ursing, J; Veiga, MI | 1 |
| Alegana, VA; Gething, PW; Hill, J; Kirui, V; Snow, RW; ter Kuile, FO; van Eijk, AM | 1 |
| Alemu, H; Anbessie, J; Diro, E; Mao, P; Pinchouk, N; Seboxa, T | 1 |
| Davis, TM; Griffin, S; Ilett, KF; Kose, K; Moore, B; Mueller, I; Pitus, N; Salman, S; Siba, P; Winmai, J | 1 |
| Dimbu, R; do Rosário, VE; Figueiredo, P; Fortes, F; Lopes, D; Neto, Z | 1 |
| Alam, MT; Asamoa, K; Barnwell, JW; de Souza, DK; Duah, NO; Ghansah, A; Griffing, SM; Koram, KA; Poe, AC; Slutsker, L; Udhayakumar, V; Vinayak, S; Wilson, MD | 1 |
| Bouraima, A; Briand, V; Choudat, I; Cot, M; Cottrell, G; Dechavanne, C; Fayomi, B; Garcia, A; Guerra, J; Le Port, A; Massougbodji, A; Migot-Nabias, F | 1 |
| Beeson, JG; Fowkes, FJ; Mueller, I; Richards, JS; Rogerson, SJ | 1 |
| Akor, F; Bittaye, O; Bojang, KA; Conteh, L; Conway, DJ; Greenwood, B; Jasseh, M; Milligan, PJ; Webb, E; Wiseman, V | 1 |
| Chandramohan, D; Cousens, S; Diallo, DA; Diarra, A; Gansané, A; Greenwood, B; Kaboré, Y; Kangoyé, DT; Konaté, AT; Milligan, PJ; Ouédraogo, A; Ouédraogo, AZ; Ouédraogo, E; Ouédraogo, IN; Sirima, SB; Soulama, I; Tiono, AB; Yaro, JB | 1 |
| Alonso, P; Armstrong Schellenberg, JR; Chemba, M; Maokola, W; Mshinda, H; Schellenberg, D; Shirima, K; Tanner, M; Willey, BA | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Coulibaly, CO; Diakite, M; Diawara, A; Maiga, AS; Sango, HA | 1 |
| Adhikari, M; Alifrangis, M; Bygbjerg, IC; Kapel, CM; Ranjitkar, S; Schousboe, ML; Thomsen, TT | 1 |
| Chandramohan, D; Chico, RM | 1 |
| Dev, V; Dua, VK; Joshi, H; Prajapati, SK | 1 |
| Coffie, PA; Dabis, F; Eholie, SP; Ekouevi, DK; Kanhon, S; Kone, M; Kouakou, F; Menan, H; Sloan, C; Vanga-Bosson, HA | 1 |
| Mishra, SK; Rath, SK; Singh, P | 1 |
| Anto, F; Asoala, V; Cairns, M; Carneiro, I; Chandramohan, D; Ghani, A; Gosling, R; Greenwood, B; Milligan, P; Okell, L; Owusu-Agyei, S | 1 |
| Bera, DK; Biswas, A; Das, M; Das, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Roy, D; Saha, P; Sengupta, S | 1 |
| Gabor, JJ; Greutélaers, B; Greutélaers, KC; Grobusch, MP; Issifou, S; Kremsner, PG; Kun, JF; Kurth, F; Lell, B; Mombo-Ngoma, G; Ord, R; Oyakhirome, S; Profanter, K; Roper, C | 1 |
| Ajayi, IO; Akinleye, SO | 1 |
| Agboton-Zoumenou, MA; Briand, V; Cottrell, G; d'Almeida, TC; Garcia, A; Imorou, Y; Massougbodji, A | 1 |
| Jansen, FH | 1 |
| Adjei, AA; Anderson, WA; Ceesay, FK; Gyasi, RK; Lucchi, NW; Ndjakani, Y; Obed, SA; Rodney, P; Stiles, JK; Wilson, NO | 1 |
| Basco, L; Menemedengue, V; Sahnouni, K; Tahar, R | 1 |
| Asgharzadeh, M; Shahbazi, A; Zaman, J | 1 |
| Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS | 1 |
| Duffy, PE; Fried, M; Harrington, WE; Kabyemela, E; Mutabingwa, TK | 1 |
| Leke, RG; Taylor, DW | 1 |
| de Sousa, A; Diallo, AT; Dicko, A; Doumbo, OK; Rogier, C; Sagara, I; Salomon, R; Sissoko, MS; Toure, OB; Toure, SO; Traore, M | 1 |
| Bertin, G; Bonaventure, D; Briand, V; Carrieu, A; Cot, M; Deloron, P; Massougbodji, A | 1 |
| Bojang, K; Greenwood, B; Pagnoni, F; Tagbor, H | 1 |
| Dieng, Y; Diouf, I; Faye, B; Faye, O; Gaye, A; Gaye, O; Mengue, ML; Ndiaye, JL; Sylla, K; Tine, RC | 1 |
| Andrianampanalinarivo, HR; Herinirina, SA; Rakotoarisoa, H; Randriambelomanana, JA; Zafindravola, BA | 1 |
| Bygbjerg, IC; Lemnge, MM; Massawe, IS; Ringsted, FM | 1 |
| Akinyinka, OO; Orimadegun, AE; Tongo, OO | 1 |
| Adeel, AA; Chance, ML; Hassan, AA; Mubjer, RA | 1 |
| Abdullah, S; Bloland, P; Kachur, P; Malisa, A; Mshinda, H; Mutayoba, B; Pearce, R; Roper, C | 1 |
| Barry, A; Chandramohan, D; Conaré, T; Cousens, S; Dara, N; Diallo, AI; Diallo, DA; Dicko, A; Dicko, M; Dicko, Y; Doumbo, OK; Greenwood, B; Milligan, PJ; Santara, G; Sidibe, Y; Tembine, I | 1 |
| Chandramohan, D; Cousens, S; Diallo, DA; Diarra, A; Gansané, A; Greenwood, BM; Kaboré, Y; Kangoyé, DT; Konaté, AT; Milligan, PJ; Ouédraogo, A; Ouédraogo, AZ; Ouédraogo, E; Ouédraogo, IN; Sirima, SB; Soulama, I; Tiono, AB; Yaro, JB | 1 |
| Bousema, T; Drakeley, C; Gosling, R; Hermsen, R; Masokoto, A; Mosha, F; Mwanziva, C; Okell, L; Sauerwein, R; Semvua, S; Shekalaghe, SA; Teelen, K; ter Braak, R; van den Bijllaardt, W; van den Bosch, S | 1 |
| Antwi, G; Chandramohan, D; Greenwood, B; Jones, C; Lagarde, M; Smith Paintain, L; Tagbor, H; Webster, J | 1 |
| Praveen, N; Saifi, MA; Shadab, GG | 1 |
| Egwang, TG; Kiyingi, HS; Nannyonga, M | 1 |
| Ali, D; Filler, SJ; Jafali, J; Kachur, SP; Luka, M; Mace, KE; Mathanga, DP; Mwandama, D; Sande, J; Skarbinski, J | 1 |
| Barnes, KI; Beavogui, AH; Djimde, AA; Doumbo, OK; Evans, A; Fredericks, A; Maiga, H; Sangare, CP; Smith, P; Tekete, MM; Toure, S; Traore, ZI | 1 |
| Cissé, M; Lalou, R; Le Hesran, JY; Sarrassat, S | 1 |
| Clarke, SE; Hansen, KS; Hutchison, CL; Magnussen, P; Ndyomugyenyi, R | 1 |
| Chinkhumba, J; Mathanga, DP; Uthman, OA | 1 |
| Arguin, PM; Doney, AC; Galev, A; Green, M; Kapella, BK; Mekonnen, L; Phares, CR; Stauffer, WM; Weinberg, M | 1 |
| Atua, B; Emch, M; Hand, CC; Meshnick, SR; Messina, JP; Muwonga, J; Mwandagalirwa, K; Taylor, SM; Ter Kuile, FO; Tshefu, AK; van Eijk, AM | 1 |
| Pradhan, P; Rai, SK; Sharma, A; Shrestha, RK | 1 |
| Afsharpad, M; Djadid, ND; Pirahmadi, S; Zakeri, S | 2 |
| Adeoye, SB; Balogun, ST; Fehintola, FA | 1 |
| Abdullah, S; Bloland, P; Kachur, PS; Malisa, AL; Mshinda, H; Mutayoba, BM; Pearce, RJ; Roper, C | 1 |
| Blackstock, AJ; Garner, K; Gatei, W; Gimnig, JE; Hamel, MJ; Hawley, WA; Kariuki, S; Lindblade, K; Nahlen, B; Phillips-Howard, P; Shah, M; Shi, YP; Slutsker, L; ter Kuile, F; Terlouw, D; Vanden Eng, J; Walker, E | 1 |
| Abubakar, I; Bojang, KA; Ceesay, SJ; Conway, DJ; Coulibaly, M; Coulibaly, TF; Dao, A; Diakité, M; Diarra, A; Diawara, S; Doumbia, SO; Duraisingh, M; Fairhurst, RM; Faye, B; Faye, O; Gaye, O; Jawara, M; Kandeh, B; Kéita, M; Koita, OA; Konaté, L; Krogstad, DJ; Long, CA; Muskavitch, MA; Ndiaye, D; Ndiaye, JL; Nwakanma, D; Okebe, J; Perry, R; Poudiougou, B; Sangaré, L; Sarr, O; Sissako, A; Sogoba, N; Sy, N; Traoré, SF; Valim, C; Volkman, SK; Wirth, DF | 1 |
| Ariey, F; Bouchier, C; Chim, P; Durand, R; Fandeur, T; Ke, S; Khim, N; Kim, S; Man, S; Ménard, D; Ratsimbasoa, A; Sum, S; Tichit, M | 1 |
| Adovohekpe, P; Affo, A; de Sousa, A; Guidetti, F; Hassan, J; Lambo, N; Ndiaye, JL; Ndyiae, M; Rabarijaona, LP; Recht, J; Sow, D | 1 |
| Bassene, C; Bygbjerg, IC; Faye, B; Gaye, O; Magnussen, P; Ndiaye, JL; Ndiaye, M; Ndour, CT; Ndour, JD; Sylla, K; Tine, RC | 1 |
| Anvikar, AR; Das, MK; Dash, AP; Gupta, P; Gupta, YK; Kamal, VK; Kumar, H; Mishra, N; Pradhan, K; Shah, NK; Sharma, SK; Srivastava, HC; Valecha, N | 1 |
| Kinde-Gazard, D; Kossou, HD; Sossa, CJ; Vignon Makong, J | 1 |
| Browne, E; Lawson, B; Tutu, EO | 1 |
| Alonso, P; Manzi, F; Maokola, W; Mrisho, M; Mshinda, H; Mushi, A; Schellenberg, DM; Schellenberg, JR; Shirima, K; Tanner, M | 1 |
| D'Alessandro, U; Dramaix, MW; Likwela, JL; Lokwa, BL; Meuris, S | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Dobaño, C; Doolan, DL; Macete, E; Menéndez, C; Nhampossa, T; Puyol, L; Quelhas, D; Quintó, L; Sanz, S; Serra-Casas, E | 1 |
| Ali, I; Barends, M; Beshir, K; Durrani, N; Hallett, R; Kolaczinski, K; Lee, S; Leslie, T; Ord, R; Rowland, M | 1 |
| Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
| Akadiri, G; Bizuneh, K; Bjelic, I; de Sousa, A; Dicko, A; Dodoo, A; Hassan, J; Inkoom, E; Kubalalika, P; Mathanga, D; Ndiaye, JL; Ndiaye, M; Ndiaye, Y; Njarasoa, S; Rabarijaona, LP; Randriasamimanana, JR; Ravelomanantena, HV; Recht, J; Sagara, I; Sow, D; Tenkorang, O; Whang, JN | 1 |
| Gutman, J; Kachur, SP; Mutabingwa, T; Nzila, A; Slutsker, L | 1 |
| Ajah, LO; Obi, SN; Okafor, II; Onah, HE; Ugwu, EO; Umeh, CR; Umeh, UA | 1 |
| Dicko, A; Doumbo, O; Konare, M; Rogier, C; Salamon, R; Testa, J; Traore, D | 1 |
| Atasige, S; Schneider, TA; van Spronsen, JH | 1 |
| D'Alessandro, U; Drabo, MK; Guiguemde, RT; Huybregts, L; Kolsteren, P; Ouedraogo, JB; Sorgho, H; Tinto, H; Valea, I; van Geertruyden, JP | 1 |
| Escalante, AA; Griffing, SM; Kariuki, S; Lal, AA; McCollum, AM; Schneider, KA; Shi, YP; Slutsker, L; Ter-Kuile, F; Udhayakumar, V; Zhou, Z | 1 |
| Diarra, A; Dodoo, D; Konate, A; Nebie, I; Ouedraogo, A; Sirima, SB; Soulama, I; Theisen, M; Tiono, A; Traore, A | 1 |
| Antonia, AL; Chaluluka, E; Feng, G; Meshnick, SR; Molyneux, ME; Mwapasa, V; Rogerson, SJ; Taylor, SM; ter Kuile, FO | 1 |
| Amor, A; Baquero, M; Benito, A; Berzosa, P; Fernández-Martínez, A; Toro, C | 1 |
| Aponte, JJ; Barnadas, C; Beeson, JG; Iga, J; Ley, S; Manong, D; Mueller, I; Rarau, P; Reeder, JC; Robinson, L; Rogerson, SJ; Rosanas-Urgell, A; Salib, M; Schofield, L; Senn, N; Siba, P; Stanisic, DI; Tarongka, N; Zimmerman, PA | 1 |
| Abdulla, SM; Charlwood, JD; Ferguson, HM; Huho, BJ; Kachur, SP; Kihonda, A; Kihonda, J; Killeen, GF; Lengeler, C; Smith, TA; Tami, A | 1 |
| Borgella, S; Briand, V; Cot, M; Deloron, P; Fievet, N; Huynh, BT; Massougbodji, A | 1 |
| Ayisi, J; Desai, M; Gatei, W; Hamel, MJ; Iriemenam, NC; Kariuki, S; Lal, AA; Moore, J; Nahlen, B; Omosun, YO; Otieno, K; Ouma, P; Owino, SO; Shah, M; Shi, YP; Slutsker, L; ter Kuile, FO; van Eijk, AM; Vanden Eng, J | 1 |
| Abdulla, SM; Bloland, PB; Elling, BF; Genton, B; Goodman, CA; Gutman, JR; Kabanywanyi, AM; Kachur, SP; Kahigwa, E; Khatib, RA; Lyimo, T; MacArthur, JR; Mills, A; Mshinda, H; Mwita, A; Njau, JD; Roberts, JM; Skarbinski, J; Smith, EE; Somi, MF; Tanner, M | 1 |
| Ademowo, OG; Adisa, RA; Ogunbayo, OA; Olorunsogo, OO | 1 |
| D'Alessandro, U; Hamed, K; Juma, E; Kayentao, K; Manyando, C; Okafor, HU | 1 |
| Onwujekwe, O; Onwujekwe, OC; Shu, E; Soremekun, RO; Uzochukwu, B | 1 |
| Francis, F; Ishengoma, DS; Kamugisha, ML; Lemnge, MM; Malecela, EK; Mmbando, BP; Rutta, AS; Sadi, JY; Sembuche, SH | 1 |
| Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Bin Dajem, SM | 1 |
| Baret, E; Bercion, R; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, F; Fall, KB; Mbaye, PS; Pascual, A; Pradines, B; Rogier, C; Sow, K; Wade, B; Wurtz, N | 1 |
| Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Beja-Pereira, A; Bin Dajem, SM; Idris, MA | 1 |
| Dzinjalamala, FK; Gilliams, EA; Jacob, CG; Kenefic, LJ; Laufer, MK; Laurens, MB; Molyneux, ME; Nyirenda, OM; Plowe, CV; Shaukat, AM; Taylor, TE; Thesing, PC | 1 |
| Campos, PA; Campos, RB; Gonçalves, L; Rosário, VE; Silveira, H; Valente, B; Varandas, L | 1 |
| Cheung, YB; Lam, KF; Milligan, P; Xu, Y | 1 |
| Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Gaudart, J; Giorgi, R; Sagara, I; Sanogo, K; Sidibe, B; Togo, A; Toure, S | 1 |
| Chaluluka, E; Feng, G; Meshnick, SR; Molyneux, ME; Rogawski, ET; Rogerson, SJ | 1 |
| Ashorn, P; Cheung, YB; Kulmala, T; Luntamo, M; Maleta, K; Meshnick, SR; Rantala, AM | 1 |
| Crawley, J; Goodman, T; Milligan, P; Sismanidis, C | 1 |
| Boncy, J; Carter, TE; Existe, A; Fukuda, MM; Memnon, G; Mulligan, CJ; Okech, BA; Oscar, R; Victor, YS; Warner, M | 1 |
| Kironde, F; Mirembe, F; Namusoke, F; Ntale, M; Wahlgren, M | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Baird, JK; de Monbrison, F; Laihad, F; Picot, S; Ruckert, P; Suprianto, S; Sutanto, I; von Bethmann, A; Widiaty, A | 1 |
| McGready, R; Nosten, F | 2 |
| Anglewicz, PA; Bennett, A; Eisele, TP; Hutchinson, P; Keating, J; Larsen, DA; Steketee, RW; Yukich, J | 1 |
| Ahiante, BO; Anaba, FC; Pepple, DJ | 1 |
| Burguillo, FJ; López-Abán, J; Muro, A; Pérez del Villar, L | 1 |
| Abuaku, BK; Duah, NO; Koram, KA; Kronmann, KC; Quashie, NB; Sebeny, PJ | 1 |
| Akbari, S; Vaidya, NK; Wahl, LM | 1 |
| Jia, JY; Liu, GY; Liu, Y; Liu, YM; Lu, C; Pu, HH; Song, YX; Yu, C; Zhang, HC; Zhang, KE; Zheng, QS; Zhu, JM | 1 |
| Carlsted, A; Nystrom, L; Urassa, DP | 1 |
| Abdul-Ghani, R; Allam, AF; Farag, HF | 1 |
| Adegnika, AA; Basra, A; Diop, DA; Fürstenau, M; Gonzalez, R; Kremsner, PG; Mackanga, JR; Melser, MC; Menendez, C; Mombo-Ngoma, G; Ramharter, M; Würbel, H; Zoleko, RM | 1 |
| Mita, T; Tanabe, K | 1 |
| Brilhante, RS; de Aguiar Cordeiro, R; de Farias Marques, FJ; de Jesus Pinheiro Gomes Bandeira, T; de Oliveira Miranda, DF; Mourão, CI; Neto, LV; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| Ashorn, P; Lin, JT; Luntamo, M; Mbewe, B; Meshnick, SR; Taylor, SM | 1 |
| Alonso, P; Kaur, H; Lupala, C; Manzi, F; Mshinda, H; Ord, R; Pearce, RJ; Roper, C; Schellenberg, D; Schellenberg, J; Shirima, K; Tanner, M | 1 |
| Abimbola, EA; Albert Taiwo, EO; Douglass, IA; Eigbibhalu, UG | 1 |
| Ding, S; McCutchan, TF; Pan, W; Sun, X; Ye, R; Zhang, D; Zhou, H | 1 |
| Das Sutar, SK; Dhangadamajhi, G; Kar, SK; Ranjit, M | 1 |
| Ashorn, P; Doumbo, OK; Garner, P; Kayentao, K; Luntamo, M; MacArthur, JR; Mulokozi, A; Naidoo, I; Roper, C; ter Kuile, FO; van Eijk, AM | 1 |
| Ashorn, P; Cheung, YB; Kulmala, T; Luntamo, M; Maleta, K | 1 |
| Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP | 2 |
| Angheben, A; Bisoffi, Z; Buonfrate, D; Gobbi, F; Sirima, BS; Tinto, H; Van den Ende, J | 1 |
| Kleinschmidt, I; Tsoka-Gwegweni, JM | 1 |
| Dent, AE; Goldenberg, RL; McClure, EM; Meshnick, SR | 1 |
| Awab, GR; Day, NP; Dondorp, AM; Imwong, M; Jamornthanyawat, N; Pukrittayakamee, S; White, NJ; Woodrow, CJ; Yamin, F | 1 |
| Abiola, A; Ba, el-H; Cairns, M; Cisse, B; Dieng, Y; Faye, B; Faye, O; Gaye, O; Gomis, JF; Hallett, R; Lo, AC; Milligan, P; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Ndir, O; Sokhna, C; Sutherland, C; Tine, R | 1 |
| Azagnandji, C; Bello, M; Chippaux, JP; d'Almeida, S; Kinde Gazard, D; Koussihoude, L; Massougbodji, A; Ndam, NT; Ogouyèmi-Hounto, A; Ollo, E | 1 |
| Opare, DA | 1 |
| Bonaparte, F; Hobday, K; Kelly, PM; Martins, JS; Zwi, AB | 1 |
| Barrera, SM; Cucunubá, ZM; Guerra, AP; Hernández, DC; Nicholls, RS | 1 |
| Bamba, S; Dao, B; Guiguemdé, RT; Halidou, T; Nikiéma, R; Séré, A; Thiéba, B | 1 |
| Khwa-Otsyula, B; O'Meara, WP; Obala, A; Thirumurthy, H | 1 |
| Alifrangis, M; De Tove, YS; Deloron, P; Doritchamou, J; Luty, AJ; Massougbodji, A; Moussiliou, A; Ndam, NT | 1 |
| Anchang-Kimbi, JK; Bissemou, ZB; Kimbi, HK; Lehman, LG; Nyabeyeu, HN; Tonga, C | 1 |
| Bruce, J; Dellicour, S; Desai, M; Hamel, MJ; Hill, J; Kariuki, S; Ombock, M; Otieno, P; Ouma, P; Smedley, J; ter Kuile, FO; Webster, J | 1 |
| Ali, D; Gutman, J; Mathanga, DP; Mwandama, D; Skarbinski, J; Wiegand, RE | 1 |
| Anvikar, AR; Das, MK; Mishra, N; Ratha, J; Shah, NK; Sharma, SK; Srivastava, B; Srivastava, P; Valecha, N | 1 |
| Beg, MA; Ghanchi, NK; Khan, MS; Raza, A | 1 |
| Dara, A; Djimdé, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Kayentao, K; Ongoiba, OA; Ouologuem, TD; Traoré, B | 1 |
| Chertok, IR; Gurka, KK; Haile, ZT; Sambamoorthi, U | 1 |
| Marma, AS; Mita, T; Nakamura, M; Ohashi, J; Plowe, CV; Tanabe, K; Venkatesan, M | 1 |
| Adjei, O; Kang, H; Kreuels, B; Krumkamp, R; May, J; Small, DS | 1 |
| D'Mello-Guyett, L; Hill, J; Hoyt, J; Smith, H; Steketee, R; Ter Kuile, FO; van Eijk, AM; Webster, J | 1 |
| Bata, GG; Boulay, A; Gondje, S; Kazanji, M; Le-Fouler, L; Manirakiza, A; Moussa, S; Moyen, JM; Sakanga, O; Sepou, A; Serdouma, E; Vray, M | 1 |
| Alifrangis, M; Plowe, CV; Roper, C; Venkatesan, M | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Sharma, L; Shukla, G | 1 |
| Flegg, JA; Gharbi, M; Guerin, PJ; Hopkins Sibley, C; Metcalf, CJE; Shewchuk, T; Venkatesan, M | 1 |
| Ades, V; Arinaitwe, E; Chang, M; Dorsey, G; Filler, S; Kamya, MR; Mugagga, O; Nasr, S; Ninsiima, B; Patil, TS; Schwartz, A; Walakira, A | 1 |
| Ba-Break, MM; Graham, KJ | 1 |
| Brieger, WR; Okeibunor, JC; Onyeneho, NG; Orji, BC | 1 |
| Birungi, J; Magnussen, P; Mbonye, AK; Yanow, S | 1 |
| Eisele, TP; Hill, J; Larsen, DA; Steketee, RW; ter Kuile, FO; van Eijk, AM; Webster, J | 1 |
| Hailemeskel, E; Kassa, M; Kebede, A; Mohammed, H; Petros, B; Sleshi, M; Taddesse, G; Tasew, G; Woyessa, A | 1 |
| Belay, KA; Diala, CC; Marin, C; Pennas, T | 1 |
| Doua, JY; Lutumba, P; Matangila, J; Van Geertruyden, JP | 1 |
| Bloch, P; Byskov, J; Magnussen, P; Mubyazi, GM | 1 |
| Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
| Molloy, AM; Nzila, A; Okombo, J | 1 |
| Gogtay, N; Kannan, S; Olliaro, PL; Sinclair, D; Thatte, UM | 1 |
| McKoy, MG; Pepple, DJ; Richards, AA; Richards, PD | 1 |
| Chandramohan, D; Chico, RM; Hack, BB; Newport, MJ; Ngulube, E | 1 |
| Bisong, CE; Dongmo, CM | 1 |
| Azagnandji, C; Bello, M; Chippaux, JP; Fadégnon, G; Kinde Gazard, D; Massougbodji, A; Moussiliou, A; Ndam, NT; Ogouyèmi-Hounto, A | 1 |
| Asma, U; Khan, W; Zakai, HA | 1 |
| Akouete, F; Akpaloo, Y; Caumes, E; D'Almeida, S; Kendjo, E; Klement, E; Patassi, A; Pitché, P; Prince-Agbodjan, S; Singo, A; Tossa, K | 1 |
| Abdul-Ghani, R; Allam, AF; Farag, HF; Shawky, SM | 1 |
| Exavery, A; Kinyonge, IP; Kweka, H; Makemba, A; Mbaruku, G; Mbuyita, S | 1 |
| Bloch, P; Bygbjerg, IC; Byskov, J; Ijumba, JN; Magnussen, P; Marero, M; Mboera, LE; Molteni, F; Mubyazi, GM | 1 |
| Barry, B; Bationo, R; Coulibaly, SO; Dabira, E; Diakite, H; Djimde, M; Doumbo, OK; Guindo, N; Guirou, EA; Kayentao, K; Keita, M; Khairallah, C; Konate, S; Magnussen, P; Meshnick, SR; Niangaly, M; Soulama, A; Taylor, S; ter Kuile, FO; Traore, B | 1 |
| Anvikar, AR; Das, MK; Gupta, R; Mishra, N; Rana, R; Shahi, B; Singh, S; Valecha, N | 1 |
| D'Alessandro, U; Drabo, MK; Guiguemde, RT; Henry, MC; Huybregts, L; Kolsteren, P; Roberfroid, D; Tinto, H; Valea, I | 1 |
| Macedo De Oliveira, A; Rodriguez, B; Soto, AM; Sridaran, S; Udhayakumar, V | 1 |
| Awad, AI; Elamin, SB; Matar, KM | 1 |
| Bruce, J; Diarwara, S; Doumbo, OK; Hill, J; Kayentao, K; Smedley, J; ter Kuile, FO; Touré, M; Webster, J | 1 |
| Kalinga, A; Kauki, JS; Kavishe, AA; Kavishe, RA; Matondo, SI; Reyburn, H; Temba, GS; van Zwetselaar, M | 1 |
| Dent, AE; Goldenberg, RL; Hudgens, M; King, CL; Lazebnik, N; McClure, EM; Meshnick, SR; Mungai, P; Siega-Riz, AM | 1 |
| Arinaitwe, E; Baliraine, FN; Conrad, MD; Dorsey, G; Greenhouse, B; Kamya, M; Mbogo, GW; Nankoberanyi, S; Nsobya, SL; Rosenthal, PJ; Staedke, SG; Tappero, J; Tukwasibwe, S | 1 |
| Fouedjio, HJ; Fouelifack, FY; Mbu, RE; Takang, WA; Tonye, R; Tumasang, FN | 1 |
| Andre, ZH; Dickerson, A; Eckert, E; Gomez, PP; Gutman, J; Hamel, MJ; Roman, E; Youll, S | 1 |
| Chase, RP; Gutman, J; Hendler, N; Khamis, AR; Kitojo, C; McElroy, PD; Msellem, MI; Plotkin, M; Roman, E; Said, K; Schwartz, AC | 1 |
| Chalwe, V; Craig, AS; Filler, SJ; Kamuliwo, M; Katalenich, BL; Mace, KE; Meshnick, SR; Nambozi, M; Tan, KR; Taylor, SM; Wiegand, RE | 1 |
| Das, MK; Savargaonkar, D; Shah, N; Srivastava, B; Valecha, N | 1 |
| Chilongola, J; Genton, B; Mosha, D; Mwingira, F; Ndeserua, R | 1 |
| Amuri, M; Chipwaza, B; Gwakisa, PS; Makungu, C; Mayumana, I; Mugasa, JP | 1 |
| Abellana, R; Cot, M; Moya-Alvarez, V | 1 |
| Boudova, S; Cohee, LM; Joshi, S; Kalilani-Phiri, L; Kamiza, S; Laufer, MK; Makwakwa, K; Mawindo, P; Muehlenbachs, A; Mukadam, R; Seydel, KB; Taylor, TE; Thesing, P | 1 |
| Davies, MA; Egger, M; Mbeye, NM; Phiri, KS; ter Kuile, FO; Wandeler, G | 1 |
| Anvikar, AR; Bharti, RS; Dev, V; Dhariwal, AC; Kaitholia, K; Mishra, N; Narayan, JP; Phookan, S; Rana, R; Shah, NK; Sonal, GS; Srivastava, B; Valecha, N | 1 |
| Achan, J; Aweeka, FT; Bigira, V; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Kamya, MR; Kapisi, J; Kinara, S; Muhindo, MK; Mwangwa, F; Osterbauer, B; Rosenthal, PJ | 1 |
| Arróspide, N; Cabezas-Sánchez, C; de Mora, D; Diaz-Cortéz, CE; Gutierrez, S; Hijar-Guerra, G; Veloz-Perez, R | 1 |
| Huang, B; Huang, S; Li, H; Lu, F; Su, XZ; Tong, X; Yan, J | 1 |
| Ahmed, MA; Bhattacharyya, DR; Bora, K; Goswami, BK; Mahanta, J; Mohapatra, PK; Prakash, A; Sarma, B; Sarma, DK | 1 |
| Basuki, S; Dachlan, YP; Riyanto, S; Uemura, H | 1 |
| Agarwal, K; Brieger, W; Dickerson, A; Rawlins, B; Roman, E; Wallon, M | 1 |
| Bisaso, RK; Byamugisha, J; Obua, C; Odongo, CO | 1 |
| Bobogare, A; Cheng, Q; Gray, KA; Gresty, KJ; Hii, J; Taleo, G; Waters, NC; Wini, L | 1 |
| Aluko, JO; Oluwatosin, OA | 1 |
| Akindeh-Nji, M; Ali, IM; Atogho-Tiedeu, B; Baldip, K; Diakite, M; Domkam, IK; Evehe, MS; Lamb, T; Mbacham, WF; Mimche, PN; Netongo, PM; Ngora, H; Ranford-Cartwright, L | 1 |
| Bamba, S; Bayane, D; Cisse, M; Guiguemde, RT; Lougue, G; Sangare, I | 1 |
| Ako, BA; Bassinka, I; Beourou, S; Bokossa, EM; Coulibaly, B; Coulibaly, MA; Esmel, B; Gba, B; Gbessi, EA; Koffi, D; Kone, PL; N' Guessan, LT; Nogbou, M; Soumahoro, A; Swa, T; Toure, OA | 1 |
| Dosani, A; Matovelo, D; Mazigo, HD; Mpogoro, FJ; Mugono, M; Ngallaba, S | 1 |
| Achan, J; Aweeka, FT; Bigira, V; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Kapisi, J; Kinara, S; Muhindo, MK; Mwangwa, F; Rosenthal, PJ | 1 |
| Ali, D; Chaluluka, E; Dzinjalamala, F; Gutman, J; Kalilani, L; Khairallah, C; Madanitsa, M; Mathanga, DP; Meshnick, S; Mwandama, D; Shi, YP; Skarbinski, J; Taylor, S; ter Kuile, FO; Thwai, KL; Wiegand, RE; Zhou, Z | 1 |
| Bardaji, A; Betuela, I; Hanieh, S; Kongs, C; Lufele, E; Menendez, C; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, SJ; Rosanas-Urgell, A; Samol, P; Schofield, L; Siba, P; Singirok, D; Suen, CS; Sui, D; Umbers, AJ; Unger, HW; Wangnapi, RA; Wapling, J | 1 |
| Artimovich, E; Dzinjalamala, FK; Escalante, AA; Kublin, JG; Laufer, MK; Plowe, CV; Schneider, K; Takala-Harrison, S; Taylor, TE | 1 |
| Aho, C; Greenhill, AR; Hanieh, S; Jack, W; Lafana, A; Michael, A; Mueller, I; Ome-Kaius, M; Rogerson, SJ; Siba, P; Umbers, AJ; Unger, HW; Wangnapi, RA | 1 |
| Akazili, J; Fernandes, S; Hanson, K; Hill, J; Kayentao, K; Madanitsa, M; Sicuri, E; ter Kuile, FO; van Eijk, AM; Webster, J; Were, V | 1 |
| Adegnika, AA; Agnandji, ST; Akerey-Diop, D; Basra, A; Bélard, S; Capan-Melser, M; González, R; Groger, M; Kremsner, PG; Lötsch, F; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo Ngoma, G; Ramharter, M; Rehman, K; Schipulle, U; Schwing, J; Würbel, H; Zoleko-Manego, R | 1 |
| Beavogui, AH; Dama, S; Dara, A; Dembele, D; Diallo, N; Djimde, AA; Doumbo, OK; Maiga, H; N'Dong, C; Niangaly, H; Sagara, I; Sangare, CP; Tekete, M; Toure, O; Traore, OB; Traore, ZI | 1 |
| Chalwe, V; Craig, AS; Filler, SJ; Kamuliwo, M; Katalenich, BL; Mace, KE; Mubikayi, L; Mulele, CK; Nambozi, M; Tan, KR; Wiegand, RE | 1 |
| Laufer, MK; Takala-Harrison, S | 1 |
| Barnwell, JW; Goldman, IF; Kariuki, S; Komino, F; Ljolje, D; Lucchi, NW; Okoth, SA; Onyona, P; Shi, YP; Udhayakumar, V | 1 |
| Abdulla, S; Aponte, J; Cot, M; Desai, M; Fernandes, S; González, R; Hanson, K; Katana, A; Kremsner, P; Kuwawenaruwa, A; Macete, E; Massougbodgi, A; Menéndez, C; Mombo-Ngoma, G; Ramharter, M; Sicuri, E; Slustker, L | 1 |
| Compaore, YD; Greenwood, B; Milligan, P; Nosten, F; Ouedraogo, JB; Rosenthal, PJ; Some, AF; Sutherland, C; Tarning, J; Zongo, I | 1 |
| Bakoua, D; Fesser, A; Koukouikila-Koussounda, F; Nkombo, M; Ntoumi, F; Vouvoungui, C | 1 |
| Girmann, M; Hahn, A; Maïga-Ascofaré, O; May, J; Poppert, S; Rakotozandrindrainy, R; Randriamampionona, N; Schwarz, NG | 1 |
| Chipeta, J; Mharakurwa, S; Michelo, C; Siame, MN; Thuma, P | 1 |
| Abdallah, J; Gutman, J; Iriemenam, NC; Mathanga, DP; Mwandama, D; Shi, YP; Skarbinski, J; Wiegand, RE | 1 |
| Batty, KT; Benjamin, JM; Davis, TM; Lorry, L; Moore, BR; Mueller, I; Page-Sharp, M; Robinson, LJ; Salman, S; Siba, PM; Tawat, S; Yadi, G | 1 |
| Baker, M; Marquart, L; McCarthy, JS; O'Rourke, P | 1 |
| Brown, GV; Hasang, W; Mueller, I; Randall, LM; Rogerson, SJ; Siba, PM; Teo, A; Unger, HW | 1 |
| Hines, CS; Kibusi, SM; Kimunai, E | 1 |
| Briand, V; Cot, M; Escolano, S; Journot, V; Massougbodji, A; Tubert-Bitter, P | 1 |
| Abate, L; Awono-Ambéné, PH; Berry, A; Chauvin, P; Iriart, X; Menard, S; Morlais, I; Nsango, SE; Tchioffo, MT | 1 |
| Boakye, DA; Grobler, AF; Mbacham, WF; Ndong, IC; Reenen, Mv | 1 |
| Cot, M; Denoeud-Ndam, L; Ezinmegnon, S; Girard, PM; Ibitokou, SA; Ladékpo, R; Luty, AJ; Massougbodji, A; Ndam, NT; Zannou, DM | 1 |
| Bejon, P; Gitonga, CW; Karuri, SW; Kibuchi, E; Mwandawiro, C; Noor, AM; Sang, G; Snow, RW | 1 |
| Alifrangis, M; Birungi, J; Magnussen, P; Malamba, S; Mbonye, AK; Shokoples, S; Yanow, SK | 1 |
| Bardají, A; Ferenchick, E; Mangiaterra, V; Menéndez, C; Roman, E | 1 |
| Bahamontes-Rosa, N; Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP; Nzong, J; Tshibola, ML; Tsoumbou-Bakana, G | 1 |
| Abubakar, I; Akor, F; Awine, T; Bationo, R; Bojang, K; Cairns, M; Chandramohan, D; Coulibaly, SO; Dabira, E; Djimdé, M; Doumbo, O; Greenwood, B; Guirou, E; Hodgson, A; Kayentao, K; Magnussen, P; Meshnick, S; Milligan, P; Mohammed, K; Njie, F; Oduro, A; Ordi, J; Quaye, S; Soulama, A; Tagbor, H; Taylor, S; ter Kuile, F; Williams, J; Woukeu, A | 1 |
| Eckert, E; Moran, A; Nsabagasani, X; Yé, Y; Yoder, PS | 1 |
| Anvikar, A; Chandra, J; Gahlawat, SK; Gupta, P; Kumar, A; Moirangthem, R; Singh, V; Valecha, N | 1 |
| Ariti, C; Cano, J; Chandramohan, D; Chico, RM; Collier, TJ; Greenwood, B; Roper, C | 1 |
| Amu, A; Anyorigiya, T; Asante, KP; Awini, E; Bart-Plange, C; Dosoo, D; Gyapong, M; Hodgson, A; Jakpa, G; Mahama, E; Oduro, AR; Ofei, E; Owusu, R; Owusu-Agyei, S; Segbaya, S | 1 |
| D'Alessandro, U; Erhart, A; Fitzhenry, R; Guiguemde, RT; Kazienga, A; Ouedraogo, JB; Rosanas-Urgell, A; Tahita, MC; Tinto, H; Van Geertruyden, JP; VanOvermeir, C | 1 |
| Boeuf, P; Karl, S; Mueller, I; Ome-Kaius, M; Rogerson, SJ; Unger, HW; Wangnapi, RA | 1 |
| Adiossan, LG; Brittenham, GM; Diakité, VG; Glinz, D; Hurrell, RF; N'Goran, EK; Ouattara, M; Righetti, AA; Seifert, B; Utzinger, J; Wegmüller, R; Zimmermann, MB | 1 |
| Asih, PB; Dewi, RM; Lobo, NF; Marantina, SS; Nababan, R; Rozi, IE; Sauerwein, RW; Sumarto, W; Syafruddin, D; Taufik, AS; Tuti, S | 1 |
| Desai, M; Gutman, J; Juma, E; Kariuki, S; Katana, A; L'lanziva, A; Laserson, K; Otieno, K; Ouma, P; ter Kuile, FO; Were, V; Williamson, J | 1 |
| Guma, GT; Kassa, M; Kebede, A; Leta, GT; Mohammed, H; Petros, B; Tessema, SK; Woyessa, A | 1 |
| Artimovich, E; Brown, S; Escalante, AA; Joshi, S; Kapito-Tembo, A; Laufer, MK; Mathanga, D; Nyirenda, O; Pensulo, P; Takala-Harrison, S; Taylor, TE | 1 |
| Ades, V; Arinaitwe, E; Chaluluka, E; Coulibaly, SO; Desai, M; Doumbo, O; Edgar, D; Gutman, J; Kalilani, L; Kamuliwo, M; Kayentao, K; Khairallah, C; Mace, KE; Magnussen, P; Mathanga, DP; Meshnick, S; Otieno, K; Ouma, P; Shi, YP; Skarbinski, J; Taylor, SM; Ter Kuile, FO; Wiegand, RE | 1 |
| Aucamp, M; Liebenberg, W; Milne, M | 1 |
| Baraka, V; Fransis, F; Ishengoma, DS; Madebe, RA; Minja, DT; Ngatunga, D; Van Geertruyden, JP | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Bisaso, KR; Byamugisha, J; Mukonzo, JK; Ntale, M; Obua, C; Odia, G; Odongo, CO; Ojara, FW | 1 |
| Basu, A; Guha, SK; Saha, S | 1 |
| Alifrangis, M; Baraka, V; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Hashim, R; Ishengoma, D; Mosha, J; Poirot, E; Vittinghoff, E | 1 |
| Auma, A; Bigira, V; Bowen, K; Boyle, MJ; Dorsey, G; Farrington, LA; Feeney, ME; Jagannathan, P; Kamya, MR; Kapisi, J; McIntyre, TI; Nalubega, M; Naluwu, K; Nankya, F; Sikyomu, E; Vance, HM; Wamala, S | 1 |
| Bamaga, OA; Lim, YA; Mahdy, MA | 1 |
| Arevalo-Herrera, M; Cartwright, RA; Escalante, AA; Herrera, S; Pacheco, MA; Schwartz, RS; Vallejo, AF; Winter, DJ | 1 |
| Babakhanyan, A; Bobbili, N; Fogako, J; Leke, RG; Leke, RJ; Salanti, A; Taylor, DW; Tutterrow, YL; Wey, A | 1 |
| Kupka, R | 1 |
| Awine, T; Belko, MM; Cairns, M; Chandramohan, D; Greenwood, B; Milligan, P; Oduro, AR; Oyakhirome, S; Tagbor, H; Williams, JE | 1 |
| Abdulla, S; Accrombessi, M; Adegnika, AA; Aponte, JJ; Briand, V; Cot, M; González, R; Kabanywanyi, AM; Kakolwa, MA; Kremsner, PG; Macete, E; Manego Zoleko, R; Massougbodji, A; Menéndez, C; Mombo-Ngoma, G; Ouédraogo, S; Ramharter, M; Rupérez, M; Sevene, E; Vala, A | 1 |
| Charpiat, B; Corvaisier, S; Dupont, D; Leboucher, G; Peyron, F; Teil, J; Vial, T; Wallon, M | 1 |
| Chilongola, J; Juma, A; Mosha, D; Ndeserua, R | 1 |
| Basavaprabhu, A; Deepak, M; Soundarya, M | 1 |
| Acquah, S; Afoakwah, R; Boampong, JN; Iriemenam, NC; Nwaefuna, E; Onyeabor, OS; Orish, VN; Sanyaolu, AO | 1 |
| Ategeka, J; Awori, P; Charlebois, ED; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muehlenbachs, A; Muhindo, MK; Nakalembe, M; Natureeba, P; Nayebare, P; Olwoch, P; Opira, B; Rizzuto, G | 1 |
| Anchang-Kimbi, JK; Fokam, EB; Ngimuh, L; Wanji, S | 1 |
| Carlton, JM; Chauhan, K; Das, A; Kar, NP; Kumar, A; Nanda, N | 1 |
| Kalilani, L; Khairallah, C; Meshnick, SR; Mwapasa, V; Patel, JC; Taylor, SM; Ter Kuile, FO; Thwai, KL | 1 |
| Heide, L; Jähnke, RW; Khuluza, F; Kigera, S | 1 |
| Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A | 1 |
| Akpet, OEO; Ameh, S; Ekpenyong, N; Enembe, O; Etokidem, A; Kabiru, CW; Owoaje, E; Oyo-Ita, A | 1 |
| Caillet, C; Guerin, PJ; Newton, PN | 1 |
| Abd-Elmajid, MB; Adam, MA; Adeel, AA; Ali, MS; Atta, H; Barrette, A; Elhelo, MM; Elmardi, KA; Elnour, FA; Mohammady, HE; Nada, RA; Warsame, M; Zamani, G | 1 |
| Al-Jasari, A; Al-Mekhlafi, HM; Atroosh, WM; Lau, YL; Nasr, NA; Sady, H; Snounou, G; Surin, J | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
| Almeida-de-Oliveira, NK; Daniel-Ribeiro, CT; Ferreira-da-Cruz, Mde F; Fortes, F; Gama, BE; Gomes, LR; Kaingona-Daniel, EP; Ménard, D | 1 |
| Ambounda, N; Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Mawili-Mboumba, DP; Moutandou Chiesa, S; Tshibola Mbuyi, ML; Tsoumbou-Bakana, G; Zong, J | 1 |
| de Nguefack, MA; Eko, FE; Enow, RM; Essiben, F; Foumane, P; Mboudou, ET; Njotang, PN | 1 |
| Ayoub, A; Duparc, S; Kamiza, S; Kimani, J; Orrico, R; Phiri, K; Robbins, J; Rojo, R; Vandenbroucke, P | 1 |
| Moshiro, C; Protas, J; Tarimo, D | 1 |
| Alifrangis, M; Ishengoma, D; Kaaya, RD; Kavishe, AA; Kavishe, RA; Krogsgaard, C; Nag, S; Notland, JG; Roper, C | 1 |
| Abdul-Ghani, R; Alareqi, LMQ; Fong, MY; Lau, YL; Mahdy, MAK; Mahmud, R | 1 |
| Ishunga, E; Kimambo, R; Matasha, E; Matumu, G; Ngilangwa, DP; Noronha, R; Peng, Y; Sambili, B | 1 |
| Graham, K; Gudoi, SS; King, R; Meier, J; Mufubenga, P; Rassi, C | 1 |
| Barnwell, JW; Boncy, J; Chang, MA; Griffing, S; Huber, C; Ljolje, D; Lucchi, N; McMorrow, M; Morton, LC; Okoth, SA; Oscar, R; Townes, D; Udhayakumar, V | 1 |
| Banik, A; Das, S; Hati, AK; Roy, S | 1 |
| Diarra, NH; Diop, SI; Doumbia, SO; Harvey, SA; Hurley, EA; Klein, MC; Rao, N | 1 |
| Katamba, H; Okullo, AE; Rubahika, D; Wanzira, H | 1 |
| Ali, D; Faragher, B; Kalilani, L; Kang'ombe, A; Khairallah, C; Levitt, B; Madanitsa, M; Meshnick, S; Mwapasa, V; Pace, C; Smedley, J; Taylor, SM; Ter Kuile, FO; Thwai, KL; van Eijk, AM; Wang, D | 1 |
| Grobusch, MP; Hakizimana, E; Kateera, F; Kumar, N; Mens, PF; Mutesa, L; Nsobya, SL; Tukwasibwe, S; van Vugt, M | 1 |
| Agyepong, IA; Amoakoh-Coleman, M; Ansah, EK; Grobbee, DE; Kayode, GA; Klipstein-Grobusch, K | 1 |
| Basco, LK; Gaye, O; Lebatt, SM; Lo, B; Ouldabdallahi, MM; Sarr, O | 1 |
| Ba, EH; Cairns, M; Cissé, B; Fall, FB; Faye, B; Gaye, O; Gomis, JF; Greenwood, BM; Kouevijdin, E; Milligan, PJ; Molez, JF; NDiaye, JL; Ndour, CT; Niane, FK; Rogier, C; Sokhna, C; Trape, JF | 1 |
| Abdullah, NR; Imwong, M; Jelip, J; Mohd Abd Razak, MR; Mudin, RN; Muhammad, A; Muniandy, PK; Norahmad, NA; Rundi, C; Saat, MN; Sastu, UR; Syed Mohamed, AF; Tikuson, M; Yusof, N | 1 |
| Arez, AP; Berzosa, P; de Sousa, B; Guerra, M; Mendes, C; Ndong-Mabale, N; Neres, R; Salgueiro, P | 1 |
| Chi, BH; Kumwenda, A; Smid, M; Stoner, MC; Stringer, E; Stringer, JS; Vwalika, B | 1 |
| Abdul-Azeez, J; Abegunde, D; Austin, AM; Beal, K; Fapohunda, B; Ganiyu, H; Ibrahim, M; Mohammed, Z; Nanbol, Z; Orobaton, N | 1 |
| Jain, S; Kumari, S; Lakshman, A; Sharma, N; Singh, C; Singhal, M; Varma, S | 1 |
| Baba, ES; Bruce, J; Chandramohan, D; Enato, IG; Falade, CO; Hamade, P; Meek, S; Oguike, MC; Roper, C; Shu, E; Sutherland, CJ; Warhurst, D; Watila, I; Webster, J | 1 |
| Dorsey, G; Gutman, J; Kovacs, S; Stergachis, A; Ter Kuile, FO | 1 |
| Ba, EH; Cairns, M; Cissé, B; Dial, Y; Fall, FB; Faye, B; Faye, E; Faye, O; Faye, OK; Faye, S; Flach, C; Gaye, O; Gomis, JF; Greenwood, B; Konate, L; Kouevijdin, E; Lo, A; Milligan, P; NDiaye, JL; NDiaye, M; Pitt, C; Sokhna, C; Sutherland, C; Sy, O; Thior, PM; Tine, R; Trape, JF | 1 |
| Benavente, ED; Campino, S; Clark, TG; Craig, A; Jensen, AT; Kwiatkowski, DP; Mipando, M; Montgomery, J; Ocholla, H; Phiri, KS; Ravenhall, M; Roper, C; Sepúlveda, N; Sutherland, CJ; Terlouw, A | 1 |
| Rogerson, SJ; Unger, HW | 1 |
| Gutman, J; Slutsker, L | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| Esimone, C; Ezenduka, C; Godman, BB; Massele, A; Nworgu, C | 1 |
| Benito, A; Berzosa, P; Esteban-Cantos, A; Fernández, T; García, L; González, V; Herrador, Z; Navarro, M; Ncogo, P; Riloha, M; Romay-Barja, M; Rubio, JM; Santana-Morales, M; Valladares, B | 1 |
| da Luz, RI; Doua, JY; Lutumba, P; Matangila, JR; Mitashi, P; Van Geertruyden, JP | 1 |
| Awandare, GA; Cisse, M; Guiguemdé, RT; Hayette, MP; Soulama, A; Tinto, H | 1 |
| Afari, EA; Malm, KL; Nyarko, KM; Sackey, SO; Stephen, AA; Wurapa, F | 1 |
| Chemla, C; Villena, I | 1 |
| Dupont, D; Peyron, F | 1 |
| Lee, SJ; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO | 1 |
| Duffy, PE; Fried, M | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, CA; Phiri, K | 1 |
| Baiwog, F; Davis, TME; Griffin, S; Ilett, KF; Karunajeewa, HA; Mueller, I; Page-Sharp, M; Rogerson, SJ; Salman, S; Siba, PM | 1 |
| Cairns, M; Floyd, J; Ter Kuile, F; Walker, PG | 1 |
| Ariti, C; Chandramohan, D; Chaponda, EB; Chico, RM | 1 |
| d'Alessandro, U; de Jong, MD; Derra, K; Geskus, RB; Lompo, P; Mens, PF; Ruizendaal, E; Schallig, HDFH; Scott, S; Tahita, MC; Tinto, H; Traore-Coulibaly, M; Versteeg, I | 1 |
| Achidi, EA; Anchang-Kimbi, JK; Mendimi, JN; Nkegoum, B; Sverremark-Ekström, E; Troye-Blomberg, M | 1 |
| Chatterjee, M; Ganguly, S; Guha, SK; Maji, AK; Saha, P | 1 |
| Gudo, ES; Sacarlal, J; Salomão, C | 1 |
| Ali, NA; Bharti, PK; Dhariwal, AC; Kashyotia, SS; Kumar, A; Mishra, S; Shukla, MM; Singh, N | 1 |
| York, A | 1 |
| Bailey, JA; Doctor, SM; Gutman, J; Hathaway, NJ; Ishengoma, DS; Juliano, JJ; Kaspar, N; Keeler, C; Kitojo, C; Lalji, S; Meshnick, SR; Mkude, S; Munishi, OM; Ngondi, JM; Paxton, LA; Thwai, KL; Willilo, RA | 1 |
| Adam, I; Barnes, KI; de Kock, M; Denti, P; Nyunt, MM; Tarning, J; Workman, L | 1 |
| Clark, RL | 1 |
| Amambua-Ngwa, A; Awolola, TS; Idowu, ET; Olukosi, YA; Oyebola, KM | 1 |
| Baiwog, F; Davis, TME; Ilett, KF; Karunajeewa, HA; Kose, K; Mueller, I; Page-Sharp, M; Rogerson, SJ; Salman, S; Siba, PM | 1 |
| Bhagavathula, AS; Gebreyohannes, EA; Seid, MA; Tegegn, HG | 1 |
| Bhadhuria, S; Bhatta, RS; Bhosale, VV; Chandasana, H; Chhonker, YS; Choudhary, SC; Gaur, SPS; Jain, GK; Kumar, D; Sharma, S; Singh, RK; Sonkar, SK; Vaish, AK; Vaish, S | 1 |
| Griffin, JT; Okell, LC; Roper, C | 1 |
| Anto, F; Owusu-Boateng, I | 1 |
| Mens, PF; Ruizendaal, E; Schallig, HDFH; Tahita, MC; Tinto, H; Traoré-Coulibaly, M | 1 |
| Boudová, S; Divala, T; Laufer, MK; Mawindo, P; Mungwira, R; Tomoka, T | 1 |
| Aweeka, F; Conrad, MD; Dorsey, G; Foster, M; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Legac, J; Mota, D; Nayebare, P; Rosenthal, PJ; Tukwasibwe, S; Tumwebaze, P; Wallender, E; Whalen, M | 1 |
| Cissé, B; Conteh, L; Gaye, O; Gomis, JF; Hadj Ba, E; Milligan, PJ; Ndiaye, JL; Ndiaye, M; Pitt, C; Sy, O | 1 |
| Bendavid, E; Brandeau, ML; Choi, SE | 1 |
| Coldiron, ME; Grais, RF; Von Seidlein, L | 1 |
| Bansal, D; Bharti, PK; Bhattacharyya, DR; Mahanta, J; Mohapatra, PK; Parida, P; Sarma, K; Sarmah, NP; Sehgal, R; Singh, N; Sultan, AA | 1 |
| Bateko, JP; Imir, T; Ruh, E; Taylan-Ozkan, A | 2 |
| Falade, CO; Fayemiwo, SA; Meyer, CG; Nguetse, CN; Ojurongbe, O; Ojurongbe, TA; Thomas, BN; Velavan, TP | 1 |
| Berens-Riha, N; Esu, E; Gai, P; Loescher, T; Meremikwu, M; Pritsch, M; Tacoli, C | 1 |
| Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF | 1 |
| Allen, EN; Barnes, KI; Bell, DJ; de Kock, M; Denti, P; Djimde, AA; Tarning, J; Tekete, MM; Ward, SA; Workman, L | 1 |
| Ashorn, P; Ashorn, U; Cheung, YB; Gladstone, M; Hallamaa, L; Kulmala, T; Luntamo, M; Maleta, K; Mangani, C | 1 |
| Amambua-Ngwa, A; Bouriema, SH; D'Alessandro, U; Fandeur, T; Grais, RF; Guérin, PJ; Laminou, IM; Langendorf, C; Makarimi, R; Sibley, CH; Woi-Messe, L | 1 |
| Adibe, MO; Aguwa, NC; Igboeli, NU; Ukwe, CV | 1 |
| Apanga, PA; Bachan, EG; Ibrahim, H; Issah, K; Maya, ET; Noora, CL | 1 |
| Arnaldo, P; Chiheb, D; Enosse, SM; Guetens, P; Kestens, L; Langa, JS; Rosanas-Urgell, A; Rovira-Vallbona, E; Salvador, C; Xavier, B | 1 |
| Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO | 2 |
| Alifrangis, M; Magnussen, P; Osarfo, J; Tagbor, H | 1 |
| Kestens, L; Mens, PF; Natama, HM; Rosanas-Urgell, A; Rovira-Vallbona, E; Sawadogo, O; Schallig, HDFH; Scott, S; Somé, MA; Sorgho, H; Tinto, H; Traoré-Coulibaly, M; Valéa, I; Zango, SH; Zongo, SC | 1 |
| Azizi, SC; Chipukuma, H; Chongwe, G; Jacobs, C; Michelo, C; Zgambo, J | 1 |
| Accrombessi, M; Cot, M; Moya-Alvarez, V; Ouédraogo, S | 1 |
| Awantang, GN; Babalola, SO; Fox, KA; Koenker, H; Lewicky, N; Toso, M | 1 |
| Abdus-Salam, R; Akinyotu, O; Arowojolu, A; Bello, F | 2 |
| Anvikar, A; Goomber, S; Mishra, N; Valecha, N; Yadav, CP | 1 |
| Berens-Riha, N; Esu, E; Loescher, T; Meremikwu, M; Nwachuku, N; Pritsch, M | 1 |
| Aweeka, F; Beeson, J; Charlebois, ED; Clark, TD; Dorsey, G; Drakeley, C; Feeney, ME; Greenhouse, B; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, MK; Nakalembe, M; Nankya, F; Natureeba, P; Okiring, J; Olwoch, P; Opira, B; Prahl, M; Reiling, L; Rodriguez-Barraquer, I; Ssewanyana, I; Tetteh, K; Wallender, E | 1 |
| Al-Harthi, SA | 1 |
| Boudová, S; Divala, TH; Goswami, J; Kanjala, M; Kennedy, J; Laufer, MK; Masonga, R; Mawindo, PM; Mbilizi, Y; Muehlenbachs, A; Mungwira, RG; Muwalo, F; Mvula, P; Ndaferankhande, M; Ndovie, L; Nyirenda, OM; Potter, GE; Tomoka, T; Tsirizani, LE; Wylie, BJ | 1 |
| Ansah, F; Asante, KP; Awandare, GA; Duah, NO; Matrevi, SA; Osei, M; Quashie, NB | 1 |
| Deloron, P; Dhiab, J; Jafari-Guemouri, S; Massougbodji, A; Tuikue, NN | 1 |
| Feng, Z; Gurski, K; Manore, CA; Peace, A; Prosper, O; Teboh-Ewungkem, MI | 1 |
| Baliga, S; Boloor, A; Devi, R; Gai, P; Gai, PP; Jain, A; Kulkarni, SS; Mahabala, C; Mockenhaupt, FP; Rasalkar, R; Shenoy, D; Siegert, K; Tacoli, C; Wedam, J | 1 |
| Kilonzi, M; Marealle, AI; Mbwambo, DP; Mikomangwa, WP; Mlyuka, HJ; Mutagonda, RF | 1 |
| Akerey-Diop, D; Basra, A; Geditz, M; Gonzalez, R; Hofmann, U; Kerb, R; Kremsner, PG; Lehr, T; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo-Ngoma, G; Ramharter, M; Schwab, M; Wojtyniak, JG; Würbel, H; Zoleko Manego, R | 1 |
| Armstrong, O; Casson, K; Dolk, H; Etiendem, D; Leke, AZ; Loane, M; Maboh, NM; Maeya, SE; Ndumbe, LD; Nyenti, PB | 1 |
| Boxberger, M; Gaillard, T; Madamet, M; Pradines, B | 1 |
| Ariami, P; Armika, B; Basuki, S; Dachlan, YP; Hidayat, A; Kanbara, H; Risamasu, PM; Riyanto, S; Susilowati, D; Uemura, H | 1 |
| Arnaldo, P; Cambe, MI; Chicumbe, S; Enosse, SM; Magaço, A; Rosanas-Urgell, A; Rovira-Vallbona, E | 1 |
| Bhattacharya, A; Cohen, JM; Emegbuonye, L; Graves, JC; Guillot, A; Kerac, M; Le Menach, A; Maloney, K; Milch Hariharan, K; Nepomnyashchiy, LE; Omoluabi, E; Omoniwa, OF; Opondo, C; Ward, A; Wiwa, O | 1 |
| Barry, A; Cairns, M; Chandramohan, D; Coumare, S; Diarra, M; Dicko, A; Doumbo, O; Greenwood, B; Kuepfer, I; Milligan, P; Nikiema, F; Ouedraogo, JB; Sagara, I; Tapily, A; Thera, I; Tinto, H; Traore, A; Yerbanga, S; Zongo, I | 1 |
| Csajka, C; Décosterd, L; Genton, B; Guidi, M; Mueller, I; Schneider, M; Senn, N; Sottas, O; Thieffry, B | 1 |
| Brasil, P; Daniel-Ribeiro, CT; Ferreira-da-Cruz, MF; Gomes, LR; Lavigne, A; Ménard, D; Peterka, CL | 1 |
| Anuan, AA; Beeson, JG; Buffet, C; Hansa, AP; Hasang, W; Karl, S; Mueller, I; Ome-Kaius, M; Randall, L; Rogerson, SJ; Stock, SJ; Teo, A; Unger, HW | 1 |
| Amimo, F; Lambert, B; Magit, A; Moon, TD; Nomura, S; Sacarlal, J | 1 |
| John-Stewart, G; Juma, DW; Kamau, E; Muiruri, P; Ottichilo, R; Polyak, C; Singa, B; Waitumbi, J; Yuhas, K | 1 |
| Amari, ASG; Assemian, A; Assi, SB; Balayssac, E; Kamagaté, M; Kouamé, R; Yavo, JC | 1 |
| Ategeka, J; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Nayebare, P; Ochieng, T; Ochokoru, H; Opira, B; Ruel, T | 1 |
| Laufer, MK | 1 |
| Chen, J; Du, W; Eyi, JUM; Fu, H; Jiang, T; Li, J; Lin, M; Matesa, RA; Obono, MMO; Tan, H; Wu, K; Yao, Y | 1 |
| Desai, M; Gutman, J; Hopkins Sibley, C; Kayentao, K; Khairallah, C; Koshy, G; Larsen, DA; Meshnick, SR; Okell, LC; Rogerson, SJ; Roper, C; Slaughter, DEC; Taylor, SM; Ter Kuile, FO; van Eijk, AM | 1 |
| Cohee, LM; Divala, TH; Laufer, MK | 1 |
| Ajayi, I; Ajumobi, O; Gubio, AB; Ilesanmi, OS; Nguku, PM; Olugbade, OT | 1 |
| Aoun, K; Ben Abdallah, R; Bouhlel, S; Bouratbine, A; Maatoug, R; Souissi, O | 1 |
| Diakité, M; Diarra, SS; Diawara, SI; Doumbia, S; Konaté, D; Tall, M | 1 |
| Adeoye, IA; Fagbamigbe, AF | 1 |
| Esu, E; Meremikwu, M; Oduwole, O; Okusanya, BO; Olaleye, A | 1 |
| Ashorn, P; Ashorn, U; Cheung, YB; Hallamaa, L; Kulmala, T; Luntamo, M; Mangani, C | 1 |
| Buffet, C; Karahalios, A; Khairallah, C; Kuile, FOT; Madanitsa, M; Mwapasa, V; Narum, DL; Phiri, LK; Randall, LM; Rogerson, SJ; Teo, A | 1 |
| Baker, DA; Benavente, ED; Campino, S; Clark, TG; Ravenhall, M; Sutherland, CJ | 1 |
| Adda, R; Amenga-Etego, S; Anane, EA; Asante, KP; Dosoo, DK; Gyaase, S; Nettey, OEA; Oppong, FB; Owusu-Agyei, S; Zandoh, C | 1 |
| Aklillu, E; Kamuhabwa, AAR; Mikomangwa, WP; Oms, M | 1 |
| Ario, AR; Atugonza, S; Biribawa, C; Kizza, CT; Kyabayinze, D; Nabatanzi, M; Okethwangu, D; Opigo, J | 1 |
| Bangoura, L; Colaço, R; Fitch, ER; Flueckiger, RM; Fofana, A; Guilavogui, T; Reithinger, R; Taton, JL; Thierno, DM | 1 |
| Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G | 1 |
| Barnes, KI; Frean, J; Kagoro, FM; Mabuza, A; Malatje, G; Raman, J; Reid, A | 1 |
| Adewole, AO; Ajayi, I; Ajumobi, O; Fawole, O; Nguku, P; Oladimeji, A; Waziri, E; Yusuf, B | 1 |
| Doumbia, SO; Hurley, EA; Searle, AR; Winch, PJ | 1 |
| Feng, L; Qi-Cheng, Z | 1 |
| Attaher, O; Barry, A; Cisse, KB; Coulibaly, B; Dembele, A; Diarra, BS; Diarra, K; Dicko, A; Duffy, PE; Fried, M; Issiaka, D; Kanoute, MB; Keita, S; Kwan, JL; Mahamar, A; Samassekou, MB; Sissoko, S; Traore, T; Zaidi, I | 1 |
| Aydemir, O; Bailey, JA; Bhatt, S; Brazeau, NF; Carrel, M; Deutsch-Feldman, M; Juliano, JJ; Kashamuka, M; Meshnick, SR; Taylor, SM; Tshefu, AK; Verity, R | 1 |
| Aponte, JJ; Cisteró, P; Cot, M; Desai, M; González, R; Gupta, H; Huijben, S; Kariuki, S; Macete, E; Massougbodji, A; Mayor, A; Menéndez, C; Mombo-Ngoma, G; Mwangoka, G; Ndam, NT; Ramharter, M; Shi, YP; Uberegui, E | 1 |
| Bishwajit, G; Buh, A; Kota, K; Yaya, S | 1 |
| Akamah, J; Jerela, JY; Manu, A; Maya, ET; Peprah, NY; Titiati, P; Torpey, K; Vandy, AO | 1 |
| Chacky, F; Kishimba, R; Mchwampaka, WM; Mohamed, A; Samwel, A; Tarimo, D | 1 |
| Chen, X; Huang, Y; Li, C; Lu, Y; Pi, L; Qin, P; Qin, Y; Rosenthal, BM; Si, Y; Wang, S; Xiang, Z; Yang, G; Yang, Z; Zeng, W; Zhang, Y; Zhao, L | 1 |
| Agboghoroma, CO; Iregbu, KC; Umemmuo, MU | 1 |
| Anang, AK; Asare, GQ; Coleman, N; Cot, M; Cottrell, G; Deloron, P; Escriou, G; Fobil, J; Houze, P; Kusi, KA; Laar, A; Ndam, NT; Ofori, MF; Quakyi, I; Tornyigah, B | 1 |
| Badio, C; Bakula, E; Bousema, T; Cibenda, D; Grignard, L; Lanke, K; Lassovski, M; Okell, L; Ouabo, A; Piriou, E; Rao, B; Roper, C; van der Meulen, R; van Lenthe, M | 1 |
| Bi Shamamba, SK; Mandoko, PN; Mbongi, DM; Mumba, DN; Muyembe, JJ; Parzy, D; Sinou, V; Tshilolo, LM | 1 |
| Abuaku, B; Anto, F; Aydemir, O; Bailey, J; Ghansah, A; Hathaway, NJ; Marsh, PW; Mensah, BA; Myers-Hansen, JL; Opoku, M | 1 |
| Adetiloye, O; Grenier, L; Kabue, M; Noguchi, L; Onguti, B; Orji, B; Oyetunji, J; Suhowatsky, S; Ugwa, E; Whiting-Collins, L | 1 |
| Bello, OO; Oni, O | 1 |
| Achidi, EA; Anchang-Kimbi, JK; Apinjoh, TO; Dionne-Odom, J; Kalaji, LN; Mbacham, HF; Ngole Sumbele, IU; Tita, ATN; Wepnje, GB | 1 |
| Day, NPJ; Dondorp, AM; Imwong, M; Kunasol, C; Mathema, VB; Prempree, P; Sudathip, P; Sugaram, R; Suwannasin, K | 1 |
| Ayivi-Vinz, G; Azandjèmé, C; Biaou, COA; Glèlè-Ahanhanzo, Y; Kpozehouen, A; Ouro-Koura, AR | 1 |
| Alongo Mike-Antoine, M; Bosunga Gedeon, K; Likwela Joris, L; Mukonkole Jean-Paulin, M; Nguma Jean-Didier, B; Okenge Jean-Pascal, M; Otuli Noël, L | 1 |
| Azizi, SC | 1 |
| Freedman, B; Kalilani-Phiri, L; Khairallah, C; Levitt, B; Madanitsa, M; Meshnick, SR; Mwapasa, V; Taylor, SM; Ter Kuile, FO; Thwai, KL | 1 |
| Arinaitwe, E; Ategeka, J; Chico, RM; Dorsey, G; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Muehlenbachs, A; Ochokoru, H; Wasswa, R; Yeka, A | 1 |
| Allen, K; Bernard, K; Damazo, KT; Dathan, BM; Godfrey, A; Keith, B; Martin, MK; Patricia, N; Rogers, T; Venantius, KB | 1 |
| Aklillu, E; Baraka, V; Kamuhabwa, AAR; Mikomangwa, WP; Minzi, O; Mlugu, EM; Mutagonda, R | 1 |
| Aydemir, O; Bailey, JA; Brazeau, NF; Conrad, M; Denton, M; Fulton, T; Ghani, AC; Ghansah, A; Gutman, J; Hathaway, NJ; Ishengoma, DS; Juliano, JJ; Marsh, PW; Mensah, BA; Meshnick, SR; Morgan, AP; Moss, WJ; Mulenga, M; Mwandagalirwa, MK; Myers-Hansen, JL; Ngondi, J; Norris, DE; Parr, JB; Rosenthal, PJ; Thwai, K; Tshefu, AK; Tumwebaze, PK; Verity, R; Watson, OJ | 1 |
| Naidoo, M; Peters, GO | 1 |
| Alegana, VA; Kirakoya-Samadoulougou, F; Rouamba, T; Samadoulougou, S; Tinto, H | 1 |
| Agola, EL; Gikunju, SW; Kimani, F; King, C; Kinyua, J; LaBeaud, AD; Malhotra, I; Mutuku, F; Ondondo, RO; Thiong'o, K | 1 |
| Akwah, L; Bede, F; Cumber, SN; Diengou, NH; Judith, AK; Mbinyui, MS; Nkfusai, CN; Tsoka-Gwegweni, JM; Viyoff, VZ | 1 |
| Chandramohan, D; Compaore, YD; Frédéric, N; Greenwood, B; Hema-Ouangraoua, S; Kabore, NF; Kuepfer, I; Ouedraogo, JB; Tinto, H; Yerbanga, RS; Zongo, I | 1 |
| Davis, TME; Moore, B; Salman, S | 1 |
| Chico, RM; Desai, M; Dorsey, G; Glymour, MM; Gosling, R; Gutman, J; Kajubi, R; Kakuru, A; Kamya, MR; Kuile, FOT; L'Ianziva, A; Rerolle, F; Roh, ME; Shiboski, S | 1 |
| Chen, JH; Chen, SB; Igbasi, U; Okolie, C; Omilabu, S; Oyibo, W; Quan, H; Shen, HM; Zhou, XN | 1 |
| Awab, GR; Boonyuen, U; Dondorp, AM; Duanguppama, J; Imwong, M; Rakmark, K | 1 |
| Bwire, GM; Kilonzi, M; Mikomangwa, WP | 1 |
| Bojang, K; Cairns, M; Coulibaly, SO; Desai, M; Ghani, ACH; Griffin, JT; Gutman, J; Hill, J; Kalilani-Phiri, L; Kariuki, S; Kayentao, K; Khairallah, C; Madanitsa, M; Meshnick, SR; Mwapasa, V; Slater, H; Tagbor, H; Taylor, S; Ter Kuile, FO; Walker, PGT; Williams, JE | 1 |
| Anitube, O; Ezeoke, U; Mbachu, C; Ndu, A | 1 |
| Badolo, O; Brieger, WR; Burke, D; Dodo, M; Gutman, JR; Savadogo, Y; Stephens, DK; Tiendrebeogo, J; Vibbert, K; Williamson, J; Youll, SJ | 1 |
| Chandramohan, D; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Ochieng, T; Ochokoru, H; Ruel, T; Staedke, SG | 1 |
| Diwan, V; Gawariker, S; Mårtensson, A; Pathak, A; Purohit, M; Sharma, A; Ursing, J | 1 |
| Djontu, JC; Leke, RGF; Lloyd, YM; Megnekou, R; Salanti, A; Seumko'o, RMN; Taylor, DW | 1 |
| Briand, V; McGready, R; Min, AM; Saito, M | 1 |
| Aberese-Ako, M; Ampofo, GD; Gyapong, M; Magnussen, P; Tagbor, H | 1 |
| Boncy, J; Chang, MA; Hamre, KES; Lemoine, JF; Mace, K; Namuyinga, R; Pierre, B; Rogier, EW; Udhayakumar, V | 1 |
| Bridges, DJ; Chipeta, J; Chizema-Kawesha, E; Daniels, RF; Eisele, TP; Hamainza, B; Hawela, MB; Lindtjorn, B; Miller, JM; Mudenda-Chilufya, M; Mwenda, MC; Nerland, AH; Sitali, L | 1 |
| Abateneh, DD; Agu, AP; Akamike, IC; Alo, CN; Ndukwe, CD; Nzeh, CB; Okedo-Alex, IN; Okoro, OO; Uneke, CJ | 1 |
| Bazié, DLC; Coulibaly-Traoré, M; Kirakoya-Samadoulougou, F; Natama, HM; Samadoulougou, S; Tinto, H; Toussaint, R | 1 |
| Amimo, F; Hashizume, M; Lambert, B; Magit, A; Sacarlal, J; Shibuya, K | 1 |
| Cheng, W; Jiang, T; Li, J; Tan, H; Wu, K; Yao, Y | 1 |
| Abdulhaq, AA; Al-Mekhlafi, HM; Anwar, AA; Atroosh, WM; Eisa, ZM; Ghailan, KY; Ghzwani, AH; Madkhali, AM; Zain, KA | 1 |
| Ategeka, J; Chandramohan, D; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Ochieng, T; Ochokoru, H; Roh, ME; Ruel, T; Staedke, SG | 1 |
| Abuaku, B; Ahorlu, C; Awandare, G; Ghansah, A; Koram, KA; Mensah, BA; Myers-Hansen, JL; Ngwa, AA; Oyebola, MK; Wilson, MD | 1 |
| Abdoulaye Louis Padounou, M; Adamou, R; Courtin, D; Diallo, A; Ibrahim, ML; Mahaman Moustapha, L; Ndiaye, JLA; Testa, J | 1 |
| Afutu, LL; Boampong, JN; Quashie, NB | 1 |
| Bousema, T; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Graumans, W; Lanke, K; Mahamar, A; Niambele, SM; Roh, ME; Sanogo, K | 1 |
| Ajogbasile, FV; Akano, K; Eromon, PJ; Folarin, OA; Happi, CT; Kayode, AT; Oluniyi, PE; Sowunmi, A; Uwanibe, JN; Wirth, DF | 1 |
| Bruce, J; Chandramoha, D; Chaponda, EB; Matthew Chico, R; Mharakurwa, S; Michelo, C | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Berthomieu, A; Buysse, M; Rivero, A; Villa, M | 1 |
| Amoako, BK; Anto, F | 1 |
| Adeothy, A; Dagnon, F; Halsey, ES; Houngbo, E; Kpemasse, A; Lucchi, NW; Patton, ME; Saliou, R; Sianou, A; Svigel, SS; Tchevoede, A; Udhayakumar, V | 1 |
| Ambrose, T; Mbotwa, CH; Moshi, FV; Mushi, V; Zacharia, A | 1 |
| Cairns, M; Conteh, L; Diawara, F; Diawara, H; Dicko, A; Duval, L; Eckert, E; Kamate, B; Mihigo, J; Sadou, A; Sagara, I; Sicuri, E; Steinhardt, LC; Walker, P | 1 |
| Agongo, G; Amenga-Etego, LN; Asoala, V; Awandare, GA; Goncalves, S; Jacob, C; Kwiatkowski, D; Rockett, KA | 1 |
| Angora, KE; Bedia-Tanoh, AV; Djohan, V; Gnagne, AP; Kassi, KF; Kiki-Barro, PCM; Konaté, A; Menan, EIH; Miezan, AJS; Vanga-Bosson, AH; Yavo, W | 1 |
| Chaturvedi, R; Chhibber-Goel, J; Gopinathan, S; Parvez, S; Sharma, A; Verma, I | 1 |
| Agyeman, YN; Annor, RB; Newton, S; Owusu-Dabo, E | 1 |
| Assan, A; Majdzadeh, R; Muhammad, FM; Nedjat, S; Parsaeian, M; Sajadi, HS | 1 |
| Beebe, M; Doumbia, S; Sangho, O; Tounkara, M; Whiting-Collins, LJ; Winch, PJ | 1 |
| Andronescu, LR; Chinkhumba, J; Gutman, JR; Kachepa, W; Kachingwe, M; Laufer, MK; Liang, Y; Mathanga, DP; Peterson, I; Sharma, A | 1 |
| Hajizadeh, M; Khanam, R; Okoli, CI; Rahman, MM | 1 |
| DeMol, P; Devleesschauwer, B; Hayette, MP; Kabututu, PZ; Kayiba, NK; Lusamba, PD; Mukomena, ES; Mvumbi, DM; Mvumbi, GL; Rosas-Aguirre, A; Speybroeck, N; Tchakounang, VRK; Yobi, DM | 1 |
| Achidi, EA; Bila, RB; Feugaing Sofeu, DD; Ivo, EP; Taiwe, GS; Tatsinkou Fossi, B; Toukam, LL | 1 |
| Belem, AMG; Chandramohan, D; Cohuet, A; Compaoré, YD; Greenwood, B; Lefèvre, T; Nikièma, F; Ouattara, SB; Ouédraogo, JB; Tinto, H; Yaméogo, KB; Yao, FA; Yerbanga, RS; Zongo, I | 1 |
| Bata, GGB; Boulay, A; Briand, V; Gondje, S; Kazanji, M; Ketta, MYB; Le-Fouler, L; Lombart, JP; Manirakiza, A; Moyen, JM; Sakanga, O; Sepou, A; Serdouma, E; Tondeur, L; Vray, M | 1 |
| Asante, KP; Atibilla, D; Chandramohan, D; Dosoo, DK; Greenwood, B; Gyasi, R; Malm, K; Oduro, A; Oppong, FB; Owusu-Agyei, S; Peprah, NY; Twumasi, M; Williams, J | 1 |
| Diarra, A; Drakeley, C; Lindsay, SW; Nébié, I; Ouedraogo, A; Ouedraogo, ZA; Sirima, SB; Sombié, S; Tiono, AB; Wilson, AL; Yaro, JB | 1 |
| Bojang, K; Cairns, M; Ceesay, SJ; Diallo, A; Dicko, A; Eloike, T; Gamougam, K; Kessely, H; Merle, C; Milligan, P; Moroso, D; Ndiaye, JL; Ogboi, JS; Ouedraogo, JB; Sagara, I; Scott, S; Snell, P; Van Hulle, S; Zongo, I | 1 |
| Agu, AP; Akamike, IC; Akpa, CO; Alo, C; Eze, NC; Nnabu, RC; Okedo-Alex, IN; Umeokonkwo, CD; Uneke, JC | 1 |
| Cao, JP; Feng, J; Feng, XY; Huang, F; Kong, XL; Lin, KM; Xia, ZG; Yan, H; Yin, JH; Zhang, T; Zhou, SS | 1 |
| Aberese-Ako, M; Ampofo, GD; Ansah, E; Gyapong, M; Magnussen, P; Tagbor, H | 1 |
| Chen, N; Chu, X; Feng, L; Li, M; Liu, Y; Wang, Q; Wang, S; Yan, P; Yang, K; Zhang, N; Zhang, Z | 1 |
| Bennis, I; Diakalia, K; Doumbia, I; Seydou, F | 1 |
| Counihan, H; de Cola, MA; Diar, MSI; Moukenet, A; Rassi, C; Richardson, S; Roca-Feltrer, A | 1 |
| Champo, D; Chongwe, G; Ippolito, MM; Kabuya, JB; Manyando, C; Mulenga, M; Mwakazanga, D; Sikalima, J; Tende, C; Young, AMP | 1 |
| Chirwa, T; Divala, T; Kazembe, L; Laufer, MK; Mathanga, D; Mukaka, M; Patson, N; Peterson, I | 1 |
| Agboraw, E; Churcher, TS; Diarra, A; Lambert, B; Lankouande, M; Lindsay, SW; Ouedraogo, A; Ouedraogo, ZA; Ranson, H; Sagnon, N; Sanou, A; Soulama, I; Tiono, AB; Traore, A; Wilson, AL; Worrall, E; Yaro, JB | 1 |
| Attaher, O; Barry, A; Dembele, AB; Diarra, BN; Dicko, A; Djimde, A; Duffy, PE; Freedman, B; Fried, M; Issiaka, D; Kanoute, MB; Levitt, B; Mahamar, A; Sagara, I; Sumner, KM; Taylor, SM; Traore, A | 1 |
| Bartelt, LA; Carroll, I; Chinkhumba, J; Gutman, JR; Itoh, M; Juliano, JJ; Kayange, M; Mathanga, DP; McQuade, ETR; Meshnick, SR; Mzembe, E; Operario, DJ; Puerto-Meredith, SM; Waltmann, A | 1 |
| Afagbedzi, S; Guure, C | 1 |
| Adu, B; Ahiabor, C; Anang, AK; Ariey, F; Courtin, D; Deloron, P; Frempong, NA; Houzé, S; Kusi, KA; Mama, A; Ndam, NT; Ofori, MF; Tornyigah, B | 1 |
| Dolo, Z; Lovett, JL; Saye, S; Strassmann, BI; Vincenz, C | 1 |
| Kalawong, L; Khumchum, N; Kuesap, J; Suphakhonchuwong, N | 1 |
| Adom, J; Ankomah, SE; Duvor, F; Fusheini, A; Karikari, AK; Kokuro, C; Kumah, E; Otchere, G | 1 |
| Amone, J; Dall'Oglio, G; De Vita, E; Di Gennaro, F; Fantoni, M; Iacobelli, V; Ictho, J; L'Episcopia, M; Lochoro, P; Marotta, C; Murri, R; Ngole, B; Ogwang, J; Okori, S; Olal, L; Onapa, E; Putoto, G; Saracino, A; Segala, FV; Severini, C | 1 |
| Asante, KP; Bailey, JA; Chandramohan, D; Dosoo, DK; Greenwood, B; Niaré, K; Opoku-Mensah, J; Oppong, FB; Owusu-Agyei, S | 1 |
| Barnes, KI; Dahlström Otienoburu, S; Flegg, JA; Guerin, PJ; Hopkins Sibley, C; Humphreys, GS; Jacome-Meza, ZJ; Montanez, B; Raman, J; Strickland, T | 1 |
| Bhullar, S; Mishra, N | 1 |
| Arya, A; Chaudhry, S; Foko, LPK; Hawadak, J; Kumar, A; Nana, RRD; Singh, V | 1 |
| Achidi, EA; Amambua-Ngwa, A; Anchang-Kimbi, JK; Apinjoh, TO; Chi, HF; Dionne-Odom, J; Kwi, PN; Mayaba, JM; Moyeh, MN; Ntui, VN; Tangi, LN; Tita, ATN; Titanji, VPK; Toussi, CT | 1 |
| Ameyaw, EK | 1 |
| Chenet, SM; Cortés, LJ; Guerra, AP; Lucchi, NW; Macedo de Oliveira, A; Olivera, MJ | 1 |
| Bazie, T; Beshir, KB; Bojang, K; Cairns, M; Ceesay, S; Diallo, A; Dicko, A; Doumagoum, D; Eloike, T; Gamougam, K; Kessely, H; Kolie, F; Lamine, MM; Laminou, IM; Loua, K; Maiga, H; Mansukhani, R; Merle, CS; Milligan, P; Moroso, D; Muwanguzi, J; Nader, J; NDiaye, JL; Ogboi, SJ; Ouedraogo, JB; Razafindralambo, L; Sagara, I; Scott, S; Snell, P; Sutherland, CJ; Traore, A; Zongo, I | 1 |
| Berry, A; Bidzogo Lebobo, M; Cohen, O; Eboumbou, C; Guemas, E; Iriart, X; Menard, S; Ondobo Ekae, C; Talom Ngassa, C; Tiyou Kenmeni, C; Tsague Kenfack, M | 1 |
| Ashorn, P; Ashorn, U; Cheung, YB; Fan, YM; Hallamaa, L; Kulmala, T; Luntamo, M; Maleta, K; Mangani, C | 1 |
| Akinola, O; Amusan, AI; Ategbero, E; Gbotosho, GO | 1 |
| Alifrangis, M; Ashorn, U; Barsosio, HC; Chico, RM; Dodd, J; Gesase, S; Gutman, JR; Hansson, H; Hill, J; Kariuki, S; Kavishe, RA; Klein, N; Lusingu, JPA; Madanitsa, M; Magnussen, P; Maleta, K; Minja, DTR; Mosha, JF; Msemo, OA; Mtove, G; Mukerebe, C; Mwapasa, V; Onyango, ED; Otieno, K; Phiri, KS; Saidi, Q; Schmiegelow, C; Ter Kuile, FO; Wang, D | 1 |
| Cândido, ALM; Dimbu, PR; Ferreira, CM; Fortes, F; Horth, R; Kelley, J; Labuda, S; Martins, JF; Morais, JFM; Nieto Andrade, B; Oh, JM; Pluciński, MM; Rosillo, SR; Talundzic, E | 1 |
| Derra, K; Donnen, P; Dramaix, M; Kaboré, B; Lingani, M; Robert, A; Rouamba, T; Samadoulougou, S; Sanou, M; Somé, G; Sorgho, H; Tahita, MC; Tinto, H; Valéa, I; Zango, SH | 1 |
| Boncy, J; Chang, MA; Fouché, B; Gaul, DA; Green, M; Holmes, K; Juin, S; Kheradmand, T; LaFortune, W; Marseille, S; Moore, SG; Rigodon, J; Rogier, E; Telfort, MA | 1 |
| Abram, A; Alruwaili, M; Eckert, E; Gutman, JR; Mbituyumuremyi, A; Munguti, K; Murindahabi, M; Piercefield, E; Sethi, R; Sullivan, DJ; Umulisa, N; Uwimana, A | 1 |
| Duah-Quashie, NO; Tandoh, KZ | 1 |
| Arikpo, I; Bissombolo, D; Doderer-Lang, C; Figueroa-Romero, A; González, R; Lemba, E; Llach, M; Ma, L; Maly, C; Mayor, A; Menard, D; Menéndez, C; Meremikwu, M; Nhama, A; Pagnoni, F; Pons-Duran, C; Rakotosaona, R; Ratsimbasoa, A; Roman, E; Sacoor, C; Sanz, S | 1 |
98 review(s) available for pyrimethamine and fanasil, pyrimethamine drug combination
| Article | Year |
|---|---|
[The risks of pyrimethamine-sulfadoxine combination in the prenatal treatment of toxoplasmosis].
Topics: Antimalarials; Cleft Palate; Contraindications; Drug Combinations; Female; Humans; Kernicterus; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Toxoplasmosis | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combinations; Humans; Mycobacterium avium-intracellulare Infection; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Toxoplasma; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
Prophylaxis and treatment of Pneumocystis carinii pneumonia.
Topics: Antimalarials; CD4-Positive T-Lymphocytes; Clinical Protocols; Dapsone; Drug Combinations; HIV Infections; HIV-1; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Clinical Trials as Topic; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Humans; Product Surveillance, Postmarketing; Pyrimethamine; Sulfadoxine | 1990 |
Prophylaxis of AIDS-related opportunistic infections (OIs).
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combinations; Humans; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Malaria in Switzerland].
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Switzerland | 1988 |
Malaria chemoprophylaxis: an update.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child, Preschool; Dapsone; Drug Combinations; Female; Humans; Malaria; Proguanil; Pyrimethamine; Sulfadoxine | 1987 |
The chemoprophylaxis of malaria.
Topics: Amodiaquine; Animals; Chloroquine; Dapsone; Drug Combinations; Drug Resistance; Malaria; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 1987 |
Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Topics: Acquired Immunodeficiency Syndrome; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1987 |
Falciparum malaria: the urgent need for safe and effective drugs.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Dapsone; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Sulfadoxine | 1983 |
Malaria 1984. Part I. Malaria prophylaxis.
Topics: Antimalarials; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Mosquito Control; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; South Africa; Sulfadoxine | 1984 |
Practical therapeutics malaria chemoprophylaxis.
Topics: Adult; Africa, Eastern; Aminoquinolines; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Sulfadoxine | 1984 |
[Urgent need for new antimalarias (author's transl)].
Topics: Antimalarials; Biological Availability; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Immunotherapy; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine; World Health Organization | 1981 |
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Topics: Africa, Eastern; Africa, Western; Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Costs; Humans; Malaria; Mefloquine; Patient Selection; Phenanthrenes; Pyrimethamine; Quinine; Safety; Sulfadoxine; Treatment Outcome | 1999 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2001 |
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?
Topics: Africa South of the Sahara; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2001 |
Malaria: a rising incidence in the United States.
Topics: Antimalarials; Chemoprevention; Chloroquine; Drug Combinations; Drug Resistance; Female; Global Health; Humans; Incidence; Malaria; Malaria, Falciparum; Male; Medical History Taking; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Travel; United States | 2002 |
[Antiprotozoal drugs].
Topics: Animals; Antiprotozoal Agents; Drug Combinations; Emetine; Humans; Mefloquine; Metronidazole; Phenanthrenes; Primaquine; Protozoan Infections; Pyrimethamine; Quinine; Sulfadoxine; Tinidazole | 2003 |
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa.
Topics: Africa South of the Sahara; Antimalarials; Drug Combinations; Endemic Diseases; Female; Humans; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2003 |
Amodiaquine for treating malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2003 |
WHO, the Global Fund, and medical malpractice in malaria treatment.
Topics: Africa; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Costs; Drug Resistance; Drug Therapy, Combination; Humans; International Agencies; Malaria; Malaria, Falciparum; Malpractice; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; World Health Organization | 2004 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
Topics: Africa; Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Effectiveness of antimalarial drugs.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Life Cycle Stages; Malaria; Mefloquine; Patient Compliance; Plasmodium; Primaquine; Pyrimethamine; Quinine; Secondary Prevention; Sulfadoxine; Treatment Failure | 2005 |
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Disease Transmission, Infectious; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Plasmodium falciparum; Population Density; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.
Topics: Amodiaquine; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2006 |
Comparative efficacy of chloroquine and sulphadoxine--pyrimethamine in pregnant women and children: a meta-analysis.
Topics: Adolescent; Adult; Africa; Antimalarials; Child; Chloroquine; Drug Combinations; Endemic Diseases; Female; Gravidity; Hemoglobins; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Therapeutic potential of folate uptake inhibition in Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Folic Acid; Folic Acid Antagonists; Malaria, Falciparum; Plasmodium falciparum; Probenecid; Pyrimethamine; Sulfadoxine | 2004 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sulfadoxine; Treatment Failure | 2006 |
Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.
Topics: Africa; Amodiaquine; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Multicenter Studies as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2007 |
From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
Topics: Africa South of the Sahara; Animals; Antimalarials; Delivery of Health Care; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; World Health Organization | 2007 |
Antifolates can have a role in the treatment of Plasmodium vivax.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Humans; Malaria, Vivax; Mutation; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2007 |
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Topics: Abnormalities, Drug-Induced; Africa; Animals; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant, Newborn; Kernicterus; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Antimalarial drug quality in Africa.
Topics: Africa; Antimalarials; Artemisinins; Biological Availability; Dosage Forms; Drug Combinations; Drug Stability; Drug Storage; Humans; Product Surveillance, Postmarketing; Pyrimethamine; Quality Control; Sesquiterpenes; Sulfadoxine | 2007 |
Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria; Mefloquine; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Malaria, Falciparum; Patient Admission; Pyrimethamine; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Risk Factors; Safety; Sulfadoxine; Treatment Outcome | 2009 |
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Design; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Health Care Surveys; Health Knowledge, Attitudes, Practice; Malaria; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Population Density; Pyrimethamine; Sulfadoxine; Travel; Treatment Outcome | 2009 |
Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sudan; Sulfadoxine; Treatment Failure | 2010 |
Intermittent preventive treatment against malaria: an update.
Topics: Africa South of the Sahara; Animals; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2010 |
Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum.
Topics: Africa; Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Population Surveillance; Prevalence; Pyrimethamine; Sulfadoxine | 2010 |
Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.
Topics: Africa; Amino Acid Substitution; Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Mutant Proteins; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Geography; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2011 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Topics: Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimalarials; Azithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Public Health; Pyrimethamine; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome | 2011 |
Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.
Topics: Africa; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Mutation; Plasmodium; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.
Topics: Antimalarials; Drug Combinations; Female; HIV Seropositivity; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2011 |
Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Probenecid; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2012 |
Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
Topics: Antibodies, Bacterial; Antibodies, Viral; Antimalarials; Diphtheria-Tetanus-Pertussis Vaccine; Drug Administration Schedule; Drug Combinations; Female; Humans; Immunization Programs; Immunization Schedule; Infant; Malaria; Male; Measles Vaccine; Measles virus; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
Topics: Adolescent; Adult; Africa; Animals; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Plasmodium falciparum; Poisson Distribution; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Retrospective Studies; Sulfadoxine; Young Adult | 2012 |
Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis.
Topics: Antiprotozoal Agents; Artemisinins; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Humans; Praziquantel; Pyrimethamine; Schistosomiasis; Sulfadoxine; Treatment Outcome | 2012 |
Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.
Topics: Antimalarials; Biomarkers; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Evolution, Molecular; Genes, Protozoan; Geography; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance.
Topics: Africa; Antimalarials; Artemisinins; Asia, Southeastern; Biological Evolution; Chloroquine; Drug Combinations; Drug Resistance; Gene Flow; Humans; Plasmodium falciparum; Pyrimethamine; South America; Sulfadoxine | 2012 |
Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis.
Topics: Africa; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Risk; Sulfadoxine | 2013 |
A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia.
Topics: Africa South of the Sahara; Anemia; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Sulfadoxine | 2013 |
Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antimalarials; Delivery of Health Care; Drug Combinations; Female; Humans; Insecticide-Treated Bednets; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2013 |
Monitoring antifolate resistance in intermittent preventive therapy for malaria.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2013 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria.
Topics: Africa; Antimalarials; Drug Combinations; Drug Resistance; Geographic Mapping; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2013 |
Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.
Topics: Adult; Africa South of the Sahara; Antimalarials; Drug Combinations; Family Characteristics; Female; Humans; Insecticides; Malaria; Mosquito Nets; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Preventive Medicine; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate.
Topics: Anencephaly; Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Tetrahydrofolates; Treatment Outcome | 2014 |
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Vivax; Parasitemia; Primaquine; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfadoxine | 2013 |
On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Malaria, Falciparum; Male; Pregnancy; Pregnancy Outcome; Pyrimethamine; Reproductive Tract Infections; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome; Vaginosis, Bacterial | 2013 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Pregnancy-associated malaria and malaria in infants: an old problem with present consequences.
Topics: Adult; Africa South of the Sahara; Antimalarials; Comorbidity; Complement Activation; Developmental Disabilities; Drug Combinations; Drug Resistance; Female; Fetal Diseases; Fetal Growth Retardation; Genetic Predisposition to Disease; HIV Infections; HLA-G Antigens; Humans; Immune Tolerance; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infectious Disease Transmission, Vertical; Malaria; Malaria, Cerebral; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Risk Factors; Stillbirth; Sulfadoxine | 2014 |
Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antimalarials; Child; Drug Combinations; Drug Resistance; HIV Infections; Humans; Malaria; Mutation; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Topics: Africa South of the Sahara; Anemia; Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quality-Adjusted Life Years; Sulfadoxine | 2015 |
Antimalarial drug resistance in Africa: key lessons for the future.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Forecasting; Humans; Malaria; Pyrimethamine; Sulfadoxine | 2015 |
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gravidity; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2015 |
The role of folate in malaria - implications for home fortification programmes among children aged 6-59 months.
Topics: Africa South of the Sahara; Antimalarials; Child, Preschool; Dietary Supplements; Dose-Response Relationship, Drug; Drug Combinations; Folic Acid; Folic Acid Deficiency; Food, Fortified; Humans; Infant; Iron, Dietary; Malaria; Micronutrients; Nutritional Requirements; Observational Studies as Topic; Plasmodium falciparum; Powders; Prevalence; Pyrimethamine; Randomized Controlled Trials as Topic; Recommended Dietary Allowances; Sulfadoxine; Vitamin A; Zinc | 2015 |
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2017 |
Prevention and control of malaria in pregnancy - new threats, new opportunities?
Topics: Adult; Animals; Antimalarials; Artemisinins; Culicidae; Drug Combinations; Drug Resistance; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Primary Prevention; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Malaria during Pregnancy.
Topics: Africa; Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria Vaccines; Mefloquine; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine | 2017 |
Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2017 |
Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy; Pregnancy Trimester, First; Pyrimethamine; Quinine; Quinolines; Rabbits; Rats; Sulfadoxine; Teratogens | 2017 |
Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Failure | 2017 |
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa.
Topics: Africa; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Models, Statistical; Mutation; Plasmodium falciparum; Population Surveillance; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Mefloquine for preventing malaria in pregnant women.
Topics: Abortion, Spontaneous; Africa South of the Sahara; Antimalarials; Dizziness; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Low Birth Weight; Insecticide-Treated Bednets; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Thailand; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Malaria; Mefloquine; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Stillbirth; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
Topics: Africa; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2019 |
A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2019 |
[Progress of researches on genes associated with sulfadoxine-pyrimethamine resistance in
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium vivax; Pyrimethamine; Research; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2019 |
Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs.
Topics: Abnormalities, Drug-Induced; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Observational Studies as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Systematic Reviews as Topic | 2020 |
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2021 |
Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
Topics: Africa, Western; Age Factors; Amodiaquine; Antimalarials; Case-Control Studies; Child, Preschool; Communicable Disease Control; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasite Load; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Risk Assessment; Risk Factors; Seasons; Sulfadoxine; Time Factors; Treatment Outcome | 2021 |
The efficacy and safety of intermittent preventive treatment with sulphadoxine-pyrimethamine vs artemisinin-based drugs for malaria: a systematic review and meta-analysis.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2022 |
Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2022 |
Intermittent preventive treatment with Sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women.
Topics: Antimalarials; COVID-19; Drug Combinations; Female; Humans; Malaria; Pharmaceutical Preparations; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Sulfadoxine | 2023 |
400 trial(s) available for pyrimethamine and fanasil, pyrimethamine drug combination
| Article | Year |
|---|---|
Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1992 |
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combinations; Humans; Mycobacterium avium-intracellulare Infection; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Toxoplasma; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Sulfalene; Tanzania; Time Factors | 1991 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
Efficacy of pyrimethamine/sulfadoxine in uncomplicated severe falciparum malaria in Kenya.
Topics: Animals; Antimalarials; Drug Combinations; Humans; Kenya; Malaria; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Sulfanilamides | 1990 |
[Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
Topics: Adolescent; Adult; Antimalarials; Child; Clinical Trials as Topic; Drug Combinations; Humans; Pyrimethamine; Recurrence; Sulfadoxine; Sulfanilamides; Time Factors; Toxoplasmosis, Ocular | 1989 |
Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Topics: Adolescent; Adult; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Topics: Adolescent; Adult; Antimalarials; Child; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Parenteral Fansidar in falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Clinical Trials as Topic; Drug Combinations; Humans; Injections, Intramuscular; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1988 |
[Efficacy of amodiaquine, Fansidar and their combination in the treatment of chloroquine-resistant falciparum malaria].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Child; Double-Blind Method; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1987 |
Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chloroquine; Chlorpromazine; Drug Combinations; Drug Synergism; Female; Humans; Male; Middle Aged; Pyrimethamine; Random Allocation; Schizophrenia; Sulfadoxine | 1988 |
Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors | 1986 |
An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
Topics: Adolescent; Adult; Brazil; Clinical Trials as Topic; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
Topics: Adult; Brazil; Double-Blind Method; Drug Combinations; Drug Evaluation; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Clinical Trials as Topic; Colombia; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980.
Topics: Child; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides; Tetracycline; Thailand | 1981 |
Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya.
Topics: Adolescent; Amodiaquine; Blood; Child; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Kenya; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 1984 |
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; China; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Quinolines; Random Allocation; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1984 |
Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Blood Cell Count; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Liver; Malaria; Male; Middle Aged; Nigeria; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors; Vision Disorders | 1984 |
Falciparum malaria acquired in the area of the Thai-Khmer border resistant to treatment with Fansidar.
Topics: Antimalarials; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Military Medicine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides; Thailand | 1982 |
A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Topics: Antimalarials; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1982 |
The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Malaria; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1981 |
The treatment of malaria in glucose-6-phosphate dehydrogenase deficient patients in Sabah.
Topics: Adolescent; Adult; Anemia, Hemolytic; Antimalarials; Child; Chloroquine; Drug Combinations; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria; Male; Primaquine; Pyrimethamine; Sulfadoxine | 1981 |
Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1995 |
Sulphadoxine concentrations in plasma, red blood cells and whole blood in healthy and Plasmodium falciparum malaria cases after treatment with Fansidar using high-performance liquid chromatography.
Topics: Adult; Animals; Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Erythrocytes; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Spectrophotometry, Ultraviolet; Sulfadoxine | 1994 |
Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique.
Topics: Adolescent; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Blotting, Western; C-Reactive Protein; Child; Chloroquine; Computer Simulation; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Haptoglobins; Humans; Luminescent Measurements; Malaria, Falciparum; Models, Biological; Mozambique; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Recombinant Proteins; Sulfadoxine | 1995 |
In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1994 |
A study of the comparative bioavailability of pyrimethamine-sulfadoxine obtained from two oral preparations.
Topics: Administration, Oral; Adult; Antimalarials; Biological Availability; Drug Combinations; Humans; Male; Pyrimethamine; Sulfadoxine | 1994 |
Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
Topics: Adult; Animals; Antibodies, Protozoan; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1993 |
The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.
Topics: Analysis of Variance; Antimalarials; Chi-Square Distribution; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Seasons; Sulfadoxine | 1994 |
Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Combinations; Half-Life; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Dropouts; Pyrimethamine; Sulfadoxine | 1993 |
Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Equatorial Guinea; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1993 |
Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria.
Topics: Adolescent; Animals; Anti-Bacterial Agents; Antimalarials; Child; Child, Preschool; Chloroquine; Clindamycin; Drug Combinations; Drug Resistance; Female; Gabon; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1995 |
Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age.
Topics: Age Factors; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Malawi; Pyrimethamine; Sulfadoxine; Treatment Failure | 1996 |
A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Gambia; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 1996 |
A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1996 |
A comparative study of parenteral chloroquine, quinine and pyrimethamine-sulfadoxine in the treatment of Gambian children with complicated, non-cerebral malaria.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Data Interpretation, Statistical; Drug Combinations; Drug Resistance; Gambia; Humans; Infant; Infusions, Parenteral; Malaria, Falciparum; Pyrimethamine; Quinine; Sulfadoxine; Time Factors | 1996 |
Response of childhood malaria to chloroquine and Fansidar in an area of intermediate chloroquine resistance in Côte d'Ivoire.
Topics: Animals; Antimalarials; Body Temperature; Child; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1996 |
Efficacy of artemether in severe falciparum malaria in African children.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1996 |
Chloroquine versus pyrimethamine/sulphadoxine in the treatment of uncomplicated P. falciparum malaria in northern Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Kenya; Malaria, Falciparum; Male; Pyrimethamine; Rural Health; Sulfadoxine | 1997 |
[Clinical view of toxoplasmosis in children--personal observations].
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Infant; Infant, Newborn; Mass Screening; Pyrimethamine; Serologic Tests; Spiramycin; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 1998 |
Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Monitoring; Drug Resistance; Female; Humans; Infant; Kenya; Malaria, Falciparum; Malawi; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia | 1998 |
Population structure of recrudescent Plasmodium falciparum isolates from western Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 1999 |
A community perspective on the efficacy of malaria treatment options for children in Lundazi district, Zambia.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Community Health Services; Drug Combinations; Female; Health Education; Health Services Accessibility; Humans; Malaria; Male; Patient Acceptance of Health Care; Pyrimethamine; Sulfadoxine; Treatment Outcome; Zambia | 1999 |
Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Drug Combinations; Female; Humans; Liver Transplantation; Male; Middle Aged; Pneumonia, Pneumocystis; Prospective Studies; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Disease Transmission, Infectious; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure | 1999 |
Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1999 |
Effect of a single oral dose of Fansidar on the pharmacokinetics of halofantrine in healthy volunteers: a preliminary report.
Topics: Adult; Antimalarials; Cross-Over Studies; Drug Combinations; Drug Interactions; Humans; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine | 2000 |
Monitoring efficacy of commonly used antimalarials by a 14-day in-vivo test in a new settler's camp in endemic zone at Cox's Bazar.
Topics: Adolescent; Adult; Antimalarials; Bangladesh; Child; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Prospective Studies; Pyrimethamine; Sulfadoxine; Transients and Migrants; Treatment Failure | 1998 |
Micronutrient and iron supplementation and effective antimalarial treatment synergistically improve childhood anaemia.
Topics: Anemia, Iron-Deficiency; Antimalarials; Child, Preschool; Dietary Supplements; Drug Combinations; Drug Synergism; Female; Hemoglobins; Humans; Infant; Iron, Dietary; Linear Models; Malaria, Falciparum; Male; Micronutrients; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2000 |
Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.
Topics: Anemia, Iron-Deficiency; Antimalarials; Developing Countries; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Survival Rate; Tanzania; Treatment Outcome; Vaccination | 2001 |
Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Middle Aged; Naphthoquinones; Peru; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quinine; South Africa; Sulfadoxine; Time Factors | 2001 |
Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Indonesia; Infant; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Risk; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Failure; Treatment Outcome | 2001 |
Anemia of persistent malarial parasitemia in Nigerian children.
Topics: Anemia; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Nigeria; Parasitemia; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
Topics: Animals; Antimalarials; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Antimalarials; Bradycardia; Cameroon; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Heart Rate; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2001 |
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Topics: Antimalarials; Biomarkers; Child; Child, Preschool; Dapsone; Dihydropteroate Synthase; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Humans; Infant; Malaria, Falciparum; Mutation; Proguanil; Prospective Studies; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2002 |
Therapeutic efficacy of sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria 3 years after introduction in Mpumalanga.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; South Africa; Sulfadoxine; Time Factors; Treatment Outcome | 2001 |
Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Ghana; Humans; Infant; Malaria, Falciparum; Male; Outpatients; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Area Under Curve; Child; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Philippines; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
Sulfadoxine-pyrimethamine monotherapy in Tanzanian children gives rapid parasite clearance but slow fever clearance that is improved by chloroquine in combination therapy.
Topics: Acetaminophen; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prospective Studies; Pyrimethamine; Secondary Prevention; Sulfadoxine; Tanzania; Treatment Failure; Treatment Outcome | 2002 |
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Cameroon; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hematocrit; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2002 |
In vivo drug resistance of falciparum malaria in mining areas of Venezuela.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Health Promotion; Humans; Malaria, Falciparum; Male; Mining; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Failure; Treatment Outcome; Venezuela | 2002 |
Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial.
Topics: Anemia; Anthropometry; Antimalarials; Double-Blind Method; Drug Combinations; Female; Hemoglobins; Humans; Infant; Iron; Kenya; Malaria; Male; Pyrimethamine; Seasons; Sulfadoxine | 2002 |
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Topics: Antimalarials; Cause of Death; Child, Preschool; Dapsone; Developing Countries; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobinometry; Humans; Infant; Kenya; Malaria, Falciparum; Malawi; Male; Proguanil; Pyrimethamine; Recurrence; Retreatment; Sulfadoxine; Survival Rate | 2002 |
Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
Topics: Anemia; Animals; Antimalarials; Burkina Faso; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
Topics: Adolescent; Adult; Animals; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Vivax; Male; Plasmodium vivax; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2002 |
[Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies].
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation, Preclinical; Drug Monitoring; Drug Resistance; Female; Geography; Humans; Infant; Madagascar; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Patient Selection; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2000 |
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
Topics: Amodiaquine; Animals; Child; Child, Preschool; Drug Combinations; Female; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Cohort Studies; Drug Combinations; Humans; Incidence; Infant; Malaria Vaccines; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Research Design; Seasons; Sulfadoxine; Treatment Outcome | 2002 |
Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2003 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia.
Topics: Adolescent; Adult; Animals; Antimalarials; Chi-Square Distribution; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Female; Gametogenesis; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Statistics, Nonparametric; Sulfadoxine; Treatment Failure | 2002 |
Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya.
Topics: Anemia; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Iron; Kenya; Malaria; Male; Multivariate Analysis; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda | 2003 |
[Efficacy of amodiaquine and sulfadoxine/pyrimethamine in the treatment of malaria not complicated by Plasmodium falciparum in Nariño, Colombia, 1999-2002].
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure | 2003 |
A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Administration, Oral; Amodiaquine; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Ketotifen; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2003 |
Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2003 |
Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo.
Topics: Antimalarials; Child, Preschool; Chloroquine; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Hematocrit; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadoxine; Treatment Failure | 2003 |
Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Health Planning Guidelines; Humans; Laos; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2003 |
Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Vietnam | 2003 |
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
Topics: Animals; Antimalarials; Biomarkers; Child, Preschool; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mutation; Outcome Assessment, Health Care; Plasmodium falciparum; Polymerase Chain Reaction; Population Surveillance; Prevalence; Prognosis; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Uganda | 2003 |
Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antimalarials; Body Temperature; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Severity of Illness Index; Sulfadoxine; Treatment Outcome | 2003 |
The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Middle Aged; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2004 |
Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Family; Female; Health Education; Humans; Infant; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Refugees; Sesquiterpenes; Sulfadoxine; Surveys and Questionnaires; Treatment Refusal; Zambia | 2004 |
Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya.
Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Disease Susceptibility; Double-Blind Method; Drug Combinations; Female; Hemoglobins; Humans; Infant; Iron; Kenya; Malaria; Male; Phenotype; Pyrimethamine; Sickle Cell Trait; Sulfadoxine | 2004 |
Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antimalarials; Child, Preschool; Congo; Drug Combinations; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2004 |
Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Uganda | 2004 |
Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2004 |
Daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western Kenya.
Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Drug Administration Schedule; Drug Combinations; Endemic Diseases; Female; Hemoglobins; Humans; Infant; Iron; Kenya; Malaria; Male; Osmolar Concentration; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.
Topics: Acute Disease; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Parasitemia; Probenecid; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Genetic Markers; Humans; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso.
Topics: Antimalarials; Burkina Faso; Child, Preschool; Cohort Studies; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of combined chloroquine and sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria in Bangladesh.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.
Topics: Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine; Suppositories | 2004 |
Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
Topics: Africa; Animals; Antimalarials; Child; Child, Preschool; Dapsone; Double-Blind Method; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Methemoglobin; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
[Gametocyte levels in response to differing malaria treatments in two municipalities of Colombia].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Gametogenesis; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Third; Pyrimethamine; Sulfadoxine | 2004 |
Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sudan; Sulfadoxine; Treatment Outcome | 2004 |
[In vivo evaluation of sulfadoxine-pyrimethamine efficacy during uncomplicated falciparum malaria in children of Yopougon (Abidjan, Côte d'Ivoire)].
Topics: Antimalarials; Child, Preschool; Cote d'Ivoire; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2004 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine | 2004 |
Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Parasitemia; Patient Selection; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Sulfadoxine | 2004 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Plasmodium falciparum hyperparasitaemia in children. Risk factors, treatment outcomes, and gametocytaemia following treatment.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gametogenesis; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Treatment Outcome | 2004 |
Efficacies of chloroquine, sulfadoxine-pyrimethamine and quinine in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Quinine; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Comparison of the parasitologic efficacy of amodiaquine and sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in the Bungoma District of western Kenya.
Topics: Amodiaquine; Animals; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anemia; Birth Weight; Chemoprevention; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Mali; Multivariate Analysis; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine | 2005 |
Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Developing Countries; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genomics; Humans; Infant; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Refugees; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Zambia | 2005 |
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Evidence-Based Medicine; Female; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sierra Leone; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Ghana; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Patient Dropouts; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan.
Topics: Adolescent; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sudan; Sulfadoxine | 2005 |
Efficacy comparison between anti-malarial drugs in Africans presenting with mild malaria in the Central Republic of Africa: a preliminary study.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Central African Republic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Trimethoprim | 2005 |
Therapeutic efficacy of antimalarial drugs along the eastern Indo-Nepal border: a cross-border collaborative study.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Nepal; Pyrimethamine; Sex Distribution; Sulfadoxine; Treatment Failure | 2005 |
Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.
Topics: Animals; Anopheles; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Gametogenesis; Humans; Infant; Malaria, Falciparum; Male; Mosquito Control; Plasmodium falciparum; Pyrimethamine; Single-Blind Method; Sulfadoxine | 2005 |
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Protozoan Proteins; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2005 |
In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
Topics: Animals; Antimalarials; Disease Susceptibility; Drug Combinations; Drug Resistance; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Microbial Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Peru; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Health Policy; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Therapeutic efficacy of sulfadoxine-pyrimethamine for Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; South Africa; Sulfadoxine; Treatment Outcome | 2005 |
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Infections; Malaria; Male; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Uganda | 2005 |
Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children.
Topics: Anemia; Antimalarials; C-Reactive Protein; Child, Preschool; Drug Combinations; Erythropoiesis; Erythropoietin; Ferritins; Humans; Infant; Pyrimethamine; Sulfadoxine; Vitamin A | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia.
Topics: Anti-Infective Agents; Child, Preschool; Drug Combinations; Erythromycin; Humans; Infant; Malaria; Malawi; Nutritional Status; Pneumonia, Bacterial; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidence; Infant; Malaria; Parasitemia; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of sulfadoxin pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Recurrence; Seasons; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure | 2004 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Failure; Treatment Outcome | 2005 |
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
Topics: Adolescent; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Gabon; Genes, MDR; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
(Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nucleic Acid Amplification Techniques; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
Topics: Antimalarials; Artemisinins; Artesunate; Bedding and Linens; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Prevalence; Pyrimethamine; Seasons; Senegal; Sesquiterpenes; Sulfadoxine | 2006 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Genes, Protozoan; Genotype; Humans; India; Malaria, Vivax; Male; Mutation; Plasmodium vivax; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2006 |
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Geography; Humans; Infant; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome; Uganda | 2006 |
Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor.
Topics: Adolescent; Adult; Aged; Alleles; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Timor-Leste; Treatment Outcome | 2006 |
Existence of antimalarial formulations with low bioavailability in Tanzania.
Topics: Adult; Antimalarials; Area Under Curve; Biological Availability; Cross-Over Studies; Drug Combinations; Drugs, Generic; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quality Control; Single-Blind Method; Sulfadoxine; Tanzania; Therapeutic Equivalency | 2006 |
Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
Topics: Adult; Amodiaquine; Antimalarials; Blood Cell Count; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Fatigue; Female; Hematocrit; Humans; Malaria, Falciparum; Male; Neutropenia; Pruritus; Pyrimethamine; Rwanda; Sulfadoxine; Treatment Outcome | 2006 |
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Dietary Supplements; Drug Combinations; Female; Folic Acid; Gambia; Gravidity; Hematinics; Hemoglobins; Humans; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid; Hematinics; Humans; Infant; Malaria, Falciparum; Naphthoquinones; Parasitemia; Population Density; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Failure; Zambia | 2006 |
Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2006 |
Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks.
Topics: Amodiaquine; Animals; Anthelmintics; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria; Pilot Projects; Pyrimethamine; Schistosoma haematobium; Schistosomiasis haematobia; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
Topics: Animals; Antimalarials; Chemoprevention; Child, Preschool; Cross-Sectional Studies; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Placebos; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2006 |
Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Topics: Adolescent; Adult; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Gambia; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Middle Aged; Parasitemia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Rural Health; Seasons; Sulfadoxine | 2006 |
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda.
Topics: Administration, Oral; Adult; Antimalarials; Biological Availability; Chloroquine; Chromatography, High Pressure Liquid; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Drugs, Generic; Female; Humans; Male; Probability; Pyrimethamine; Reference Values; Sensitivity and Specificity; Sulfadoxine; Therapeutic Equivalency; Uganda | 2006 |
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Zambia | 2006 |
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; CD4 Lymphocyte Count; Drug Combinations; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Zambia | 2006 |
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Prospective Studies; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
Topics: Adult; Amodiaquine; Antimalarials; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prevalence; Proguanil; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia | 2006 |
Return of chloroquine antimalarial efficacy in Malawi.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malawi; Male; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine | 2006 |
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2006 |
Short course of quinine plus a single dose of sulfadoxine/pyrimethamine for Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Gabon; Humans; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2006 |
Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; DNA, Protozoan; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sulfadoxine; Tanzania | 2007 |
Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitemia; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2007 |
Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemeter followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian childr
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Suppositories | 2007 |
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2007 |
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Uganda | 2007 |
Thiamin deficiency and uncomplicated falciparum malaria in Laos.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Beriberi; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Enzyme Activation; Erythrocytes; Female; Humans; Infant; Laos; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Thiamine Deficiency; Transketolase; Treatment Outcome | 2007 |
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Clindamycin; Drug Combinations; Female; Fosfomycin; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2007 |
Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Half-Life; Humans; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Unusual pattern of Plasmodium falciparum drug resistance in the northwestern Peruvian Amazon region.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2007 |
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genes, Protozoan; Genetic Markers; Genotype; Guinea; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2007 |
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Madagascar; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
Topics: Adolescent; Adult; Afghanistan; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Resistance; Female; Folic Acid Antagonists; Humans; Malaria, Vivax; Male; Middle Aged; Pakistan; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda; Urban Population | 2007 |
Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Prevalence; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine | 2007 |
A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
Topics: Animals; Antimalarials; Double-Blind Method; Drug Combinations; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Placebos; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.
Topics: Adult; Animals; Antimalarials; Birth Weight; Chloroquine; Drug Combinations; Female; Hematocrit; Humans; Infant, Newborn; Malaria, Falciparum; Nigeria; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Comoros; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Dizziness; Drug Combinations; Female; Humans; Malaria; Male; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Genotype; Humans; Malaria; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2007 |
Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo).
Topics: Amodiaquine; Antimalarials; Carrier State; Child, Preschool; Congo; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Topics: Adolescent; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Humans; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Nepal; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Drug Combinations; Female; Half-Life; HIV Infections; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania; Treatment Outcome | 2007 |
Home-based management of fever and malaria treatment practices in Uganda.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Community Health Services; Drug Combinations; Drug Therapy, Combination; Fever; Health Knowledge, Attitudes, Practice; Home Nursing; Humans; Malaria; Mothers; Outcome Assessment, Health Care; Patient Compliance; Pyrimethamine; Rural Health; Sulfadoxine; Surveys and Questionnaires; Uganda | 2007 |
Comparison of the therapeutic efficacy of chloroquine and sulphadoxine-pyremethamine in children and pregnant women.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Failure | 2007 |
Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants.
Topics: Animals; Antimalarials; Child; Double-Blind Method; Drug Combinations; Ghana; Humans; Immunoglobulin G; Incidence; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2007 |
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate plus s
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rwanda; Sesquiterpenes; Sulfadoxine; Sulfalene | 2007 |
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2007 |
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 2007 |
Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; Hemoglobins; Humans; Incidence; Malaria; Odds Ratio; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Outcome; Zambia | 2007 |
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; Hemoglobins; HIV Seropositivity; Humans; Incidence; Malaria, Falciparum; Odds Ratio; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Outcome; Zambia | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Gabon; Hematocrit; Hemoglobins; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Parasitemia; Patient Selection; Pyrimethamine; Research Design; Sulfadoxine; Treatment Outcome | 2007 |
Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Sudan; Sulfadoxine | 2007 |
Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya.
Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Humans; Insecticides; Kenya; Linear Models; Malaria; Maternal Health Services; Pregnancy; Prenatal Care; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Urban Population | 2007 |
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
Topics: Analysis of Variance; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Respiratory Tract Infections; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2007 |
A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children.
Topics: Amodiaquine; Antimalarials; Arsenites; Child; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Pyrimethamine; Seasons; Senegal; Sulfadoxine | 2008 |
[Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali].
Topics: Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Mali; Placenta Diseases; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2007 |
Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.
Topics: Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Infant; Malaria; Malawi; Mutation; Pyrimethamine; Selection, Genetic; Sulfadoxine; Treatment Outcome | 2008 |
Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Female; Humans; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2008 |
Intermittent preventive treatment of malaria in pregnancy: a new delivery system and its effect on maternal health and pregnancy outcomes in Uganda.
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Maternal Welfare; Middle Aged; Pregnancy; Pregnancy Outcome; Prevalence; Program Development; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Uganda | 2008 |
Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Biomarkers; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Time Factors; Vomiting | 2008 |
Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
Topics: Animals; Antimalarials; Biomarkers; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2008 |
Herba Artemisiae annuae tea preparation compared to sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial.
Topics: Adult; Animals; Antimalarials; Artemisia annua; Double-Blind Method; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Phytotherapy; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2008 |
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana.
Topics: Anemia; Drug Administration Schedule; Drug Combinations; Ghana; Humans; Infant; Malaria; Placebos; Pyrimethamine; Sulfadoxine | 2008 |
Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Child, Preschool; Drug Administration Schedule; Drug Combinations; Erythrocytes; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Malaria, Falciparum; Mozambique; Plasmodium falciparum; Pyrimethamine; Recombinant Proteins; Sulfadoxine; Treatment Outcome | 2008 |
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Muscle Weakness; Pyrimethamine; Single-Blind Method; Sulfadoxine; Uganda | 2008 |
Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali.
Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; Humans; Incidence; Infant; Malaria; Mali; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2008 |
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Amodiaquine; Anemia; Animals; Antimalarials; Child; Child, Preschool; Cluster Analysis; Cognition; Cross-Sectional Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Feces; Female; Humans; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2008 |
[Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Colombia; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
Topics: Adult; Anemia; Anti-HIV Agents; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Malaria, Falciparum; Mozambique; Nevirapine; Placenta Diseases; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pyrimethamine; RNA, Viral; Sulfadoxine; Viral Load | 2008 |
From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control.
Topics: Antimalarials; Community Health Services; Drug Combinations; Health Care Costs; Health Plan Implementation; Health Resources; Humans; Infant; Interviews as Topic; Malaria; Planning Techniques; Preventive Health Services; Pyrimethamine; Residence Characteristics; Sulfadoxine; Tanzania | 2008 |
[Gametocytemia in falciparum malaria treated with amodiaquine or artesunate].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Chloroquine; Drug Combinations; Female; Health Promotion; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.
Topics: Antimalarials; Drug Administration Schedule; Drug Combinations; Gabon; Ghana; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Regression Analysis; Sulfadoxine; Time Factors; Treatment Outcome | 2008 |
Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria.
Topics: Adult; Animals; Antimalarials; Dietary Supplements; Drug Combinations; Female; Folic Acid; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Survival Analysis; Treatment Failure; Young Adult | 2008 |
dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Ghana; Humans; Infant; Kaplan-Meier Estimate; Malaria; Placebos; Pyrimethamine; Seasons; Sulfadoxine | 2008 |
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Malaria, Falciparum; Male; Oxidants; Polymorphism, Genetic; Proguanil; Pyrimethamine; Sulfadoxine | 2008 |
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome | 2009 |
Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Topics: Adult; Anemia; Animals; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Parasitemia; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2009 |
Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
Topics: Animals; Artemisinins; Artesunate; Carrier State; Child, Preschool; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Germ Cells; Humans; Infant; Kenya; Malaria, Falciparum; Mutation; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Longitudinal Studies; Malaria; Plasmodium; Pyrimethamine; Sulfadoxine; Treatment Failure; Uganda | 2009 |
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Topics: Alleles; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Reduced efficacy of intermittent preventive treatment of malaria in malnourished children.
Topics: Antimalarials; Double-Blind Method; Drug Combinations; Ghana; Humans; Infant; Infection Control; Malaria; Malnutrition; Nutritional Status; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.
Topics: Animals; Child, Preschool; Codon; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Humans; Infant; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Failure | 2009 |
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mali; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.
Topics: Analysis of Variance; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Cohort Studies; Drug Combinations; Female; Fever; Follow-Up Studies; Genotype; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan.
Topics: Adolescent; Animals; Anthelmintics; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Praziquantel; Pyrimethamine; Schistosoma mansoni; Schistosomiasis mansoni; Sudan; Sulfadoxine; Treatment Outcome | 2009 |
Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Community Health Services; Drug Combinations; Female; Health Promotion; Humans; Malaria; Multivariate Analysis; Odds Ratio; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Socioeconomic Factors; Sulfadoxine; Young Adult | 2009 |
Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
Topics: Adult; Amodiaquine; Artemisinins; Artesunate; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2009 |
Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment.
Topics: Animals; Antimalarials; Child; Drug Combinations; Genotype; Haplotypes; Humans; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2009 |
Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2009 |
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.
Topics: Adolescent; Anemia; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mali; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Proportional Hazards Models; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2009 |
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Humans; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2009 |
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Single-Blind Method; Stillbirth; Sulfadoxine; Young Adult | 2009 |
Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2009 |
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Papua New Guinea; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2009 |
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Dapsone; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Malawi; Male; Medication Adherence; Plasma; Proguanil; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2009 |
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Dapsone; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Half-Life; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Logistic Models; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Proguanil; Pyrimethamine; Safety; Sulfadoxine; Tanzania; Treatment Outcome | 2009 |
Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
Topics: Adult; Africa; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
Topics: Antimalarials; Artemisinins; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Quinolines; Rural Population; Senegal; Sulfadoxine; Treatment Outcome | 2009 |
Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Community Health Services; Drug Combinations; Female; Ghana; Home Care Services; Humans; Infant; Malaria, Falciparum; Male; Program Evaluation; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2009 |
Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens.
Topics: Adult; Animals; Antimalarials; Burkina Faso; Chemoprevention; Chloroquine; Drug Combinations; Female; Fetal Blood; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome; Young Adult | 2009 |
Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
Topics: Analysis of Variance; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Gene Frequency; Genes, Protozoan; Haplotypes; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Rwanda; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.
Topics: Anemia; Antimalarials; Child, Preschool; Cohort Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Gabon; Humans; Infant; Kaplan-Meier Estimate; Malaria; Morbidity; Pyrimethamine; Sulfadoxine | 2009 |
Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial.
Topics: Anemia, Sickle Cell; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Malaria; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2009 |
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
Topics: Amino Acid Sequence; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Alignment; Sulfadoxine; Uganda | 2009 |
The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
Topics: Antibodies, Protozoan; Antimalarials; Chemoprevention; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; HIV Infections; Humans; Infant; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Mozambique; Placebos; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
Topics: Age Factors; Amodiaquine; Antimalarials; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2010 |
Active malaria morbidity management has limited impact on height status of preschool Senegalese children.
Topics: Antimalarials; Body Height; Child, Preschool; Chloroquine; Drug Combinations; Female; Growth Disorders; Humans; Infant; Malaria; Male; Pyrimethamine; Senegal; Sulfadoxine | 2010 |
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2010 |
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Cameroon; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sulfadoxine; Time Factors; Treatment Outcome | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Malaria, Falciparum; Multivariate Analysis; Prevalence; Primaquine; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine; Tanzania | 2010 |
Malaria prevention with IPTp during pregnancy reduces neonatal mortality.
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Infant Mortality; Infant, Newborn; Malaria; Mozambique; Multivariate Analysis; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Assessment; Risk Factors; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
Topics: Antimalarials; Dapsone; Drug Administration Schedule; Drug Combinations; Drug Resistance; Humans; Immunization Schedule; Infant; Infant, Newborn; Malaria; Mefloquine; Pediatrics; Placebos; Proguanil; Pyrimethamine; Research Design; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.
Topics: Alleles; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Genes, MDR; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Prevalence; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2010 |
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Dapsone; Double-Blind Method; Drug Combinations; Humans; Incidence; Infant; Kenya; Malaria; Premedication; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2010 |
Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.
Topics: Anemia; Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug-Related Side Effects and Adverse Reactions; Female; Gambia; Genetic Markers; Genotype; Hospitals; Humans; Malaria; Male; Nutritional Status; Parasites; Patient Compliance; Patient Discharge; Pyrimethamine; Secondary Prevention; Sulfadoxine | 2010 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients-a randomized placebo-controlled trial.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antimalarials; Double-Blind Method; Drug Combinations; Female; Humans; Incidence; Malaria; Male; Periodicity; Placebos; Pyrimethamine; Seasons; Senegal; Sulfadoxine; Young Adult | 2011 |
Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.
Topics: Antigens, Protozoan; Antimalarials; Chemoprevention; Drug Combinations; Female; Ghana; Humans; Infant; Malaria; Male; Merozoite Surface Protein 1; Placebos; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2010 |
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Ghana; Humans; Infant; Malaria; Preventive Health Services; Pyrimethamine; Seasons; Sulfadoxine | 2010 |
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.
Topics: Alcohol Dehydrogenase; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria.
Topics: Anemia; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid; Humans; Infant; Iron; Malaria; Male; Nigeria; Pyrimethamine; Sulfadoxine | 2010 |
The effects of a pre-season treatment with effective antimalarials on subsequent malaria morbidity in under five-year-old children living in high and seasonal malaria transmission area of Burkina Faso.
Topics: Age Distribution; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child, Preschool; Disease Susceptibility; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Seasons; Sex Distribution; Sulfadoxine; Treatment Outcome | 2010 |
Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery.
Topics: Adult; Aging; Antimalarials; Delivery, Obstetric; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Mozambique; Odds Ratio; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors | 2011 |
Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Ghana; Humans; Infant; Malaria, Falciparum; Placebos; Protozoan Proteins; Pyrimethamine; Risk Factors; Sulfadoxine | 2010 |
Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Premature Birth; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment.
Topics: Adult; Alleles; Antimalarials; Chemoprevention; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genetic Markers; HIV Infections; Humans; Infant, Newborn; Malaria, Falciparum; Mozambique; Placebos; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2011 |
Population pharmacokinetics of sulfadoxine and pyrimethamine in Malawian children with malaria.
Topics: Age Factors; Antimalarials; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria; Male; Models, Biological; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2011 |
Impact of malaria at the end of pregnancy on infant mortality and morbidity.
Topics: Antimalarials; Drug Combinations; Female; Humans; Infant Mortality; Infant, Newborn; Malaria, Falciparum; Morbidity; Mozambique; Placebos; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proportional Hazards Models; Pyrimethamine; Risk Factors; Sulfadoxine; Surveys and Questionnaires | 2011 |
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Drug Resistance; Female; Geography; Ghana; Humans; Malaria; Models, Statistical; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2010 |
A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Gambia; Humans; Incidence; Infant; Malaria; Male; Placebos; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome | 2011 |
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine.
Topics: Age Factors; Antibodies, Protozoan; Antibody Formation; Antigenic Variation; Antigens, Protozoan; Antigens, Surface; Drug Combinations; Growth Inhibitors; Humans; Immunoglobulin G; Infant; Infant, Newborn; Malaria, Falciparum; Membrane Proteins; Mozambique; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2011 |
Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.
Topics: Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2011 |
Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
Topics: Adult; Antimalarials; Benin; Chloroquine; Drug Combinations; Female; Health Policy; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Maternal Age; Mefloquine; Multivariate Analysis; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2011 |
Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Insecticide-Treated Bednets; Malaria; Male; Pyrimethamine; Sulfadoxine | 2011 |
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
Topics: Amodiaquine; Antimalarials; Burkina Faso; Child, Preschool; Double-Blind Method; Drug Combinations; Humans; Infant; Insecticide-Treated Bednets; Malaria; Pyrimethamine; Sulfadoxine | 2011 |
Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.
Topics: Anemia; Antimalarials; Comorbidity; Drug Administration Schedule; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Rural Health Services; Rural Population; Sulfadoxine; Tanzania | 2011 |
[Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Endemic Diseases; Environment; Female; Health Knowledge, Attitudes, Practice; Humans; Infant, Newborn; Malaria; Mali; Middle Aged; Mosquito Nets; Nausea; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Self Medication; Sulfadoxine; Vomiting; Young Adult | 2010 |
Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2011 |
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.
Topics: Amino Acid Substitution; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mutation, Missense; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2011 |
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Jaundice, Neonatal; Malaria; Mali; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Pyrimethamine; Skin Diseases; Sulfadoxine; Treatment Outcome; Young Adult | 2011 |
Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.
Topics: Antimalarials; Cluster Analysis; Cross-Sectional Studies; Drug Combinations; Female; Humans; Immunization Programs; Infant; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine; Vaccines | 2011 |
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mali; Morbidity; Mosquito Nets; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2011 |
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Burkina Faso; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Morbidity; Mosquito Nets; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2011 |
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Infant; Malaria; Male; Microscopy; Middle Aged; Parasitemia; Placebos; Primaquine; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2011 |
Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Child, Preschool; Drug Combinations; Drug Interactions; Female; Half-Life; Humans; Infant; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine | 2011 |
Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uga
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Drug Combinations; Female; House Calls; Humans; Infant, Low Birth Weight; Infant, Newborn; Insecticide-Treated Bednets; Malaria; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2011 |
Effect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Insecticide-Treated Bednets; Kenya; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Multivariate Analysis; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2011 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Community Health Workers; Disease Management; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Health Promotion; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prevalence; Preventive Health Services; Pyrimethamine; Rural Population; Seasons; Senegal; Sulfadoxine | 2011 |
Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Drug Therapy; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Middle Aged; Pregnancy; Pyrimethamine; Sulfadoxine; Survival Analysis; Tanzania; Young Adult | 2011 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.
Topics: Antimalarials; Chemokines; Child; Drug Combinations; Flow Cytometry; Humans; Incidence; Infant; Intracellular Space; Malaria, Falciparum; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Th1 Cells; Th2 Cells | 2012 |
Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Pakistan; Patient Selection; Plasmodium falciparum; Polymerase Chain Reaction; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control.
Topics: Antimalarials; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine; Survival Analysis | 2012 |
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
Topics: Adult; Anemia; Antimalarials; Burkina Faso; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimesters; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Time Factors; Young Adult | 2012 |
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2012 |
Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine | 2012 |
The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Azithromycin; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Male; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Time Factors | 2012 |
Pharmacokinetic properties and bioequivalence of two sulfadoxine/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Antimalarials; Asian People; Chemistry, Pharmaceutical; Chi-Square Distribution; China; Chromatography, Liquid; Drug Combinations; Drugs, Generic; Humans; Indicator Dilution Techniques; Linear Models; Male; Mass Spectrometry; Middle Aged; Models, Biological; Pyrimethamine; Sulfadoxine; Tablets; Therapeutic Equivalency; Young Adult | 2012 |
Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial.
Topics: Adult; Albendazole; Anemia; Anemia, Iron-Deficiency; Anthelmintics; Antimalarials; Cluster Analysis; Drug Combinations; Female; Folic Acid; Follow-Up Studies; Gestational Age; Helminthiasis; Hemoglobins; Humans; Iron; Malaria; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Single-Blind Method; Sulfadoxine; Tanzania; Young Adult | 2011 |
Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.
Topics: Adult; Animals; Anthelmintics; Chemoprevention; Drug Combinations; Feces; Female; Gabon; Humans; Mefloquine; Parasite Egg Count; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Schistosoma haematobium; Schistosomiasis haematobia; Single-Blind Method; Sulfadoxine; Treatment Outcome; Young Adult | 2013 |
A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.
Topics: Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mutation; Peptide Synthases; Plasmodium; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2013 |
The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Birth Weight; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Fetal Development; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Reproductive Tract Infections; Sulfadoxine; Young Adult | 2013 |
A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Prevalence; Prospective Studies; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2013 |
Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).
Topics: Antimalarials; Central African Republic; Clinical Protocols; Coinfection; Drug Administration Schedule; Drug Combinations; Female; Folic Acid Antagonists; HIV Infections; Hospitals, Maternity; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Research Design; Sulfadoxine; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.
Topics: Antimalarials; Child; Clinical Protocols; Congo; Drug Combinations; Drug Therapy, Combination; Ethics, Medical; Humans; Malaria; Pyrimethamine; Quinolines; Research Design; Sample Size; Sulfadoxine | 2013 |
Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Incidence; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Togo; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2014 |
Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimethamine; Regression Analysis; Sulfadoxine; Young Adult | 2010 |
Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Volunteers; Young Adult | 2014 |
Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Quinolines; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2014 |
Host candidate gene polymorphisms and associated clearance of P. falciparum amodiaquine and fansidar resistance mutants in children less than 5 years in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Infant, Newborn; Interleukin-22; Interleukin-4; Interleukins; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2014 |
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Cohort Studies; Drug Combinations; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2014 |
Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial.
Topics: Adult; Antimalarials; Azithromycin; Chloroquine; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Papua New Guinea; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Single-Blind Method; Sulfadoxine; Young Adult | 2015 |
Impact of intermittent preventive treatment in pregnancy with azithromycin-containing regimens on maternal nasopharyngeal carriage and antibiotic sensitivity of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus: a cross-sectional
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antimalarials; Azithromycin; Bacterial Infections; Carrier State; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Haemophilus influenzae; Humans; Malaria; Microbial Sensitivity Tests; Nasopharynx; Papua New Guinea; Pregnancy; Pyrimethamine; Serotyping; Staphylococcus aureus; Streptococcus pneumoniae; Sulfadoxine; Young Adult | 2015 |
Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Pyrimethamine; Sulfadoxine | 2015 |
Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Topics: Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female; HIV Infections; Humans; Kenya; Malaria; Mefloquine; Mozambique; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2015 |
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemisinins; Burkina Faso; Case-Control Studies; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Seasons; Sulfadoxine | 2015 |
In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.
Topics: Adolescent; Adult; Antimalarials; Asymptomatic Infections; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malawi; Parasitemia; Parity; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.
Topics: Adolescent; Adult; Algorithms; Antimalarials; Area Under Curve; Drug Combinations; Female; Half-Life; Humans; Malaria; Male; Mefloquine; Models, Statistical; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Young Adult | 2015 |
Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission.
Topics: Adult; Antibodies, Protozoan; Antimalarials; Azithromycin; Chloroquine; Drug Combinations; Erythrocytes; Female; Humans; Malaria, Falciparum; Papua New Guinea; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2015 |
Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
Topics: Anemia; Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; Mefloquine; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Stillbirth; Sulfadoxine; Treatment Outcome | 2015 |
Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
Topics: Adult; Antimalarials; Benin; Drug Combinations; Female; HIV Infections; Humans; Interleukin-10; Interleukin-2; Interleukin-4; Interleukin-5; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Topics: Adolescent; Adult; Africa; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Gambia; Ghana; Hemoglobins; Humans; Malaria; Mali; Mass Screening; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2015 |
The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Child, Preschool; Cote d'Ivoire; Diphosphates; Drug Combinations; Edetic Acid; Ferric Compounds; Food, Fortified; Hemoglobins; Humans; Infant; Inflammation; Iron; Iron Deficiencies; Malaria; Male; Prevalence; Pyrimethamine; Sulfadoxine | 2015 |
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-lab
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Mass Screening; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Treatment Outcome; Young Adult | 2015 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Topics: Antimalarials; Cohort Studies; Dapsone; Double-Blind Method; Drug Combinations; Female; Genotype; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Logistic Models; Malaria; Male; Mefloquine; Multivariate Analysis; Odds Ratio; Poisson Distribution; Polymorphism, Single Nucleotide; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 2015 |
Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood.
Topics: Artemisinins; Child, Preschool; Drug Combinations; GPI-Linked Proteins; Humans; Immune Tolerance; Infant; Longitudinal Studies; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinolines; Receptors, Antigen, T-Cell, gamma-delta; Receptors, IgG; Sulfadoxine; T-Lymphocyte Subsets; Up-Regulation | 2016 |
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
Topics: Adult; Africa, Southern; Antimalarials; Child; Child Development; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Maternal Exposure; Mefloquine; Morbidity; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Pyrimethamine; Sulfadoxine; Survival Rate; Treatment Outcome | 2016 |
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Incidence; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Vomiting; Young Adult | 2016 |
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders; Coinfection; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
Topics: Adolescent; Adult; Azithromycin; Chloroquine; Drug Combinations; Female; Humans; Infant, Newborn; Intention to Treat Analysis; Malaria, Falciparum; Pregnancy; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2016 |
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Tr
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Diagnostic Tests, Routine; Drug Combinations; Female; Humans; Malaria; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2016 |
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Health Services; Hospitalization; Humans; Infant; Jaundice; Malaria; Male; Pyrimethamine; Seasons; Senegal; Sulfadoxine; Survival Analysis | 2016 |
Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Seasons; Senegal; Sulfadoxine | 2016 |
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
Topics: Adolescent; Anemia; Antimalarials; Chemoprevention; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Hemoglobins; Humans; Malaria; Male; Parasitemia; Pyrimethamine; Quinolines; Schools; Students; Sulfadoxine; Treatment Outcome | 2017 |
Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery.
Topics: Adult; Africa; Antimalarials; Drug Combinations; Female; Humans; Malaria; Models, Biological; Postpartum Period; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
Assessment of Clinical Pharmacokinetic Drug-Drug Interaction of Antimalarial Drugs α/β-Arteether and Sulfadoxine-Pyrimethamine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Chromatography, Liquid; Drug Combinations; Drug Interactions; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tandem Mass Spectrometry; Young Adult | 2017 |
Placental but Not Peripheral Plasmodium falciparum Infection During Pregnancy Is Associated With Increased Risk of Malaria in Infancy.
Topics: Chloroquine; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Longitudinal Studies; Malaria, Falciparum; Multivariate Analysis; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine | 2017 |
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2018 |
Child Health Outcomes After Presumptive Infection Treatment in Pregnant Women: A Randomized Trial.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Child Development; Child Health; Child Mortality; Child, Preschool; Drug Combinations; Female; Fetal Death; Follow-Up Studies; Growth Disorders; Humans; Incidence; Infant; Malaria; Malawi; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Rural Population; Sulfadoxine | 2018 |
Comparative study of mefloquine and sulphadoxine-pyrimethamine for malaria prevention among pregnant women with HIV in southwest Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine | 2018 |
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Benin; Burkina Faso; Drug Combinations; Female; Gambia; Humans; Malaria; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome; Young Adult | 2019 |
Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Chemoprevention; Drug Combinations; Female; Humans; Incidence; Malaria, Falciparum; Mass Screening; Nigeria; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2018 |
Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Time Factors; Treatment Outcome; Uganda; Young Adult | 2018 |
Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2018 |
Seasonal malaria chemoprevention packaged with malnutrition prevention in northern Nigeria: A pragmatic trial (SMAMP study) with nested case-control.
Topics: Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria; Male; Malnutrition; Nigeria; Pyrimethamine; Seasons; Sulfadoxine | 2019 |
Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial.
Topics: Antimalarials; Cross-Sectional Studies; Drug Combinations; Feasibility Studies; Female; Humans; Infant; Malaria; Male; Medication Adherence; Papua New Guinea; Parents; Pyrimethamine; Self Administration; Sulfadoxine | 2019 |
Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection.
Topics: Azithromycin; Biomarkers; Drug Combinations; Female; Humans; Infant, Newborn; Live Birth; Malaria; Neovascularization, Physiologic; Papua New Guinea; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2019 |
The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Topics: Adolescent; Adult; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Haplotypes; HIV Infections; Humans; Kenya; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pre-Exposure Prophylaxis; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2019 |
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Topics: Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Young Adult | 2019 |
The impact of maternal antenatal treatment with two doses of azithromycin and monthly sulphadoxine-pyrimethamine on child weight, mid-upper arm circumference and head circumference: A randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Arm; Azithromycin; Birth Weight; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Head; Humans; Incidence; Infant; Infant, Newborn; Malaria; Malawi; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pyrimethamine; Respiratory Tract Infections; Sulfadoxine | 2019 |
Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria, Falciparum; Malawi; Mass Screening; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2019 |
A randomized controlled trial of azithromycin and sulphadoxine-pyrimethamine as prophylaxis against malaria in pregnancy among human immunodeficiency virus-positive women.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Drug Combinations; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Malaria; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2019 |
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine | 2019 |
Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2020 |
Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
Topics: Adolescent; Adult; Antimalarials; Cluster Analysis; Cohort Studies; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Insecticide-Treated Bednets; Kenya; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
Topics: Adolescent; Adult; Animals; Birth Weight; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant, Newborn; Linear Models; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis.
Topics: Adult; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2020 |
A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Cluster Analysis; Community Health Centers; Drug Combinations; Drug Delivery Systems; Female; Humans; Pregnancy; Pregnant Women; Public Health; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
Topics: Adult; Antimalarials; Artesunate; Double-Blind Method; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria; Male; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Infant sex modifies associations between placental malaria and risk of malaria in infancy.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Falciparum; Male; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2020 |
The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Infant; Malaria; Malawi; Parasitemia; Piperazines; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome | 2022 |
Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.
Topics: Amodiaquine; Animals; Antimalarials; Azithromycin; Chemoprevention; Child, Preschool; Culicidae; Drug Combinations; Genetic Fitness; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
Topics: Adult; Antimalarials; Central African Republic; Drug Combinations; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2021 |
Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized
Topics: Antimalarials; Artemisinins; Clinical Trials, Phase III as Topic; Diagnostic Tests, Routine; Drug Combinations; Female; HIV Infections; Humans; Infant; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Retrospective Studies; Sulfadoxine | 2021 |
The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
Topics: Antimalarials; Birth Weight; Cryptosporidiosis; Cryptosporidium; Drug Combinations; Escherichia coli; Female; Gestational Weight Gain; Humans; Infant; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2022 |
The Impact of Antenatal Azithromycin and Monthly Sulfadoxine-Pyrimethamine on Maternal Malaria during Pregnancy and Fetal Growth: A Randomized Controlled Trial.
Topics: Antimalarials; Azithromycin; Drug Combinations; Female; Fetal Development; Humans; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine | 2023 |
Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled tr
Topics: Adult; Antimalarials; Azithromycin; Drug Combinations; Female; Humans; Infant, Newborn; Kenya; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Tanzania; Young Adult | 2023 |
Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial.
Topics: Abortion, Spontaneous; Antimalarials; Azithromycin; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Malaria; Pregnancy; Premature Birth; Pyrimethamine; Stillbirth; Sulfadoxine | 2023 |
1008 other study(ies) available for pyrimethamine and fanasil, pyrimethamine drug combination
| Article | Year |
|---|---|
Death from a severe case of Plasmodium falciparum in a Canadian.
Topics: Adult; Animals; Antimalarials; Cause of Death; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Multiple Organ Failure; Plasmodium falciparum; Pyrimethamine; Quinidine; Sulfadoxine; Travel | 1992 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.
Topics: Adult; Aerosols; Aged; CD4-Positive T-Lymphocytes; Drug Combinations; Encephalitis; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Primary Prevention; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Cerebral | 1992 |
Antimalarial drug sensitivity patterns in the western province of Zambia. Implications for the management of primary health care (PHC).
Topics: Adolescent; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Zambia | 1992 |
Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/sulphalene against P. falciparum in northeastern Nigeria.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Humans; Incidence; Infant; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfalene | 1992 |
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.
Topics: Administration, Oral; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Kenya; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 1992 |
Pyrimethamine/sulfadoxine for falciparum malaria.
Topics: Adolescent; Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Retrospective Studies; Sulfadoxine | 1991 |
[Trends of tissue hypoxia following chemotherapy of acute malaria in mice].
Topics: Animals; Antimalarials; Cell Hypoxia; Drug Combinations; Malaria; Male; Mice; Mice, Inbred Strains; Oxygen; Pyrimethamine; Sulfadoxine | 1991 |
[Prevention and treatment of malaria in expatriates living in Black Africa. Influence of chemoresistance. Investigations conducted in Brazzaville (Congo)].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance, Microbial; Europe; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Treatment of malaria with sulfadoxine/pyrimethamine: note of caution.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1990 |
Malaria prophylaxis and self-therapy in airline crews.
Topics: Aerospace Medicine; Africa; Animals; Antimalarials; Culicidae; Drug Combinations; Drug Resistance; Emergencies; Humans; Incidence; Insect Bites and Stings; Malaria; Mefloquine; Patient Compliance; Protective Clothing; Pyrimethamine; Self Medication; Sulfadoxine | 1990 |
Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya.
Topics: Adolescent; Adult; Animals; Antibodies, Protozoan; Child; Child, Preschool; Drug Combinations; Ethnicity; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Indonesia; Infant; Malaria; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1991 |
Pyrimethamine-sulfadoxine (Fansidar) resistance in a non-immune Kenyan--a case report.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Kenya; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1991 |
[Imported fever in a 4-year-old boy].
Topics: Africa, Central; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1990 |
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Eruptions; Female; Hematologic Diseases; Humans; Male; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadoxine; Sulfanilamides | 1990 |
Treatment of toxic epidermal necrolysis and a review of six cases.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Antimalarials; Chlorpromazine; Clavulanic Acids; Diagnosis, Differential; Drug Combinations; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrimethamine; Retrospective Studies; Stevens-Johnson Syndrome; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Zimeldine | 1990 |
[Drug-induced exudative erythema multiforme major with a chronic progressive course and bilateral blindness. Clinical and immunohistologic follow-up].
Topics: Adult; Antimalarials; Blindness; Conjunctiva; Drug Combinations; Drug Eruptions; Epithelium; Follow-Up Studies; Histocompatibility Antigens Class II; Humans; Immunohistochemistry; Lymphocyte Activation; Male; Microscopy, Electron; Mouth Mucosa; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine | 1990 |
Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
Topics: Adult; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides | 1990 |
[Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1990 |
[Acute hepatitis following administration of fansidar].
Topics: Adult; Alanine Transaminase; Antimalarials; Aspartate Aminotransferases; Biopsy; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Liver; Liver Function Tests; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1990 |
Prophage induction by 4 antimalaria drugs (daraprim, fansidar, nivaquine and camoquine) and in combination with aflatoxin B1.
Topics: Aflatoxin B1; Aflatoxins; Amodiaquine; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Escherichia coli; In Vitro Techniques; Lysogeny; Mutagenicity Tests; Pyrimethamine; Sulfadoxine | 1989 |
Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
Topics: Animals; Antimalarials; Dapsone; Drug Combinations; Humans; Kenya; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1989 |
Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria; Medication Errors; Pyrimethamine; Self Medication; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides; Travel | 1989 |
Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia.
Topics: Age Factors; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Indonesia; Infant; Malaria; Parasite Egg Count; Primaquine; Prospective Studies; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1989 |
Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Malaria; Plasmodium falciparum; Pyrimethamine; South Africa; Sulfadoxine; Sulfanilamides | 1989 |
Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
Topics: Adult; Antimalarials; Drug Combinations; Drug Hypersensitivity; Female; Humans; Lymphocyte Activation; Malaria; Pulmonary Eosinophilia; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1989 |
Curative and preventive treatment of uncomplicated malaria in public health institutions in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Female; Humans; Malaria; Medicine; Nurses; Physicians; Pregnancy; Public Health; Pyrimethamine; Quinine; Specialization; Sulfadoxine; Surveys and Questionnaires | 1989 |
Experience with pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoscopy; Drug Combinations; Follow-Up Studies; Homosexuality; Humans; Length of Stay; Male; Middle Aged; New Zealand; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Retrospective Studies; Sulfadoxine; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1989 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Artemisinins; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1985 |
Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1985 |
Adverse reactions to pyrimethamine-sulfadoxine in context of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Drug Hypersensitivity; Humans; Pyrimethamine; Sulfadoxine; Sulfamethoxazole; Sulfanilamides; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
RI quinine-Fansidar resistant falciparum malaria from Malawi.
Topics: Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Malawi; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides | 1985 |
Does chloroquine contribute to the risk of serious adverse reactions to fansidar?
Topics: Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Pyrimethamine; Skin Diseases; Sulfadoxine; Sulfanilamides | 1985 |
Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.
Topics: Acute Disease; Antimalarials; Chloroquine; Drug Combinations; Drug Eruptions; Humans; Pyrimethamine; Sulfadoxine; Sulfanilamides; Switzerland; Travel | 1986 |
Liver damage associated with fansidar.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors | 1986 |
Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Half-Life; Humans; Malaria; Male; Pyrimethamine; Sulfadoxine; Sulfanilamides; Thailand | 1988 |
An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy.
Topics: Antimalarials; Child; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Male; Photosensitivity Disorders; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1989 |
Erythroderma resembling sézary syndrome after treatment with Fansidar and chloroquine.
Topics: Antimalarials; Chloroquine; Dermatitis, Exfoliative; Drug Combinations; Humans; Malaria; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Sulfanilamides; Treponema pallidum | 1986 |
[The reliability and side effects of malaria chemoprophylaxis].
Topics: Antimalarials; Drug Combinations; Drug Eruptions; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides; Switzerland | 1986 |
Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Eruptions; Erythema Multiforme; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides; Travel; United States | 1986 |
Adverse reactions to Fansidar.
Topics: Antimalarials; Drug Combinations; Drug Eruptions; Humans; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1986 |
Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Dermatitis, Exfoliative; Drug Combinations; Ecuador; Female; Humans; Liver Diseases; Liver Function Tests; Malaria; Necrosis; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1987 |
Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia.
Topics: Adult; Antimalarials; Drug Combinations; Drug Eruptions; Female; Humans; Malaysia; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1987 |
[Fansidar-induced maculopathy and dermatitis exfoliativa].
Topics: Adult; Antimalarials; Dermatitis, Exfoliative; Drug Combinations; Female; Humans; Macula Lutea; Pyrimethamine; Retinal Diseases; Sulfadoxine; Sulfanilamides | 1987 |
Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
Topics: Adult; Antimalarials; Drug Combinations; Drug Eruptions; Erythema Multiforme; Female; Humans; Malaria; Male; Middle Aged; Pyrimethamine; Risk Factors; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides; Travel | 1987 |
Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
Topics: Africa; Animals; Antimalarials; Centers for Disease Control and Prevention, U.S.; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel; United States | 1986 |
Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
Topics: Africa; Antimalarials; Centers for Disease Control and Prevention, U.S.; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel; United States | 1986 |
[Evolving visceral malaria: an unusual occurrence in Europeans. Apropos of a case].
Topics: Animals; Antimalarials; Drug Combinations; Female; Humans; Intestinal Diseases, Parasitic; Malaria; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1988 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
[An imported case of malaria resistant to chloroquine].
Topics: Animals; Cameroon; Child; Child, Preschool; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Israel; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1988 |
The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Rwanda; Sulfadoxine; Sulfanilamides | 1988 |
[Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Ghana; Humans; Malaria; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1988 |
Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Topics: Adolescent; Adult; Animals; Child; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.
Topics: Agranulocytosis; Amodiaquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1986 |
Transient lupus anticoagulant and fansidar therapy.
Topics: Adult; Antimalarials; Blood Coagulation Factors; Drug Combinations; Humans; Lupus Coagulation Inhibitor; Male; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1986 |
[Drug-induced hepatitis caused by Fansidar].
Topics: Adult; Antimalarials; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Drug Combinations; Hepatitis C; Humans; Liver; Liver Function Tests; Male; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
Death despite malaria prophylaxis.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1988 |
Fansidar-associated fatal reaction in an HIV-infected man.
Topics: Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Homosexuality; Humans; Male; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1988 |
Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).
Topics: Chemical and Drug Induced Liver Injury; Drug Combinations; Drug Eruptions; Female; Humans; Kidney Diseases; Liver; Liver Diseases; Malaria; Middle Aged; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1985 |
Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Eruptions; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1985 |
Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Eruptions; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1985 |
Fansidar and Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Sulfadoxine; Sulfanilamides | 1988 |
Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
Topics: Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Homosexuality; Humans; Male; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1988 |
Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1988 |
Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
Topics: Animals; Chloroquine; Drug Combinations; Drug Resistance; Gabon; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
[Diagnosis of drug-resistant strains of Plasmodium falciparum].
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Plasmodium falciparum; Pyrimethamine; Reagent Kits, Diagnostic; Sulfadoxine; World Health Organization | 1987 |
In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination.
Topics: Animals; Antimalarials; Drug Combinations; Drug Synergism; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfamethoxazole; Sulfanilamides; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Pyrimethamine-sulfadoxine still effective against Plasmodium falciparum in Jayapura, Irian Jaya: RI-type resistance in 2 of 18 patients.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Plasmodium falciparum; Pyrimethamine; R Factors; Sulfadoxine; Sulfanilamides | 1987 |
Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand.
Topics: Adult; Animals; Child; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Thailand | 1987 |
A case of Plasmodium falciparum infection resistant to chloroquine.
Topics: Adult; Animals; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
Fansidar resistance in the Philippines.
Topics: Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Philippines; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
[2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
[Development of drug resistance in cases of P. falciparum malaria of African origin in a Parisian hospital. Comparison with field data and therapeutic consequences].
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; France; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1987 |
Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
Topics: Animals; Antimalarials; Chloroquine; Delayed-Action Preparations; Democratic Republic of the Congo; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Sulfadoxine; Sulfanilamides | 1987 |
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamine; Sarcoma, Kaposi; Sulfadoxine; Sulfanilamides | 1986 |
Absence of pharmacokinetic interaction between Fansidar and mefloquine.
Topics: Antimalarials; Drug Combinations; Drug Interactions; Humans; Kinetics; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1986 |
Fansidar--a treatment for AIDS-related pneumocystis?
Topics: Acquired Immunodeficiency Syndrome; Antimalarials; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
Effects of Fansidar on chloroquine-resistant Plasmodium falciparum in Pakistan.
Topics: Disease Reservoirs; Drug Combinations; Drug Resistance; Humans; Malaria; Pakistan; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1986 |
The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Microbial; Humans; In Vitro Techniques; Malaria; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1986 |
Imported cases of chloroquine-resistant falciparum malaria in Iran.
Topics: Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Iran; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadiazine; Sulfadoxine; Travel | 1986 |
[Malaria prevention. Risk of infection in relation to preventive measures].
Topics: Adult; Africa; Antimalarials; Chloroquine; Drug Combinations; Female; Germany, West; Humans; India; Malaria; Male; Middle Aged; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Travel | 1986 |
Serious problems with antimalarial drugs.
Topics: Antimalarials; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinine; Sulfadoxine | 1986 |
The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
Topics: Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 1986 |
Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
Topics: Adult; Aged; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Tanzania; Travel | 1986 |
Concurrent chloroquine- and Fansidar-resistant Plasmodium falciparum: an imported case into Zimbabwe.
Topics: Adult; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Zimbabwe | 1986 |
Chloroquine-resistant falciparum malaria from East Africa.
Topics: Adult; Africa, Eastern; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1986 |
A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria.
Topics: Adolescent; Adult; Aged; Chloroquine; Drug Combinations; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinine; Sulfadoxine; Sulfamonomethoxine; Sulfanilamides | 1986 |
In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria; Male; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1986 |
Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.
Topics: Aminoquinolines; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Kenya; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Switzerland; Travel; United States | 1987 |
Chloroquine and Fansidar prophylaxis--a reply.
Topics: Chloroquine; Drug Combinations; Erythrocytes; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1987 |
Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man.
Topics: Adult; Antimalarials; Drug Combinations; Erythrocytes; Female; Half-Life; Humans; Kinetics; Male; Plasma; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
Topics: Adult; Antimalarials; Biological Availability; Blood Proteins; Drug Combinations; Drug Interactions; Erythrocytes; Half-Life; Humans; Kinetics; Male; Mefloquine; Middle Aged; Protein Binding; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
[Pruritus, exanthema, icterus and fever].
Topics: Antimalarials; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Combinations; Exanthema; Female; Fever; Humans; Middle Aged; Pruritus; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
Fansidar hypersensitivity pneumonitis.
Topics: Alveolitis, Extrinsic Allergic; Antimalarials; Drug Combinations; Drug Hypersensitivity; Humans; Male; Middle Aged; Pyrimethamine; Radiography; Sulfadoxine; Sulfanilamides | 1987 |
Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
Topics: Child, Preschool; Chloroquine; Drug Combinations; Humans; Malaria; Male; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1986 |
Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects.
Topics: Antimalarials; Drug Combinations; Female; Humans; Kinetics; Malaria; Male; Medication Errors; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1986 |
Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1987 |
[Effect of pyrimethamine sulfadoxine (Fansidar) on an avirulent cystogenic strain of Toxoplasma gondii (Prugniaud strain) in white mice].
Topics: Animals; Drug Combinations; Mice; Pyrimethamine; Sulfadoxine; Sulfanilamides; Toxoplasmosis, Animal | 1985 |
Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
Topics: Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1985 |
[A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Meningoencephalitis; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
Topics: Amodiaquine; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance, Microbial; Geography; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
Chloroquine-resistant falciparum malaria in northern Malawi.
Topics: Adult; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Malawi; Male; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1985 |
In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
Topics: 4-Aminobenzoic Acid; Animals; Drug Combinations; Humans; Malaria; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Thailand | 1985 |
Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine (qinghaosu) and artemether.
Topics: Animals; Artemether; Artemisinins; Chloroquine; Drug Combinations; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Thailand | 1985 |
Malaria in the province of Takeo, Cambodia.
Topics: Adolescent; Adult; Age Factors; Animals; Cambodia; Child; Child, Preschool; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Rain; Seasons; Sulfadoxine; Sulfanilamides; Time Factors; Tropical Climate | 1985 |
Fansidar for malaria prophylaxis.
Topics: Antimalarials; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1985 |
Malaria prophylaxis for Canadian travellers.
Topics: Amodiaquine; Canada; Chloroquine; Dapsone; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Malaria; Plasmodium; Plasmodium falciparum; Pregnancy; Premedication; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1985 |
In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Follow-Up Studies; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Tanzania | 1985 |
Decreased red cell deformability and vascular obstruction in falciparum malaria illustrated by a fatal case.
Topics: Blood Viscosity; Cell Survival; Drug Combinations; Erythrocyte Deformability; Erythrocytes; Exchange Transfusion, Whole Blood; Hematocrit; Hemolysis; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Rheology; Sulfadoxine | 1985 |
[Malaria chemoprophylaxis. Resistance problems].
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1985 |
Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1985 |
Fansidar in malaria prophylaxis.
Topics: Antimalarials; Chloroquine; Drug Combinations; Humans; Malaria; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1985 |
Systemic reaction to pyrimethamine-sulfadoxine.
Topics: Aged; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Drug Combinations; Eosinophilia; Female; Humans; Liver Function Tests; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1986 |
[Is the use of Fansidar as an antimalarial justified?].
Topics: Adult; Aged; Antimalarials; Chemical and Drug Induced Liver Injury; Drug Combinations; Humans; Middle Aged; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1985 |
Erythema multiforme (Stevens-Johnson) precipitated by Fansidar.
Topics: Adult; Antimalarials; Drug Combinations; Humans; Malaria; Male; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1985 |
Fansidar and hepatic granulomas.
Topics: Aged; Antimalarials; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Granuloma; Humans; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1985 |
Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.
Topics: Adult; Antibodies, Viral; Chloroquine; Developing Countries; Drug Combinations; Female; Humans; Immune Tolerance; Immunization; Kenya; Pyrimethamine; Rabies; Rabies Vaccines; Rabies virus; Sulfadoxine; United States | 1985 |
[Malaria in 1985: new recommendations].
Topics: Africa; Asia; Chloroquine; Drug Combinations; Humans; Malaria; Pyrimethamine; South America; Sulfadoxine; Sulfanilamides | 1985 |
[Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
Topics: Adult; Antimalarials; Drug Combinations; Eosinophilia; Female; Humans; Lung Diseases; Prednisone; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1985 |
Boxed warning added to Fansidar labeling.
Topics: Drug Combinations; Humans; Malaria; Product Labeling; Pyrimethamine; Sulfadoxine; Sulfanilamides; United States; United States Food and Drug Administration | 1985 |
[Malaria prevention with Fansidar as a cause of Stevens-Johnson syndrome].
Topics: Adult; Antimalarials; Drug Combinations; Female; Humans; Male; Middle Aged; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1985 |
[Remarks on the drug prevention of malaria].
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Plasmodium; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Travel | 1985 |
Curative and suppressive treatment of P. falciparum malaria with oral and parenteral Fansidar.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Synergism; Female; Humans; Infant; Injections, Intramuscular; Malaria; Mozambique; Plasmodium falciparum; Pyrimethamine; Pyrimidines; Quinine; Sulfadoxine; Sulfonamides | 1971 |
Fansidar-resistant falciparum malaria in Papua New Guinea.
Topics: Antimalarials; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Male; New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1980 |
Fansidar-resistant falciparum malaria in Papua New Guinea.
Topics: Drug Combinations; Drug Resistance, Microbial; Humans; New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1981 |
Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
Topics: Adolescent; Adult; Cambodia; Child; Drug Combinations; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Refugees; Sulfadoxine; Sulfanilamides; Thailand | 1981 |
Drug-resistant malaria.
Topics: Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1981 |
Problems with pyrimethamine/sulfadoxine malaria prophylaxis.
Topics: Antimalarials; Drug Combinations; Female; Humans; Malaria; Male; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Sulfanilamides; Suriname | 1982 |
Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania.
Topics: Adult; Drug Combinations; Drug Resistance; Humans; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Tanzania | 1982 |
Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
Topics: Africa, Eastern; Drug Combinations; Humans; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
Topics: Aged; Agranulocytosis; Antimalarials; Drug Combinations; Female; Humans; Jaundice; Malaria; Male; Middle Aged; Photosensitivity Disorders; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1982 |
Falciparum malaria despite pyrimethamine/suifadoxine in five tourists to East Africa.
Topics: Adult; Africa, Eastern; Antimalarials; Berlin; Drug Combinations; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Travel | 1982 |
Adverse reactions to pyrimethamine/sulfadoxine.
Topics: Antimalarials; Drug Combinations; Humans; Pyrimethamine; Risk; Sulfadoxine; Sulfanilamides | 1982 |
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1984 |
Chemoprophylaxis of malaria in non-immune residents in Dar es Salaam, Tanzania.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Middle Aged; Patient Compliance; Plasmodium falciparum; Proguanil; Pyrimethamine; Retrospective Studies; Sulfadoxine; Tanzania | 1984 |
[Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
Topics: Child, Preschool; Drug Combinations; Female; Humans; Infant; Leucovorin; Male; Pyrimethamine; Sulfadoxine; Sulfanilamides; Toxoplasmosis, Congenital | 1984 |
[Falciparum malaria in East African tourists in spite of fansidar prevention. A contribution on increased chloroquine and pyrimethamine-sulfadoxine resistance in areas of East Africa].
Topics: Adult; Africa, Eastern; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Erythrocytes; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1983 |
[Drug-resistant malaria in East Africa].
Topics: Adult; Africa, Eastern; Aged; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1983 |
Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Tanzania | 1983 |
The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1983 |
[Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
Topics: Adult; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Tanzania | 1983 |
Fansidar resistant Plasmodium falciparum infection in Surinam.
Topics: Antimalarials; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Suriname | 1983 |
[Chloroquine- and fansidar-resistant falciparum malaria treated with minocycline].
Topics: Adult; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Minocycline; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Tetracyclines | 1983 |
Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Malaysia; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1983 |
Chloroquine-resistant falciparum malaria from Malawi.
Topics: Adult; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Malawi; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1984 |
High-performance liquid chromatographic assay of pyrimethamine, sulfadoxine and its N4-acetyl metabolite in serum and urine after ingestion of Suldox.
Topics: Acetylation; Adult; Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Female; Humans; Plasmodium falciparum; Pyrimethamine; Quality Control; Sulfadoxine; Sulfanilamides | 1984 |
[Malaria and intestinal parasitosis in Indians of the Nadeb-Maku tribe, State of Amazonas, Brazil].
Topics: Adolescent; Adult; Antimalarials; Brazil; Child; Child, Preschool; Drug Combinations; Feces; Female; Humans; Indians, South American; Intestinal Diseases, Parasitic; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1984 |
Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
Topics: Adolescent; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Quinidine; Sulfadoxine; Sulfanilamides | 1984 |
Malaria chemoprophylaxis--which drug?
Topics: Adult; Antimalarials; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 1983 |
Clinical efficacy of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Sabah, Malaysia.
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Malaria; Malaysia; Male; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors | 1984 |
The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Middle Aged; Plasmodium falciparum; Pyrimethamine; Reproduction; Sulfadoxine; Sulfanilamides; Thailand | 1984 |
[Malaria prevention with Fansidar].
Topics: Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria; Nigeria; Plasmodium; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1983 |
Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1983 |
Falciparum malaria resistant to chloroquine and Fansidar.
Topics: Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1984 |
Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.
Topics: Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1984 |
Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
Topics: Antimalarials; Drug Combinations; Humans; Lung Diseases; Malaria; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1984 |
Jarisch-Herxheimer reaction in falciparum malaria?
Topics: Adult; Antimalarials; Body Temperature; Drug Combinations; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1984 |
[Guillain-Barré syndrome associated with Fansidar intake].
Topics: Adult; Antimalarials; Drug Combinations; Humans; Male; Polyradiculoneuropathy; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1984 |
[Stevens-Johnson syndrome and granulopenia induced by sulfadoxine-pyrimethamine (Fansidar)].
Topics: Adult; Agranulocytosis; Antimalarials; Drug Combinations; Female; Humans; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1983 |
Effect of antimalarial drugs on human neutrophil chemotaxis in vitro.
Topics: Antimalarials; Chemotaxis, Leukocyte; Chloroquine; Drug Combinations; Humans; Neutrophils; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Tetracycline; Triazines | 1983 |
Fansidar prophylaxis, therapy, and immune responses in rodent malaria (Plasmodium berghei).
Topics: Animals; Antimalarials; Drug Combinations; Female; Malaria; Mice; Plasmodium berghei; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Efficacy of Fansidar against Plasmodium falciparum in continuous culture.
Topics: Antimalarials; Drug Combinations; Drug Resistance, Microbial; Gambia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Thailand | 1982 |
A case of fansidar-resistant Plasmodium falciparum from Tanzania.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Fansidar-resistant Plasmodium falciparum infection from Tanzania.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
[Resistance of Plasmodium falciparum to fansidar, quinine and tetracycline].
Topics: Adolescent; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides; Tetracycline | 1982 |
Antimalarial combination available.
Topics: Drug Combinations; Humans; Malaria; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Problems encountered with using Fansidar as prophylaxis for malaria.
Topics: Adult; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Cardiovascular effects of "Fansidar" (an antimalarial drug) in anaesthetized cats.
Topics: Anesthesia; Animals; Antimalarials; Cats; Drug Combinations; Female; Heart; Heart Rate; Hemodynamics; Injections, Intravenous; Male; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1983 |
Highly sensitive and specific determination of mefloquine in biological fluids using gas chromatography mass spectrometry with selected ion monitoring.
Topics: Drug Combinations; Gas Chromatography-Mass Spectrometry; Humans; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine | 1981 |
Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
Topics: Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Drug Therapy, Combination; Fluorescence; Half-Life; Humans; Kinetics; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1982 |
Malaria prophylaxis in travelers.
Topics: Africa; Antimalarials; Asia; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant, Newborn; Lactation; Malaria; Plasmodium falciparum; Pregnancy; Pyrimethamine; Risk; South America; Sulfadoxine; Travel; United States | 1980 |
Plasmodium falciparum resistant to fansidar.
Topics: Adolescent; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1981 |
Fansidar resistant falciparum malaria acquired in South East Asia.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria; Malaysia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1981 |
Ineffective malaria prophylaxis.
Topics: Adult; Drug Combinations; Female; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Adoptive transfer of resistance to Plasmodium berghei with spleen cells and serum from Fansidar-cured mice.
Topics: Animals; Antimalarials; B-Lymphocytes; Drug Combinations; Female; Malaria; Mice; Plasmodium berghei; Pyrimethamine; Spleen; Sulfadoxine; Sulfanilamides; T-Lymphocytes | 1982 |
Possible sulfadoxine-pyrimethamine resistance in Plasmodium falciparum malaria from Kenya.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Microbial; Humans; Kenya; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Falciparum malaria resistant to Fansidar (sulphadoxine-pyrimethamine) occurring in three children of the same family.
Topics: Child, Preschool; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Malaria; Malaysia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
Indications for the use of Fansidar in malaria.
Topics: Antimalarials; Drug Combinations; Drug Labeling; Humans; Malaria; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1982 |
[Malaria prophylaxis and therapy].
Topics: Antimalarials; Drug Combinations; Humans; Malaria; Pyrimethamine; Sulfadoxine | 1982 |
Fansidar-induced Stevens-Johnson Syndrome.
Topics: Antimalarials; Drug Combinations; Female; Humans; Male; Middle Aged; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine; Sulfanilamides | 1982 |
[Malaria chemotherapy].
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Pyrimethamine; Sulfadoxine; Travel | 1981 |
Severe malaria in children at Port Moresby General Hospital, Papua New Guinea.
Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Glasgow Coma Scale; Hospitals, General; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Male; New Guinea; Nutritional Status; Prognosis; Prospective Studies; Pyrimethamine; Quinine; Sulfadoxine | 1995 |
Tumour necrosis factor alpha in uncomplicated malaria in young adults.
Topics: Adolescent; Adult; Antimalarials; Case-Control Studies; Chloroquine; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sex Factors; Sulfadoxine; Tumor Necrosis Factor-alpha; Zambia | 1995 |
Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine.
Topics: Administration, Oral; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Humans; Infant; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1995 |
Malaria treatment in Vanuatu: new national treatment guidelines.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Malaria; Practice Guidelines as Topic; Pregnancy; Primaquine; Pyrimethamine; Sulfadoxine | 1994 |
Prevention of malaria in travellers from the United Kingdom.
Topics: Adult; Antimalarials; Developing Countries; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Pyrimethamine; Quinine; Sulfadoxine; Travel; United Kingdom | 1993 |
Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
Self-medication with antimalarial drugs in Dar es Salaam, Tanzania.
Topics: Antimalarials; Chi-Square Distribution; Drug Combinations; Female; Humans; Malaria; Male; Medicine, Traditional; Pyrimethamine; Quinine; Self Medication; Sex Factors; Sulfadoxine; Surveys and Questionnaires; Tanzania | 1995 |
Congenitally acquired chloroquine-resistant P. falciparum malaria in an infant born in the United States.
Topics: Adult; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Quinine; Sulfadoxine; United States | 1995 |
Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
Topics: Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Failure | 1994 |
Response of chloroquine-resistant falciparum malaria to sulfadoxine/pyrimethamine in Gokwe area of Zimbabwe.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Monitoring; Drug Resistance; Follow-Up Studies; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Pyrimethamine; Sulfadoxine; Treatment Outcome; Zimbabwe | 1994 |
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Combinations; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Toxoplasmosis | 1994 |
Chloroquine-resistant falciparum malaria in an area of rising endemicity in Zimbabwe.
Topics: Absenteeism; Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Disease Outbreaks; Drug Combinations; Drug Resistance; Follow-Up Studies; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pruritus; Pyrimethamine; Rural Population; Sulfadoxine; Zimbabwe | 1994 |
Prosthetic valve dysfunction in a Nigerian.
Topics: Adult; Antimalarials; Drug Combinations; Drug Interactions; Fatal Outcome; Heart Failure; Heart Valve Prosthesis; Humans; Male; Nigeria; Prosthesis Failure; Pyrimethamine; Shock, Hemorrhagic; Sulfadoxine; Tachycardia, Supraventricular; Warfarin | 1993 |
[Current possibilities of malaria chemoprophylaxis].
Topics: Africa; Animals; Antimalarials; Contraindications; Developing Countries; Drug Combinations; Humans; Hungary; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1994 |
Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Administration Schedule; Drug Combinations; Drug Hypersensitivity; Encephalitis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Sulfadoxine; Toxoplasmosis, Cerebral | 1993 |
How frequent are notified severe cutaneous adverse reactions to Fansidar?
Topics: Adverse Drug Reaction Reporting Systems; Antimalarials; Drug Combinations; Drug Eruptions; Drug Utilization; Erythema Multiforme; Humans; Malaria; Pyrimethamine; Risk Factors; Stevens-Johnson Syndrome; Sulfadoxine; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
A case of dual chloroquine and halofantrine treatment failure in Zimbabwe.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine; Zimbabwe | 1995 |
[Fansidar in the treatment of toxoplasmosis].
Topics: Adolescent; Adult; Antiprotozoal Agents; Drug Combinations; Humans; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Ocular | 1996 |
Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.
Topics: Adolescent; Adult; Africa; Animals; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Proguanil; Pyrimethamine; Rural Population; Sequence Analysis, DNA; Sulfadoxine | 1996 |
Chloroquine resistance of Plasmodium falciparum malaria in Ethiopia and Eritrea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Eritrea; Ethiopia; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 1996 |
[A case of hypersensitivity type of liver injury induced by pyrimetamine and sulfadoxin (Fansidar)].
Topics: Adult; Antimalarials; Chemical and Drug Induced Liver Injury; Drug Combinations; Drug Hypersensitivity; Female; Humans; Pyrimethamine; Sulfadoxine | 1997 |
Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Antagonism; Drug Combinations; Drug Resistance, Microbial; Folic Acid; Genetic Linkage; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Recombination, Genetic; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1997 |
Multi-drug resistant malaria in Sri Lanka.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sri Lanka; Sulfadoxine | 1996 |
Malaria in Mvumi, central Tanzania and the in vivo response of Plasmodium falciparum to chloroquine and sulphadoxine pyrimethamine.
Topics: Adolescent; Adult; Aged; Animals; Anopheles; Antimalarials; Child; Chloroquine; Cross-Sectional Studies; Culex; Drug Combinations; Drug Resistance; Humans; Insect Vectors; Malaria, Falciparum; Middle Aged; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania | 1997 |
In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda.
Topics: Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 1997 |
Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; India; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1996 |
A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance.
Topics: Animals; Antimalarials; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Erythrocytes; Folic Acid; Humans; Hypoxanthine; Parasitology; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Reproducibility of Results; Sulfadoxine | 1997 |
Pyrimethamine-resistant Plasmodium falciparum parasites among Tanzanian children: a facility-based study using the polymerase chain reaction.
Topics: Animals; Antimalarials; Child, Preschool; DNA Mutational Analysis; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Infant; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1997 |
Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.
Topics: Africa; Alleles; Animals; Antimalarials; Dihydropteroate Synthase; DNA Mutational Analysis; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genes, Protozoan; Humans; Malaria, Falciparum; Middle East; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Vietnam | 1997 |
Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Monitoring, Physiologic; Nigeria; Phenanthrenes; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1997 |
Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test.
Topics: Adolescent; Adult; Afghanistan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Pakistan; Pyrimethamine; Refugees; Sulfadoxine | 1997 |
High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance.
Topics: Animals; Antimalarials; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 1997 |
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
Topics: Africa; Amino Acid Sequence; Animals; Antimalarials; Base Sequence; Bolivia; Cloning, Molecular; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Molecular Epidemiology; Molecular Sequence Data; Molecular Structure; Mutagenesis, Insertional; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1997 |
Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Culicidae; Drug Combinations; Female; Humans; Insect Vectors; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Zambia | 1997 |
Effect of intramuscular sulfadoxine-pyrimethamine on pregnant Wistar rats.
Topics: Animals; Antimalarials; Cricetinae; Drug Combinations; Embryo Loss; Female; Folic Acid Antagonists; Gestational Age; Humans; Injections, Intramuscular; Malaria; Mice; Pregnancy; Pyrimethamine; Rats; Rats, Wistar; Sulfadoxine | 1998 |
The data presented by Jelinek et al. (1997) should not be taken as evidence against an association between resistance to sulphadoxine-pyrimethamine (S/P) and mutations in the dihydrofolate reductase gene of Plasmodium falciparum.
Topics: Animals; Antimalarials; Child; Drug Combinations; Drug Resistance, Microbial; Humans; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1998 |
Identification of a subpopulation of immune Nigerian adult volunteers by antibodies to the circumsporozoite protein of Plasmodium falciparum.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Longitudinal Studies; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Rain; Sulfadoxine | 1998 |
Sulfadoxine-pyrimethamine embryopathy in Wistar rats.
Topics: Animals; Antimalarials; Drug Combinations; Embryo, Mammalian; Female; Fetal Diseases; Folic Acid Deficiency; Pregnancy; Pyrimethamine; Rats; Rats, Wistar; Sulfadoxine | 1998 |
Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Multienzyme Complexes; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 1998 |
Oral manifestations of toxic epidermal necrolysis (TEN) in patients with AIDS: report of five cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Combinations; Female; Floxacillin; HIV Infections; Humans; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Penicillins; Pyrimethamine; Retrospective Studies; Stevens-Johnson Syndrome; Sulfadoxine | 1998 |
The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency.
Topics: Antimalarials; Autoimmune Diseases; Drug Combinations; fas Receptor; Humans; Infant; Lymphoproliferative Disorders; Pyrimethamine; Sulfadoxine; Syndrome; Tomography, X-Ray Computed | 1998 |
A systematic approach to the development of a rational malaria treatment policy in Zambia.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Policy Making; Pyrimethamine; Statistics as Topic; Sulfadoxine; Time Factors; Zambia | 1998 |
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Chloroquine; Databases, Factual; Drug Combinations; Drug Industry; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Proguanil; Prospective Studies; Pyrimethamine; Risk Factors; Safety; Sulfadoxine; Surveys and Questionnaires | 1998 |
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chorioretinitis; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leucovorin; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 1998 |
Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; HIV Infections; HIV Seroprevalence; Humans; Infant, Newborn; Kenya; Malaria; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 1998 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Gestational Age; Humans; Malaria, Falciparum; Malawi; Parity; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine | 1999 |
More on 'the efficacy of antifolate antimalarial combinations in Africa'.
Topics: Africa; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Selection and synergy in Plasmodium falciparum.
Topics: Africa; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Synergism; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
Topics: Adolescent; Adult; Age Distribution; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Indonesia; Infant; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Prevalence; Pyrimethamine; Sulfadoxine | 1999 |
Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy.
Topics: 4-Aminobenzoic Acid; Animals; Antimalarials; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Drug Synergism; Folic Acid; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Does the availability of blood slide microscopy for malaria at health centers improve the management of persons with fever in Zambia?
Topics: Ambulatory Care Facilities; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Humans; Interviews as Topic; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Reproducibility of Results; Seasons; Sulfadoxine; Zambia | 1999 |
Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Female; Humans; Leukocytes; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Random Allocation; Regression Analysis; Rural Population; Sulfadoxine; Tropical Climate; Venezuela | 1999 |
Lack of an association between the ASN-108 mutation in the dihydrofolate reductase gene and in vivo resistance to sulfadoxine/pyrimethamine in Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Electrophoresis, Agar Gel; Gene Amplification; Genetic Markers; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
[Non-Hodgkin's lymphoma with Toxoplasma encephalitis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Combinations; Encephalitis; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Pyrimethamine; Remission Induction; Sulfadoxine; Toxoplasmosis, Cerebral; Vincristine | 1999 |
Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; DNA Restriction Enzymes; DNA, Protozoan; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Venezuela | 1999 |
Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Uganda | 1999 |
Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania.
Topics: Age Factors; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Urban Population | 1999 |
Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambaréné, Gabon.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Case-Control Studies; Child; Clindamycin; Deoxyribonucleases, Type II Site-Specific; DNA; DNA Primers; Drug Combinations; Electrophoresis, Agar Gel; Female; Gabon; Humans; Intercellular Adhesion Molecule-1; Malaria, Falciparum; Male; Nigeria; Papua New Guinea; Parasitemia; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Quinine; Sulfadoxine; Thailand; Virulence | 1999 |
Molecular epidemiology of malaria in Yaounde, Cameroon IV. Evolution of pyrimethamine resistance between 1994 and 1998.
Topics: Adolescent; Adult; Animals; Antimalarials; Cameroon; Child; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Electrophoresis, Agar Gel; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Phenotype; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Scintillation Counting; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Population dynamics of Plasmodium falciparum in an unstable malaria area of eastern Sudan.
Topics: Alleles; Animals; Antigens, Protozoan; Antimalarials; Chloroquine; Cohort Studies; DNA Primers; DNA, Protozoan; Drug Combinations; Genetic Variation; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Seasons; Sudan; Sulfadoxine | 2000 |
A toxoplasmic uveitis case of a 60-year-old male in Korea.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Biomarkers; Drug Combinations; Humans; Immune Tolerance; Korea; Male; Middle Aged; Pyrimethamine; Recurrence; Sulfadoxine; Toxoplasma; Toxoplasmosis; Uveitis | 2000 |
Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Coccidiosis; Cryptosporidiosis; Cryptosporidium parvum; Drug Combinations; Eucoccidiida; Female; Humans; Infant; Intestinal Diseases, Parasitic; Malaria, Falciparum; Male; Mass Screening; Middle Aged; Plasmodium falciparum; Pyrimethamine; Refugees; Schistosomiasis haematobia; Schistosomiasis mansoni; Somalia; Sulfadoxine; United States | 2000 |
Epidemiologic tools for malaria surveillance in an urban setting of low endemicity along the Colombian Pacific coast.
Topics: Animals; Antimalarials; Blood; Blotting, Southern; Chloroquine; Colombia; Cross-Sectional Studies; DNA Primers; DNA, Protozoan; Drug Combinations; Electrophoresis, Agar Gel; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Primaquine; Pyrimethamine; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sentinel Surveillance; Sulfadoxine; Urban Population | 2000 |
Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Insect Vectors; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2000 |
An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; India; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Chloroquine resistant malaria.
Topics: Africa South of the Sahara; Anti-Bacterial Agents; Antimalarials; Chloroquine; Doxycycline; Drug Antagonism; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Patient Selection; Pyrimethamine; Quinine; Sulfadoxine | 2000 |
Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Middle Aged; Molecular Sequence Data; Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2000 |
In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Rural Population; Students; Sulfadoxine; Time Factors; Uganda | 2000 |
Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pilot Projects; Plasmodium falciparum; Pyrimethamine; Rural Health; Sulfadoxine; Zambia | 2000 |
Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Came
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Health | 2000 |
Patterns of care for childhood malaria in Zambia.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Infant; Interviews as Topic; Malaria; Male; Patient Acceptance of Health Care; Pyrimethamine; Seizures; Sulfadoxine; Zambia | 2000 |
Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2000 |
Management of life-threatening malaria.
Topics: Africa; Animals; Antimalarials; Child, Preschool; Drug Combinations; Emergency Medical Services; Female; Humans; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel; Treatment Outcome | 2000 |
African research. Traditional and modern medicine merge to save lives.
Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; Humans; Infusions, Intravenous; Malaria, Cerebral; Mali; Medicine, African Traditional; Phytotherapy; Pyrimethamine; Quinine; Sulfadoxine | 2000 |
Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cohort Studies; Drug Combinations; Drug Evaluation; Drug Hypersensitivity; Encephalitis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Pneumonia, Pneumocystis; Prospective Studies; Pyrimethamine; Safety; Secondary Prevention; Sulfadoxine; Toxoplasmosis, Cerebral | 2001 |
Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Cost-Benefit Analysis; Disease Transmission, Infectious; Drug Combinations; Female; Gambia; Gametogenesis; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Random Allocation; Rural Health; Seasons; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2001 |
[Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2001 |
Folic acid antagonists during pregnancy and risk of birth defects.
Topics: Abnormalities, Drug-Induced; Antimalarials; Drug Combinations; Female; Folic Acid Antagonists; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimethamine; Sulfadoxine | 2001 |
HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Follow-Up Studies; HIV Antibodies; HIV-1; Humans; Infant; Malaria, Falciparum; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2001 |
Imported malaria in a Japanese male: an autopsy report.
Topics: Animals; Antimalarials; DNA, Protozoan; Drug Combinations; Fatal Outcome; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2001 |
Malaria control in Tanzania.
Topics: Antimalarials; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Sulfadoxine; Tanzania | 2001 |
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Point Mutation; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 2001 |
Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Disease Outbreaks; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mauritania; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2001 |
History and importance of antimalarial drug resistance.
Topics: Africa; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; History, 20th Century; History, 21st Century; Humans; Malaria, Falciparum; Mosquito Control; Pyrimethamine; Sulfadoxine; Treatment Outcome; World Health Organization | 2001 |
Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience.
Topics: Africa, Eastern; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Geography; Health Care Rationing; Humans; International Cooperation; Malaria; National Health Programs; Pyrimethamine; Sentinel Surveillance; Sulfadoxine | 2001 |
Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy.
Topics: Adolescent; Adult; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Endemic Diseases; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Malaria; Middle Aged; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania; Treatment Outcome | 2001 |
Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.
Topics: Africa South of the Sahara; Antimalarials; Case Management; Child; Child, Preschool; Chloroquine; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Drug Costs; Drug Resistance; Drugs, Essential; Health Policy; Humans; Malaria; Models, Econometric; Patient Compliance; Pyrimethamine; Quality-Adjusted Life Years; Sulfadoxine | 2001 |
Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure | 2001 |
[Frequency of persistent or transitory serologic negative values in infants with congenital toxoplasmosis. Experience of the Reims Toxoplasmosis Group (1980-1997)].
Topics: Animals; Antibodies, Protozoan; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newborn; Pyrimethamine; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital | 2002 |
African scientists discuss drug-resistant malaria.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria; Plasmodium; Pyrimethamine; Sulfadoxine; Uganda | 2002 |
Intermittent malaria treatment as a component of the EPI (Expanded Programme on Immunization) schedule in Africa.
Topics: Africa; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Immunization Programs; Infant; Malaria; Pilot Projects; Pyrimethamine; Sulfadoxine; World Health Organization | 2002 |
Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Topics: Adolescent; Antimalarials; Apoptosis; Autoimmune Diseases; Case-Control Studies; Caspase 3; Caspases; Cell Division; Cells, Cultured; Child; Cohort Studies; Cytochrome c Group; DNA Mutational Analysis; Drug Combinations; Female; Humans; Infant; Jurkat Cells; Lymphocytes; Lymphoproliferative Disorders; Male; Pyrimethamine; Receptors, Tumor Necrosis Factor; Sulfadoxine; Syndrome | 2002 |
[In vivo sensitivity of Plasmodium falciparum to amino-4-quinolines and sulfadoxine pyrimethamine in Agou (Ivory Coast)].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi.
Topics: Animals; Antimalarials; Chromosomes; Crosses, Genetic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, Protozoan; Genetic Markers; Molecular Sequence Data; Muridae; Mutation; Plasmodium chabaudi; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2002 |
A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali.
Topics: Adolescent; Animals; Anopheles; Antimalarials; Child; Drug Combinations; Female; Humans; Insect Bites and Stings; Insect Vectors; Malaria, Falciparum; Male; Mali; Parasitemia; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2002 |
Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2002 |
Resistance to antimalarials.
Topics: Africa; Antimalarials; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance, Multiple; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Sulfadoxine; Survival Analysis | 2002 |
A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.
Topics: Adult; Animals; Anti-Infective Agents; Antibodies, Protozoan; Cerebral Cortex; Drug Combinations; Female; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Opportunistic Infections; Prednisolone; Pyrimethamine; Sulfadoxine; Sulfamonomethoxine; Tomography, X-Ray Computed; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome | 2002 |
Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Base Sequence; Cameroon; Child; Child, Preschool; Chloroquine; DNA Primers; Drug Combinations; Drug Resistance, Multiple; Genetic Markers; Humans; Malaria, Falciparum; Molecular Epidemiology; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2002 |
[Blackwater fever].
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Blackwater Fever; Critical Care; Diagnosis, Differential; Drug Combinations; Humans; Mefloquine; Middle Aged; Naphthoquinones; Phenanthrenes; Prognosis; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2002 |
Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Combinations; Erythrocytes; Folic Acid; Glycine Hydroxymethyltransferase; Humans; Malaria, Falciparum; Multienzyme Complexes; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transcription, Genetic | 2002 |
Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia.
Topics: Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Somalia; Sulfadoxine; Treatment Outcome | 2002 |
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2002 |
Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
Topics: Animals; Antimalarials; Child, Preschool; Drug Combinations; Female; Hemoglobin A; Hemoglobin, Sickle; Humans; Infant; Kenya; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Retrospective Studies; Sickle Cell Trait; Sulfadoxine; Treatment Outcome | 2002 |
A safety and efficacy trial of artesunate, sulphadoxine-pyrimethamine and primaquine in P falciparum malaria.
Topics: Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2002 |
Massive hepatosplenomegaly in a child with malaria.
Topics: Age Factors; Animals; Antimalarials; Child; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Hepatomegaly; Humans; Liver; Malaria, Falciparum; Proguanil; Pyrimethamine; Quinine; Spleen; Splenomegaly; Sulfadoxine; Time Factors; Travel | 2002 |
Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in Southern Mauritania.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Malaria, Falciparum; Male; Mauritania; Mutation; Odds Ratio; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine | 2002 |
[HIV-associated cerebral toxoplasmosis -- review and retrospective analysis of 36 patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Brain; Dapsone; Diagnosis, Differential; Diagnostic Imaging; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadoxine; Survival Rate; Toxoplasmosis, Cerebral; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Preventing malaria in pregnancy.
Topics: Antimalarials; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania | 2003 |
Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Disease Outbreaks; Drug Combinations; Drug Resistance; Female; Humans; Incidence; Indonesia; Malaria, Falciparum; Male; Middle Aged; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Failure | 2002 |
Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya.
Topics: Age Factors; Animals; Antimalarials; Body Weight; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Humans; Infant; Kenya; Malaria; Plasmodium falciparum; Plasmodium malariae; Pyrimethamine; Retrospective Studies; Sulfadoxine; Treatment Failure | 2003 |
[Diagnosis and treatment of a case with cerebral falciparum malaria].
Topics: Adult; Antimalarials; Drug Combinations; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2001 |
Short communication: point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Colombia.
Topics: Adult; Aged; Animals; Antimalarials; Colombia; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
Cerebral toxoplasmosis in an AIDS patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Combinations; Humans; Magnetic Resonance Imaging; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Cerebral | 2003 |
The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi.
Topics: Adolescent; Antimalarials; Child; Drug Combinations; Humans; Malaria; Malawi; Pyrimethamine; Sulfadoxine | 2003 |
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure; Uganda | 2003 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
[Malaria study in the cyclone risk zone: entomological , diagnostic and therapeutic approach in the southeastern region of Madagascar].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Disasters; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Insect Vectors; Madagascar; Malaria; Male; Middle Aged; Mosquito Control; Parasitic Sensitivity Tests; Population Density; Population Surveillance; Prevalence; Pyrimethamine; Risk Factors; Seasons; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome | 2002 |
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Haplotypes; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2003 |
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Malawi; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Rural Population; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
The hospital- and field-based performances of the OptiMAL test, for malaria diagnosis and treatment monitoring in central India.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; False Negative Reactions; False Positive Reactions; Female; Humans; Immunologic Tests; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine | 2003 |
Antifolate antimalarial resistance in southeast Africa: a population-based analysis.
Topics: Adult; Alleles; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; South Africa; Sulfadoxine | 2003 |
Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Drug Stability; Drug Storage; Evaluation Studies as Topic; Pharmaceutical Preparations; Pharmacies; Pyrimethamine; Quality Control; Sulfadoxine; Tanzania | 2003 |
High prevalence of double Plasmodium falciparum dhfr mutations at codons 108 and 59 in the Sistan-Baluchistan province, Iran.
Topics: Animals; Antimalarials; Codon; Drug Combinations; Drug Resistance; Female; Humans; Iran; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
Health seeking behavior by families of children suspected to have malaria in Kabale: Uganda.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Family; Female; Health Facilities; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Infant; Malaria, Falciparum; Male; Medicine, African Traditional; Patient Acceptance of Health Care; Pyrimethamine; Quinine; Sulfadoxine; Uganda | 2002 |
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malawi; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 2003 |
Molecular survey of Plasmodium falciparum resistance in south-eastern Iran.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Humans; Iran; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya.
Topics: Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Commerce; Drug Combinations; Female; Guideline Adherence; Health Education; Humans; Kenya; Malaria; Male; Pyrimethamine; Rural Health Services; Sulfadoxine; Urban Health Services | 2003 |
Anaemia in African children: malaria or iron deficiency?
Topics: Africa; Anemia; Anemia, Iron-Deficiency; Antimalarials; Child, Preschool; Drug Combinations; Humans; Infant; Iron; Iron Deficiencies; Malaria; Pyrimethamine; Sulfadoxine | 2003 |
Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Rural Health Services; Rwanda; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Urban Health Services | 2003 |
Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2003 |
New malaria drug to be unveiled in Africa.
Topics: Africa; Antimalarials; Dapsone; Drug Combinations; Drug Costs; Drug Industry; Drug Utilization; Humans; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Infant; Laos; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine | 2003 |
Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2003 |
Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.
Topics: Adolescent; Adult; Aged; Alleles; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunocompromised Host; Male; Middle Aged; Pneumocystis; Pneumocystis Infections; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pyrimethamine; Sulfadoxine | 2003 |
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
Topics: Africa, Eastern; Amodiaquine; Antimalarials; Chloroquine; Disease Susceptibility; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Malaria; Parasitic Sensitivity Tests; Predictive Value of Tests; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Evaluation of a simple operational approach for monitoring resistance to antimalarial drugs in Peru.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Monitoring; Drug Resistance; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Peru; Pyrimethamine; Quality of Health Care; Sulfadoxine; Treatment Failure | 2003 |
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Gametocyte sex ratios in children with asymptomatic, recrudescent, pyrimethamine-sulfadoxine-resistant, Plasmodium falciparum malaria.
Topics: Antimalarials; Area Under Curve; Child; Drug Combinations; Drug Resistance; Female; Germ Cells; Humans; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sex Ratio; Sulfadoxine; Time Factors; Treatment Outcome | 2003 |
Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.
Topics: Animals; Antimalarials; Bedding and Linens; Culicidae; Dapsone; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Insecticides; Malaria, Falciparum; Mosquito Control; Mutation; Plants; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Topics: Animals; Antimalarials; Bedding and Linens; Child, Preschool; Culicidae; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Folic Acid Antagonists; Genotype; Humans; Infant; Insecticides; Malaria, Falciparum; Male; Mosquito Control; Mutation; Plants; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2003 |
[Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents; Antiprotozoal Agents; Azithromycin; Chorioretinitis; Clindamycin; Decision Trees; Diagnosis, Differential; Drug Combinations; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male; Middle Aged; Paracentesis; Polymerase Chain Reaction; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Ocular; Treatment Outcome | 2003 |
Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan.
Topics: Animals; Antimalarials; ATP-Binding Cassette Transporters; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2003 |
Use of antenatal care services and intermittent preventive treatment for malaria among pregnant women in Blantyre District, Malawi.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Cluster Analysis; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Malawi; Middle Aged; Parity; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine | 2004 |
Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Genetic Markers; Guinea-Bissau; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Biomarkers; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Population Surveillance; Predictive Value of Tests; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2003 |
Therapeutic efficacies of antimalarial drugs in the treatment of uncomplicated, Plasmodium falciparum malaria in Assam, north-eastern India.
Topics: Adolescent; Adult; Aged; Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Malawi; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Birth Weight; Cohort Studies; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Kenya; Malaria; Placenta Diseases; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2004 |
Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Topics: Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Folic Acid Antagonists; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Naphthoquinones; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Proguanil; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Triazines | 2004 |
Sulfadoxine-pyrimethamine remains efficacious against uncomplicated, Plasmodium falciparum malaria in north-eastern Afghanistan.
Topics: Afghanistan; Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Artesunate combinations for malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2004 |
Treating malaria in Africa.
Topics: Africa; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria; Pyrimethamine; Sulfadoxine | 2004 |
Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan.
Topics: Alleles; Animals; Antimalarials; Chloroquine; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Regression Analysis; Seasons; Sequence Analysis, DNA; Sudan; Sulfadoxine | 2004 |
Use of intermittent presumptive treatment and insecticide treated bed nets by pregnant women in four Kenyan districts.
Topics: Adult; Antimalarials; Bedding and Linens; Clinical Competence; Delivery, Obstetric; Drug Administration Schedule; Drug Combinations; Female; Health Care Surveys; Humans; Insecticides; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine | 2004 |
Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya.
Topics: Adult; Antimalarials; Attitude to Health; Awareness; Drug Combinations; Female; Gestational Age; Humans; Malaria, Falciparum; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Care; Pyrimethamine; Sulfadoxine | 2004 |
High frequency of the genetic polymorphisms associated with sulfadoxine-pyrimethamine resistance, among Plasmodium falciparum isolates from São Tomé and Príncipe, West Africa.
Topics: Africa, Western; Animals; Antimalarials; Drug Combinations; Drug Resistance; Genes, Protozoan; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine | 2004 |
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
Topics: Adolescent; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2004 |
Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: sulfadoxine-pyrimethamine is not working in Malawi.
Topics: Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Malawi; Pyrimethamine; Sulfadoxine; Treatment Failure | 2004 |
Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: treatment failure and resistance in Malawi remain subject for debate.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2004 |
Comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for uncomplicated Plasmodium falciparum malaria and impact on gametocyte carriage rates in the East Nusatenggara province of Indonesia.
Topics: Adolescent; Adult; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2004 |
Chlorproguanil-dapsone for malaria in Africa.
Topics: Africa; Animals; Antimalarials; Dapsone; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2004 |
Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Adult; Animals; Antimalarials; ATP-Binding Cassette Transporters; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genetic Markers; Genotype; Humans; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Mutation; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2004 |
Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya.
Topics: Adolescent; Age Factors; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Cohort Studies; Disease Reservoirs; Drug Combinations; Humans; Infant; Kenya; Malaria, Falciparum; Mass Screening; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine | 2004 |
Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones.
Topics: Animals; Antimalarials; Chloroquine; Cross-Sectional Studies; Disease Outbreaks; DNA, Protozoan; Drug Combinations; Drug Resistance, Microbial; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Mali; Molecular Epidemiology; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Warfare | 2004 |
Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Cohort Studies; Disease Outbreaks; Drug Combinations; Humans; Infant; Kenya; Malaria, Falciparum; Middle Aged; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Time Factors | 2004 |
Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated, Plasmodium falciparum malaria in Saharevo, Madagascar.
Topics: Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Madagascar; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Outcome | 2004 |
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania.
Topics: Adult; Age Factors; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Malaria, Falciparum; Mosquito Control; Odds Ratio; Patient Education as Topic; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Surveys and Questionnaires; Tanzania | 2004 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo re
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Genetic Markers; Genotype; Health Policy; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2004 |
Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Risk Factors; Sesquiterpenes; Socioeconomic Factors; Sulfadoxine; Tanzania | 2004 |
Influence of chemotherapy on the Plasmodium gametocyte sex ratio of mice and humans.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mice; Plasmodium; Pyrimethamine; Sex Ratio; Species Specificity; Sulfadoxine; Time Factors | 2004 |
Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Variation; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2004 |
Comparative effects of pyrimethamine-sulfadoxine, with and without probenecid, on Plasmodium falciparum gametocytes in children with acute, uncomplicated malaria.
Topics: Acute Disease; Animals; Antimalarials; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Probenecid; Pyrimethamine; Sex Ratio; Sulfadoxine; Treatment Outcome; Uricosuric Agents | 2004 |
[Assessment of sulfadoxine-pyriméthamine (Fansidar, Paludar) efficacy in patients with uncomplicated malaria in Madagascar: preliminary study to propose a simplified study protocol].
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Climate; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Feasibility Studies; Female; Follow-Up Studies; Humans; Madagascar; Malaria, Falciparum; Male; Middle Aged; Observation; Parasitic Sensitivity Tests; Pyrimethamine; Research Design; Residence Characteristics; Rural Health; Sulfadoxine; Treatment Outcome | 2003 |
Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes.
Topics: Animals; Antimalarials; Cells, Cultured; DNA Damage; Drug Combinations; Female; Humans; Lymphocytes; Micronucleus Tests; Mutagenicity Tests; Pregnancy; Pyrimethamine; Sister Chromatid Exchange; Sulfadoxine | 2004 |
Mefloquine--its 20 years in the Thai Malaria Control Program.
Topics: Animals; Antimalarials; Communicable Disease Control; Contraindications; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Sulfadoxine; Thailand | 2004 |
Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia.
Topics: Adult; Animals; Antigens, Protozoan; Colombia; Cross Infection; Drug Combinations; Equipment Contamination; Fatal Outcome; Genotype; Humans; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2005 |
High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana.
Topics: Adult; Animals; Antimalarials; Biomarkers; Chloroquine; Drug Combinations; Drug Resistance; Humans; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzy
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2005 |
The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.
Topics: Africa; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Malaria, Falciparum; Models, Theoretical; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Recurrence; Retrospective Studies; Self-Sustained Sequence Replication; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya.
Topics: Animals; Antimalarials; Child; Community Health Workers; Counseling; Drug Administration Schedule; Drug Combinations; Guideline Adherence; Humans; Kenya; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
Topics: Adolescent; Adult; Age Distribution; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sex Distribution; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
Topics: Administration, Oral; Animals; Antimalarials; Child, Preschool; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infusions, Parenteral; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Ocular manifestations in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular; Vision Disorders | 2006 |
Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum.
Topics: Africa; Alleles; Animals; Antimalarials; Drug Combinations; Drug Resistance; Gene Frequency; Genes, Protozoan; Genetic Variation; Genome, Protozoan; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Recombination, Genetic; Retrospective Studies; Selection, Genetic; Sulfadoxine | 2005 |
Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Codon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Treatment Outcome; Uganda | 2005 |
The pattern of home treatment of malaria in under-fives in south eastern Nigeria.
Topics: Adult; Antimalarials; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Female; Health Care Surveys; Home Nursing; Humans; Infant; Infant, Newborn; Interviews as Topic; Malaria; Mothers; Nigeria; Pyrimethamine; Self Medication; Sulfadoxine | 2005 |
The quality of antimalarials available in Yemen.
Topics: Antimalarials; Chloroquine; Dosage Forms; Drug Combinations; Product Surveillance, Postmarketing; Pyrimethamine; Quality Control; Sulfadoxine; Yemen | 2005 |
Malaria cure with sulphadoxine/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes.
Topics: Africa, Central; Africa, Western; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Emigration and Immigration; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Spain; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Topics: Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania.
Topics: Antimalarials; Delivery of Health Care; Drug Administration Schedule; Drug Combinations; Female; Guideline Adherence; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Malaria; Patient Acceptance of Health Care; Patient Compliance; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania | 2005 |
Effectiveness of antimalarial drugs.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Effectiveness of antimalarial drugs.
Topics: Africa; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Pyrimethamine; Risk; Sulfadoxine | 2005 |
Effects of antifolates--co-trimoxazole and pyrimethamine-sulfadoxine--on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria.
Topics: Acute Disease; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sex Ratio; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda.
Topics: Adolescent; Adult; Child; Drug Combinations; Female; Health Policy; Humans; Malaria; Middle Aged; Pregnancy; Public Opinion; Pyrimethamine; Rural Population; Sulfadoxine; Uganda | 2006 |
Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Assessment; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2005 |
Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Pyrimethamine; Sentinel Surveillance; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
Detection of Plasmodium falciparum in pregnancy by laser desorption mass spectrometry.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfadoxine | 2005 |
Rare Congolese Plasmodium falciparum DHFR alleles.
Topics: Alleles; Animals; Antimalarials; Child, Preschool; Congo; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Topics: Antimalarials; Biomarkers; Child, Preschool; Chloroquine; Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Patient Compliance; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Urban Health | 2005 |
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community.
Topics: Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Malaria, Falciparum; Male; Patient Acceptance of Health Care; Population Surveillance; Pyrimethamine; Rural Health; Self Administration; Sesquiterpenes; Sulfadoxine; Tanzania | 2005 |
Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
Topics: Ambulatory Care; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Prescriptions; Ethanolamines; Fluorenes; Health Policy; Humans; Malaria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Zambia | 2005 |
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Health Policy; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Research; Sulfadoxine; Tanzania; World Health Organization | 2005 |
Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Prevalence; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sudan; Sulfadoxine | 2006 |
Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethiopia; Female; Humans; Infant; Malaria, Falciparum; Male; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Use of intermittent preventive treatment for malaria in pregnancy in a rural area of western Kenya with high coverage of insecticide-treated bed nets.
Topics: Adult; Antimalarials; Bedding and Linens; Cross-Sectional Studies; Drug Combinations; Endemic Diseases; Female; Humans; Infant, Newborn; Insecticides; Kenya; Malaria, Falciparum; Patient Acceptance of Health Care; Population Surveillance; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine | 2005 |
Intermittent preventive treatment for malaria in infants: moving forward, cautiously.
Topics: Antimalarials; Chemoprevention; Drug Administration Schedule; Drug Combinations; Humans; Infant; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Amodiaquine and combination chemotherapy for malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Lactones; Malaria; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2005 |
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.
Topics: Animals; Antigens, Protozoan; Antimalarials; Body Temperature; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Genotype; Health Policy; Hemoglobins; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2005 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad.
Topics: Amodiaquine; Animals; Chad; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Genes, Protozoan; Genotype; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Population | 2006 |
The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Drug Stability; Drug Storage; Kenya; Nonprescription Drugs; Pharmacies; Pharmacopoeias as Topic; Product Surveillance, Postmarketing; Pyrimethamine; Quality Control; Solubility; Sulfadoxine; United States | 2005 |
The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market.
Topics: Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Hardness; Pharmacopoeias as Topic; Pyrimethamine; Quality Control; Solubility; Sulfadoxine; Tablets; Tanzania; United Kingdom; United States | 2005 |
Infectious diseases. Will a preemptive strike against malaria pay off?
Topics: Animals; Antimalarials; Controlled Clinical Trials as Topic; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Infant; Malaria; Mozambique; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Seasons; Sulfadoxine; Tanzania | 2005 |
In vitro processing of donor blood with sulfadoxine-pyrimethamine for eradication of transfusion-induced malaria.
Topics: Adult; Animals; Antimalarials; Blood Coagulation Tests; Blood Donors; Blood Transfusion; Blood-Borne Pathogens; Drug Combinations; Hematocrit; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine | 2005 |
Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance, Multiple; Ethiopia; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
[Prenatal treatment of congenital toxoplasmosis].
Topics: Antimalarials; Drug Combinations; Female; Follow-Up Studies; Humans; Leucovorin; Neutropenia; Pregnancy; Prenatal Care; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Vitamin B Complex | 2005 |
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
Topics: Antimalarials; Attitude to Health; Chloroquine; Drug Combinations; Drug Therapy, Combination; Focus Groups; Humans; Malaria; Patient Acceptance of Health Care; Perception; Pyrimethamine; Rural Population; Sulfadoxine; Tanzania | 2006 |
CD4 T cell activation as a predictor for treatment failure in Ugandans with Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Age Factors; Animals; Antimalarials; Body Temperature; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Lymphocyte Activation; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Uganda | 2006 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; DNA Primers; Drug Combinations; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sri Lanka; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2006 |
Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Central African Republic; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Gene Frequency; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2006 |
Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges.
Topics: Africa South of the Sahara; Antimalarials; Attitude to Health; Delivery of Health Care, Integrated; Drug Combinations; Fees and Charges; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Personnel; Health Policy; Health Services Accessibility; Health Services Needs and Demand; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome; World Health Organization | 2006 |
Microscopy and outpatient malaria case management among older children and adults in Kenya.
Topics: Adolescent; Adult; Ambulatory Care; Amodiaquine; Antimalarials; Case Management; Child; Cross-Sectional Studies; Drug Combinations; Humans; Kenya; Malaria, Falciparum; Microscopy; Parasitemia; Population Surveillance; Prevalence; Pyrimethamine; Quinine; Sensitivity and Specificity; Sulfadoxine | 2006 |
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
Topics: Adult; Amodiaquine; Analgesics, Non-Narcotic; Anemia; Antimalarials; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Fever; Humans; Malaria, Falciparum; Male; Parasitemia; Patient Acceptance of Health Care; Pharmacies; Prevalence; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Protocols; Drug Combinations; Health Care Costs; Health Education; Health Personnel; Health Policy; Humans; Malaria, Falciparum; Practice Guidelines as Topic; Pyrimethamine; Sulfadoxine; Tanzania | 2006 |
Prevention of malaria during pregnancy in West Africa: policy change and the power of subregional action.
Topics: Africa, Western; Antimalarials; Chloroquine; Communication Barriers; Drug Combinations; Drug Resistance; Evidence-Based Medicine; Female; Financing, Organized; Health Education; Health Policy; Humans; International Cooperation; Interprofessional Relations; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
Topics: Alleles; Aminoquinolines; Animals; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mutation; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
Polymerase chain reaction and molecular genotyping to monitor parasitological response to anti-malarial chemotherapy in the Peruvian Amazon.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Child; Cohort Studies; DNA, Protozoan; Drug Combinations; Drug Resistance, Multiple; Female; Genotype; Humans; Insect Vectors; Malaria, Falciparum; Male; Middle Aged; Peru; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Treatment Failure | 2006 |
A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods.
Topics: Adult; Antimalarials; Bedding and Linens; Child; Chloroquine; DDT; Drug Combinations; Drug Resistance; Eritrea; Female; Humans; Insecticides; Malaria; Malathion; Male; Mosquito Control; National Health Programs; Public Health; Pyrimethamine; Sulfadoxine; Time Factors | 2006 |
The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Child; Chloroquine; Cohort Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gametogenesis; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Rural Health; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2006 |
Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine.
Topics: Algorithms; Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Models, Biological; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2006 |
Single-dose sulfadoxine-pyrimethamine in intermittent preventive treatment of malaria.
Topics: Antimalarials; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Sulfadoxine | 2006 |
Sulfadoxine-pyrimethamine as an anti-malaria preventative in donated blood.
Topics: Antimalarials; Blood Donors; Cross Infection; Drug Approval; Drug Combinations; Global Health; Humans; Malaria; Pyrimethamine; Sulfadoxine; United States; United States Food and Drug Administration | 2006 |
Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Eruptions; Female; Humans; Infant; Infant, Newborn; Malaria; Malawi; Male; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Severity of Illness Index; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Disease-Free Survival; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Medically Underserved Area; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Uganda | 2006 |
Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2007 |
Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK) among internally displaced people in Gulu district, Uganda.
Topics: Adult; Antimalarials; Caregivers; Child, Preschool; Chloroquine; Drug Combinations; Drug Packaging; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Patient Compliance; Pyrimethamine; Refugees; Sulfadoxine; Surveys and Questionnaires; Uganda | 2006 |
Impact of chloroquine on viral load in breast milk.
Topics: Adult; Anti-HIV Agents; Antimalarials; Breast Feeding; CD4 Lymphocyte Count; Chloroquine; Drug Combinations; Female; HIV Infections; Humans; Malaria; Milk, Human; Pyrimethamine; RNA, Viral; Sulfadoxine; Viral Load; Zambia | 2006 |
Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso.
Topics: Adolescent; Adult; Burkina Faso; Chloroquine; Contraindications; Drug Combinations; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles.
Topics: Alleles; Animals; Antimalarials; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; HIV Infections; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Ethiopia; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Mutation; Plasmodium falciparum; Plasmodium vivax; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2006 |
Intermittent preventive treatment in infants--adjusting expectations and seeing opportunity.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Protecting pregnant women from malaria in areas of high HIV infection prevalence.
Topics: Africa South of the Sahara; Antimalarials; Chemoprevention; Disease Outbreaks; Drug Combinations; Female; HIV Infections; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
Topics: Animals; Antimalarials; Codon; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genetic Markers; Genotype; Humans; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, MDR; Humans; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Recurrence; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
Topics: Amodiaquine; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Drug Combinations; Erythrocytes; Female; Follow-Up Studies; Gabon; Glucosephosphate Dehydrogenase; Humans; Immunoglobulin G; Infant; Kinetics; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Protein Subunits; Protozoan Proteins; Pyrimethamine; Sickle Cell Trait; Sulfadoxine; Treatment Outcome | 2007 |
Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Bedding and Linens; Burkina Faso; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Insecticides; Malaria; Middle Aged; National Health Programs; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.
Topics: Africa; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Female; Genotype; Humans; Infant; Malaria; Male; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Risk; Sulfadoxine; Treatment Outcome | 2006 |
Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antimalarials; Child, Preschool; Chloroquine; Cytokines; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Fever; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Statistics, Nonparametric; Sulfadoxine; Tanzania | 2006 |
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
Topics: Animals; Antimalarials; Cohort Studies; Drug Combinations; Drug Resistance; Family; HIV Infections; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Health Policy; Humans; Malaria, Falciparum; Molecular Epidemiology; Pyrimethamine; Sulfadoxine | 2006 |
Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.
Topics: Animals; Antimalarials; Codon; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
[In vivo sensitivity of Plasmodium faciparum to chloroquine and sulfadoxine pyrimethamine in the Bobo Dioulasso region (1998-2001): risk factors associated with treatments failures to the two drugs].
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Combinations; Humans; Infant; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure | 2006 |
Submicroscopic Plasmodium falciparum infections before and after sulfadoxine-pyrimethamine and artesunate association treatment in Dienga, Southeastern Gabon.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; DNA, Protozoan; Drug Combinations; Gabon; Genotype; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Ethanolamines; Fluorenes; Health Care Costs; Humans; Infant; Malaria; Practice Guidelines as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome; World Health Organization | 2006 |
Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Topics: Amino Acid Sequence; Animals; Antimalarials; Asia, Southeastern; China; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Melanesia; Molecular Sequence Data; Plasmodium vivax; Point Mutation; Proguanil; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Triazines | 2006 |
Use of area under the curve to characterize transmission potential after antimalarial treatment.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
Topics: Adolescent; Adult; Animals; Antimalarials; Bangladesh; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Failure | 2006 |
Amodiaquine, malaria, pregnancy: the old new drug.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2006 |
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2006 |
HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
Topics: Adult; Anemia; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; Fever; HIV Infections; Humans; Immunocompromised Host; Kenya; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2006 |
Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
Topics: Adolescent; Adult; Animals; Antimalarials; Biomarkers; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Middle Aged; Mutation; Placenta; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Malaria. Chloroquine makes a comeback.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Malawi; Plasmodium; Pyrimethamine; Sulfadoxine | 2006 |
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.
Topics: Analgesics, Non-Narcotic; Antimalarials; Chloroquine; Drug Combinations; Health Policy; Humans; Malaria, Falciparum; Pharmacies; Pyrimethamine; Sulfadoxine; Tanzania | 2006 |
A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Fluorescence; Humans; Ligases; Malaria, Falciparum; Membrane Transport Proteins; Microspheres; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Treating malaria at home in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Caregivers; Chloroquine; Developing Countries; Diagnostic Errors; Drug Combinations; Drug Resistance, Viral; Ethanolamines; Fluorenes; Health Services Accessibility; Home Nursing; Humans; Malaria; Measles; Pyrimethamine; Sulfadoxine; Uganda | 2006 |
Consumers stated and revealed preferences for community health workers and other strategies for the provision of timely and appropriate treatment of malaria in southeast Nigeria.
Topics: Adult; Animals; Antimalarials; Chloroquine; Community Health Services; Community Health Workers; Consumer Behavior; Drug Combinations; Female; Health Care Surveys; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Patient Satisfaction; Plasmodium falciparum; Pyrimethamine; Rural Population; Sulfadoxine; Surveys and Questionnaires | 2006 |
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
Topics: Adolescent; Adult; Aging; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Female; Half-Life; Humans; Infant; Malaria, Falciparum; Male; Metabolic Clearance Rate; Pyrimethamine; Regression Analysis; Sulfadoxine | 2006 |
[Opportunistic infections in HIV-infected subjects: no wonders].
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Drug Combinations; Early Diagnosis; Fatal Outcome; Female; Humans; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Cerebral; Treatment Outcome | 2006 |
Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2007 |
Home-based management of fever in rural Uganda: community perceptions and provider opinions.
Topics: Adolescent; Adult; Antimalarials; Child, Preschool; Chloroquine; Community Health Services; Community Health Workers; Drug Combinations; Female; Fever; Focus Groups; Health Knowledge, Attitudes, Practice; Home Nursing; Humans; Infant; Malaria; Mother-Child Relations; Public Opinion; Pyrimethamine; Self Administration; Sulfadoxine; Uganda | 2007 |
Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
Topics: Adult; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Venezuela | 2007 |
Antimalarial drug combinations in vastly different settings.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Microbial; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 2007 |
Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Gametogenesis; Histamine H1 Antagonists; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso.
Topics: Animals; Antimalarials; Bedding and Linens; Burkina Faso; Child, Preschool; Chloroquine; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Infant; Insect Vectors; Insecticides; Malaria, Falciparum; Membrane Transport Proteins; Mosquito Control; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Rural Population; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya.
Topics: Adult; Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid; Hematinics; HIV Seronegativity; HIV Seropositivity; Humans; Iron; Kenya; Malaria; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
The role of communication between clients and health care providers: implications for adherence to malaria treatment in rural Gambia.
Topics: Antimalarials; Attitude to Health; Child; Child, Preschool; Chloroquine; Communication Barriers; Drug Administration Schedule; Drug Combinations; Female; Fever; Gambia; Humans; Infant; Malaria; Male; Patient Compliance; Professional-Patient Relations; Pyrimethamine; Rural Health; Sulfadoxine | 2007 |
Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
Topics: Animals; Antimalarials; Child, Preschool; Cote d'Ivoire; Dihydropteroate Synthase; Drug Combinations; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Genetic Variation; Haplotypes; Humans; Malaria, Vivax; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Sri Lanka; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Efficacy of combined treatment with alpha/beta-arteether and sulfadoxine-pyrimethamine, for cases of Plasmodium falciparum malaria in Jharkhand, India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Drug Combinations; Female; Humans; India; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Codon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.
Topics: Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Democratic Republic of the Congo; Drug Approval; Drug Combinations; Drug Industry; Pharmaceutical Preparations; Product Surveillance, Postmarketing; Proguanil; Pyrimethamine; Quality Control; Quinine; Sulfadoxine; Tablets | 2007 |
Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Animals; Child; Child, Preschool; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Uganda | 2007 |
Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Child; Delivery of Health Care; Drug Combinations; Female; Gestational Age; Gravidity; Health Personnel; Health Services Accessibility; Humans; Malaria; Patient Compliance; Patient Education as Topic; Patient Satisfaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pyrimethamine; Rural Health; Sulfadoxine; Uganda | 2007 |
Central nervous system toxoplasmosis in adult Ethiopians.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Combinations; Ethiopia; Female; Humans; Male; Middle Aged; Pyrimethamine; Retrospective Studies; Sex Distribution; Sulfadoxine; Toxoplasmosis, Cerebral; Treatment Outcome | 2006 |
Therapeutic efficacy of sulfadoxin/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Enseno, Meskan Woreda, Gurage zone, SNNPR, Ethiopia.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Ethiopia; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Subclinical Plasmodium falciparum infection and HIV-1 viral load.
Topics: Adult; Animals; Antimalarials; Drug Combinations; HIV Infections; HIV-1; Humans; Infant; Kenya; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Viral Load | 2007 |
Assessing malaria burden during pregnancy in Mali.
Topics: Adult; Animals; Antimalarials; Chloroquine; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria; Mali; Parasitemia; Placenta; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine | 2007 |
Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Malawi; Membrane Transport Proteins; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Zimbabwe | 2007 |
Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion.
Topics: Animals; Antimalarials; Biomarkers; Chloroquine; Codon; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos).
Topics: Adolescent; Animals; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Laos; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2007 |
Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Topics: Alleles; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Infant; Malaria, Falciparum; Molecular Epidemiology; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Ethnographic study of factors influencing compliance to intermittent preventive treatment of malaria during pregnancy among Yao women in rural Malawi.
Topics: Antimalarials; Communication; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria; Malawi; Nurse-Patient Relations; Patient Compliance; Patient Education as Topic; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine | 2007 |
Battling the malaria iceberg with chloroquine in India.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Delivery of Health Care; Drug Combinations; Drug Resistance; Humans; India; Malaria; Preventive Health Services; Pyrimethamine; Sesquiterpenes; Socioeconomic Factors; Sulfadoxine; Time Factors | 2007 |
The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Therapy, Combination; Gene Frequency; Genes, Protozoan; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
The influence of genetic innate resistance and acquired immunity on drug treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania.
Topics: Animals; Antimalarials; Awards and Prizes; Child, Preschool; Comorbidity; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Endemic Diseases; Genetic Predisposition to Disease; Genetic Testing; Glucosephosphate Dehydrogenase; Glycogen Storage Disease Type I; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Immunity, Innate; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2006 |
The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Cross-Sectional Studies; Drug Combinations; Endemic Diseases; Female; Health Personnel; Humans; Kenya; Malaria, Falciparum; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine | 2007 |
[Molecular surveillance of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in São Tomé and Príncipe].
Topics: Adolescent; Animals; Antimalarials; Atlantic Islands; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2007 |
A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda.
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Female; Humans; Malaria; Patient Compliance; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2007 |
Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Point Mutation; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications.
Topics: Antimalarials; Bedding and Linens; Drug Administration Schedule; Drug Combinations; Humans; Infant; Insecticides; Malaria; Mosquito Control; Mozambique; Public Health; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Tablets; Tanzania | 2007 |
Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Attitude of Health Personnel; Chloroquine; Clinical Competence; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Guideline Adherence; Health Policy; Humans; Interviews as Topic; Malaria; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Tanzania; Urban Health | 2007 |
Extensive genetic diversity in the Plasmodium falciparum Na+/H+ exchanger 1 transporter protein implicated in quinine resistance.
Topics: Amino Acid Sequence; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Gene Frequency; Genetic Variation; Genotype; Geography; India; Molecular Sequence Data; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Quinine; Sequence Homology, Amino Acid; Sodium-Potassium-Chloride Symporters; Sulfadoxine | 2007 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Topics: Animals; Antimalarials; Child, Preschool; Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Resistance, Multiple; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Malaria treatment efficacy among people living with HIV: the role of host and parasite factors.
Topics: Adolescent; Adult; Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; HIV Infections; Humans; Immunocompromised Host; Longitudinal Studies; Malaria; Malawi; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Birth Weight; Chemoprevention; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Infant, Newborn; Malaria, Falciparum; Middle Aged; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome | 2007 |
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Infant; Iran; Malaria, Falciparum; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Intermittent preventive therapy with sulfadoxine-pyrimethamine during pregnancy: seeking information on optimal dosing frequency.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Disease Susceptibility; Drug Administration Schedule; Drug Combinations; Female; Humans; Incidence; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Zambia | 2007 |
Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antibodies, Protozoan; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Immunocompetence; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2007 |
Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Health Policy; Humans; Malaria, Falciparum; Mutation; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Intermittent preventive treatment of malaria during pregnancy in central Mozambique.
Topics: Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Health Policy; Humans; Malaria; Mozambique; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Protective Devices; Pyrimethamine; Sulfadoxine; World Health Organization | 2007 |
Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania | 2007 |
A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
Topics: Adolescent; Adult; Anti-Infective Agents; Bandages; Burn Units; Child; Child, Preschool; Developing Countries; Drug Combinations; Female; Humans; Male; Nigeria; Prognosis; Pyrimethamine; Retrospective Studies; Staphylococcal Scalded Skin Syndrome; Stevens-Johnson Syndrome; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Madagascar; Malaria, Vivax; Male; Molecular Sequence Data; Mutation; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2008 |
Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya.
Topics: Adolescent; Adult; Antimalarials; Bedding and Linens; Delivery of Health Care; Drug Combinations; Female; Health Care Surveys; Health Services Accessibility; Humans; Insecticides; Interviews as Topic; Kenya; Malaria, Falciparum; Middle Aged; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Population; Sulfadoxine | 2008 |
Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda.
Topics: Adult; Antimalarials; Bedding and Linens; Cross-Sectional Studies; Delivery of Health Care; Drug Combinations; Female; Health Care Surveys; Humans; Insecticides; Malaria; Mosquito Control; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine; Uganda | 2008 |
Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae.
Topics: Amodiaquine; Animals; Antimalarials; Child; Drug Combinations; Gametogenesis; Humans; Malaria; Plasmodium falciparum; Plasmodium malariae; Pyrimethamine; Sulfadoxine | 2008 |
Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
Topics: Adolescent; Adult; Antimalarials; Community Health Services; Drug Administration Schedule; Drug Combinations; Female; Health Services Accessibility; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Socioeconomic Factors; Sulfadoxine; Uganda | 2008 |
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Clinical Protocols; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?
Topics: Antimalarials; Drug Combinations; Humans; Infant; Malaria; Models, Theoretical; Protective Agents; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Outcome | 2008 |
The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Biomarkers; Drug Combinations; Malaria, Falciparum; Papua New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Sudden enlargement of the prostate in a patient taking Fansidar for malaria.
Topics: Aged; Antimalarials; Drug Combinations; Humans; Malaria; Male; Prostatic Hyperplasia; Pyrimethamine; Sulfadoxine | 2007 |
Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 2008 |
Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Area Under Curve; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mutation, Missense; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; South Africa; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Treatment Outcome | 2008 |
Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.
Topics: Adolescent; Anemia; Animals; Antimalarials; Community Health Services; Cost-Benefit Analysis; Drug Combinations; Drug Delivery Systems; Female; Health Services Accessibility; Humans; Infant, Newborn; Malaria; Maternal-Child Health Centers; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Risk Factors; Sulfadoxine; Uganda | 2008 |
Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Senegal; Sulfadoxine; Treatment Failure | 2008 |
[Self-medication in the treatment of acute malaria: study based on users of private health drug stores in Ouagadougou, Burkina Faso].
Topics: Acute Disease; Adult; Antimalarials; Artemisinins; Burkina Faso; Child; Chloroquine; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Utilization; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Male; Middle Aged; Motivation; Pharmacies; Pyrimethamine; Self Medication; Sulfadoxine; Urban Population | 2008 |
Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Topics: Amodiaquine; Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Infant; Malaria, Vivax; Male; Mutation, Missense; Papua New Guinea; Plasmodium vivax; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2008 |
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Gene Frequency; Haplotypes; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Mozambique; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Madagascar; Molecular Sequence Data; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.
Topics: Amodiaquine; Animals; Antimalarials; Attitude to Health; Caregivers; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Medication Adherence; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Rural Health; Senegal; Sulfadoxine; Treatment Outcome | 2008 |
Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Peru; Pyrimethamine; Sulfadoxine | 2008 |
The challenges of diagnosis and treatment of malaria in pregnancy in low resource settings.
Topics: Antimalarials; Developing Countries; Drug Combinations; Female; Health Resources; Humans; Malaria; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine; World Health Organization | 2008 |
Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants.
Topics: Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Humans; Immune System; Infant; Malaria; Models, Biological; Models, Statistical; Models, Theoretical; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2008 |
Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets.
Topics: Adolescent; Adult; Antimalarials; Bedding and Linens; Cross-Sectional Studies; Drug Combinations; Female; Hospitals; Humans; Incidence; Infant, Newborn; Insecticides; Malaria; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania | 2008 |
Preventing malaria in infants: a strategy that works.
Topics: Africa South of the Sahara; Antimalarials; Developing Countries; Drug Combinations; Humans; Immunization Schedule; Infant; Infant, Newborn; Malaria; Pyrimethamine; Sulfadoxine | 2008 |
Molecular epidemiology of drug-resistant malaria in western Kenya highlands.
Topics: Adolescent; Animals; Antimalarials; Child; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Kenya; Malaria, Falciparum; Membrane Transport Proteins; Molecular Epidemiology; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Anti malarial drugs for prevention of malaria.
Topics: Africa; Animals; Antimalarials; Drug Combinations; Humans; India; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2008 |
Intermittent preventive antimalarial treatment to children (IPTc): firebreak or fire trap?
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Decision Making; Drug Administration Schedule; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Pyrimethamine; Sulfadoxine | 2008 |
[Is the antimalarial fight effective in Mayotte?].
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Comoros; Drug Combinations; Female; Humans; Incidence; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2008 |
Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania.
Topics: Chemoprevention; Communicable Disease Control; Drug Combinations; Education; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Infant; Infant, Newborn; Malaria; Patients; Pregnant Women; Pyrimethamine; Sulfadoxine; Tanzania; Vaccination | 2008 |
Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya.
Topics: Anemia; Antimalarials; Chemoprevention; Communicable Disease Control; Cost-Benefit Analysis; Drug Combinations; Humans; Kenya; Malaria; Parasitemia; Population; Pyrimethamine; Sulfadoxine | 2008 |
Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
Topics: Adolescent; Adult; Animals; Antimalarials; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Ghana; Humans; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2008 |
Intermittent preventive antimalarial treatment in infancy.
Topics: Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Sulfadoxine; Treatment Failure | 2008 |
Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Senegal; Sulfadoxine; Young Adult | 2008 |
Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
Topics: Adolescent; Angola; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Cross-Sectional Studies; Decision Making; Drug Combinations; Ethanolamines; Fluorenes; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Interviews as Topic; Malaria; Medication Systems; Pharmacies; Practice Guidelines as Topic; Private Sector; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania | 2008 |
Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Somalia; Sulfadoxine; Treatment Outcome | 2009 |
Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Carrier State; Child; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Gambia; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Multivariate Analysis; Parasitemia; Plasmodium falciparum; Proportional Hazards Models; Pyrimethamine; Retrospective Studies; Sulfadoxine; Tanzania; Thailand | 2008 |
Prevalence of polymorphisms in DHFR, DHPS, PFMDR1 and PFCRT genes of Plasmodium falciparum isolates in Quang Tri Province, Vietnam.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Humans; Male; Middle Aged; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Vietnam; Young Adult | 2008 |
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.
Topics: Analysis of Variance; Animals; Antimalarials; Case-Control Studies; Child; Child, Preschool; Drug Combinations; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Natriuretic Peptide, C-Type; Plasmodium falciparum; Pyrimethamine; Quinine; Statistics, Nonparametric; Sulfadoxine | 2008 |
The evolution of drug-resistant malaria.
Topics: Africa; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Evolution, Molecular; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2009 |
Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.
Topics: Animals; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Guideline Adherence; Health Care Surveys; Health Facilities; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Malaria; Patient Acceptance of Health Care; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania; Time Factors | 2008 |
Intermittent preventive treatment with antimalarial drugs.
Topics: Amodiaquine; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Infant; Kenya; Malaria; Pyrimethamine; Sulfadoxine | 2009 |
Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Chloroquine; Drug Combinations; Female; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Mozambique; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Protozoan Proteins; Pyrimethamine; Recurrence; Sensitivity and Specificity; Sulfadoxine | 2009 |
Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
Topics: Adolescent; Adult; Anemia; Antimalarials; Birth Weight; Community Health Services; Drug Combinations; Female; Humans; Malaria; Malawi; Parasitemia; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Prevalence; Program Evaluation; Pyrimethamine; Sulfadoxine | 2009 |
Rural Gambian women's reliance on health workers to deliver sulphadoxine-pyrimethamine as recommended intermittent preventive treatment for malaria in pregnancy.
Topics: Adolescent; Adult; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Gambia; Guideline Adherence; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Qualitative Research; Rural Population; Sulfadoxine; Young Adult | 2009 |
Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
Topics: Alleles; Animals; Antimalarials; Catalytic Domain; Dihydropteroate Synthase; Disasters; Drug Combinations; Drug Resistance; Geography; India; Membrane Transport Proteins; Models, Molecular; Mutation; Plasmodium falciparum; Protein Conformation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Tidal Waves; Time Factors | 2009 |
Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Community Health Workers; Community-Institutional Relations; Drug Combinations; Drug Therapy, Combination; Feasibility Studies; Female; Fever; Humans; Malaria, Falciparum; Male; Middle Aged; Outcome and Process Assessment, Health Care; Patient Acceptance of Health Care; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Surveys and Questionnaires; Volunteers; Young Adult | 2009 |
Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.
Topics: Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Infant; Malaria; Male; Mozambique; Multivariate Analysis; Pyrimethamine; Sulfadoxine; Tanzania | 2009 |
Malaria - change in therapeutic policy.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Mapping the spread of malaria drug resistance.
Topics: Africa; Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Maps as Topic; Plasmodium falciparum; Polymorphism, Single Nucleotide; Population Surveillance; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.
Topics: Africa; Alleles; Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Phylogeny; Plasmodium falciparum; Polymorphism, Single Nucleotide; Population Surveillance; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Haplotypes; Humans; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.
Topics: Adolescent; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Genetics, Population; Haplotypes; Humans; Kenya; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Travel | 2009 |
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.
Topics: Amniocentesis; Animals; Antibodies, Protozoan; DNA, Protozoan; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; France; Hospitals, University; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant, Newborn; Polymerase Chain Reaction; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Pyrimethamine; Sensitivity and Specificity; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital | 2009 |
Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.
Topics: Adult; Alleles; Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Haplotypes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; United Kingdom | 2009 |
Chloroquine resistance before and after its withdrawal in Kenya.
Topics: Animals; Antimalarials; Chloroquine; Drug Approval; Drug Combinations; Drug Resistance; Genotype; Humans; Kenya; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Restriction Mapping; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2009 |
Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.
Topics: Adult; Alleles; Animals; Antimalarials; Cohort Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mice; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Young Adult | 2009 |
Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence and risk factors.
Topics: Adolescent; Adult; Anthelmintics; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Helminthiasis; Humans; Hygiene; Intestinal Diseases, Parasitic; Malaria; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Young Adult | 2009 |
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
Topics: Amodiaquine; Animals; Antimalarials; Caregivers; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Logistic Models; Malaria; Male; Medication Adherence; Plasmodium; Pyrimethamine; Rural Population; Senegal; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome | 2009 |
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Mutation; Plasmodium vivax; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area.
Topics: Animals; Antimalarials; Brazil; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Haplotypes; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine | 2009 |
Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Guideline Adherence; Humans; Infant; Infant, Newborn; Malaria; Practice Guidelines as Topic; Pyrimethamine; South Africa; Sulfadoxine; Young Adult | 2009 |
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon.
Topics: Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Cameroon; Child, Preschool; Drug Combinations; Health Personnel; Health Services Research; Humans; Infant; Malaria; Middle Aged; Practice Guidelines as Topic; Pyrimethamine; Quinine; Rural Health; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2009 |
Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Haplotypes; Madagascar; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Child age or weight: difficulties related to the prescription of the right dosage of antimalarial combinations to treat children in Senegal.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Body Weight; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Infant; Malaria; Male; Medication Adherence; Practice Guidelines as Topic; Practice Patterns, Nurses'; Pyrimethamine; Senegal; Sulfadoxine; Surveys and Questionnaires | 2010 |
Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Commerce; Drug Combinations; Drug Costs; Ethanolamines; Financing, Government; Fluorenes; Health Services Accessibility; Humans; Malaria; Pilot Projects; Private Sector; Pyrimethamine; Rural Health; Rural Population; Sulfadoxine; Tanzania | 2009 |
PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Blood; Child, Preschool; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Microscopy; Molecular Diagnostic Techniques; Protozoan Proteins; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Treatment Outcome | 2009 |
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.
Topics: Amodiaquine; Antimalarials; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 2009 |
Intermittent preventive treatment of malaria in infancy.
Topics: Africa; Antimalarials; Drug Combinations; Global Health; Humans; Immunization Programs; Infant; Infant Mortality; Infant Welfare; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2009 |
Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Geography; Haplotypes; India; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia.
Topics: Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Humans; Indonesia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Seasons; Sulfadoxine | 2009 |
Comparative study of artesunate, ACTs and their combinants on the spermatic parameters of the male guinea pig.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Guinea Pigs; Male; Pyrimethamine; Sperm Count; Sperm Motility; Spermatozoa; Sulfadoxine | 2009 |
Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003.
Topics: Adolescent; Adult; Afghanistan; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Disease Outbreaks; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Humans; Infant; Insect Control; Insect Vectors; Malaria, Falciparum; Male; Pakistan; Plasmodium falciparum; Population Surveillance; Pyrimethamine; Refugees; Sulfadoxine; Young Adult | 2009 |
Mathematical model for optimal use of sulfadoxine-pyrimethamine as a temporary malaria vaccine.
Topics: Animals; Antimalarials; Drug Combinations; Humans; Malaria; Malaria Vaccines; Mali; Models, Immunological; Plasmodium; Pyrimethamine; Seasons; Sulfadoxine | 2010 |
Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Folic Acid; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda; Young Adult | 2009 |
Pharmacokinetic disposition of sulfadoxine in children with acute uncomplicated falciparum malaria treated with sulfadoxine-pyrimethamine in South West Nigeria.
Topics: Acute Disease; Age Factors; Antimalarials; Area Under Curve; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2012 |
Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.
Topics: Amodiaquine; Antimalarials; Caregivers; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Logistic Models; Malaria; Male; Medication Adherence; Plasmodium; Prescriptions; Pyrimethamine; Senegal; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome | 2009 |
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
Topics: Adolescent; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Young Adult | 2010 |
High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
Topics: Alleles; Amino Acid Substitution; Animals; Antimalarials; Blood; Dihydropteroate Synthase; DNA Restriction Enzymes; Drug Combinations; Drug Resistance; Female; Gabon; Genotype; Humans; Malaria, Falciparum; Mutation, Missense; Placenta; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.
Topics: Antimalarials; Child, Preschool; Cross-Sectional Studies; DNA Mutational Analysis; DNA, Protozoan; Drug Combinations; Humans; Infant; Infant, Newborn; Malaria; Male; Mali; Plasmodium; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure | 2010 |
High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
Topics: Adolescent; Alleles; Animals; Antimalarials; Bangladesh; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
Topics: Africa; Antimalarials; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2010 |
Implementing intermittent preventive treatment in infants.
Topics: Antimalarials; Drug Combinations; Humans; Immunization Programs; Infant; Malaria, Falciparum; Meta-Analysis as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2010 |
Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.
Topics: Adolescent; Adult; Age Distribution; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Mosquito Nets; Odds Ratio; Placenta; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2010 |
Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria.
Topics: Animals; Antimalarials; Carrier State; Drug Combinations; Drug Resistance; Follow-Up Studies; Host-Parasite Interactions; Humans; Malaria, Falciparum; Models, Biological; Mozambique; Plasmodium falciparum; Pyrimethamine; Sporozoites; Sulfadoxine; Time Factors | 2010 |
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Topics: Alleles; Amplified Fragment Length Polymorphism Analysis; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Eswatini; Genotype; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Pyrimethamine; Retrospective Studies; Sequence Analysis, DNA; Sulfadoxine | 2010 |
Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
Topics: Afghanistan; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Female; Haplotypes; Humans; Male; Molecular Sequence Data; Mutation; Plasmodium vivax; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Intermittent preventive treatment of malaria in pregnancy (IPTp): do frequent antenatal care visits ensure access and compliance to IPTp in Ugandan rural communities?
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Female; Health Services Accessibility; Humans; Malaria; Medication Adherence; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Uganda; Young Adult | 2010 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Comparative study of artesunate, ACTs and their combinants on the hormonal parameters of the male guinea pig.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Guinea Pigs; Luteinizing Hormone; Male; Prolactin; Pyrimethamine; Sulfadoxine; Testosterone | 2009 |
Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Surface; Antimalarials; Chondroitin Sulfates; Drug Combinations; Erythrocytes; Female; Humans; Immunoglobulin G; Longitudinal Studies; Malaria, Falciparum; Malawi; Parity; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Case-Control Studies; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Membrane Transport Proteins; Middle Aged; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Vanuatu; Young Adult | 2010 |
High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Antimalarials; Base Sequence; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genes, Protozoan; Haplotypes; Humans; Infant; Iran; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Young Adult | 2010 |
Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges.
Topics: Africa; Antimalarials; Comorbidity; Drug Combinations; Drug Resistance; Female; HIV Infections; Humans; Malaria; Pregnancy; Pyrimethamine; Sulfadoxine | 2011 |
Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Population Surveillance; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2010 |
Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.
Topics: Animals; Anopheles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Gene Expression Regulation, Enzymologic; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
Origin and dissemination across the Colombian Andes mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.
Topics: Alleles; Animals; Antimalarials; Colombia; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Emigration and Immigration; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Molecular Sequence Data; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival.
Topics: Animals; Anopheles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Host-Parasite Interactions; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Delivery, Obstetric; Drug Combinations; Female; Ferrous Compounds; Folic Acid; Health Surveys; Hematinics; Hospitals; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Malawi; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Rural Health Services; Rural Population; Sulfadoxine | 2010 |
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
Topics: Africa South of the Sahara; Antimalarials; Cost-Benefit Analysis; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Sulfadoxine | 2010 |
Analysis of an ordinal outcome in a multicentric randomized controlled trial: application to a 3- arm anti- malarial drug trial in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Epidemiologic Methods; Humans; Infant; Malaria, Falciparum; Models, Statistical; Multicenter Studies as Topic; Proportional Hazards Models; Pyrimethamine; Randomized Controlled Trials as Topic; Regression Analysis; Sulfadoxine; Treatment Outcome | 2010 |
Sulfadoxine-pyrimethamine-based intermittent preventive treatment, bed net use, and antenatal care during pregnancy: demographic trends and impact on the health of newborns in the Kassena Nankana District, northeastern Ghana.
Topics: Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Health Knowledge, Attitudes, Practice; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Insecticides; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Sulfadoxine | 2010 |
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.
Topics: Alleles; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2010 |
Long-term outcome of children with congenital toxoplasmosis.
Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Risk Assessment; Spiramycin; Sulfadoxine; Time Factors; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular | 2010 |
Vivax-induced ARDS: report of two cases.
Topics: Adult; Antimalarials; Drug Combinations; Female; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Pyrimethamine; Respiratory Distress Syndrome; Sulfadoxine; Treatment Outcome | 2010 |
Plasmodium vivax: prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Haplotypes; Humans; Infant; Malaria, Vivax; Male; Mutation; Pakistan; Plasmodium vivax; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Perception and practice of malaria prophylaxis in pregnancy among health care providers in Ibadan.
Topics: Antimalarials; Chloroquine; Community Health Services; Drug Combinations; Female; Guideline Adherence; Health Facilities; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Interviews as Topic; Malaria; Nigeria; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Prescriptions; Program Evaluation; Pyrimethamine; Sulfadoxine | 2007 |
Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets.
Topics: Drug Combinations; Female; Hospitals; Humans; Longitudinal Studies; Malaria; Malawi; Mosquito Nets; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Time Factors | 2010 |
Bottlenecks for high coverage of intermittent preventive treatment in pregnancy: the case of adolescent pregnancies in rural Burkina Faso.
Topics: Adolescent; Age Distribution; Attitude to Health; Burkina Faso; Drug Combinations; Female; Health Promotion; Humans; Malaria; Patient Compliance; Pregnancy; Pregnancy Complications; Prenatal Care; Pyrimethamine; Rural Health Services; Rural Population; Shame; Sulfadoxine; Young Adult | 2010 |
Community management of anti-malarials in Africa and iatrogenic risk.
Topics: Antimalarials; Atovaquone; Child; Community Health Services; Contraindications; Cote d'Ivoire; Diagnostic Errors; Drug Combinations; Female; Humans; Iatrogenic Disease; Liver Failure, Acute; Malaria; Proguanil; Pyrimethamine; Sulfadoxine | 2011 |
Whole genome re-sequencing identifies a mutation in an ABC transporter (mdr2) in a Plasmodium chabaudi clone with altered susceptibility to antifolate drugs.
Topics: Amino Acid Substitution; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; DNA, Protozoan; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genes, MDR; Mice; Mice, Inbred CBA; Mutation, Missense; Plasmodium chabaudi; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine | 2011 |
Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Gene Frequency; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Melanesia; Middle Aged; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria.
Topics: Adult; Anemia; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Middle Aged; Nigeria; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Premature Birth; Prospective Studies; Pyrimethamine; Sulfadoxine; Young Adult | 2011 |
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Bacterial Infections; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2010 |
Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy.
Topics: Antimalarials; Drug Combinations; Female; Humans; Malaria; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2010 |
Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Codon; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Folic Acid Antagonists; Genotype; Humans; Inhibitory Concentration 50; Kenya; Malaria; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium; Prevalence; Protozoan Proteins; Pyrimethamine; Quinolones; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China.
Topics: Alleles; Amino Acid Sequence; Antimalarials; China; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Vivax; Molecular Sequence Data; Plasmodium vivax; Point Mutation; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
Topics: Adolescent; Adult; Antimalarials; Delivery of Health Care; Drug Combinations; Female; Health Surveys; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2010 |
Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.
Topics: Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chemoprevention; Child, Preschool; Drug Combinations; Female; Humans; Immunoglobulin G; Infant; Malaria; Male; Placebos; Plasmodium falciparum; Pyrimethamine; Senegal; Sulfadoxine | 2010 |
Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal.
Topics: Antimalarials; Blood; Child, Preschool; Cross-Sectional Studies; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genetic Markers; Humans; Immunization; Infant; Infant, Newborn; Malaria, Falciparum; Mutation, Missense; Pilot Projects; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Senegal; Specimen Handling; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Female; HIV Infections; Humans; Malaria; Malawi; Middle Aged; Parasitemia; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2011 |
Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005.
Topics: Adolescent; Age Factors; Antimalarials; Artemisinins; Artesunate; Case Management; Child; Child, Preschool; Drug Combinations; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Humans; Infant; Malaria; Practice Patterns, Physicians'; Prospective Studies; Pyrimethamine; Rural Health Services; Sulfadoxine; Tanzania | 2011 |
Follow-up survey of children who received sulfadoxine-pyrimethamine for intermittent preventive antimalarial treatment in infants.
Topics: Antibodies, Protozoan; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Seroepidemiologic Studies; Sulfadoxine | 2011 |
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Pakistan; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data.
Topics: Adolescent; Adult; Africa South of the Sahara; Antimalarials; Drug Combinations; Female; Humans; Insecticide-Treated Bednets; Malaria; Middle Aged; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2011 |
Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Ethiopia; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sentinel Surveillance; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.
Topics: Angola; Antimalarials; Chemoprevention; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Female; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.
Topics: Alleles; Amino Acid Substitution; Antimalarials; Biological Evolution; Child, Preschool; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Evolution, Molecular; Genotype; Ghana; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and delivery.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Pregnancy; Pyrimethamine; Sulfadoxine | 2011 |
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Malaria, Vivax; Nepal; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2011 |
Molecular epidemiology of Plasmodium vivax anti-folate resistance in India.
Topics: Amino Acid Substitution; Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Folic Acid Antagonists; Genotype; Humans; India; Malaria; Molecular Epidemiology; Molecular Sequence Data; Mutation, Missense; Phylogeny; Phylogeography; Plasmodium vivax; Point Mutation; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.
Topics: Adolescent; Adult; Chemoprevention; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Drug Utilization; Female; Health Services Research; Humans; Infant, Newborn; Malaria; Parasitemia; Pregnancy; Pregnancy Complications; Pregnant Women; Pyrimethamine; Sulfadoxine; Young Adult | 2011 |
A study of toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulphadoxine-pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Gene Expression Profiling; Histocytochemistry; Liver; Male; Mice; Microarray Analysis; Oxidative Stress; Pyrimethamine; Sulfadoxine | 2011 |
Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.
Topics: Antimalarials; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Models, Theoretical; Pyrimethamine; Seasons; Sulfadoxine | 2011 |
Knowledge of malaria and preventive measures among pregnant women attending antenatal clinics in a rural local government area in Southwestern Nigeria.
Topics: Adolescent; Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Female; Health Education; Health Knowledge, Attitudes, Practice; Humans; Insecticide-Treated Bednets; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine | 2011 |
Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation.
Topics: Adolescent; Adult; Antimalarials; Benin; Chemoprevention; Child; Drug Combinations; Drug Utilization; Female; Health Services Research; Humans; Infant, Newborn; Longitudinal Studies; Malaria; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Retrospective Studies; Sulfadoxine; Young Adult | 2011 |
Effectiveness of ACTs in cases of resistance to partner drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2011 |
Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2011 |
Molecular epidemiology of malaria in Cameroon. XXX. sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyr
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mitochondrial Proton-Translocating ATPases; Molecular Epidemiology; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Plasmodium vivax dhfr mutations among isolates from malarious areas of Iran.
Topics: Amino Acid Substitution; Antimalarials; Drug Combinations; Drug Resistance; Haplotypes; Humans; Iran; Malaria, Vivax; Mutation, Missense; Plasmodium vivax; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.
Topics: Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Plasmodium; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2011 |
The use of intermittent preventive treatment with sulfadoxine-pyrimethamine for preventing malaria in pregnant women.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; Plasmodium; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2011 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Combining community case management and intermittent preventive treatment for malaria.
Topics: Africa; Antimalarials; Case Management; Child; Child, Preschool; Chloroquine; Community Health Services; Community Health Workers; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Pregnancy; Preventive Health Services; Pyrimethamine; Seasons; Sulfadoxine | 2011 |
[Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal].
Topics: Adolescent; Adult; Antibodies, Viral; Antigens, Protozoan; Antimalarials; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Senegal; Sulfadoxine | 2011 |
[Comparison of efficacy of chloroquine versus sulfadoxine-pyrimethamine in malaria prevention in pregnant women in the Toamasina region (Madagascar)].
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Madagascar; Malaria; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Sulfadoxine | 2011 |
Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT).
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Drug Utilization; Female; Humans; Interviews as Topic; Pharmacies; Pregnancy; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania | 2011 |
Utilisation of malaria preventive measures during pregnancy and birth outcomes in Ibadan, Nigeria.
Topics: Adult; Animals; Antimalarials; Attitude to Health; Chloroquine; Drug Combinations; Female; Health Promotion; Humans; Malaria; Maternal Health Services; Maternal Welfare; Mosquito Control; Nigeria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2011 |
Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genetic Markers; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2011 |
Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genetic Variation; Haplotypes; Humans; Malaria, Falciparum; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Young Adult | 2011 |
Evaluating health workers' potential resistance to new interventions: a role for discrete choice experiments.
Topics: Adult; Aging; Choice Behavior; Drug Combinations; Evaluation Studies as Topic; Female; Ghana; Health Personnel; Health Planning Guidelines; Humans; Malaria; Midwifery; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2011 |
Cytogenetic evaluation of Fansidar on human lymphocyte chromosomes in vitro.
Topics: Antimalarials; Chromosome Aberrations; Chromosomes, Human; Drug Combinations; Humans; In Vitro Techniques; Lymphocytes; Pyrimethamine; Sulfadoxine | 2011 |
Prolonged elevation of viral loads in HIV-1-infected children in a region of intense malaria transmission in Northern Uganda: a prospective cohort study.
Topics: Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Chloroquine; Disease Progression; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; RNA, Viral; Sulfadoxine; Treatment Outcome; Uganda; Viral Load | 2010 |
Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria; Malawi; Male; Middle Aged; Patient Compliance; Plasmodium; Pyrimethamine; Rural Population; Sulfadoxine; Young Adult | 2011 |
Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices.
Topics: Adolescent; Amodiaquine; Antimalarials; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Guideline Adherence; Hospitals, District; Humans; Infant; Malaria; Male; Nurses; Pyrimethamine; Senegal; Sulfadoxine | 2011 |
Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Pyrimethamine; Refugees; Sulfadoxine; Tanzania; United States | 2011 |
Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.
Topics: Anemia; Antimalarials; Birth Weight; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Plasmodium malariae; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2011 |
First case of congenital toxoplasmosis from Nepal.
Topics: Antimalarials; Antiprotozoal Agents; Drug Combinations; Fatal Outcome; Humans; Infant; Male; Nepal; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2011 |
Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; DNA Fingerprinting; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Iran; Malaria, Falciparum; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Haplotypes; Humans; Infant; Iran; Malaria, Vivax; Middle Aged; Mutation; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Intermittent preventive treatment during pregnancy with sulphadoxine-pyrimethamine may promote Plasmodium falciparum gametocytogenesis.
Topics: Adolescent; Adult; Antimalarials; Chi-Square Distribution; Drug Combinations; Drug Therapy, Combination; Female; Gametogenesis; Geography; Humans; Incidence; Malaria; Mosquito Nets; Nigeria; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Statistics as Topic; Sulfadoxine; Time Factors; Young Adult | 2012 |
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2011 |
Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes.
Topics: Africa, Western; Animals; Antimalarials; Artemisinins; Communicable Disease Control; Culicidae; Disease Transmission, Infectious; Drug Combinations; Female; Health Policy; Humans; Insect Bites and Stings; Insecticide-Treated Bednets; Insecticides; Malaria, Falciparum; National Health Programs; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Seasons; Sulfadoxine | 2012 |
Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.
Topics: Africa; Animals; Antimalarials; Cambodia; Drug Combinations; Drug Resistance; Genetic Variation; Humans; Madagascar; Malaria; Mutation; Parasitic Sensitivity Tests; Plasmodium malariae; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Antipyretics; Attitude of Health Personnel; Bacterial Vaccines; Benin; Community Health Services; Decision Making; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Immunization Programs; Infant; Madagascar; Malaria; Male; Measles Vaccine; Middle Aged; Parents; Patient Acceptance of Health Care; Perception; Pyrimethamine; Residence Characteristics; Senegal; Sulfadoxine; Vaccination; World Health Organization; Young Adult | 2012 |
Prescription practices and availability of artemisinin monotherapy in India: where do we stand?
Topics: Antimalarials; Artemisinins; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Health Facilities; Humans; Inappropriate Prescribing; India; Logistic Models; Malaria; Pharmacists; Practice Patterns, Physicians'; Private Practice; Public Sector; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires | 2011 |
[Evaluation of the use of insecticide-treated nets and intermittent preventive treatment in three health zones in Benin].
Topics: Antimalarials; Benin; Child, Preschool; Drug Administration Schedule; Drug Combinations; Female; Geography; Humans; Infant; Infant, Newborn; Insecticide-Treated Bednets; Insecticides; Malaria; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine | 2012 |
The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Evidence-Based Practice; Female; Focus Groups; Ghana; Health Promotion; Hemoglobins; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Preventive Health Services; Program Evaluation; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2011 |
Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Congo; Drug Combinations; Drug Resistance; Female; Fetal Development; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria; Pregnancy; Pregnancy Outcome; Pyrimethamine; Retrospective Studies; Risk Factors; Sulfadoxine; Young Adult | 2012 |
Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.
Topics: Adverse Drug Reaction Reporting Systems; Africa; Antimalarials; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunization; Infant; Malaria; Malaria Vaccines; Male; Pharmacovigilance; Pyrimethamine; Sulfadoxine | 2012 |
The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
Topics: Adult; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana.
Topics: Adult; Animals; Antimalarials; Apgar Score; Drug Combinations; Female; Ghana; Hospitals, District; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Perinatal Mortality; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.
Topics: Alleles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Kenya; Longitudinal Studies; Malaria, Falciparum; Microsatellite Repeats; Mutation; Phylogeography; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Recombination, Genetic; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.
Topics: Adolescent; Antibodies, Protozoan; Antimalarials; Biomarkers; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Infant; Malaria Vaccines; Malaria, Falciparum; Male; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Haplotypes; Hemoglobins; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.
Topics: Africa; Alleles; Animals; Antimalarials; Artemisinins; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Mutant Proteins; Mutation, Missense; Peptide Synthases; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Travel | 2012 |
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Asymptomatic Diseases; Child, Preschool; Culicidae; Disease Vectors; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania | 2012 |
Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
Topics: Adult; Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Kenya; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Infectious; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Health Facilities; Health Services Research; Humans; Infant; Malaria, Falciparum; Parasitemia; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2012 |
Sulphadoxine-pyrimethamine alters the antioxidant defense system in blood of rabbit.
Topics: Animals; Antimalarials; Antioxidants; Catalase; Drug Combinations; Glutathione; Lipid Peroxidation; Lipid Peroxides; Male; Pyrimethamine; Rabbits; Reactive Oxygen Species; Sulfadoxine; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2011 |
Patterns of case management and chemoprevention for malaria-in-pregnancy by public and private sector health providers in Enugu state, Nigeria.
Topics: Adult; Antimalarials; Case Management; Chemoprevention; Chloroquine; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Infant, Newborn; Malaria; Nigeria; Outcome Assessment, Health Care; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Parasitic; Private Sector; Public Sector; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires | 2012 |
Using community-owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north-eastern Tanzania.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Community Health Workers; Drug Combinations; Early Diagnosis; Ethanolamines; Fluorenes; Health Services Research; Humans; Incidence; Infant; Infant, Newborn; Malaria; Parasitemia; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2012 |
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Gene Dosage; Gene Frequency; Genes, Protozoan; Hospitals, Military; Humans; Malaria, Falciparum; Male; Mutation, Missense; Plasmodium falciparum; Point Mutation; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2012 |
Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Microsatellite Repeats; Models, Genetic; Mutation; Plasmodium falciparum; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment.
Topics: Anemia; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Fever; Humans; Infant; Malaria; Malawi; Male; Microsatellite Repeats; Plasmodium; Pyrimethamine; Recurrence; Sulfadoxine | 2012 |
Plasmodium falciparum infection in pregnant women attending antenatal care in Luanda, Angola.
Topics: Adolescent; Adult; Angola; Antimalarials; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Prevalence; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Young Adult | 2012 |
Estimation of summary protective efficacy using a frailty mixture model for recurrent event time data.
Topics: Algorithms; Antimalarials; Computer Simulation; Drug Combinations; Ghana; Humans; Infant; Malaria; Models, Statistical; Monte Carlo Method; Poisson Distribution; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Survival Analysis | 2012 |
The effects of malaria and intermittent preventive treatment during pregnancy on fetal anemia in Malawi.
Topics: Anemia, Neonatal; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Fetal Blood; Fetal Diseases; Hemoglobins; Humans; Infant, Newborn; Malaria; Malawi; Odds Ratio; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine | 2012 |
Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Haiti; Humans; Malaria, Falciparum; Mutant Proteins; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study.
Topics: Adolescent; Adult; Antimalarials; Blood; Chemoprevention; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Drug Combinations; Drug Utilization; Female; Humans; Malaria; Medication Adherence; Plasma; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Self Medication; Sulfadoxine; Uganda; Young Adult | 2012 |
Proxies and prevention of malaria in pregnancy.
Topics: Animals; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2012 |
In vitro hemolytic effect of sulfadoxine/pyrimethamine and artemether/lumefantrine on malaria parasitized erythrocytes of female patients.
Topics: Adult; Analysis of Variance; Antimanic Agents; Artemether, Lumefantrine Drug Combination; Artemisinins; Case-Control Studies; Dose-Response Relationship, Drug; Drug Combinations; Erythrocytes; Ethanolamines; Female; Fluorenes; Hemolysis; Humans; Malaria; Middle Aged; Nigeria; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.
Topics: Alcohol Oxidoreductases; Alleles; Antimalarials; Biomarkers; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Gene Expression Regulation, Enzymologic; Ghana; Health Policy; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Population Surveillance; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2012 |
The time distribution of sulfadoxine-pyrimethamine protection from malaria.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Computer Simulation; Culicidae; Drug Administration Schedule; Drug Combinations; Humans; Malaria, Falciparum; Mali; Models, Biological; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2012 |
Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Combinations; Environmental Microbiology; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Malaria, Falciparum; Malawi; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting.
Topics: Advisory Committees; Antimalarials; Drug Combinations; Drug Costs; Drug Resistance; Expert Testimony; Female; Health Policy; Humans; Malaria; Malaria Vaccines; Male; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Private Sector; Pyrimethamine; Sulfadoxine; Switzerland; World Health Organization | 2012 |
Effect of selected anti-malarial drugs on the blood chemistry and brain serotonin levels in male rabbits.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Biomarkers; Blood Chemical Analysis; Brain; Chromatography, High Pressure Liquid; Drug Combinations; Liver; Male; Pyrimethamine; Rabbits; Serotonin; Sulfadoxine; Time Factors | 2013 |
Anti-folate combination therapies and their effect on the development of drug resistance in Plasmodium vivax.
Topics: Alcohol Dehydrogenase; Antimalarials; China; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genetic Variation; Genotype; Linkage Disequilibrium; Methionine; Microsatellite Repeats; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Thymidine Monophosphate | 2013 |
Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.
Topics: Antimalarials; Artemisinins; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Bigger babies for women given extra prophylaxis against malaria.
Topics: Africa South of the Sahara; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; World Health Organization | 2013 |
Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
Topics: Adult; Analysis of Variance; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Gabon; Guideline Adherence; Humans; Insecticide-Treated Bednets; Malaria; Midwifery; Patient Acceptance of Health Care; Patient Compliance; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; World Health Organization | 2013 |
Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.
Topics: Adult; Amodiaquine; Antimalarials; Burkina Faso; Child, Preschool; Decision Making; Drug Combinations; Fever; Humans; Malaria; Point-of-Care Systems; Probability; Pyrimethamine; Rural Health Services; Rural Population; Seasons; Sulfadoxine | 2013 |
Malaria control aimed at the entire population in KwaZulu-Natal negates the need for policies to prevent malaria in pregnancy.
Topics: Adolescent; Adult; Antimalarials; Communicable Disease Control; Drug Combinations; Female; Humans; Incidence; Insecticides; Malaria, Falciparum; Outcome Assessment, Health Care; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Prevalence; Pyrimethamine; Socioeconomic Factors; South Africa; Sulfadoxine | 2013 |
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
Topics: Adult; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation Rate; Plasmodium falciparum; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2013 |
Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
Topics: Adolescent; Antimalarials; Benin; Blood; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation Rate; Plasmodium falciparum; Point Mutation; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Congenital malaria in newborn twins.
Topics: Adult; Diseases in Twins; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Male; Mosquito Nets; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine; Twins, Monozygotic | 2012 |
Changing the malaria treatment protocol policy in Timor-Leste: an examination of context, process, and actors' involvement.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Protocols; Cooperative Behavior; Drug Combinations; Drug Substitution; Ethanolamines; Fluorenes; Health Planning Organizations; Health Policy; Humans; Interinstitutional Relations; Malaria, Falciparum; Policy Making; Pyrimethamine; Sulfadoxine; Time Factors; Timor-Leste | 2013 |
Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.
Topics: Adult; Antimalarials; Colombia; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Genes, Protozoan; Haplotypes; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
[Intermittent preventive treatment with sulfadoxine--pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso].
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug Combinations; Female; Hospitals, Urban; Humans; Malaria; Medication Adherence; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Commerce; Drug Combinations; Drug Storage; Drug Utilization; Ethanolamines; Financing, Government; Fluorenes; Kenya; Malaria; Private Sector; Pyrimethamine; Quinine; Sulfadoxine | 2013 |
High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin.
Topics: Adolescent; Adult; Antimalarials; Benin; Dihydropteroate Synthase; Drug Combinations; Female; Haplotypes; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Point Mutation; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Protozoan Proteins; Pyrimethamine; Recurrence; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2013 |
Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.
Topics: Adolescent; Adult; Antimalarials; Cameroon; Drug Combinations; Female; Fetus; Humans; Infant, Newborn; Malaria, Falciparum; Middle Aged; Mosquito Nets; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Risk Factors; Social Class; Sulfadoxine | 2013 |
Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Insecticide-Treated Bednets; Kenya; Malaria; Middle Aged; Mosquito Control; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
Topics: Adult; Antimalarials; Dose-Response Relationship, Drug; Drug Combinations; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Malawi; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Hospitals, University; Humans; Malaria, Vivax; Mutation; Pakistan; Plasmodium vivax; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
[Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali].
Topics: Adolescent; Adult; Anemia; Chloroquine; Delivery, Obstetric; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
Factors associated with utilization of sulphadoxine-pyrimethamine during pregnancy among women in Kenya: a cross-sectional study.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Gravidity; Guideline Adherence; Humans; Kenya; Malaria; Pregnancy; Prenatal Care; Pyrimethamine; Sulfadoxine | 2014 |
Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Topics: Amino Acid Sequence; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Evolution, Molecular; Haplotypes; Humans; Malaria, Falciparum; Molecular Sequence Data; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2014 |
The causal effect of malaria on stunting: a Mendelian randomization and matching approach.
Topics: Antimalarials; Case-Control Studies; Causality; Child Development; Child, Preschool; Cohort Studies; Drug Combinations; Female; Genetic Predisposition to Disease; Ghana; Growth Disorders; Hemoglobin A; Hemoglobin, Sickle; Heterozygote; Humans; Infant; Malaria; Male; Mendelian Randomization Analysis; Multivariate Analysis; Poisson Distribution; Pyrimethamine; Regression Analysis; Sickle Cell Trait; Sulfadoxine | 2013 |
Treatment of pregnant BALB/c mice with sulphadoxine pyrimethamine or chloroquine abrogates Plasmodium berghei induced placental pathology.
Topics: Animals; Antimalarials; Antioxidants; Chloroquine; DNA Fragmentation; Drug Combinations; Female; Lipid Peroxidation; Malaria; Mice; Mice, Inbred BALB C; Parasitemia; Placenta Diseases; Plasmodium berghei; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2014 |
Trends in antimalarial drug use in Africa.
Topics: Africa; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Health Surveys; Humans; Malaria, Falciparum; Models, Statistical; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 2013 |
Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda.
Topics: Adult; Cross-Sectional Studies; Dihydropteroate Synthase; Documentation; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Mutation; Parturition; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Uganda; Young Adult | 2013 |
Systemic constraints continue to limit coverage of intermittent preventive treatment for malaria in pregnancy in southeast Tanzania.
Topics: Adult; Antimalarials; Attitude of Health Personnel; Clinical Competence; Delivery of Health Care; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Guideline Adherence; Health Personnel; Health Services Needs and Demand; Humans; Interviews as Topic; Malaria; Male; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania | 2013 |
Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.
Topics: Adolescent; Adult; Antimalarials; Child; Child Mortality; Cross-Sectional Studies; Drug Combinations; Female; Health Education; Health Knowledge, Attitudes, Practice; Humans; Malaria; Maternal Mortality; Medication Adherence; Middle Aged; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2013 |
A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Promotion; Humans; Malaria; Medication Adherence; Middle Aged; Midwifery; Patient Acceptance of Health Care; Patient Education as Topic; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Professional-Patient Relations; Program Evaluation; Pyrimethamine; Rural Health Services; Sulfadoxine; Trust; Uganda; Young Adult | 2013 |
Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethiopia; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Nucleic Acid Hybridization; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2013 |
Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Malaria; Male; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Rural Population; Suburban Population; Sulfadoxine; Young Adult | 2013 |
Feasibility and coverage of implementing intermittent preventive treatment of malaria in pregnant women contacting private or public clinics in Tanzania: experience-based viewpoints of health managers in Mkuranga and Mufindi districts.
Topics: Antimalarials; Attitude of Health Personnel; Drug Administration Schedule; Drug Combinations; Female; Health Facility Administrators; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania | 2013 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
The in vitro effects of sulfadoxine/pyrimethamine and artemether/lumefantrine on the viscoelasticity of erythrocyte membrane of healthy females.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood Viscosity; Drug Combinations; Erythrocyte Membrane; Ethanolamines; Female; Fluorenes; Humans; In Vitro Techniques; Pyrimethamine; Sulfadoxine; Young Adult | 2014 |
Utilization of malaria prevention methods by pregnant women in Yaounde.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Antimalarials; Cameroon; Cross-Sectional Studies; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Insecticides; Malaria; Mosquito Nets; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2013 |
Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
Topics: Adolescent; Animals; Antimalarials; Benin; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Prevalence of mutation and phenotypic expression associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum and Plasmodium vivax.
Topics: Drug Combinations; Drug Resistance; Gene Expression Regulation; Mutation; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2013 |
Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asparagine; Child; Child, Preschool; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Frequency; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2014 |
Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Logistic Models; Malaria; Middle Aged; Models, Biological; Multivariate Analysis; Pregnancy; Pyrimethamine; Socioeconomic Factors; Sulfadoxine; Tanzania; Young Adult | 2014 |
Health facility-based data on women receiving sulphadoxine-pyrimethamine during pregnancy in Tanzania: lessons to learn from a cross-sectional survey in Mkuranga and Mufindi districts and other national survey reports.
Topics: Adult; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania | 2014 |
Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
Topics: Adolescent; Adult; Antimalarials; Asymptomatic Infections; Biomarkers; Burkina Faso; Dried Blood Spot Testing; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria; Mali; Parasite Load; Polymerase Chain Reaction; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2014 |
Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Health Facilities; Humans; Inappropriate Prescribing; India; Infant; Malaria; Male; Practice Patterns, Physicians'; Prescriptions; Prospective Studies; Public Sector; Pyrimethamine; Retrospective Studies; Sulfadoxine | 2013 |
Submicroscopic infections among children with adequate clinical and parasitological response (ACPR).
Topics: Amodiaquine; Antimalarials; Artemisinins; Blood; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Male; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2014 |
Molecular analysis of chloroquine and sulfadoxine-pyrimethamine resistance-associated alleles in Plasmodium falciparum isolates from Nicaragua.
Topics: Alleles; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Nicaragua; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2014 |
Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey.
Topics: Adult; Demography; Drug Combinations; Family Characteristics; Female; Health Care Surveys; Humans; Infant, Low Birth Weight; Insecticide-Treated Bednets; Malaria; Mali; Multivariate Analysis; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2014 |
High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
Topics: Adult; Antimalarials; Child; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2014 |
A cohort study of Plasmodium falciparum malaria in pregnancy and associations with uteroplacental blood flow and fetal anthropometrics in Kenya.
Topics: Adult; Anthropometry; Antimalarials; Cohort Studies; Drug Combinations; Female; Fetal Development; Humans; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Middle Aged; Placental Circulation; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2014 |
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2014 |
Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Cameroon; Case-Control Studies; Chemoprevention; Cohort Studies; Drug Administration Schedule; Drug Combinations; Female; Gestational Age; Gravidity; Humans; Insecticide-Treated Bednets; Malaria; Parity; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2014 |
Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries.
Topics: Africa; Antimalarials; Chemoprevention; Drug Combinations; Female; Health Policy; Health Services Research; Humans; Insecticide-Treated Bednets; Malaria; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine | 2014 |
Placental malaria is rare among Zanzibari pregnant women who did not receive intermittent preventive treatment in pregnancy.
Topics: Adolescent; Adult; Antimalarials; Dried Blood Spot Testing; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Middle Aged; Placenta; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Prospective Studies; Pyrimethamine; Sulfadoxine; Tanzania | 2014 |
Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Survival Analysis; Treatment Failure; Young Adult; Zambia | 2014 |
Plasmodium malariae infection: a case of missed diagnosis.
Topics: Artemisinins; Artesunate; Azure Stains; Child; Chromatography, Affinity; Diagnostic Errors; Drug Combinations; Female; Humans; India; Malaria; Plasmodium malariae; Polymerase Chain Reaction; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2014 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Malaria, Falciparum; Numbers Needed To Treat; Parasitemia; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Parasitic; Prevalence; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2014 |
Self-medication with anti-malarials is a common practice in rural communities of Kilosa district in Tanzania despite the reported decline of malaria.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Utilization; Female; Focus Groups; Humans; Infant; Infant, Newborn; Interviews as Topic; Male; Middle Aged; Pyrimethamine; Quinine; Rural Population; Self Medication; Sulfadoxine; Tanzania; Young Adult | 2014 |
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Asymptomatic Diseases; DNA, Protozoan; Drug Administration Schedule; Drug Combinations; Drug Resistance; Erythrocytes; Ethanolamines; False Negative Reactions; Female; Fetal Diseases; Fluorenes; Follow-Up Studies; Hemeproteins; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria; Malawi; Parasitemia; Placenta; Plasmodium; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimesters; Prevalence; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure | 2014 |
[Mutant alleles associated to chloroquine and sulfadoxine-pyrimethanime resistance in Plasmodium falciparum of the Ecuador-Peru and Ecuador-Colombia borders].
Topics: Alleles; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance; Ecuador; Humans; Mutation; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2014 |
Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China.
Topics: Adult; Antimalarials; Child; Child, Preschool; China; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Haplotypes; Humans; Malaria, Vivax; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium vivax; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2014 |
Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Codon; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; India; Malaria, Falciparum; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2014 |
Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia.
Topics: Adolescent; Adult; Amino Acid Substitution; Dihydropteroate Synthase; Drug Combinations; Female; Genotype; Humans; Indonesia; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Young Adult | 2014 |
Moving malaria in pregnancy programs from neglect to priority: experience from Malawi, Senegal, and Zambia.
Topics: Antimalarials; Capacity Building; Drug Combinations; Female; Health Policy; Health Priorities; Health Promotion; Humans; Insecticide-Treated Bednets; Malaria; Malawi; Maternal Health Services; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quality Assurance, Health Care; Senegal; Sulfadoxine; Zambia | 2014 |
Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria; Medication Adherence; Models, Statistical; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2014 |
Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.
Topics: Antimalarials; Artemisinins; Cross-Sectional Studies; Dihydropteroate Synthase; Dried Blood Spot Testing; Drug Combinations; Drug Therapy, Combination; Genetic Markers; Humans; Malaria; Melanesia; Mutation; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Vanuatu | 2014 |
Compliance with intermittent preventive treatment during pregnancy among postpartum women in Ibadan, Nigeria.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria; Medication Adherence; Middle Aged; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2014 |
Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Topics: Adolescent; Adult; Age Factors; Anemia; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug Combinations; Female; Gestational Age; Humans; Insecticide-Treated Bednets; Logistic Models; Malaria, Falciparum; Parity; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2014 |
Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
Topics: Adolescent; Adult; Antimalarials; Blood; Chemoprevention; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Drug Utilization; Female; Health Services Research; Humans; Infant, Newborn; Malaria, Falciparum; Male; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2014 |
Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Middle Aged; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2014 |
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.
Topics: Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pregnancy; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2015 |
Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Haplotypes; Humans; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Drug Combinations; Female; Gabon; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Rectum; Streptococcal Infections; Streptococcus agalactiae; Sulfadoxine; Vagina; Young Adult | 2015 |
Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Topics: Adolescent; Adult; Antimalarials; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Malaria, Falciparum; Multivariate Analysis; Poisson Distribution; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Retrospective Studies; Sulfadoxine; Treatment Outcome; Young Adult; Zambia | 2015 |
Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
Topics: Adult; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Kenya; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Topics: Adolescent; Adult; Alleles; Antimalarials; Congo; Drug Combinations; Drug Resistance; Female; Gene Frequency; Haplotypes; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Molecular epidemiology and seroprevalence in asymptomatic Plasmodium falciparum infections of Malagasy pregnant women in the highlands.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antimalarials; Asymptomatic Infections; Chloroquine; Drug Combinations; Drug Resistance; Female; Fluorescent Antibody Technique, Indirect; Humans; Madagascar; Malaria; Middle Aged; Molecular Epidemiology; Plasmodium; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Real-Time Polymerase Chain Reaction; Seroepidemiologic Studies; Sulfadoxine; Young Adult | 2015 |
High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult; Zambia | 2015 |
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Biological Availability; Dietary Fats; Drug Combinations; Female; Follow-Up Studies; Food-Drug Interactions; Humans; Infant, Newborn; Malaria, Falciparum; Models, Statistical; Papua New Guinea; Pregnancy; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2015 |
Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Care Surveys; Humans; Malaria; Middle Aged; Pre-Exposure Prophylaxis; Pregnancy; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2015 |
Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
Topics: Adult; Antimalarials; Cameroon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Frequency; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.
Topics: Antimalarials; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2015 |
Trends in malaria case management following changes in the treatment policy to artemisinin combination therapy at the Mbakong Health Centre, Cameroon 2006-2012: a retrospective study.
Topics: Adolescent; Adult; Aged; Antimalarials; Cameroon; Child; Child, Preschool; Community Health Centers; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Malaria; Male; Middle Aged; Practice Patterns, Physicians'; Pyrimethamine; Retrospective Studies; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2015 |
Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control.
Topics: Adolescent; Adult; Aged; Antimalarials; Bayes Theorem; Child; Child, Preschool; Chloroquine; Climate; Drug Combinations; Drug Resistance; Female; Health Surveys; Humans; Insecticide-Treated Bednets; Kenya; Malaria, Falciparum; Male; Middle Aged; Mosquito Control; Plasmodium falciparum; Prevalence; Pyrimethamine; Rainforest; Retrospective Studies; Sulfadoxine | 2015 |
Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
Topics: Antimalarials; Bacterial Proteins; Birth Weight; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Uganda | 2015 |
Malaria in pregnancy: challenges for control and the need for urgent action.
Topics: Africa South of the Sahara; Antimalarials; Chemoprevention; Comorbidity; Drug Combinations; Early Diagnosis; Female; Guideline Adherence; Health Policy; HIV Infections; Humans; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; World Health Organization | 2015 |
Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation.
Topics: Antimalarials; Carrier State; Chemoprevention; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Female; Gabon; Gene Frequency; Humans; Malaria, Falciparum; Mutant Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Perspectives of health care providers on the provision of intermittent preventive treatment in pregnancy in health facilities in Malawi.
Topics: Adult; Ambulatory Care Facilities; Antimalarials; Drug Combinations; Female; Health Personnel; Humans; Interviews as Topic; Malaria; Malawi; Midwifery; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Primary Prevention; Pyrimethamine; Qualitative Research; Sulfadoxine; Trust | 2015 |
Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.
Topics: Adult; Antimalarials; Cohort Studies; Drug Combinations; Female; Ghana; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hematologic Diseases; Hemoglobins; Humans; Malaria; Pregnancy; Pyrimethamine; Sulfadoxine | 2015 |
Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine.
Topics: Adult; Antimalarials; Burkina Faso; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Azithromycin-containing intermittent preventive treatment in pregnancy affects gestational weight gain, an important predictor of birthweight in Papua New Guinea - an exploratory analysis.
Topics: Adolescent; Antimalarials; Azithromycin; Birth Weight; Body Mass Index; Drug Combinations; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Linear Models; Malnutrition; Maternal Exposure; Multivariate Analysis; Nutritional Status; Papua New Guinea; Pregnancy; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Weight Gain | 2016 |
Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Frequency; Humans; Indonesia; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tetrahydrofolate Dehydrogenase; Treatment Failure; Young Adult | 2015 |
Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Ethiopia; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
The effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi.
Topics: Antimalarials; Disease Transmission, Infectious; DNA, Protozoan; Drug Combinations; Drug Resistance; Genetic Variation; Genotype; Haplotypes; Humans; Malaria; Malawi; Microsatellite Repeats; Peptide Synthases; Plasmodium; Prevalence; Pyrimethamine; Rural Population; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Urban Population | 2015 |
Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
Topics: Adult; Africa South of the Sahara; Amino Acid Substitution; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Mutant Proteins; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2016 |
Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Drug Combinations; Drug Compounding; Drug Stability; Kinetics; Microscopy, Electron, Scanning; Models, Chemical; Polymers; Povidone; Powders; Pyrimethamine; Solubility; Sulfadoxine; Temperature; Water; X-Rays | 2016 |
High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
Topics: Antimalarials; Biomarkers; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Haplotypes; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Time Factors | 2015 |
Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant Women.
Topics: Antimalarials; Case-Control Studies; Drug Combinations; Female; Humans; Models, Biological; Pregnancy; Pregnancy Trimesters; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2015 |
Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; India; Malaria, Falciparum; Male; Middle Aged; Parasite Load; Parasitemia; Pilot Projects; Pyrimethamine; Sulfadoxine; Young Adult | 2015 |
Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genotype; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutant Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2015 |
Whole Genome Sequencing of Field Isolates Reveals Extensive Genetic Diversity in Plasmodium vivax from Colombia.
Topics: Adolescent; Antimalarials; Base Sequence; Child; Colombia; Drug Combinations; Drug Resistance; Female; Genetic Variation; Genome-Wide Association Study; Genome, Protozoan; Humans; Malaria, Vivax; Microsatellite Repeats; Molecular Sequence Data; Plasmodium vivax; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine | 2015 |
Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Cameroon; Drug Administration Schedule; Drug Combinations; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Parity; Pregnancy; Protein Structure, Tertiary; Pyrimethamine; Sulfadoxine; Young Adult | 2016 |
The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine.
Topics: Antimalarials; Drug Combinations; Female; Ghana; Humans; Infant; Infant, Newborn; Malaria; Male; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2016 |
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
Topics: Antimalarials; Causality; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Congenital | 2016 |
Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnant Women; Prevalence; Pyrimethamine; Risk Factors; Severity of Illness Index; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2015 |
Multiple intracerebral lesions in a young male.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Protozoan; Brain; Drug Combinations; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Pyrimethamine; Serologic Tests; Stroke; Sulfadoxine; Toxoplasma; Toxoplasmosis, Cerebral; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2015 |
Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Ghana; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Regression Analysis; Socioeconomic Factors; Sulfadoxine; Treatment Outcome | 2015 |
Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
Topics: Adolescent; Adult; Anemia; Antimalarials; Blood; Cameroon; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Female; Health Services Research; Hemoglobins; Humans; Insecticide-Treated Bednets; Malaria; Microscopy; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2016 |
Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
Topics: Alleles; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ecotype; Gene Expression; Haplotypes; Humans; India; Linkage Disequilibrium; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Absence of Association Between Sickle Trait Hemoglobin and Placental Malaria Outcomes.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Genotype; Hemoglobin, Sickle; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Real-Time Polymerase Chain Reaction; Risk Factors; Sickle Cell Trait; Sulfadoxine; Young Adult | 2016 |
Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi.
Topics: Acetaminophen; Antimalarials; Chromatography, Thin Layer; Counterfeit Drugs; Drug Combinations; Feasibility Studies; Malawi; Pyrimethamine; Quality Control; Sulfadoxine; Tablets; Technology, Pharmaceutical; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Family Characteristics; Female; Health Services Accessibility; Humans; Insecticide-Treated Bednets; Logistic Models; Malaria; Middle Aged; Nigeria; Patient Compliance; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine | 2016 |
A link between poor quality antimalarials and malaria drug resistance?
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2016 |
High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Markers; Genotype; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Young Adult | 2016 |
Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Gene Frequency; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Primaquine; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Yemen; Young Adult | 2016 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Topics: Angola; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Cities; Cross-Sectional Studies; Drug Combinations; Female; Gabon; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Malaria, Falciparum; Parasitemia; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Sulfadoxine; Urban Population; Young Adult | 2016 |
[Factors associated with the failure of Intermittent Preventive Treatment for malaria among pregnant women in Yaounde].
Topics: Adult; Antimalarials; Cameroon; Case-Control Studies; Drug Combinations; Female; Hospitalization; Humans; Logistic Models; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Young Adult | 2016 |
Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Health Facilities; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Multivariate Analysis; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Time Factors; Urban Health; Young Adult | 2016 |
Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotyping Techniques; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tanzania | 2016 |
Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Topics: Alleles; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen | 2016 |
Factors Influencing Anti-Malarial Prophylaxis and Iron Supplementation Non-Compliance among Pregnant Women in Simiyu Region, Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dietary Supplements; Drug Combinations; Female; Humans; Iron; Malaria; Middle Aged; Patient Compliance; Pregnancy; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2016 |
Assessing supply-side barriers to uptake of intermittent preventive treatment for malaria in pregnancy: a qualitative study and document and record review in two regions of Uganda.
Topics: Antimalarials; Drug Combinations; Female; Health Services Accessibility; Humans; Interviews as Topic; Malaria; Male; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Uganda | 2016 |
Plasmodium falciparum Drug-Resistant Haplotypes and Population Structure in Postearthquake Haiti, 2010.
Topics: Alleles; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Earthquakes; Genetics, Population; Haiti; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2016 |
Low prevalence of dihydro folate reductase (dhfr) and dihydropteroate synthase (dhps) quadruple and quintuple mutant alleles associated with SP resistance in Plasmodium vivax isolates of West Bengal, India.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Frequency; Humans; India; Malaria, Vivax; Male; Middle Aged; Mutant Proteins; Plasmodium vivax; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2016 |
Underreporting and Missed Opportunities for Uptake of Intermittent Preventative Treatment of Malaria in Pregnancy (IPTp) in Mali.
Topics: Adult; Antimalarials; Drug Combinations; Female; Focus Groups; Health Surveys; Humans; Interviews as Topic; Malaria; Mali; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Retrospective Studies; Sulfadoxine | 2016 |
The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Uganda; Young Adult | 2016 |
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Infant; Infant, Newborn; Kenya; Malaria; Malaria, Falciparum; Malawi; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Rwanda; Sulfadoxine; Tanzania; Uganda | 2016 |
Public health facility resource availability and provider adherence to first antenatal guidelines in a low resource setting in Accra, Ghana.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Guideline Adherence; Health Facilities; Health Resources; Hospitals; Humans; Magnesium Sulfate; Medically Underserved Area; Practice Guidelines as Topic; Pregnancy; Prenatal Care; Prospective Studies; Pyrimethamine; Sulfadoxine; Tocolytic Agents; Workload | 2016 |
Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in southern Mauritania.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mauritania; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Young Adult | 2016 |
Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
Topics: Adult; Alleles; Antimalarials; Biomarkers; Child; Chloroquine; Drug Combinations; Drug Resistance; Gene Dosage; Humans; Malaria, Falciparum; Malaysia; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2016 |
Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Equatorial Guinea; Female; Genetic Loci; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Immune Sera; Infant; Infant, Low Birth Weight; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult; Zambia | 2017 |
Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Care Costs; Humans; Infant, Newborn; Local Government; Malaria; Male; Middle Aged; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Young Adult | 2016 |
A Curious Case of "Septic Shock".
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Ceftriaxone; Drug Combinations; Female; Humans; Malaria, Vivax; Norepinephrine; Plasmodium vivax; Primaquine; Pyrimethamine; Shock, Septic; Sulfadoxine; Takayasu Arteritis; Vasoconstrictor Agents; Vasopressins | 2017 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Humans; Malaria, Falciparum; Mutant Proteins; Mutation, Missense; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Young Adult | 2016 |
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.
Topics: Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genetic Variation; Genome, Protozoan; Genotype; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Selection, Genetic; Sequence Analysis, DNA; Sulfadoxine | 2016 |
Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial?
Topics: Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2017 |
Antimalarial treatment patterns among pregnant women attending antenatal care clinics in south east Nigeria and the future implications.
Topics: Adult; Ambulatory Care Facilities; Antimalarials; Drug Combinations; Female; Humans; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine | 2016 |
Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Topics: Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Equatorial Guinea; Gene Frequency; Genotype; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Hemoglobins; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
Factors influencing utilization of intermittent preventive treatment for pregnancy in the Gushegu district, Ghana, 2013.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Directly Observed Therapy; Drug Combinations; Female; Ghana; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Unemployment; Young Adult | 2016 |
Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2017 |
In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2017 |
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Topics: Adolescent; Adult; Anorexia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Host-Parasite Interactions; Humans; Malaria; Male; Mefloquine; Nausea; Outcome Assessment, Health Care; Plasmodium falciparum; Plasmodium vivax; Psychotic Disorders; Pyrimethamine; Sulfadoxine; Thailand; Vomiting; Young Adult | 2017 |
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.
Topics: Adult; Antimalarials; Azithromycin; Drug Combinations; Female; Humans; Inactivation, Metabolic; Malaria; Pregnancy; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires | 2017 |
Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
Topics: Africa South of the Sahara; Antimalarials; Birth Weight; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria; Models, Theoretical; Pregnancy; Pyrimethamine; Sulfadoxine | 2017 |
Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
Topics: Adult; Anti-Infective Agents; Chemoprevention; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Pyrimethamine; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome; Young Adult; Zambia | 2017 |
Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Humans; Longitudinal Studies; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
IgG isotypic antibodies to crude Plasmodium falciparum blood-stage antigen associated with placental malaria infection in parturient Cameroonian women.
Topics: Adolescent; Adult; Age Factors; Antibodies, Protozoan; Antigens, Protozoan; Cameroon; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Immunoglobulin M; Malaria, Falciparum; Parity; Placenta; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2016 |
Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.
Topics: Adult; Antimalarials; Artemisinins; Child; Cities; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Expression; Genotype; Humans; India; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Retrospective Studies; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Assessment of coverage of preventive treatment and insecticide-treated mosquito nets in pregnant women attending antenatal care services in 11 districts in Mozambique in 2011: the critical role of supply chain.
Topics: Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans; Insecticide-Treated Bednets; Malaria; Mozambique; Pregnancy; Pyrimethamine; Retrospective Studies; Sulfadoxine | 2017 |
Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Female; Genes, Protozoan; Genotype; Genotyping Techniques; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2017 |
Seasonal malaria chemoprevention in the Sahel.
Topics: Africa; Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Female; Humans; Infant; Insecticide-Treated Bednets; Malaria; Male; Pharmacovigilance; Pyrimethamine; Seasons; Sulfadoxine | 2017 |
Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; High-Throughput Nucleotide Sequencing; Humans; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2017 |
Pooled-DNA sequencing identifies genomic regions of selection in Nigerian isolates of Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Gene Frequency; Genetic Variation; Haplotypes; Humans; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Selection, Genetic; Sequence Analysis, DNA; Sulfadoxine | 2017 |
Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Metabolic Clearance Rate; Models, Biological; Papua New Guinea; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2017 |
Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Health Policy; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Topics: Adolescent; Adult; Amino Acid Substitution; Antimalarials; Burkina Faso; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Parasomnias; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Community Health Workers; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Pyrimethamine; Seasons; Senegal; Sulfadoxine | 2017 |
Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
Topics: Africa South of the Sahara; Antimalarials; Coinfection; Cost-Benefit Analysis; Drug Combinations; Female; HIV Infections; Humans; Malaria; Models, Theoretical; Pregnancy; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2017 |
Seasonal malaria chemoprevention: successes and missed opportunities.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Seasons; Sulfadoxine | 2017 |
Antifolate drug resistance: Novel mutations and haplotype distribution in
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Contraindications, Drug; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Expression; Haplotypes; Humans; India; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Amino Acid Substitution; Antimalarials; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2018 |
High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.
Topics: Adolescent; Adult; Animals; Antimalarials; Asymptomatic Diseases; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Microscopy; Mutation, Missense; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2018 |
Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; Genotype; Humans; Malaria, Falciparum; Mutation; Mutation Rate; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
Topics: Africa; Age Factors; Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Body Weight; Chemoprevention; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Nutritional Status; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2018 |
Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Multidrug Resistance-Associated Proteins; Mutant Proteins; Niger; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Seasons; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Prevalence of Low Birth Weight before and after Policy Change to IPTp-SP in Two Selected Hospitals in Southern Nigeria: Eleven-Year Retrospective Analyses.
Topics: Adult; Drug Combinations; Female; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine | 2018 |
Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani Municipality, Ghana.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Health Knowledge, Attitudes, Practice; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
Topics: Antimalarials; Drug Combinations; Female; Health Facilities; Humans; Insecticide-Treated Bednets; Labor, Obstetric; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2018 |
Investigation of pregnancy-associated malaria by microscopy, rapid diagnostic test and PCR in Bandundu, the Democratic Republic of Congo.
Topics: Adolescent; Adult; Antimalarials; Democratic Republic of the Congo; Diagnostic Tests, Routine; Dose-Response Relationship, Drug; Drug Combinations; Female; Health Surveys; Humans; Malaria; Microscopy; Plasmodium; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Retrospective Studies; Rural Health; Sulfadoxine; Treatment Outcome; Young Adult | 2018 |
Molecular Markers of
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Genetic Markers; Ghana; Haplotypes; Humans; Infant, Newborn; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life.
Topics: Adult; Antimalarials; Burkina Faso; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mass Screening; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2018 |
Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans; Logistic Models; Malaria; Malawi; Middle Aged; Multivariate Analysis; Patient Acceptance of Health Care; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Population; Sulfadoxine; Urban Population; Young Adult | 2018 |
High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin.
Topics: Anemia; Benin; Cohort Studies; Dietary Supplements; Drug Combinations; Female; Folic Acid; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk; Sulfadoxine | 2018 |
Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans; Madagascar; Malaria, Falciparum; Middle Aged; Patient Acceptance of Health Care; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2018 |
Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bangladesh; Chloroquine; Drug Combinations; Drug Resistance; Erythrocytes; Gene Expression; Haplotypes; Humans; India; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Myanmar; Phylogeny; Phylogeography; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2018 |
RETROSPECTIVE INVESTIGATION OF PYRIMETHAMINE-SULFADOXINE RESISTANCE INDICATORS IN FALCIPARUM-MALARIA POSITIVE BLOOD SAMPLES FROM SOUTH-WESTERN SAUDI ARABIA.
Topics: Alleles; Codon; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pyrimethamine; Retrospective Studies; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana.
Topics: Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Ghana; GTP Cyclohydrolase; Humans; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Benin; Drug Combinations; Female; Humans; Malaria, Falciparum; Membrane Proteins; Plasmodium falciparum; Pregnancy; Protozoan Proteins; Pyrimethamine; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sulfadoxine; Young Adult | 2018 |
Intermittent Preventive Treatment (IPT): Its Role in Averting Disease-Induced Mortality in Children and in Promoting the Spread of Antimalarial Drug Resistance.
Topics: Antimalarials; Basic Reproduction Number; Child; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mathematical Concepts; Models, Biological; Mosquito Vectors; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2019 |
Molecular Evidence for
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Artemisinins; Artesunate; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Female; Gene Expression; Humans; India; Kelch Repeat; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Molecular Epidemiology; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
A decade since sulfonamide-based anti-malarial medicines were limited for intermittent preventive treatment of malaria among pregnant women in Tanzania.
Topics: Antimalarials; Clinical Competence; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Pharmacies; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Sulfalene; Sulfonamides; Tanzania | 2018 |
Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Humans; Malaria; Mefloquine; Pharmacokinetics; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |
First trimester medication use in pregnancy in Cameroon: a multi-hospital survey.
Topics: Adult; Analgesics; Anti-Bacterial Agents; Antimalarials; Cameroon; Drug Combinations; Drug Prescriptions; Female; Humans; Logistic Models; Multivariate Analysis; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires | 2018 |
Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
Topics: Africa; Antimalarials; Artemisinins; Doxycycline; Drug Combinations; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Quinolines; Sulfadoxine | 2018 |
Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Indonesia; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2018 |
Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.
Topics: Adult; Antimalarials; Communication; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Humans; Malaria; Mozambique; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Qualitative Research; Referral and Consultation; Rural Health Services; Rural Population; Sulfadoxine; Young Adult | 2019 |
Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Azithromycin; Burkina Faso; Child Mortality; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Infant; Infant Mortality; Malaria; Male; Mali; Mass Drug Administration; Parasitemia; Pyrimethamine; Sulfadoxine | 2019 |
Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas.
Topics: Alleles; Antimalarials; Brazil; DNA, Protozoan; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria, Vivax; Plasmodium vivax; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2019 |
Trends in comparative efficacy and safety of malaria control interventions for maternal and child health outcomes in Africa: a study protocol for a Bayesian network meta-regression exploring the effect of HIV and malaria endemicity spectrum.
Topics: Africa South of the Sahara; Antimalarials; Bayes Theorem; Child Health; Child, Preschool; Clinical Protocols; Drug Combinations; Drug Resistance; Endemic Diseases; Female; HIV Infections; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Mass Screening; Maternal Health; Meta-Analysis as Topic; Network Meta-Analysis; Pregnancy; Propensity Score; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Systematic Reviews as Topic | 2019 |
[Evaluation of the knowledge of intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine in Ivory Coast].
Topics: Adult; Antimalarials; Clinical Competence; Cote d'Ivoire; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Infectious Disease Transmission, Vertical; Malaria; Male; Medical Staff; Middle Aged; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Parasitic; Preventive Medicine; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |
Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
Topics: Artemisinins; Double-Blind Method; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pyrimethamine; Quinolines; Risk Assessment; Sulfadoxine | 2019 |
High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Equatorial Guinea; Gene Frequency; Genotype; Humans; Linkage Disequilibrium; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2019 |
The remarkable tenacity of sulfadoxine-pyrimethamine.
Topics: Africa; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2019 |
Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Drug Combinations; Female; Health Surveys; Humans; Logistic Models; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimesters; Prenatal Care; Pyrimethamine; Socioeconomic Factors; Sulfadoxine; Young Adult | 2019 |
[Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
Topics: Adult; Drug Combinations; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prenatal Diagnosis; Pyrimethamine; Seroconversion; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital; Tunisia; Young Adult | 2018 |
Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Drug Combinations; Economic Status; Educational Status; Female; Humans; Logistic Models; Malaria; Mali; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Sulfadoxine; Surveys and Questionnaires; Urban Population; Young Adult | 2019 |
What is the Link between Malaria Prevention in Pregnancy and Neonatal Survival in Nigeria?
Topics: Adolescent; Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Insecticide-Treated Bednets; Malaria; Middle Aged; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Prevalence; Proportional Hazards Models; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2019 |
An analysis of large structural variation in global Plasmodium falciparum isolates identifies a novel duplication of the chloroquine resistance associated gene.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Gene Deletion; Gene Duplication; Genome; Genome-Wide Association Study; Genotype; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2019 |
Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
Topics: Adolescent; Adult; Antimalarials; Child; Drug Administration Schedule; Drug Combinations; Educational Status; Female; Ghana; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Retrospective Studies; Sulfadoxine; Young Adult | 2019 |
Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Premature Birth; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Tanzania; Young Adult | 2019 |
Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Surveys; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnant Women; Prenatal Care; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2019 |
Using Short Message Service Alerts to Increase Antenatal Care and Malaria Prevention: Findings from Implementation Research Pilot in Guinea.
Topics: Antimalarials; Drug Combinations; Female; Guinea; Health Facilities; Humans; Malaria; Patient Acceptance of Health Care; Pilot Projects; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Text Messaging | 2019 |
Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
Topics: Antimalarials; Artemisinins; Diagnostic Tests, Routine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Lumefantrine; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Selection, Genetic; South Africa; Sulfadoxine | 2019 |
Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.
Topics: Adult; Antimalarials; Directly Observed Therapy; Drug Combinations; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Primary Health Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2019 |
"They Merely Prescribe and I Merely Swallow": Perceptions of Antenatal Pharmaceuticals and Nutritional Supplements Among Pregnant Women in Bamako, Mali.
Topics: Adult; Antimalarials; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Iron; Malaria; Mali; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pregnant Women; Prenatal Care; Prescriptions; Pyrimethamine; Qualitative Research; Quality of Health Care; Sulfadoxine | 2020 |
Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.
Topics: Amodiaquine; Antigens, CD; Antimalarials; Biomarkers; CD4-Positive T-Lymphocytes; Child, Preschool; Drug Combinations; Female; Forkhead Transcription Factors; Humans; Infant; Lymphocyte Activation Gene 3 Protein; Malaria, Falciparum; Male; Programmed Cell Death 1 Receptor; Pyrimethamine; Seasons; Sulfadoxine; T-Lymphocytes, Regulatory | 2020 |
The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Alcohol Dehydrogenase; Antimalarials; Chloroquine; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Gene Frequency; Humans; Longitudinal Studies; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Spatio-Temporal Analysis; Sulfadoxine; Young Adult | 2019 |
Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
Topics: Adolescent; Adult; Antimalarials; Cote d'Ivoire; Drug Combinations; Female; Humans; Infant, Newborn; Logistic Models; Malaria; Multivariate Analysis; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tetanus; Tetanus Toxoid; Young Adult | 2019 |
Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Humans; Logistic Models; Malaria; Medication Adherence; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |
Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Directly Observed Therapy; Drug Combinations; Educational Status; Female; Health Facilities; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Interviews as Topic; Male; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Pregnant Women; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania; Young Adult | 2019 |
Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa.
Topics: Adolescent; Adult; Africa, Central; Africa, Western; Antimalarials; China; Cohort Studies; Communicable Diseases, Imported; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
The efficacy of intermittent preventive therapy in the eradication of peripheral and placental parasitemia in a malaria-endemic environment, as seen in a tertiary hospital in Abuja, Nigeria.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Nigeria; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Tertiary Care Centers | 2020 |
High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana.
Topics: Adolescent; Adult; Birth Weight; Cohort Studies; Drug Combinations; Female; Ghana; Humans; Linear Models; Malaria; Middle Aged; Multivariate Analysis; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |
Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention.
Topics: Adolescent; Antimalarials; Biomarkers; Chemoprevention; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Plasmodium; Pyrimethamine; Sulfadoxine | 2019 |
Dare we dream of the end of malaria?
Topics: Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Insecticide-Treated Bednets; Malaria; Pregnancy; Pyrimethamine; Sulfadoxine; Treatment Refusal | 2020 |
Evaluation of the application of national malaria treatment guidelines in private pharmacies in a rural area in the Democratic Republic of Congo.
Topics: Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Case Management; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Female; Guideline Adherence; Humans; Malaria; Male; Middle Aged; Pharmaceutical Services; Pharmacies; Private Sector; Pyrimethamine; Rural Health; Sulfadoxine; Young Adult | 2019 |
Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Ghana; High-Throughput Nucleotide Sequencing; Humans; Infant; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2020 |
Health Workers' Awareness and Knowledge of Current Recommendation of Intermittent Preventive Treatment in Pregnancy in South-Western Nigeria.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Malaria; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires | 2020 |
Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
Topics: Adolescent; Adult; Antimalarials; Cameroon; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
Topics: Antimalarials; Cambodia; DNA, Protozoan; Dried Blood Spot Testing; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine; Thailand | 2020 |
[Sulfadoxine-pyrimethamine-based intermittent preventive treatment in pregnant women and its effect on birth weight: application of 3-dosing regimen in the urban area of South Benin in 2017].
Topics: Adult; Antimalarials; Benin; Birth Weight; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Male; Medication Adherence; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2019 |
Prevalence of Congenital Malaria in Kisangani, A Stable Malaria Transmission Area in Democratic Republic of the Congo.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Care Surveys; Health Policy; Humans; Malaria; Malawi; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; World Health Organization; Young Adult | 2020 |
Relationships Between Measures of Malaria at Delivery and Adverse Birth Outcomes in a High-Transmission Area of Uganda.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Malaria; Microscopy; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Parturition; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Premature Birth; Pyrimethamine; Randomized Controlled Trials as Topic; Stillbirth; Sulfadoxine; Uganda; Young Adult | 2020 |
Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
Topics: Adolescent; Adult; Antimalarials; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Malaria; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pyrimethamine; Socioeconomic Factors; Sulfadoxine; Uganda; Young Adult | 2020 |
Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Endemic Diseases; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2020 |
The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC.
Topics: Antimalarials; Chloroquine; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Genome, Protozoan; Genotype; Geography; Haplotypes; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Principal Component Analysis; Pyrimethamine; Sulfadoxine | 2020 |
Factors influencing the use of intermittent preventive treatment of pregnant women seeking care at primary healthcare facilities in the Bwari Area Council, Abuja, Nigeria.
Topics: Adult; Antimalarials; Clinical Competence; Drug Combinations; Female; Health Services Accessibility; Humans; Malaria; Nigeria; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Primary Health Care; Pyrimethamine; Sulfadoxine | 2020 |
Severe-malaria infection and its outcomes among pregnant women in Burkina Faso health-districts: Hierarchical Bayesian space-time models applied to routinely-collected data from 2013 to 2018.
Topics: Adult; Antimalarials; Bayes Theorem; Burkina Faso; Drug Combinations; Female; Humans; Incidence; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Severity of Illness Index; Spatial Analysis; Sulfadoxine; Treatment Outcome; Young Adult | 2020 |
Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Kenya; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2020 |
Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon.
Topics: Adolescent; Adult; Cameroon; Cross-Sectional Studies; Directly Observed Therapy; Drug Administration Schedule; Drug Combinations; Female; Health Facilities; Health Personnel; Humans; Malaria; Medication Adherence; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Preventive Health Services; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2020 |
Serotype Profile of Nasopharyngeal Isolates of
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Azithromycin; Burkina Faso; Carrier State; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Mass Drug Administration; Nasopharynx; Pneumococcal Infections; Pneumococcal Vaccines; Pyrimethamine; Seasons; Serogroup; Streptococcus pneumoniae; Sulfadoxine | 2020 |
Defining the combined benefit of intermittent preventive malaria treatment in pregnancy.
Topics: Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pyrimethamine; Sulfadoxine | 2020 |
High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Genotype; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2020 |
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
Topics: Afghanistan; Antimalarials; Drug Combinations; Drug Resistance; Genetic Markers; Plasmodium vivax; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2020 |
Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance, Microbial; Female; Haplotypes; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2020 |
Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa.
Topics: Antimalarials; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparum; Mass Screening; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania; World Health Organization | 2020 |
Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Care Surveys; Health Services Accessibility; Healthcare Disparities; Humans; Malaria; Middle Aged; Nigeria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Humans; India; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Antibodies to full-length and the DBL5 domain of VAR2CSA in pregnant women after long-term implementation of intermittent preventive treatment in Etoudi, Cameroon.
Topics: Adult; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Cameroon; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Managing intermittent preventive treatment of malaria in pregnancy challenges: an ethnographic study of two Ghanaian administrative regions.
Topics: Adolescent; Adult; Anthropology, Cultural; Antimalarials; Communicable Disease Control; Drug Combinations; Female; Ghana; Health Policy; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Establishing a National Molecular Surveillance Program for the Detection of
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Haiti; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sentinel Surveillance; Sulfadoxine; Young Adult | 2020 |
Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2020 |
Reaching the unreached: effectiveness and satisfaction with community-directed distribution of sulfadoxine-pyrimethamine for preventing malaria in pregnancy in rural South-East, Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; Humans; Malaria; Nigeria; Personal Satisfaction; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Sulfadoxine; Young Adult | 2020 |
Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
Topics: Adolescent; Adult; Artemether, Lumefantrine Drug Combination; Burkina Faso; Carrier State; Drug Combinations; Female; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2020 |
Topics: Antimalarials; Drug Combinations; Female; Humans; Kenya; Malaria, Falciparum; Mali; Nigeria; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2020 |
Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China.
Topics: Africa; Antimalarials; Asia, Southeastern; China; Communicable Diseases, Imported; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2020 |
Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2020 |
Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
Topics: Adolescent; Adult; Africa, Central; Africa, Western; Amodiaquine; Antimalarials; Case-Control Studies; Chemoprevention; Child; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Feasibility Studies; Humans; Incidence; Malaria; Program Evaluation; Pyrimethamine; Safety; Seasons; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2020 |
Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Topics: Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Carrier State; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2020 |
Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
Topics: Amodiaquine; Antibodies, Protozoan; Antibody Formation; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Niger; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?
Topics: Antimalarials; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine | 2021 |
Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Drug Combinations; Humans; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; RNA, Messenger; RNA, Protozoan; Sulfadoxine; Time Factors; Young Adult | 2021 |
Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
Topics: Antigens, Protozoan; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Population Surveillance; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2021 |
Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
Topics: Adult; Antimalarials; Cohort Studies; Drug Combinations; Female; Genetic Markers; Humans; Malaria, Falciparum; Mutation; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult; Zambia | 2021 |
The transmission-blocking effects of antimalarial drugs revisited: fitness costs and sporontocidal effects of artesunate and sulfadoxine-pyrimethamine.
Topics: Animals; Anopheles; Antimalarials; Artesunate; Drug Combinations; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2021 |
Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Young Adult | 2021 |
Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin.
Topics: Alleles; Antimalarials; Benin; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2021 |
Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicat
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Health Facilities; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2021 |
Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Communicable Disease Control; Cost-Benefit Analysis; Drug Combinations; Humans; Infant; Malaria; Mali; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genetic Variation; Genotype; Ghana; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine; Young Adult | 2021 |
Effectiveness of intermittent preventive treatment with Sulfadoxine-Pyrimethamine in pregnant women in San Pedro, Côte D'Ivoire.
Topics: Adult; Antimalarials; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Female; Humans; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Sulfadoxine; Young Adult | 2021 |
Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Educational Status; Female; Ghana; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Odds Ratio; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Sample Size; Sulfadoxine | 2021 |
Malaria intermittent preventive treatment in Nigeria: a qualitative study to explore barriers.
Topics: Adolescent; Adult; Antimalarials; Delivery of Health Care; Drug Combinations; Female; Focus Groups; Humans; Malaria; Male; Nigeria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Qualitative Research; Sulfadoxine; Young Adult | 2021 |
Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey.
Topics: Adolescent; Adult; Antimalarials; Communicable Disease Control; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria; Mali; Middle Aged; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2021 |
Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Healthcare Disparities; Humans; Malaria; Middle Aged; Nigeria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Socioeconomic Factors; Sulfadoxine; Young Adult | 2021 |
Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Antimalarials; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Female; Hospitals; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Young Adult | 2021 |
In vivo antimalarial activity of a probiotic bacterium Lactobacillus sakei isolated from traditionally fermented milk in BALB/c mice infected with Plasmodium berghei ANKA.
Topics: Animals; Antimalarials; Cameroon; Chloroquine; Disease Models, Animal; Drug Combinations; Fermented Foods; Latilactobacillus sakei; Malaria; Mice; Mice, Inbred BALB C; Milk; Parasitemia; Plasmodium berghei; Probiotics; Pyrimethamine; Sulfadoxine | 2021 |
Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana.
Topics: Antimalarials; Drug Combinations; Female; Ghana; Humans; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2021 |
Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2021 |
Knowledge of malaria control and attitudes towards community involvement among female community volunteers: effect of capacity building in a rural community, Southeast Nigeria.
Topics: Adult; Antimalarials; Capacity Building; Child, Preschool; Community Health Workers; Community Participation; Controlled Before-After Studies; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria; Nigeria; Pregnancy; Pyrimethamine; Rural Population; Sulfadoxine; Volunteers; Young Adult | 2021 |
High Frequency Mutations in
Topics: Africa; Antimalarials; China; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2021 |
An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Topics: Adult; Anthropology, Cultural; Antimalarials; Community Health Planning; Drug Combinations; Female; Ghana; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Pregnant Women; Prenatal Care; Preventive Health Services; Pyrimethamine; Sulfadoxine; Young Adult | 2021 |
The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study.
Topics: Antimalarials; Drug Combinations; Feasibility Studies; Female; Humans; Knowledge; Malaria; Mali; Pilot Projects; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires | 2021 |
Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013-2018).
Topics: Amodiaquine; Antimalarials; Chad; Chemoprevention; Child, Preschool; Disability-Adjusted Life Years; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Effect of adverse events on non-adherence and study non-completion in malaria chemoprevention during pregnancy trial: A nested case control study.
Topics: Antimalarials; Case-Control Studies; Chemoprevention; Chloroquine; Data Analysis; Drug Combinations; Female; Humans; Incidence; Malaria; Medication Adherence; Models, Theoretical; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2022 |
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
Topics: Adolescent; Adult; Amodiaquine; Antigens, Protozoan; Antimalarials; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Factors; Rural Population; Seasons; Sulfadoxine; Treatment Outcome; Young Adult | 2022 |
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
Predicting the effect of sulfadoxine-pyrimethamine uptake by pregnant women on birth weight using a generalized ordered partial proportional odds model.
Topics: Adult; Antimalarials; Birth Weight; Demography; Drug Combinations; Female; Fetal Macrosomia; Ghana; Humans; Infant, Low Birth Weight; Malaria; Models, Statistical; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2022 |
Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
Topics: Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Infant, Newborn; Malaria, Falciparum; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine | 2022 |
Risk factors for placental malaria, sulfadoxine-pyrimethamine doses, and birth outcomes in a rural to urban prospective cohort study on the Bandiagara Escarpment and Bamako, Mali.
Topics: Cohort Studies; Drug Combinations; Female; Gravidity; Humans; Malaria; Mali; Placenta; Pregnancy; Prospective Studies; Pyrimethamine; Risk Factors; Sulfadoxine | 2022 |
Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 2022 |
Intermittent Preventive Treatment of Malaria in Pregnancy with Sulphadoxine-Pyrimethamine and its Associated Factors in the Atwima Kwanwoma District, Ghana.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2022 |
Impact of antimalarial resistance and COVID-19 pandemic on malaria care among pregnant women in Northern Uganda (ERASE): protocol of a prospective observational study.
Topics: Antimalarials; Artemisinins; COVID-19; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Observational Studies as Topic; Pandemics; Pregnancy; Pregnant Women; Prospective Studies; Pyrimethamine; Retrospective Studies; Sulfadoxine; Uganda | 2022 |
The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Drug Resistance; Female; Forests; Ghana; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2022 |
Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990-2020.
Topics: Antimalarials; Bayes Theorem; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pyrimethamine; South Africa; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2022 |
Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudi
Topics: Antimalarials; Birth Weight; Cameroon; Drug Combinations; Female; Humans; Infant, Newborn; Insecticides; Longitudinal Studies; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Outcome; Pregnant Women; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey.
Topics: Antimalarials; Bayes Theorem; Drug Combinations; Female; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Uganda | 2022 |
Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Codon; Colombia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine | 2022 |
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Drug Combinations; Drug Resistance; Genomics; Haplotypes; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation.
Topics: Antimalarials; Cameroon; Chemoprevention; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnant Women; Pyrimethamine; Sulfadoxine | 2023 |
Comparative efficacy of sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine against malaria infection during late-stage pregnancy in mice.
Topics: Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Malaria; Malaria, Falciparum; Mice; Plasmodium berghei; Pregnancy; Pyrimethamine | 2023 |
Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.
Topics: Angola; Antimalarials; Child; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Investigation of Four Cases of Stevens-Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020.
Topics: Antimalarials; COVID-19; Drug Combinations; Haiti; Humans; Malaria; Mass Drug Administration; Pandemics; Primaquine; Pyrimethamine; SARS-CoV-2; Stevens-Johnson Syndrome; Sulfadoxine | 2023 |
Peripheral and Placental Prevalence of Sulfadoxine-Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda.
Topics: Antimalarials; Birth Weight; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Placenta; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Rwanda; Sulfadoxine | 2023 |
Fixed prevalence of sulfadoxine-pyrimethamine resistance markers after 3 years of drug pressure.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2023 |
Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
Topics: Antimalarials; Biomarkers; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mozambique; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine | 2023 |